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Abstract	  
Accumulating	   evidence	   suggest	   that	   pluripotency	   –	   the	   ability	   to	   generate	   all	   somatic	   cell	  
types	  –	  is	  not	  a	  fixed	  state.	  Pluripotent	  cell	  populations	  encompass	  a	  heterogeneous	  group	  
of	   cells	   with	   different	   phenotypic	   and	   functional	   properties	   in	   equilibrium.	   At	   least	   two	  
phases	   of	   pluripotency,	   immature	   and	   primed	   for	   differentiation,	   have	   been	   identified	  
during	   early	   mouse	   development,	   and	   these	   are	   typified	   by	   the	   two	   distinct	   stem	   cell	  
populations	   –	  mouse	   embryonic	   (mES)	   and	   epiblast-­‐derived	   (mEpiS)	   stem	   cells	   –	   isolated	  
from	   epiblast	   layers	   of	   pre-­‐	   and	   post-­‐implantation	   embryo,	   respectively.	   Many	   lines	   of	  
human	   ES	   (hES)	   cells	   have	   also	   been	   established	   in	   vitro	   from	   the	   inner	   cell	  mass	   of	   pre-­‐
implantation	   blastocysts	   yet	   the	   precise	   in	   vivo	   lineage	   affiliation	   of	   these	   cells	   remains	  
largely	  unresolved.	  Profiling	  chromatin	   in	  a	  particular	  cell	   line	  has	  proven	   to	  be	  a	  valuable	  
signature	   for	   cell	   identity	   and	   developmental	   stage.	   One	   approach	   has	   been	   to	   assay	   the	  
timing	   of	   DNA	   replication	   during	   S-­‐phase	   of	   the	   cell	   cycle	   across	   a	   panel	   of	   loci,	   as	   an	  
indicator	  of	  chromatin	  accessibility.	  This	  replication	  timing	  profiling	  was	  notably	  capable	  of	  
discriminating	   pluripotent	   mES	   cells	   from	   cells	   with	   a	   more	   restricted	   differentiation	  
capacity.	  
This	   study	   sought	   to	   address	   whether	   distinct	   pluripotent	   states	   could	   be	   reliably	  
discriminated	   at	   the	   chromatin	   level.	   In	   particular,	   the	   replication	   timing	   profiles	   of	   a	  
number	  of	  hES	  cell	   lines	  were	  characterised	  and	  compared	  to	  those	  of	  mES	  and	  mEpiS	  cell	  
lines	  derived	  from	  different	  genetic	  backgrounds.	  Profiles	  of	  undifferentiated	  H1,	  H7	  and	  H9	  
hES	   cell	   lines	   typically	   harboured	   an	   increased	   proportion	   of	   late-­‐replicating	   loci	   during	   S-­‐
phase	   when	   compared	   to	  mES	   cells,	   which	   were	   confirmed	   to	   have	   a	   steady	   and	  mostly	  
early-­‐replicating	   profile	   regardless	   of	   their	   genetic	   background.	   Moreover,	   hES	   cell	  
replication	  profile	  greatly	  varied	  between	  cultures	  and	  cell	  lines;	  a	  level	  of	  replication	  timing	  
variability	  also	  observed	  among	  mEpiS	  cells,	  as	  opposed	  to	  mES	  cells.	  These	  results	  highlight	  
that	   hES	   and	   mEpiS	   cells	   most	   likely	   share	   a	   common	   unstable	   epigenetic	   state	   or	  
transitional	  state	  primed	  on	  the	  verge	  of	  differentiation.	  
The	  epigenetic	  state	  of	  hES	  cell	  lines	  was	  further	  interrogated	  by	  analysing	  cells	  grown	  under	  
two	  different	  culture	  conditions,	  both	  however	  similarly	  relying	  on	  TGF-­‐β/Activin	  signalling.	  
Results	  demonstrated	  that	  hES	  cells	  could	  adopt	  distinct	  yet	  reversible	  epigenetic	  signatures	  
while	  retaining	  their	  pluripotency.	   In	  particular,	  extensive	  and	  dynamic	  shifts	  of	  replication	  
timing,	  from	  late-­‐to-­‐early,	  were	  consistently	  observed	  at	  many	  target	  loci	  in	  hES	  cells	  as	  well	  




P300/CBP	  histone	  acetyltransferase	  (HAT)	  activity.	  This	  was	  accompanied	  by	  fluctuations	  in	  
the	   expression	   of	   NANOG	   and	   REX1	   (also	   known	   as	   ZFP42),	   and	   a	   change	   in	   hES	   cell’s	  
functional	  properties,	  as	   judged	  by	   their	   responsiveness	   to	  differentiation-­‐inducing	  signals.	  
Interestingly,	   inhibiting	   P300/CBP	   HAT	   activity	   by	   curcumin	   treatment	   in	   undifferentiated	  
hES	  cells	  was	  sufficient	  to	  revert	  back	  to	  a	  late-­‐replicating	  profile	  associated	  with	  a	  histone	  
hypoacetylated	  state.	  Stable	  knockdown	  of	  P300	  in	  hES	  cell	  cultures,	  however,	  resulted	  in	  a	  
gradual	   loss	   of	   the	   pluripotent	   identity	   through	   differentiation	   or	   apoptosis,	   preventing	  
further	  analysis	  of	  effects	  on	  replication	  timing.	  Collectively,	  these	  data	  strongly	  support	  the	  
view	  that	  different	  but	  interchangeable	  pluripotent	  states	  exist	  within	  hES	  cell	  cultures	  and	  
suggest	   a	   role	   for	   P300/CBP	   HAT	   activity	   in	   determining	   distinct	   epigenetic	   states	   in	   hES	  
cells.	  
As	  mentioned	  above,	  REX1	  was	  also	   significantly	  upregulated	   in	  H1	  hES	   cells	  upon	  culture	  
condition	   change.	  REX1	   is	   a	   developmental	   stage-­‐specific	  marker	   that	   is	   expressed	   in	   the	  
ICM	  of	  both	  mouse	  and	  human	  embryos,	   as	  well	   as	   in	  pluripotent	  mES,	  hES	  and	   iPS	   cells.	  
However,	   its	   function	   in	   hES	   cells	   remains	   largely	   unclear.	   Human	   ES	   cells	   overexpressing	  
REX1	  were	  here	  generated	  to	  investigate	  the	  role	  of	  REX1	   in	  regulating	  hES	  cell	  pluripotent	  
identity.	  These	  cells	  expressed	  similar	   levels	  of	  key	  pluripotency	  markers	  than	  their	  normal	  
counterparts	  and	  remained	  capable	  of	  self-­‐renewing	  and	  differentiating	  into	  the	  three	  germ	  
layers	   in	   vitro.	   Interestingly,	   however,	   upon	   withdrawal	   of	   exogenous	   Activin	   A,	   REX1	  
overexpressing	  hES	   cells	   in	   contrast	   to	   control	   cells	   retained	  a	   comparatively	   high	   level	   of	  
OCT4	  and	  stained	  positive	  for	  alkaline	  phosphatase,	  a	  known	  marker	  of	  undifferentiated	  hES	  
cells.	   Taken	   together,	   these	   results	   point	   to	   a	  possible	   role	   for	  REX1	   in	   sustaining	  hES	   cell	  
self-­‐renewal	  ability.	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Chapter	  1 Introduction	  
During	   mammalian	   development	   a	   single	   zygote,	   formed	   by	   the	   fusion	   of	   two	   totally	  
differentiated	  cells,	  the	  sperm	  and	  the	  egg,	  gives	  rise	  to	  more	  than	  200	  different	  somatic	  cell	  
types	   of	   the	   mammalian	   body.	   The	   developmental	   process	   is	   unidirectional	   where	   cells	  
progressively	   lose	   developmental	   potential	   and	   acquire	   specialised	   functions	   pertinent	   to	  
their	   lineage	   (Hochedlinger	   et	   al.	   2009).	   Even	   though	   development	   has	   been	   studied	  
intensely	   for	   decades,	   if	   not	   even	   centuries,	   deciphering	   the	   details	   of	   how	   genetically	  
identical	  cells	  diverge	  into	  cells	  with	  different	  identities	  during	  development	  remains	  one	  of	  
the	  most	  interesting	  and	  important	  questions	  in	  biology	  (Fisher	  et	  al.	  2012).	  
Experiments	   by	   John	   Gurdon	   in	   1962	   demonstrated	   that	   a	   nucleus	   of	   differentiated	   gut	  
epithelial	   cell	   from	   Xenopus	   laevis	   tadpole	   could	   give	   rise	   to	   a	   fully	   developed	   adult	   frog	  
when	  inserted	  into	  an	  enucleated	  oocyte	  (Gurdon	  1962).	  These	  results	  undisputedly	  proved	  
that	   somatic	   cells	   retain	   all	   the	   genetic	   information	   necessary	   to	   direct	   development.	   In	  
accordance,	  cloning	  of	  Dolly	  the	  sheep	  (first	  mammal	  ever	  cloned)	  (Wilmut	  et	  al.	  1997)	  and	  
subsequently	  of	   laboratory	  mice	   from	  terminally	  differentiated	   lymphocytes	   (Hochedlinger	  
et	   al.	   2002),	   demonstrated	   the	   principle	   of	   nuclear	   equivalence;	   that	   specialised	   cells	   of	  
metazoans	  possess	  a	  gene	  pool	  identical	  to	  that	  of	  the	  zygote	  nucleus.	  
The	  landmark	  work	  describing	  the	  completed	  human	  genome	  sequence	  (Lander	  et	  al.	  2001;	  
McPherson	   et	   al.	   2001)	   has	   led	   to	   current	   sequencing	   technologies,	   which	   allow	   the	  
sequencing	  of	  whole-­‐genomes	   from	   relatively	   small	   samples	  of	   cells.	  However,	   having	   the	  
genome	   sequence	   alone	   does	   not	   allow	   deciphering	  what	  makes,	   for	   example,	   a	   skin	   cell	  
different	   from	   a	   nerve	   cell	   or	   a	   blood	   cell.	   It	   is	   now	   known	   that	   superimposed	   upon	   the	  
deoxyribose	  nucleic	  acid	   (DNA)	  sequence	  exist	   layers	  of	  heritable	   information,	  which	  allow	  
for	   the	   selective	  expression	  of	  only	  a	   fraction	  of	   the	  genes	  encoded	   in	   the	  genome	   in	  any	  
given	  cell	  type.	  This	  carefully	  regulated	  control	  via	  epigenetic	  mechanisms	  imposes	  heritable	  
cellular	  memories	  that	  define	  both	  specific	  cell	   lineages	  and	  cell	  types	  during	  development	  
(Hemberger	  et	  al.	  2009).	  Different	   levels	  of	  epigenetic	  regulation	  include	  changes	  in	  higher	  
order	  chromatin	  structure,	  methylation	  of	  the	  DNA	  cytosine	  residues,	  histone	  modifications,	  
DNA	   replication	   timing,	   regulation	  by	   small	   interfering	  RNAs	  and	   the	   spatial	  positioning	  of	  
the	   genomic	   region	   within	   the	   nucleus,	   moreover,	   all	   these	   different	   levels	   of	   epigenetic	  
regulation	  are	  subject	  to	  cross-­‐talk.	  Hence,	  normal	  development	  requires	  careful	  control	  of	  
both	   genetic	   and	   epigenetic	   programs	   in	   all	   cells.	   This	   is	   to	   induce	   appropriate	  
transcriptional	   and	   epigenetic	   outcomes	   and	   to	   repress	   inappropriate	   developmental	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programs	   in	   response	   to	   signalling	   cues	  within	   the	   developing	   embryo,	   resulting	   in	   a	   fully	  
developed	  organism.	  
1.1 Levels	  of	  epigenetic	  gene	  regulation	  
The	  term	  ‘epigenetic’	  was	  originally	  coined	  by	  C.	  Waddington	  in	  1942.	  His	  original	  definition	  
for	   the	   term	  was:	   the	  causal	  mechanisms	  by	  which	   the	  genes	  of	  a	  genotype	  bring	  about	  a	  
phenotype	  (Waddington	  1942).	  The	  modern	  usage	  of	  the	  term	  refers	  to	  heritable	  traits	  (over	  
rounds	  of	  cell	  division	  and	  in	  some	  cases	  over	  generations)	  that	  occur	  without	  any	  changes	  
to	  the	  underlying	  DNA	  sequence	  (Probst	  et	  al.	  2009).	  Epigenetic	  information	  provides	  a	  form	  
of	  memory	   that	   allows	   the	  maintenance	  of	   specific	   gene	  expression	  patterns	   in	   any	   given	  
cell	   type.	   During	   development	   differentiating	   cells	   acquire	   epigenetic	   landscapes	   distinct	  
from	  those	  of	  pluripotent	  cells,	  as	  well	  as	  from	  those	  established	  in	  cells	  differentiating	  into	  
alternative	   lineage	   paths	   (Reik	   2007).	   Disruption	   of	   the	   epigenetic	   regulation	   during	  
development,	   or	   normal	   cell	   division	   can	   lead	   to	   disease	   (Probst	   et	   al.	   2009).	   The	  
mechanisms	   that	   regulate	   this	   epigenetic	   information	   are	   now	   being	   revealed,	   and	   these	  
include	  DNA	  methylation,	  modification	   of	   histones	   and	   chromatin	   structure,	   regulation	   by	  
non-­‐coding	   ribonucleic	   acids	   (RNAs)	   and	   higher	   order	   genome	   organisation	   [Figure	   (Fig.)	  
1.1].	   It	   is	   thought	   that	   DNA	   methyltransferases,	   histone-­‐modifying	   enzymes,	   chromatin-­‐
binding	  proteins,	  non-­‐coding	  RNAs	  and	  many	  other	  regulators	  act	  together	  with	  sequence-­‐
specific	   transcriptional	   factors	   to	   establish	   and	   convey	   gene	   expression	   patterns	   during	  
development,	  ensuring	  the	  stability	  of	  the	  ‘committed’	  state.	  
1.1.1 DNA	  methylation	  
DNA	   methylation	   is	   found	   in	   the	   genomes	   of	   organisms	   ranging	   from	   prokaryotes	   to	  
eukaryotes.	  In	  prokaryotes	  methylation	  occurs	  at	  both	  cytosine	  and	  adenine	  bases,	  whereas	  
in	   eukaryotes	   methylation	   seems	   to	   occur	   only	   at	   cytosine	   bases.	   Specifically	   the	  
methylation	   takes	   place	   at	   the	   positive	   five	   of	   the	   cytosine	   ring	   of	   cytosine-­‐guanine	  
dinucleotides	   (CpG)	   [5-­‐methylcytosine	   (5mC)]	   (Klose	  et	  al.	  2006).	  The	  enzymes	   responsible	  
for	   catalysing	   the	   methylation	   reaction	   in	   mammals	   are	   three	   essential	   DNA	   (cytosine-­‐5)	  
methyltransferases	  (Dnmt1,	  Dnmt3a	  and	  Dnmt3b)	  (Goll	  et	  al.	  2005).	  Mice	  lacking	  Dnmt1	  or	  
Dnmt3b	  die	  by	  embryonic	  day	  10.5	  (Li	  et	  al.	  1992;	  Okano	  et	  al.	  1999).	  Those	  lacking	  Dnmt3a	  
sometimes	  survive,	  but	  suffer	  serious	  malformation	  especially	  at	  germ	  cells	  and	  die	  within	  
weeks	  of	  their	  birth	  (Okano	  et	  al.	  1999).	  Two	  other	  related	  molecules	  also	  exist.	  Dnmt2,	   is	  
highly	   conserved	   across	   species	   and	   highly	   expressed	   in	  many	   cell	   types,	   however	   it	   only	  





Figure	  1.1	  Epigenetic	  levels	  of	  gene	  regulation.	  	  
Schematic	  representation	  of	  different	   levels	  of	  genome	  organisation	  that	  have	  an	   impact	  on	  gene	  activity.	   (a)	  
The	   DNA	   double	   helix	   carries	   the	   genetic	   information	   necessary	   for	   the	   development	   and	   function	   of	   an	  
organism.	  Beyond	  the	  sequence,	  the	  most	  direct	  mechanism	  of	  epigenetic	  regulation	  is	  DNA	  methylation	  at	  the	  
Cytosine	   (C)	   residue	  dinucleotide	  CpG	  (see	  section	  1.1.1).	   (b)	  DNA	   is	  wrapped	  around	  nucleosomes,	  made	  up	  
from	  different	  histones,	  in	  a	  ‘beads	  on	  a	  string’	  structure	  which	  folds	  to	  form	  higher	  order	  chromatin	  domains	  
(see	   section	  1.1.2).	   Specific	  amino	  acid	   residues	  within	   the	  histone	   tails	  are	   targets	   for	  a	  number	  of	   covalent	  
post-­‐translational	  modifications,	  including	  for	  example	  acetylation	  (triangle)	  and	  methylation	  (circle)	  as	  well	  as	  
phosphorylation	  and	  ubiquitination	  (see	  section	  1.1.3).	  (c)	  Higher	  order	  chromatin	  is	  compartmentalised	  within	  
the	  nucleus	  into	  specific	  chromatin	  domains	  and	  organised	  into	  functional	  nuclear	  compartments.	  These	  three-­‐
dimensional	  domains	  as	  well	  as	  temporal	  constraints	  (DNA	  replication	  timing)	  add	  to	  the	  levels	  of	  regulation	  of	  
the	  genome	  (see	  sections	  1.1.4	  and	  1.1.5).	  Taken	  together	  all	  the	  above	  mechanisms	  provide	  epigenetic	  cues	  to	  
regulate	  the	  expression	  of	  genes	  in	  any	  given	  cell	  type	  and	  elucidate	  how	  a	  single	  genome	  can	  give	  rise	  to	  such	  
a	  wide	  variety	  of	  different	   cell	   types	  Figure	  adapted	   from	   (Sparmann	  et	  al.	  2006;	  Probst	  et	  al.	  2009;	  Gaspar-­‐
Maia	  et	  al.	  2011).	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upon	  disruption	  (Okano	  et	  al.	  1998;	  Hermann	  et	  al.	  2003;	  Goll	  et	  al.	  2005;	  Klose	  et	  al.	  2006)	  
and	  hence	   its	   role	   remains	   unclear.	  Dnmt3L	   is	   a	  Dnmt-­‐related	  protein	   that	   does	   not	   have	  
intrinsic	  DNA	  methyltransferase	  activity,	  however	   it	  physically	  associates	  with	  Dnmt3a	  and	  
Dnmt3b	  to	  modulate	  their	  activity	  (Suetake	  et	  al.	  2004).	  
CpG	   methylation,	   especially	   at	   the	   promoter	   regions	   of	   genes,	   is	   associated	   with	   stable	  
transcriptional	   repression.	   In	   addition	   to	   this	   DNA	   methylation	   has	   important	   roles	   in	   X-­‐
chromosome	  inactivation,	  genomic	   imprinting	  and	  development	  as	  well	  as	  development	  of	  
cancer	   and	   other	   diseases	   (Bird	   2002;	   Reik	   2007;	   Cedar	   et	   al.	   2012).	   During	   mitotic	   cell	  
division	  methylation	  patterns	  are	  maintained	  through	  methyltransferase	  activity	  by	  Dnmt1	  
(Li	   et	   al.	   1992),	   which	   happens	   in	   concert	   with	   DNA	   replication	   as	   Dnmt1	   is	   perpetually	  
located	  at	  replication	  foci	  (Leonhardt	  et	  al.	  1992).	  Dnmt1	  is	  known	  to	  have	  a	  high	  substrate	  
preference	   for	  hemi-­‐methylated	  DNA	  (Gruenbaum	  et	  al.	  1982;	  Chuang	  et	  al.	  1997).	  As	   the	  
DNA	  is	  replicated,	  synthesis	  of	  the	  new	  DNA	  generates	  hemi-­‐methylated	  strands,	  which	  have	  
symmetrically	   disposed	  methyl	   groups	   on	   CpG	   dinucleotides.	   These	   strands	   are	   identified	  
and	   methylated	   by	   Dnmt1,	   thus	   allowing	   the	   maintenance	   of	   the	   methylation	   state	  
(Gruenbaum	  et	  al.	   1982;	  Cedar	  et	   al.	   2012).	  Dnmt3a	  and	  Dnmt3b	  have	  been	   shown	   to	  be	  
mainly	   responsible	   for	  de	  novo	  methylation,	  and	  are	  essential	   for	  establishing	  methylation	  
patterns	  during	  development	  (Okano	  et	  al.	  1999).	  
During	  mouse	  development	  the	  overall	  methylation	  patterns	  change	  dramatically	  (Santos	  et	  
al.	  2002;	  Reik	  2007;	  Cedar	  et	  al.	  2012).	   In	  early	  embryo	  development	  parental	  methylation	  
patterns	  are	  lost,	  first	  actively	  from	  the	  paternal	  genome	  (Mayer	  et	  al.	  2000)	  and	  then	  likely	  
passively	   due	   to	   exclusion	   of	   Dnmt1	   to	   the	   cytoplasm	   (Carlson	   et	   al.	   1992;	   Howell	   et	   al.	  
2001).	  Imprinted	  genes,	  such	  as	  Igf2r,	  are	  protected	  from	  the	  global	  demethylation	  in	  early	  
embryo	  development	  and	  retain	  their	  methylation	  status	  in	  the	  adult	  organism,	  apart	  from	  
the	  germ	  cells	  (Birger	  et	  al.	  1999;	  Cedar	  et	  al.	  2012).	  At	  about	  the	  time	  of	  implantation	  the	  
whole	  genome	  undergoes	  dramatic	  de	  novo	  methylation	  likely	  mediated	  by	  Dnmt3a	  and	  -­‐3b,	  
this	  however	  does	  not	  occur	  at	  CpG-­‐islands	  in	  the	  promoters	  (Okano	  et	  al.	  1999;	  Cedar	  et	  al.	  
2012).	   Post-­‐implantation	   additional	   changes	   in	   methylation	   occur	   tissue	   and	   gene	  
specifically	  at	  the	  promoter	  CpG-­‐islands	  (Cedar	  et	  al.	  2012).	  A	  well-­‐characterised	  example	  of	  
a	  locus	  that	  is	  regulated	  by	  DNA	  methylation	  is	  the	  embryonic	  stem	  (ES)	  cell-­‐specific	  factor	  
Oct4,	  which	   is	  also	  expressed	   in	  the	  early	  embryo,	  and	  undergoes	  stable	  repression	  during	  
cell	  differentiation	  (Feldman	  et	  al.	  2006;	  Yeo	  et	  al.	  2007).	  
There	   are	   two	   general	   mechanisms	   by	   which	   DNA	   methylation	   acts	   to	   induce	   gene	  




DNA	  binding	  factors	  with	  their	  cognate	  DNA	  recognition	  sequences	  (Watt	  et	  al.	  1988);	  and	  
secondly,	  methyl-­‐CpGs	   can	   be	   bound	   by	   proteins	   of	   a	   family	   that	   share	   the	  methyl	   CpG-­‐
binding	  domain,	  which	  can,	  in	  turn,	  act	  to	  repress	  transcription	  themselves	  and	  recruit	  other	  
repressive	  proteins	  (Boyes	  et	  al.	  1991;	  Hendrich	  et	  al.	  1998;	  Klose	  et	  al.	  2006).	  An	  example	  of	  
the	  former	  is	  how	  the	  CCCTC-­‐binding	  factor	  (CTCF)	   is	  unable	  to	  bind	  the	  imprinting	  control	  
region	   of	   the	   Igf2/H19	   when	   the	   CpGs	   are	   methylated	   (Holmgren	   et	   al.	   2001).	   Recent	  
genome-­‐wide	  studies	  have	  found	  high	  correlation	  with	  unmethylated	  DNA	  and	  accessibility	  
of	  the	  genome	  as	  assessed	  by	  DNaseI	  footprinting	  (Neph	  et	  al.	  2012).	  Repression	  by	  methyl	  
binding	  proteins	  has	  also	  been	  shown	  to	  involve	  histone	  deacetylases	  (HDACs)	  and	  histone	  
methyl	   transferases	   (Nan	   et	   al.	   1998;	   Klose	   et	   al.	   2006).	   Changes	   in	   histone	   acetylation	  
and/or	  methylation	  at	  a	   specific	  chromatin	   region	  with	  DNA	  methylations	  may	  be	  brought	  
about	  via	  the	  recruitment	  of	  histone	  modifying	  proteins	  by	  methyl	  binding	  proteins.	  This	  link	  
between	   DNA	   methylation	   and	   chromatin	   conformation	   could	   provide	   a	   route	   for	  
maintenance	   of	   chromatin	   regions	   during	   mitosis	   (Hashimshony	   et	   al.	   2003;	   Cedar	   et	   al.	  
2012).	  Because	   the	  underlying	  DNA	  methylation	  pattern	   is	  autonomously	   copied	   following	  
replication,	   it	   is	   possible	   that	   this	   modification	   pattern	   may	   play	   a	   role	   through	   the	  
recruitment	  of	  histone	  modifying	  enzymes	  by	  methyl	  binding	  proteins,	   in	  the	  maintenance	  
of	  histone	  modification	  patterns.	  
It	   is	   thought	   that	   the	   global	   demethylation	   seen	   in	   early	   mouse	   embryo	   development	   is	  
likely	   occurring	   passively	   through	   the	   exclusion	   of	  Dnmt1	   from	   the	   nucleus	   (Carlson	   et	   al.	  
1992).	   Interestingly	   a	   recent	   study	   reported	   evidence	   that	   DNA	   methylation	   can	   be	  
dynamically	  regulated	  by	  active	  CpG	  demethylation.	  Cyclical	  methylation	  and	  demethylation	  
of	  CpG	  dinucleotides,	  with	  a	  periodicity	  of	  1-­‐2	  hours,	  was	  shown	  to	  be	  a	  characteristic	  of	  the	  
oestrogen	   (E2)-­‐responsive	   pS2	   gene,	   in	   human	   cells	   (Kangaspeska	   et	   al.	   2008).	   Despite	  
intensive	   research,	   the	   mechanism	   for	   active	   erasure	   of	   the	   methylation	   mark	   remains	  
unclear.	   Current	   evidence	   suggests	   that	   methyl	   groups	   attach	   through	   a	   carbon–carbon	  
bond	  to	  the	  cytosine	  base	  and	  therefore	  might	  not	  be	  able	  to	  be	  directly	  removed	  (Morgan	  
et	  al.	  2005;	  Cedar	  et	  al.	  2012).	  One	  possible	  path	  for	  active	  demethylation	   is	  via	  mismatch	  
repair.	   The	   DNA	   deaminases	   Aid	   and	   Apobec1	   have	   been	   shown	   in	   vitro	   to	   deaminate	   5-­‐
methylcytosine	  in	  DNA	  to	  thymine,	  which	  results	  in	  T-­‐G	  mismatches	  that	  can	  be	  repaired	  by	  
the	   base-­‐excision	   repair	   pathway	   (Morgan	   et	   al.	   2004).	   Aid	   and	   Apobec1	   are	   highly	  
expressed	  by	  oocytes,	  stem	  cells	  and	  germ	  cells	  (Morgan	  et	  al.	  2004)	  and	  interestingly	  recent	  
studies	  with	  reprogramming	  of	  somatic	  cells	  to	  iPS	  cells	  have	  shown	  that	  AID	  is	  required	  for	  
active	   demethylation	   of	   OCT4	   and	   NANOG	   loci	   during	   the	   process	   of	   reprogramming	  
	  
	   	   	  
23	  
(Bhutani	   et	   al.	   2010).	   The	   recent	   discoveries	   that	   mammalian	   cytosines	   can	   be	  
hydroxymethylated	   to	   5-­‐hydroxymethylcytosine	   (5hmC)	   by	   the	   ten-­‐eleven	   translocation	  
(TET)	   family	   (Kriaucionis	  et	   al.	   2009;	   Tahiliani	   et	   al.	   2009),	  demonstrate	  a	  new	  pathway	  of	  
active	  DNA	  demethylation	  and	  have	  generated	  substantial	  excitement	   in	  the	  field	   (Bhutani	  
et	  al.	  2011).	  The	  5mC	  to	  5hmC	  modification	  is	  not	  a	  functional	  equivalent	  of	  5mC	  to	  cytosine	  
modification,	   which	   is	   linked	   to	   gene	   derepression.	   In	   contrast,	   5hmC	  was	   shown	   in	  mES	  
cells	   to	   be	   enriched	   at	   so-­‐called	   bivalent	   loci,	   which	   carry	   both	   activating	   and	   repressive	  
histone	   modifications	   and	   are	   thought	   to	   be	   ‘poised’	   for	   future	   activation	   (Pastor	   et	   al.	  
2011).	   Furthermore,	   the	   activity	   of	   TET	   family	   proteins	   and	   the	   5hmC	   modification	   have	  
been	   linked	   to	   the	   expression	   of	   key	   regulators	   of	   pluripotent	   mES	   cells	   as	   well	   as	  
transcriptionally	   active	   and	   repressed	   loci	   in	   ES	   cells	   (Ficz	   et	   al.	   2011;	   Wu	   et	   al.	   2011),	  
highlighting	  complex	  and	  dynamic	  nature	  of	  DNA	  methylation.	  
1.1.2 Chromatin	  structure	  
Genomic	   DNA	   in	   the	   eukaryotic	   nucleus	   is	   complexed	   with	   core	   histones	   and	   other	  
chromosomal	  proteins	   to	   form	   the	   chromatin	   (Fig.	   1.1).	   The	   compaction	  of	   the	  genome	   is	  
necessary	   for	   the	   DNA	   to	   fit	   in	   a	   cell’s	   nucleus,	   because	   for	   example	   the	   human	   genome	  
would	   stretch	   to	   about	   two	   meters	   in	   length	   in	   a	   single	   double	   helix	   thread.	   The	  
fundamental	   repeating	   unit	   in	   the	   chromosome	   is	   the	   nucleosome,	  which	   consists	   of	   146	  
base	   pairs	   (bp)	   of	   DNA	   wrapped	   in	   1.7	   super	   helical	   turns	   around	   a	   histone	   octamer,	  
consisting	   of	   an	   H3-­‐H4	   tetramer	   and	   two	   H2A-­‐H2B	   dimers,	   forming	   a	   ‘beads-­‐on-­‐a-­‐string’	  
fibre	  with	  a	  diameter	  of	   11	  nm	   (Kornberg	  1977;	  Richmond	  et	   al.	   1984;	   Luger	  et	   al.	   1997).	  
While	   the	   length	   of	   DNA	   engaged	   in	   nucleosomes	   is	   always	   the	   same,	   the	   length	   of	   the	  
spacer	  between	  nucleosomes	  varies	  from	  several	  to	  about	  80	  bp,	  making	  the	  whole	  length	  
of	  DNA	  associated	  with	  each	  nucleosome	  complex	  throughout	  all	  eukaryotic	  genomes	  200	  ±	  
40	   bp	   (Kornberg	   1977;	  McGhee	   et	   al.	   1980).	   The	   binding	   of	   the	   linker	   histone	   (H1	   or	  H5)	  
(Bates	  et	  al.	  1981;	  An	  et	  al.	  1998)	  allows	  the	  formation	  of	  the	  condensed	  30	  nm	  chromatin	  
fibre	   (Robinson	   et	   al.	   2006);	   this	   can	   compact	   DNA	   up	   to	   30-­‐50	   fold	   (Luger	   et	   al.	   1997;	  
Felsenfeld	  et	  al.	  2003;	  Bell	  et	  al.	  2011)	  and	  can	  be	  considered	  as	  the	  second	  structural	  level	  
of	  DNA	  organization	  (Li	  et	  al.	  2011).	  Chromatin	  folding	  to	  higher	  level	  conformations	  remains	  
much	  less	  understood	  (Felsenfeld	  et	  al.	  2003;	  Li	  et	  al.	  2011).	  Histone	  H1	  has	  been	  shown	  to	  
be	  required	  for	  metaphase	  chromosome	  compaction	  (Maresca	  et	  al.	  2006),	  however	  other	  




The	  positioning	  of	  the	  nucleosome	  has	  been	  shown	  to	  be	  non-­‐random	  and	  has	  a	  functional	  
significance	   in	   several	   cellular	   processes	   including	   transcriptional	   regulation,	   chromosome	  
segregation,	   DNA	   replication	   and	   DNA	   repair	   (Henikoff	   2008;	   Schones	   et	   al.	   2008).	  Many	  
chromatin	   remodelling	   ATPase	   complexes,	   such	   as	   the	   SWI/SNF,	   ISWI,	   CDH	   and	   INO80	  
complexes,	  which	  can	  move,	  destabilise,	  eject,	  or	  restructure	  nucleosomes	  have	  been	  shown	  
to	  be	  involved	  in	  these	  processes	  (Clapier	  et	  al.	  2009).	  The	  properties	  of	  histones	  that	  make	  
up	   the	   nucleosome	   also	   have	   an	   effect	   on	   nucleosome	   dynamics.	   In	   addition	   to	   the	   four	  
canonical	  histones	  numerous	  histone	  variants	  have	  been	  identified,	  such	  as	  H2A.Z	  and	  H3.3.	  
H2A.Z	  has	  been	  shown	  to	  stabilize	  the	  histone	  octamer	  (Park	  et	  al.	  2004),	  interestingly	  H2A.Z	  
has	   also	   been	   shown	   to	   be	   enriched	   in	   a	   subset	   of	   genes	   and	   necessary	   for	   lineage	  
commitment	   in	   mES	   cells	   (Creyghton	   et	   al.	   2008).	   H3.3	   is	   constitutively	   expressed	   and	  
deposited	   into	   chromatin	   throughout	   the	   cell	   cycle,	   unlike	   the	   canonical	   H3,	   which	   is	  
integrated	  to	  chromatin	  during	  DNA	  replication	  (Ahmad	  et	  al.	  2002a;	  Ahmad	  et	  al.	  2002b).	  
Interestingly	   nucleosomes	   containing	   H3.3	   have	   been	   shown	   to	   be	   highly	   unstable	  
regardless	   of	   whether	   they	   are	   partnered	   with	   H2A	   or	   H2A.Z,	   this	   could	   be	   linked	   with	  
maintenance	   of	   accessible	   chromatin	   structures	   as	   H3.3	   is	   present	   at	   promoters	   and	  
enhancers	  of	  actively	  transcribed	  genes	  (Jin	  et	  al.	  2007).	  
In	   eukaryotes	   the	   genome	   is	   packaged	   into	   the	   chromatin	   template.	   This	   packaging	  
inherently	   restricts	   accessibility	  of	   the	  DNA	   for	   regulatory	  proteins	   (Bell	   et	   al.	   2011).	   Early	  
studies	   using	   staining	   and	   light	   microscopy	   in	   1928	   by	   Emil	   Heitz	   defined	   two	   types	   of	  
interphase	   chromatin;	   less	   condensed	   euchromatin	   and	   the	   more	   condensed	  
heterochromatin	  (Dillon	  et	  al.	  2002).	  Euchromatin	  is	  lightly	  packed	  and	  therefore	  accessible	  
for	  transcription	  factors	  (TFs)	  and	  RNA	  polymerases,	  and	  is	  enriched	  in	  active	  genes	  and	  loci	  
replicating	  early	  in	  the	  S-­‐phase	  (Gilbert	  et	  al.	  2004;	  Holmquist	  et	  al.	  2006;	  Shahbazian	  et	  al.	  
2007).	  Genome-­‐wide	  analysis	  of	  DNA	  binding	  by	  119	  different	  TFs	   in	  72	  different	  cell	   lines	  
has	   indicated	   that	   most	   TFs	   are	   bound	   to	   regions	   depleted	   of	   nucleosomes	   (Wang	   et	   al.	  
2012).	  Heterochromatin,	  on	  the	  other	  hand,	  is	  thought	  to	  favour	  gene	  silencing	  (Holmquist	  
et	   al.	   2006).	   This	   has	   been	   demonstrated	   by	   position	   effect	   variegation	   (PEV),	   where	   an	  
otherwise	   active	   gene	   locus	   can	   become	   sporadically	   silenced	   due	   to	   positioning	   close	   to	  
heterochromatin.	  This	  phenomenon	  was	  first	   identified	  in	  Drosophila,	  where	  positioning	  of	  
an	   eye	   colour	   gene	   close	   to	   centromeric	   heterochromatin	   can	   give	   rise	   to	   colourless	  
phenotype	   (Muller	   et	   al.	   1930),	   and	   has	   been	   reported	   in	   other	   organisms	   from	   yeast	  
(Gottschling	   et	   al.	   1990;	   Aparicio	   et	   al.	   1991)	   to	  mammals	   (Azuara	   et	   al.	   2003;	   Hiragami-­‐
Hamada	  et	  al.	  2009).	  At	  least	  two	  types	  of	  heterochromatin	  have	  been	  distinguished.	  Firstly,	  
	  
	   	   	  
25	  
facultative	  heterochromatin,	  which	  is	  developmentally	  regulated	  and	  can	  be	  formed	  at	   loci	  
that	   in	   other	   cell-­‐types	   are	   found	   in	   euchromatic	   form	   (Arney	   et	   al.	   2004).	   One	   obvious	  
example	  of	   facultative	  heterochromatin	   formation	   is	   the	   inactivation	  of	  one	  of	   the	   two	  X-­‐
chromosomes	  in	  early	  embryonic	  development	  (Heard	  2005).	  The	  other	  type	  is	  constitutive	  
heterochromatin	   that	   is	   generally	   silenced	   in	   all	   cell	   types	   and	   includes	  major	   and	  minor	  
satellite	  DNA	  repeats	  clustered	  around	  mouse	  centromeres,	  other	  repetitive	  DNA	  elements	  
and	  transposons	  (Arney	  et	  al.	  2004).	  
1.1.3 Histone	  modifications	  
Highly	   conserved	   histone	   proteins	  make	   up	   the	   octameric	   nucleosome	   to	  which	   the	   DNA	  
wraps	  around	  (Fig.	  1.1).	  It	  has	  been	  known	  ever	  since	  the	  1960’s	  that	  histones	  could	  be	  post-­‐
translationally	  modified	   (Allfrey	  et	  al.	  1964),	  however	  this	  was	  considered	  to	  be	  artifactual	  
by	  many	  and	  only	  recently	  the	  functional	  significance	  of	  these	  modifications	  has	  started	  to	  
be	   elucidated	   (Kouzarides	   2007).	   The	   high-­‐resolution	   X-­‐ray	   structure	   of	   the	   nucleosome	  
indicated	  that	  the	  N-­‐terminal	  (and	  C-­‐terminal	   in	  the	  case	  of	  H2A	  and	  H2B)	  tails	  of	  histones	  
protrude	   out	   from	   the	   nucleosome	   and	   are	   thus	   able	   to	   interact	  with	   other	   nucleosomes	  
and	  affect	  the	  chromatin	  structure,	  as	  well	  as	  recruit	  regulatory	  proteins	  (Luger	  et	  al.	  1997;	  
Margueron	  et	  al.	  2005;	  Bannister	  et	  al.	  2011).	  These	  N-­‐	  and	  C-­‐terminal	  histone	  tails,	  as	  well	  
as	   some	   residues	   in	   the	   globular	   domains,	   can	   carry	   many	   different	   types	   of	   post-­‐
translational	   modifications	   such	   as	   acetylation,	   methylation,	   phosphorylation,	  
ubiquitination,	  sumoylation,	  biotinylation,	  citrullination	  and	  ADP-­‐ribosylation	  (Fig.	  1.2)	  all	  of	  
which	   can,	   in	   turn,	   modulate	   the	   interaction	   between	   nucleosomes	   and	   with	   regulatory	  
proteins	  and	  thus	  have	  functions	  in	  gene	  regulation	  (Bhaumik	  et	  al.	  2007;	  Kouzarides	  2007;	  
Latham	   et	   al.	   2007;	   Bannister	   et	   al.	   2011).	   The	   most	   extensively	   studied	   of	   these	  
modifications	  are	  acetylation	  and	  methylation,	  which	  were	  also	  the	  modifications	  that	  were	  
discovered	  first	  (Allfrey	  et	  al.	  1964).	  
The	  different	  types	  of	  covalent	  histone	  modifications	  act	  in	  concert	  to	  influence	  a	  multitude	  
of	  cellular	  processes	  including	  transcription,	  replication,	  DNA	  repair	  and	  cell	  cycle	  procession	  
(Bhaumik	   et	   al.	   2007).	   Many	   different	   modifications	   can	   occur	   in	   the	   same	   histone	  
simultaneously	   and	   different	   types	   of	   modifications	   occur	   in	   specific	   patterns	   related	   to	  
gene	  functions.	  Acetylation	  of	  specific	  lysine	  residues	  both	  on	  histone	  H3	  and	  H4	  N-­‐terminal	  
tails,	   such	   as,	   H3K9ac	   and	   H4K16ac,	   is	   highly	   correlated	   with	   accessible	   chromatin	   and	  
actively	   transcribed	   genes,	   whereas	   lysine	   methylation	   can	   correlate	   with	   either	   active	  




al.	   2007;	   Kouzarides	   2007).	   The	   different	   types	   of	   modifications	   can	   also	   regulate	   one	  
another	   both	   in	   cis-­‐	   on	   the	   same	   histone	   and	   in	   trans-­‐	   between	   different	   histones	   or	  
nucleosomes	  (Latham	  et	  al.	  2007;	  Lee	  et	  al.	  2010).	  It	  has	  been	  suggested	  that	  together	  the	  
different	   histone	   modifications	   on	   the	   genome	   form	   their	   own	   heritable	   ‘code’,	   which	   is	  
read	   by	   effector	   molecules	   that	  
drive	   changes	   in	   chromatin	  
conformation	   and	   gene	  
transcription	   leading	   to	   distinct	  
downstream	   effects	   (Jenuwein	  
et	   al.	   2001;	   Margueron	   et	   al.	  
2005;	  Rando	  2012).	  
1.1.3.1 Histone	  acetylation	  
Levels	   of	   histone	   acetylation	  
have	   been	   shown	   to	   correlate	  
with	   transcriptionally	   active	   and	  
inactive	   regions	   of	   the	   genome.	  
Hypoacetylation	   of	   all	   four	  
nucleosomal	   histones	   has	   been	  
consistently	   associated	   with	  
transcriptionally	   inactive	  
heterochromatin	   (Jeppesen	   et	  
al.	   1993;	   Maison	   et	   al.	   2002).	  
Conversely	   hyperacetylation	   of	  
histones	   correlates	   highly	   with	  
chromatin	   accessibility	   and	  
transcriptional	   activity	   (Pogo	   et	  
al.	   1966;	   Hebbes	   et	   al.	   1988;	  
Shogren-­‐Knaak	   et	   al.	   2006).	  
These	   correlations	   have	   been	  
confirmed	   more	   recently	   by	  
genome-­‐wide	  studies	   in	  numerous	  different	  cell	   types	  (Koch	  et	  al.	  2007;	  Wang	  et	  al.	  2008;	  
Wang	  et	  al.	  2009b;	  Djebali	  et	  al.	  2012;	  Dunham	  et	  al.	  2012;	  Sanyal	  et	  al.	  2012).	  
Acetylation	  of	  histones	  can	  occur	  on	  lysine	  residues	  on	  all	  the	  four-­‐histone	  types	  (Fig.	  1.2),	  
the	   most	   extensively	   characterised	   are	   modifications	   on	   H3	   and	   H4	   N-­‐terminal	   tails.	  
	  
Figure	  1.2	  Post-­‐translational	  modifications	  of	  human	  histones.	  	  
(a)	  Known	  post-­‐translational	  histone	  modifications	  and	  the	  amino	  acid	  
residues	   they	   modify.	   (b)	   Different	   covalent	   post-­‐translational	  
modifications	  of	   the	   four	   core	  histones	   (H2A,	  H2B,	  H3	   and	  H4)	   have	  
been	   identified	   and	   are	   here	   represented	   above	   the	   corresponding	  
amino	   acid	   residue	   in	   the	   N-­‐terminal	   tails	   of	   histones.	   Globular	  
domains	  of	  each	  core	  histones	  are	  represented	  as	  ovals.	  Acetylation	  of	  
lysines	  9	  or	  14	  of	  histone	  H3	  (H3K9ac	  or	  H3K14ac)	  or	  dimethylation	  of	  
lysine	   4	   (H3K4me2)	   are	   generally	   associated	   with	   open	   genomic	  
regions	  and	  transcription.	  H3K9me3	  or	  H3K27me3,	  are	  indicative	  of	  a	  
repressed	  chromatin	  state.	  Covalent	  histone	  modifications,	  alone	  or	  in	  
combination,	   can	   influence	   nucleosome	   mobility	   and	   function	   as	   a	  
platform	  for	  the	  recruitment	  of	  effector	  proteins.	  Figure	  adapted	  from	  
(Bhaumik	  et	  al.	  2007;	  Latham	  et	  al.	  2007).	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Acetylation	  of	  a	  lysine	  residue	  neutralises	  the	  positive	  charge	  of	  the	  target	  residue;	  this	  has	  
the	   potential	   to	  weaken	   the	   interactions	   between	   the	   histones	   and	  DNA	   (Bannister	   et	   al.	  
2011)	  as	  well	  as	  between	  different	  nucleosomes	  (Shogren-­‐Knaak	  et	  al.	  2006).	  High	  levels	  of	  
acetylation	   have	   been	   shown	   to	   inhibit	   higher	   order	   chromatin	   folding	   and	   dramatically	  
enhance	  transcription	  in	  in	  vitro	  assays	  (Tse	  et	  al.	  1998).	  More	  detailed	  studies	  have	  shown	  
that	  H4K16	  acetylation	  on	  the	  N-­‐terminal	  tail	  directly	  affects	  the	  folding	  of	  the	  nucleosomes	  
by	  disrupting	   the	  electrostatic	   interaction	  between	   the	  N-­‐terminal	   tail	  of	  H4	  and	  an	  acidic	  
patch	  of	  the	  H2A/H2B	  dimer	  on	  an	  adjacent	  nucleosome,	  thus	  preventing	  the	  formation	  of	  
compact	   30	   nm	   fibres	   (Shogren-­‐Knaak	   et	   al.	   2006;	   Robinson	   et	   al.	   2008;	   Bell	   et	   al.	   2011).	  
Apart	   from	  the	  histone	  tails,	   lysine	  acetylation	  has	  also	  been	  found	   in	  the	  globular	  histone	  
core.	   H3K56	   acetylation	   has	   been	   found	   not	   to	   directly	   affect	   chromatin	   compaction,	  
however	   it	   has	   been	   found	   to	   increase	   the	   transient	   partial	   unwrapping	   of	  DNA	   from	   the	  
histone	  core,	  also	  known	  as	  DNA	  breathing	  (Neumann	  et	  al.	  2009).	  Moreover,	  H3K56ac	  does	  
not	  directly	  correlate	  with	  transcription	  per	  se,	  but	   instead	  has	  roles	  related	  to	  DNA	  repair	  
and	  genome	  stability	   (Masumoto	  et	  al.	  2005;	  Bhaumik	  et	  al.	  2007).	   Interestingly,	  H3K56ac	  
has	   also	   been	   found	   to	   be	   enriched	   at	   active	   regulators	   of	   human	   ES	   identity	   as	   well	   as	  
inactive,	  lineage-­‐specific	  genes,	  poised	  for	  activation	  upon	  differentiation	  (Xie	  et	  al.	  2009).	  In	  
addition	   to	   these	  effects,	  histone	  acetylation	  can	  also	  enable	  binding	  of	   factors	  associated	  
with	  gene	  activation	  or	  chromatin	  modelling.	  The	  chromatin	  remodelling	  complex	  SWI/SNF,	  
which	  mobilises	   nucleosomes	   and	   has	   an	   important	   role	   in	   transcriptional	   activation,	   has	  
been	  shown	  to	  bind	  to	  acetylated	  histones	  through	  its	  bromodomain	  (Hassan	  et	  al.	  2002).	  
Acetylation	  of	  lysine	  residues	  in	  histones	  is	  highly	  dynamic	  and	  regulated	  by	  two	  families	  of	  
enzymes	  with	  opposing	  activity,	  histone	  acetyl	  transferases	  (HATs)	  and	  HDACs	  (Bannister	  et	  
al.	  2011).	   Interestingly,	  despite	   the	  positive	  correlation	   found	  between	  histone	  acetylation	  
and	   transcriptional	   activity	   high	   stable	   acetylation	   levels	   are	   not	   strictly	   important	   for	  
transcription,	  but	  instead	  a	  rapid	  turnover	  of	  high	  acetylation	  and	  deacetylation	  is	  key	  to	  this	  
process.	   Turnover	   of	   histone	   acetylation	   can	   indeed	   be	   very	   rapid	   (down	   to	   one	   to	   five	  
minutes),	  and	  remarkably	  the	  domains	  with	  the	  fastest	  turnover	  are	  associated	  with	  active	  
transcription,	  whereas	  domains	  with	  slow	  turnover	  (up	  to	  30-­‐60	  minutes)	  are	  not	  (Covault	  et	  
al.	   1980;	   Waterborg	   2002).	   Genome-­‐wide	   studies,	   have	   recently	   demonstrated	   transient	  
binding	  by	  HATs	  and	  HDACs	  and	  subsequent	  dynamic	  cycle	  of	  acetylation	  and	  deacetylation	  
at	  active	  genes,	  as	  well	  as	  genes	  poised	  for	  activation,	  however	  no	  detectable	  levels	  of	  HATs	  
or	  HDACs	  were	   found	  at	   inactive	  genes	   (Wang	  et	  al.	  2009b).	  High	   levels	  of	  HAT	  and	  HDAC	  




present.	  This	  could	  provide	  an	  advantage	  by	  allowing	  rapid	  upregulation	  of	  genes	   that	  are	  
primed,	  in	  response	  to,	  for	  example,	  hormonal	  cues	  or	  growth	  factor	  signalling	  (Wang	  et	  al.	  
2009b).	  
The	   nuclear	   HATs	   that	   acetylate	   histones	   within	   the	   genome	   can	   be	   grouped	   into	   three	  
families:	   Gcn5-­‐related	   N-­‐acetyltransferases,	   the	   MYST	   family	   (MOZ,	   Ybf2/Sas3,	   Sas2	   and	  
Tip60)	  and	  EP300	  and	  its	  paralogue	  CBP	  (Hodawadekar	  et	  al.	  2007;	  Lee	  et	  al.	  2007).	  The	  first	  
histone	  modifying	   enzyme	   identified	  was	  Gcn5	   (Brownell	   et	   al.	   1996).	   It	  was	   known	   from	  
studies	   in	   yeast	   as	   a	   transcriptional	   activator	   and	   hence	   the	   link	   that	   histone	   acetylation	  
directly	  affects	  transcription	  was	  established.	   In	  addition	  to	  the	  transcriptional	  co-­‐activator	  
function	  of	  all	  HATs,	  some	  such	  as	  PCAF	  and	  P300/CBP	  have	  also	  been	  shown	  to	  target	  non-­‐
histone	  proteins	  for	  acetylation,	  including	  p53	  and	  MyoD	  (Hodawadekar	  et	  al.	  2007;	  Lee	  et	  
al.	   2007).	   HDACs	   have	   been	   identified	   as	   transcriptional	   co-­‐repressors	   and	   can	   be	   divided	  
into	  Rpd3/Hda1	  and	  sirtuin	   families.	   In	  humans,	   the	   former	  contains	  HDAC1,	   -­‐2,	   -­‐3,	  and	   -­‐8	  
(class	   I,	   similar	   to	   yeast	   Rpd3);	   HDAC4,	   -­‐5,	   -­‐6,	   -­‐7,	   -­‐9,	   and	   -­‐10	   (class	   II,	   homologs	   of	   yeast	  
Hda1);	  and	  HDAC11	   (class	   IV)	   (Yang	  et	  al.	  2008).	  Within	   the	  sirtuin	   family,	   there	  are	  seven	  
members	  in	  humans	  (SIRT1–	  7,	  related	  to	  yeast	  Sir2;	  also	  known	  as	  class	  III	  HDACs)	  (Haigis	  et	  
al.	   2006).	   Due	   to	   the	   important	   roles	   that	   HATs	   and	   HDACs	   have	   in	   regulating	   gene	  
expression	   their	   misregulation	   has	   been	   linked	   to	   tumourigenesis	   in	   numerous	   studies	  
(Bhaumik	   et	   al.	   2007;	   Sharma	   et	   al.	   2010;	   Bannister	   et	   al.	   2011),	   and	   thus	   targeting	   their	  
activity	  could	  provide	  new	  avenues	  in	  the	  fight	  against	  cancer.	  Indeed,	  HDAC	  inhibitors	  have	  
been	   found	  to	  be	  effective	   in	   inhibiting	   tumour	  growth	  and,	   for	  example,	   suberoyllanidine	  
hydroxamic	   acid,	   which	   is	   an	   HDAC	   inhibitor,	   has	   been	   approved	   for	   use	   in	   the	   clinic	   for	  
treatment	  of	  T	  cell	  cutaneous	  lymphoma	  (Sharma	  et	  al.	  2010).	  
1.1.3.2 Histone	  methylation	  
Unlike	   acetylation,	   histone	  methylation	   does	   not	   alter	   the	   charge	   of	   histone	   proteins	   and	  
thus	   histone	   methylation	   does	   not	   seem	   to	   directly	   affect	   chromatin	   structure.	   Histone	  
methylation	   does,	   however,	   allow	   binding	   of	   numerous	   effector	   proteins	   with	   various	  
consequences	   relating	   to	   chromatin	   structure	   and	   gene	   regulation	   (Bannister	   et	   al.	   2005;	  
Taverna	  et	  al.	  2007;	  Ng	  et	  al.	  2009;	  Bannister	  et	  al.	  2011).	  Histone	  methylation	  mainly	  occurs	  
at	  lysine	  and	  arginine	  residues	  (methylation	  of	  histidine	  and	  proline	  has	  also	  been	  reported)	  
of	  histone	  H3	  and	  H4	  N-­‐terminal	  tails	  (Fig.	  1.2),	  and	  it	  has	  been	  linked	  with	  several	  different	  
cellular	  processes	  including	  DNA	  repair,	  replication,	  transcriptional	  activation	  and	  repression	  
(Kouzarides	   2007;	   Wolf	   2009).	   Distinctly	   from	   acetylation,	   the	   histone	   methylation	  
modification	   has	   added	   layers	   of	   complexity	   due	   to	   the	   fact	   that	   lysine	   residues	   may	   be	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mono-­‐,	   di-­‐	   or	   tri-­‐methylated	   and	   arginine	   residues	   may	   be	   mono-­‐,	   symmetrically	   or	  
asymmetrically	   di-­‐methylated	   (Bannister	   et	   al.	   2011).	   The	  different	   outcomes	   that	   histone	  
methylation	   is	   associated	   with	   depend	   on	   the	   site	   and	   extent	   of	   methylation	   [unlike	  
acetylation,	  which	  broadly	  correlates	  with	  transcriptional	  activation	  (Kouzarides	  2007)].	  
Histone	   methylation	   at	   arginine	   residues	   is	   catalysed	   by	   several	   protein	   arginine	  
methyltransferases	   (PRMTs).	   In	  humans,	  11	  PRMT	  proteins	  have	  been	   identified,	  based	  on	  
protein	   sequences	   and	   conserved	   catalytic	   domain,	   and	   enzymatic	   activity	   has	   been	  
confirmed	   with	   eight	   of	   them	   (Copeland	   et	   al.	   2009;	   Wolf	   2009).	   Histone	   arginine	  
methylation	  has	  been	  shown	  to	  occur	  on	  H3R2,	  H3R8,	  H3R17	  and	  H3R26	  as	  well	  as	  on	  H4R3	  
(Ng	   et	   al.	   2009).	   Transcriptional	   activation	   has	   been	   associated	  with	  methylation	   of	   H4R3	  
mediated	  by	  PRMT1	  (Strahl	  et	  al.	  2001;	  Wang	  et	  al.	  2001)	  as	  well	  as	  with	  H3R2,	  H3R17	  and	  
H3R26	  mediated	  by	  PRMT4	  (also	  known	  as	  CARM1)	  (Schurter	  et	  al.	  2001;	  Bauer	  et	  al.	  2002).	  
Interestingly,	   however,	   methylation	   of	   H3R8	   and	   H4R3	   by	   PRMT5	   has	   been	   shown	   to	   be	  
associated	   with	   transcriptional	   repression	   (Fabbrizio	   et	   al.	   2002;	   Pal	   et	   al.	   2003),	  
demonstrating	   the	   complex	   nature	   of	   regulation	   by	   arginine	   methylation.	   Recent	   studies	  
have	   shown	   that	   H3	   arginine	   methylation	   by	   PRMT4	   has	   a	   specific	   role	   in	   determining	  
embryonic	  and	  extraembryonic	  lineage	  commitment	  by	  blastomeres	  in	  the	  early	  embryo	  as	  
well	  as	  in	  mES	  cells	  (Torres-­‐Padilla	  et	  al.	  2007;	  Wu	  et	  al.	  2009).	  
Histone	  lysine	  methyltransferases	  (HKMTs)	  can	  catalyse	  methylation	  on	  at	   least	  histone	  H3	  
lysine	   4,	   9,	   14,	   23,	   27,	   36	   and	   79	   as	   well	   as	   histone	   H4	   lysine	   12	   and	   20	   (Fig.	   1.2).	   Six	  
methylation	   marks	   have	   been	   most	   extensively	   studied	   and	   of	   these	   three	   have	   been	  
implicated	   in	   activation	   of	   transcription:	   H3K4,	   H3K36	   and	   H3K79;	   and	   three	   have	   been	  
implicated	  with	  transcriptional	  repression:	  H3K9,	  H3K27	  and	  H4K20	  (Kouzarides	  2007;	  Ng	  et	  
al.	  2009).	  Genome-­‐wide	  studies	  have	  shown	  that	  H3K4	  methylation	  is	  very	  closely	  associated	  
with	   transcription	   start	   sites	   (TSS)	   of	   actively	   transcribed	   genes	   and	   H3K36	   and	   H3K79	  
methylation	   are	   present	   downstream	   of	   the	   TSS	   (i.e.	   in	   the	   gene	   body)	   of	   actively	  
transcribed	   genes	   (Koch	   et	   al.	   2007;	  Wang	   et	   al.	   2008;	  Djebali	   et	   al.	   2012;	  Dunham	  et	   al.	  
2012;	   Sanyal	   et	   al.	   2012;	   Thurman	   et	   al.	   2012).	   The	   same	   studies	   have	   also	   seen	   the	  
exclusion	  of	  H3K9,	  H3K27	  and	  H4K20	  methylation	  from	  regions	  of	  active	  transcription.	  H3K9	  
and	  H4K20	  methylation	  are	  predominantly	  found	  in	  regions	  of	  constitutive	  heterochromatin	  
(Peters	   et	   al.	   2003;	   Martin	   et	   al.	   2005)	   and	   H3K27	   methylation	   at	   facultative	  
heterochromatin	  sites,	  such	  as	  the	  inactive	  X-­‐chromosome	  (Peters	  et	  al.	  2003;	  Rougeulle	  et	  
al.	   2004).	   However,	   increased	   layers	   of	   complexity	   have	   been	   added	   to	   the	   interplay	   of	  




H3K9me1,	   H3K27me1,	   H3K79me1	   and	   H4K20me1	   with	   actively	   transcribed	   genes,	   and	  
H3K9me3,	   H3K27me3	   and	   H3K79me3	   with	   repressed	   genes	   (Barski	   et	   al.	   2007).	  
Interestingly,	  domains	  that	  possess	  both	  activating	  H3K4me3	  and	  the	  repressive	  H3K27me3	  
marks	  have	  been	   found	   in	  mES	  cells	   (Azuara	  et	  al.	  2006;	  Bernstein	  et	  al.	  2006;	  Voigt	  et	  al.	  
2012).	   These	   bivalent	   domains	   in	   pluripotent	   cells	   are	   thought	   to	   allow	   for	   low	   level	   of	  
activity	   while	   keeping	   the	   lineage	   differentiation	   options	   open	   for	   the	   cell.	   Once	   lineage	  
commitment	   has	   occurred	   through	   differentiation	   the	   loci	   in	   question	   retain	   either	   the	  
active	   or	   repressive	   marks	   according	   to	   their	   specific	   lineage	   and	   transcriptional	   status	  
(Azuara	  et	  al.	  2006;	  Bernstein	  et	  al.	  2006;	  Voigt	  et	  al.	  2012).	  
Unlike	  HATs,	  which	  often	  have	  numerous	   target	   residues,	   histone	  methyl	   transferases	   are	  
typically	  more	  specific	  with	  regards	  to	  their	  target	  residues,	  resulting	  in	  a	  very	  large	  family	  of	  
mammalian	  HKMTs.	  All	  human	  HKMTs,	  apart	  from	  the	  DOT1-­‐like	  histone	  methyltransferase,	  
contain	   a	   catalytic	   core	   formed	  by	   the	  approximately	  130	  amino	  acid	   SET	  domain	   [named	  
after	  D.	  melanogaster	  Su(var)3-­‐9,	  Enhancer	  of	  zeste	  (E(z))	  and	  trithorax	  (trx)]	  (Bhaumik	  et	  al.	  
2007;	  Kouzarides	  2007;	  Ng	  et	  al.	  2009).	  The	  first	  HKMT	  to	  be	  identified	  was	  Suv39h1,	  which	  
targets	  H3K9	  (Rea	  et	  al.	  2000).	  SET	  domain-­‐containing	  HKMTs,	  in	  general,	  target	  residues	  on	  
the	  H3	   and	  H4	   histone	   tails.	  Other	  mammalian	  HKMTs	   that	   target	  H3K9	   include	   Suv39h2,	  
G9A	  and	  ESET.	  PR-­‐Set7,	   Suv4-­‐20h1	  and	  Suv4-­‐20h2,	  all	   catalyse	  histone	  H4K20	  methylation	  
(Shilatifard	  2006;	  Sims	  et	  al.	  2006;	  Bhaumik	  et	  al.	  2007).	  H3K27	  and	  H3K4	  trimethylation	  are	  
catalysed	  by	  the	  Polycomb	  group	  protein	  Ezh2	  and	  the	  Trithorax/MLL	  complex	  respectively	  
(Shilatifard	  2006;	  Copeland	  et	  al.	  2009).	  
Both	   Polycomb	   group	   (PcG)	   and	   Trithorax	   group	   (TrxG)	   proteins	   have	   been	   implicated	   in	  
methylation	  of	  histone	  lysine	  residues.	  PcG	  and	  TrxG	  proteins	  were	  discovered	  in	  Drosophila	  
as	   gene	   mutations	   at	   these	   loci	   affect	   the	   spatially	   restricted	   expression	   pattern	   of	   Hox	  
genes	  and	  developmental	  patterning	  was	  affected	  (Lewis	  1978).	  PcG	  and	  TrxG	  proteins	  have	  
been	  shown	  to	  play	  a	  key	  role	  in	  defining	  and	  maintaining	  epigenetic	  methylation	  patterns	  
that	  define	  cell	  identity	  during	  development	  (Ringrose	  et	  al.	  2004;	  Sparmann	  et	  al.	  2006).	  It	  
is	  now	  clear	  that	  PcG	  and	  TrxG	  proteins	  regulate	  many	  genes	   in	  addition	  to	  the	  Hox	  genes	  
and	  have	  an	  effect	  on	  several	  cellular	  processes,	  including	  proliferation,	  genomic	  imprinting,	  
cancer,	   X-­‐inactivation	   and	   pluripotency	   (Heard	   2005;	   Azuara	   et	   al.	   2006;	   Bernstein	   et	   al.	  
2006;	   Boyer	   et	   al.	   2006;	   Schwartz	   et	   al.	   2006;	   Schuettengruber	   et	   al.	   2007).	   PcG	   proteins	  
have	  been	  shown	  to	  act	  to	  repress	  loci	  and	  conversely	  TrxG	  proteins	  to	  induce	  activation	  of	  
loci	  (Schuettengruber	  et	  al.	  2007).	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TrxG	  can	  be	  separated	  into	  two	  main	  classes.	  One	  class	  includes	  SET	  domain	  factors	  such	  as	  
Trx,	  Ash1	  and	  the	  vertebrate	  MLL,	  and	  their	  associated	  proteins.	  The	  second	  class	   includes	  
components	   of	   ATP-­‐dependent	   chromatin	   remodelling	   complexes	   such	   as	   SWI/SNF	   and	  
NURF	  (Schuettengruber	  et	  al.	  2007).	  As	  indicated	  previously,	  TrxG	  proteins	  have	  been	  shown	  
to	  methylate	  H3K4,	  an	  activation	  associated	  modification	  (Shilatifard	  2006;	  Ruthenburg	  et	  al.	  
2007).	   The	   basal	   MLL	   protein	   has	   been	   shown	   to	   be	   recruited	   to	   H3K4	   by	   site-­‐specific	  
transcription	   factors	   and	   basal	   transcriptional	   machinery	   as	   well	   as	   direct	   recognition	   of	  
histone	  modifications	   (Ruthenburg	   et	   al.	   2007).	   Evidence	   from	  Drosophila	   has	   also	   shown	  
that	  Ash1	  can	  be	  recruited	  to	  specific	   loci	  by	   long-­‐non	  coding	  RNA	  rising	   from	  the	   locus	   in	  
question	   (Sanchez-­‐Elsner	  et	  al.	  2006).	   It	  has	  also	  been	  shown	  that,	   for	  example,	   the	  NURF	  
complex	  can	  bind	  to	  H3K4me3	  via	  a	  plant	  homeodomain	  (PHD)	  finger	  domain	  of	  the	  Nurf-­‐
301	  protein	  (Li	  et	  al.	  2006;	  Wysocka	  et	  al.	  2006).	  
Contrasting	   the	   activity	   of	   TrxG	   proteins,	   the	   PcG	   proteins	   are	   associated	   with	   repressed	  
chromatin,	   and	   the	   H3K27	   tri-­‐methylation	  mark.	   Two	  main	   protein	   complexes	   have	   been	  
identified	   in	   humans:	   Polycomb	   repressive	   complex	   1	   (PRC1)	   and	   PRC2,	   a	   third	   complex,	  
PhoRC,	  is	  known	  in	  Drosophila,	  however	  it	  remains	  unclear	  whether	  this	  complex	  also	  exists	  
in	   humans	   (Schuettengruber	   et	   al.	   2007).	   PRC2	   complex	   contains	   four	   core	   components:	  
EZH2,	   EED,	   SUZ12	   and	   RbAp46/48	   (Cao	   et	   al.	   2004).	   PRC2	   acts	   by	   catalysing	   the	   tri-­‐
methylation	  of	  H3K27	  via	  the	  SET-­‐domain	  protein	  EZH2	  (Cao	  et	  al.	  2004).	  This	  mark	  is	  then	  
recognised	   by	   PRC1,	   which	   in	   humans	   is	   comprised	   of	   RING1A/B,	   BMI-­‐1,	   Polycomb	   and	  
polyhomeotic	   proteins	   as	   well	   as	   some	   other	   associated	   factors	   (Schuettengruber	   et	   al.	  
2007).	   RING1A/B	   in	   cooperation	  with	   BMI-­‐1	   has	   been	   shown	   to	   catalyse	   ubiquitination	   of	  
lysine	  119	  of	  histone	  H2A,	  another	  repressive	  histone	  modification	  (de	  Napoles	  et	  al.	  2004;	  
Wang	   et	   al.	   2004).	   The	   action	   of	   PRC2	   and	   PRC1	   has	   been	   shown	   to	   prevent	   active	  
transcription	   of	   a	   number	   of	   developmental	   genes	   in	   mES	   cells,	   highlighting	   the	  
collaborative	   action	   of	   PRC2	   and	   PRC1	   in	   maintaining	   silent	   chromatin	   (Jørgensen	   et	   al.	  
2006;	  Stock	  et	  al.	  2007).	  
Methylation	   marks	   on	   histones	   are	   read	   and	   bound	   by	   numerous	   different	   effector	  
molecules,	  for	  example,	  the	  already	  mentioned	  NURF	  complex	  and	  PRC1	  complex.	  There	  are	  
more	   distinct	   domain	   types	   recognising	   lysine	   methylation	   than	   any	   other	   modification.	  
These	   include	   PHD	   fingers	   and	   the	   so	   called	   ‘royal’	   family	   of	   domains,	   comprising	  
chromodomains,	  Tudor,	  PWWP	  and	  MBT	  domains	  (Bannister	  et	  al.	  2011).	  Known	  examples	  
of	   effector	   protein	   binding	   to	   methyl	   histone	   marks	   include,	   for	   example,	   the	   binding	   of	  




complex	  to	  active	  proliferation	  specific	  genes	  downregulating	  their	  activity	  (Shi	  et	  al.	  2006).	  
Another	   important	   example	   is	   the	   binding	   of	   HP1	   via	   its	   N-­‐terminal	   chromodomain	   to	  
H3K9me3	  repressive	  mark,	  which	  is	   important	  for	  the	  overall	  structure	  of	  heterochromatin	  
(Bannister	   et	   al.	   2001;	   Lachner	   et	   al.	   2001).	   The	   methylation	   marks	   can	   also	   be	   directly	  
bound	  by	  enzymes	  with	  histone	  demethylase	  activity	  such	  as	  the	  case	  of	  the	  tandem	  Tudor	  
domain	  containing	  JMJD2A	  histone	  demethylase	  binding	  to	  H3K4me3	  (Huang	  et	  al.	  2006).	  
Methyl	   groups	   can	   be	   removed	   from	   histone	   residues	   by	   histone	   demethylase	   enzymes,	  
such	   as	   JMJD2A.	   The	   first	   histone	   lysine	   demethylase	   to	   be	   discovered	   was	   the	   lysine	  
demethylase	  1	   (LSD1),	  which	  had	  previously	  been	   identified	  as	  a	  member	  of	  several	  HDAC	  
complexes	  and	  catalyses	  demethylation	  of	  mono-­‐	  and	  di-­‐methyl	  H3K4	  (Shi	  et	  al.	  2004).	  The	  
mechanism	  by	  which	  LSD1	  (and	  the	  related	  protein	  LSD2)	   initiates	  demethylation	  prevents	  
them	  from	  catalysing	  tri-­‐methylated	  substrates	  (Klose	  et	  al.	  2007).	  In	  contrast,	  another	  class	  
of	   lysine	  demethylase	  enzymes,	  which	   includes	  JMJD2A,	  containing	  a	   JmjC	  domain	  as	  their	  
catalytic	   core	   are	   able	   to	   demethylate	   tri-­‐methyl	   groups.	  Members	   of	   this	   large	   family	   of	  
proteins	   utilise	   iron	   and	   α-­‐ketoglutarate	   as	   co-­‐factors	   in	   an	   oxidative	   reaction	   for	   their	  
demethylase	   activity	   (Tsukada	   et	   al.	   2006).	   The	   JmjC	   containing	   proteins	   are	   able	   to	  
demethylate	   H3K9,	   H3K27	   and/or	   H3K36	   residues	   (Klose	   et	   al.	   2007)	   as	   well	   as	   H3K4	   as	  
mentioned	  above.	  Methylation	  at	  arginine	  residues	  can	  undergo	  either	  deamination,	  which	  
converts	  the	  arginine	  to	  citrulline,	  or,	  as	  discovered	  more	  recently,	  demethylation,	  catalysed	  
by	  PADI4	  and	  JMJD6	  enzymes,	  respectively	  (Nakashima	  et	  al.	  2002;	  Wang	  et	  al.	  2004;	  Chang	  
et	  al.	  2007;	  Klose	  et	  al.	  2007).	  
1.1.4 Spatial	  constraints	  –	  nuclear	  organisation	  
A	  striking	  feature	  of	  nuclear	  architecture	  is	  the	  existence	  of	  distinct	  structural	  and	  functional	  
compartments	   and	   the	   non-­‐homogenous	   distribution	   of	   components	   of	   the	   transcription	  
machinery	   (Lanctot	   et	   al.	   2007).	   It	   is	   known	   that,	   within	   the	   nuclei	   of	   cells,	   individual	  
chromosomes	  occupy	  distinct	  positions	  referred	  to	  as	  chromosome	  territories	  (Cremer	  et	  al.	  
2006;	   De	   et	   al.	   2010).	   As	   a	   result	   of	   different	   compaction	   levels,	   different	   chromosome	  
segments	  adopt	  a	  complex	  organisation	  and	  topography	  within	  their	  chromosome	  (Dostie	  et	  
al.	  2012).	  One	  of	  the	  widely	  conserved	  features	  of	  chromosomal	  positioning	  is	  the	  polarized	  
distribution	  of	  gene-­‐poor	  and	  gene-­‐rich	  regions	  of	  chromatin	   to	   the	  nuclear	  periphery	  and	  
nuclear	  interior,	  respectively	  (Deniaud	  et	  al.	  2009;	  Ferrai	  et	  al.	  2010).	  	  
Chromosome	   territories	   are	   dynamic	   structures	   and	   individual	   chromosomes	   can	   be	  
repositioned	  in	  relation	  to	  nuclear	  structures	  and	  other	  chromosome	  territories.	  Increasing	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evidence	  has	  linked	  repositioning	  of	  genomic	  regions	  in	  nuclear	  space	  to	  regulation	  of	  gene	  
expression	   (Gasser	   2002;	   Ferrai	   et	   al.	   2010).	   For	   instance,	   live-­‐imaging	   experiments	   using	  
induced	  activation	  of	  an	  integrated	  array	  of	  lac	  operators	  with	  viral	  activators	  in	  mammalian	  
cells	  have	  shown	  that	  activation	  of	  the	  locus	  leads	  to	  movement	  from	  the	  periphery	  to	  the	  
interior	  of	  the	  nucleus,	  and	  furthermore	  the	  movement	  was	  dependent	  on	  nuclear	  actin	  and	  
myosin	  suggesting	  the	   involvement	  of	  an	  active	  process	   (Tumbar	  et	  al.	  2001;	  Chuang	  et	  al.	  
2006).	   Importantly,	   chromosomes	   are	   distributed	   tissue-­‐specifically	   with	   respect	   to	   their	  
position	   relative	   to	   each	   other	   and	   the	   nuclear	   architecture;	   this	   suggests	   a	   role	   for	  
chromatin	   repositioning	   during	   development	   and	   cell	   differentiation	   (Parada	   et	   al.	   2004;	  
Laster	  et	  al.	  2010).	   Interestingly,	   inhibition	  of	  RNA	  polymerase	  II	  (PolII)	  driven	  transcription	  
leads	  to	  a	  reduction	  in	  relocation	  of	  chromosome	  domains	  outside	  their	  native	  chromosome	  
territories	   as	   well	   as	   in	   intermingling	   of	   chromosomal	   domains	   between	   different	  
chromosomes	   (Mahy	  et	   al.	   2002;	  Branco	  et	   al.	   2006).	   This	   suggests	   that	   the	  events	  are	  at	  
least	  partly	  driven	  by	  the	  process	  of	  transcription	  (Fraser	  et	  al.	  2007).	  
Recently	   it	   has	   become	   evident	   that	   the	   nuclear	   lamins	   have	   an	   important	   role	   in	   the	  
structural	  organisation	  and	   function	  of	   chromatin	   (Dechat	  et	   al.	   2008).	   Extensive	  genome-­‐
wide	  analysis	  of	  regions	  of	  chromosomes	  that	  interact	  with	  the	  nuclear	  lamina	  has	  mapped	  
lamina-­‐associated	  domains	  (LADs)	  of	  0.1	  to	  10	  megabase	  pair	  (Mb)	  in	  size	  at	  more	  than	  1300	  
specific	   sites	   throughout	   the	   genome	   (Guelen	   et	   al.	   2008).	   The	   data	   from	   LAD	   analysis	  
correlates	   with	   the	   previously	   seen	   polarized	   distribution	   of	   gene-­‐poor	   regions	   to	   the	  
nuclear	   periphery	   and	   gene-­‐rich	   to	   the	   interior.	   The	  mean	   gene	   density	   within	   LADs	   was	  
found	   to	   be	   approximately	   half	   of	   that	   outside	   LADs	   (Guelen	   et	   al.	   2008).	   LADs	   are	   also	  
highly	   enriched	   in	   chromatin	   modifications	   associated	   with	   heterochromatin,	   such	   as	  
H3K27me3	  and	  H3K9me2,	  and	  have	  very	  low	  levels	  of	  active	  transcription	  marker	  H3K4me2	  
and	   PolII	   (Guelen	   et	   al.	   2008).	   Association	   of	   heterochromatin	  with	   the	   nuclear	   periphery	  
has	  also	  been	  previously	  reported,	  such	  as	  with	  the	  inactive	  X	  which	  is	  often	  observed	  at	  the	  
nuclear	  periphery	  (Burke	  et	  al.	  2002).	  Interestingly,	  mutation	  in	  human	  nuclear	  lamin	  A	  has	  
been	   found	   to	   result	   in	   reduced	   amounts	   of	   constitutive	   and	   facultative	   heterochromatin	  
associated	  with	  H3K9	  and	  H3K27	  methylation	  (Shumaker	  et	  al.	  2006).	  
Analysis	  of	  LADs	  in	  neuronal	  differentiation	  of	  mES	  cells	  has	  recently	  provided	  evidence	  for	  
the	   dynamic	   relocation	   of	   chromatin	   domains	   in	   response	   to	   changing	   cellular	   identity	  
(Peric-­‐Hupkes	  et	  al.	  2010).	  Specifically,	   loci	   linked	  to	  neuronal	   identity	  such	  as	  Pcdh9	  were	  
released	  from	  the	  nuclear	  lamina	  upon	  differentiation	  from	  mES	  cells	  to	  neuronal	  progenitor	  




became	   associated	   with	   the	   nuclear	   lamina	   (Peric-­‐Hupkes	   et	   al.	   2010).	   Interestingly,	  
evidence	  also	  suggests	  that	  loci	  can	  be	  released	  from	  the	  nuclear	  lamina	  upon	  initial	  cellular	  
differentiation,	   but	   remain	   repressed	   until	   further	   differentiation,	   thus	   these	   loci	   can	   be	  
thought	  to	  have	  been	  ‘unlocked’	  for	  future	  expression	  by	  movement	  away	  from	  the	  nuclear	  
lamina	  (Peric-­‐Hupkes	  et	  al.	  2010).	  Association	  with	  the	  nuclear	  periphery	  has	  also	  been	  show	  
to	   correlate	   with	   late	   DNA	   replication	   timing	   of	   specific	   loci,	   furthermore	   activation	   of	   a	  
locus	   upon	   differentiation	   and	   migration	   from	   the	   periphery	   to	   the	   interior	   is	   also	  
accompanied	  by	  a	  shift	  of	  replication	  timing	  from	  late	  to	  earlier	  in	  the	  S-­‐phase	  (Hiratani	  et	  al.	  
2008;	  Peric-­‐Hupkes	  et	  al.	  2010)	  
1.1.5 Temporal	  constraints	  –	  DNA	  replication	  timing	  
Replication	  of	  DNA	  precisely	  once	  during	  a	  cell	  cycle	  is	  fundamental	  to	  all	  biological	  systems,	  
and	  the	  basic	  mechanism	  ensuring	  exact	  and	  complete	  duplication	  of	  the	  genome	  is	  highly	  
conserved	  across	  all	  kingdoms	  (Gilbert	  2010;	  Masai	  et	  al.	  2010).	  Unlike	  in	  prokaryotes,	  which	  
replicate	   their	   entire	   genome	   from	   a	   single	   origin	   of	   replication,	   eukaryotic	   cells	   replicate	  
their	  genome	  by	  initiating	  bidirectional	  DNA	  replication	  from	  multiple	  origins	  of	  replication	  
spread	  across	  the	  genome	  on	  average	  at	  100	  (kilobase	  pair)	  kb	  from	  each	  other	  (Huberman	  
et	  al.	  1968;	  Goren	  et	  al.	  2003).	  The	  rate	  of	  new	  DNA	  synthesis	  in	  eukaryotes	  is	  approximately	  
1-­‐3	  kb/min,	  hence	  if	  all	  the	  replication	  origins	  were	  firing	  simultaneously	  the	  entire	  genome	  
could	   be	   duplicated	   in	   approximately	   one	   hour	   (Hiratani	   et	   al.	   2009b;	   Méndez	   2009).	  
However,	   this	   is	   not	   the	   case,	   and	   activation	   of	   replication	   origins	   occurs	   in	   a	   defined	  
sequential	  order	  during	  the	  S-­‐phase	  of	  the	  cell	  cycle,	  with	  some	  origins	  firing	  early	  and	  some	  
late	  in	  S-­‐phase	  (Camargo	  et	  al.	  1982).	  The	  patterns	  of	  replication	  timing	  are	  inherited	  by	  the	  
daughter	  cells	  during	  mitosis	  and	  are	  conserved	  in	  a	  particular	  cell	  type;	  they	  do,	  however,	  
undergo	  changes	  during	  development	  and	  differentiation	  relating	  to	  activation	  or	  silencing	  
of	   specific	   loci	   (Cimbora	   et	   al.	   2001;	  Hiratani	   et	   al.	   2004;	   Perry	   et	   al.	   2004;	  Hiratani	   et	   al.	  
2008;	  Hiratani	  et	  al.	  2010).	  
Eukaryotic	   replication	   origins	   were	   first	   identified	   from	   yeast.	   In	   S.	   cerevisiae	   a	   specific	  
segment	   of	   chromosomal	   DNA	   was	   determined	   to	   confer	   autonomous	   replication	   when	  
inserted	  into	  a	  plasmid;	  this	  sequence	  was	  defined	  as	  an	  autonomously	  replicating	  sequence	  
(ARS)	   (Stinchcomb	  et	  al.	  1979).	  Further	   investigation	   in	  S.	  cerevisiae	   revealed	   that	   the	  ARS	  
contain	   sequence	   specific	   origins	   of	   replication	   that	   could	   be	   disrupted	   by	   induced	  
mutations	   (Van	  Houten	  et	   al.	   1990).	   The	   time	  of	   firing	   varies	   between	  different	   origins	   of	  
replication,	   however	   no	   sequence	   correlation	   has	   been	   found	   between	   late	   or	   early	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replicating	  ARSs	   in	  comparative	  sequence	  analyses	   (Wintersberger	  2000).	   In	  metazoans	  no	  
sequence	  specificity	  has	  been	  found	  for	  origins	  of	  replication	  and	  it	  has	  been	  reported	  that	  
circular	   DNA	   that	   contains	   matrix	   attachment	   sites	   or	   nuclear	   localisation	   signals	   can	  
replicate	   in	   transformed	   mammalian	   cell	   lines	   without	   any	   apparent	   sequence	   specificity	  
(Krysan	   et	   al.	   1993;	   Schaarschmidt	   et	   al.	   2004).	   The	   larger	   genome	   size	   and	   the	   plasticity	  
required	   for	   a	   large	   repertoire	   of	   different	   transcriptional	   programmes	   found	   in	   different	  
specialised	   cells	   in	   metazoans	   seem	   the	   most	   plausible	   explanations	   for	   the	   differences	  
observed	  in	  S.	  cerevisiae	  and	  metazoan	  replication	  origin	  specification	  (Mechali	  2001).	  
Metazoan	  replication	  occurs	  mostly	  in	  large	  domains	  that	  are	  replicated	  at	  the	  same	  time	  in	  
the	   cell	   cycle	   (Schübeler	   et	   al.	   2002;	   Woodfine	   et	   al.	  
2004;	   Karnani	   et	   al.	   2007;	   Farkash-­‐Amar	   et	   al.	   2008;	  
Hiratani	   et	   al.	   2008).	   Domains	   of	   distinct	   replication	  
timing	  were	  first	  discovered	  by	  pulse	  labelling	  cells	  with	  
the	   nucleotide	   analogue	   5-­‐bromo-­‐2-­‐deoxyuridine	  
(BrdU)	  at	  different	  times	  during	  S-­‐phase	  and	  visualizing	  
its	   incorporation	   into	   discrete	   areas	   of	   condensed	  
mitotic	  chromatin	  (Latt	  1973;	  Stubblefield	  1975).	  When	  
these	   domains	   were	   compared	   with	   Giemsa-­‐stained	  
banding,	   which	   roughly	   demarcate	   regions	   of	  
euchromatin	  and	  heterochromatin	  along	   the	   length	  of	  
a	  chromosome,	  a	  general	  overlap	  was	  revealed	  of	  light-­‐
staining	   R	   bands	   with	   early-­‐replicating	   domains	   and	  
dark	   staining	   G-­‐bands	   with	   late-­‐replicating	   domains	  
(Dutrillaux	   et	   al.	   1976).	   Replication	   timing	   analysis	   by	  
microarrays	   confirmed	   these	   correlations	   in	   high-­‐
resolution	   maps	   of	   human	   chromosomes	   (Woodfine	   et	   al.	   2004;	   Costantini	   et	   al.	   2008).	  
When	  DNA	   replication	   dynamics	   are	   observed	  with	   immunofluorescence	   by	   detecting	   the	  
BrdU	   incorporation	   into	   newly	   synthesised	   DNA,	   replication	   foci	   appear	   in	   a	   punctate	  
pattern	   that	   changes	  over	   the	  progression	  of	   the	  S-­‐phase.	  During	  early	   S-­‐phase	  numerous	  
small	   foci	   are	   distributed	   all	   across	   the	   nucleus.	   In	   middle	   S-­‐phase	   foci	   are	   preferentially	  
assembled	  around	  the	  nucleoli	  and	  nuclear	  periphery,	  while	  late	  S-­‐phase	  is	  characterized	  by	  
larger	  clusters	  of	  foci	  that	  seem	  to	  correspond	  to	  heterochromatic	  regions	  (Fig.	  1.3)	  (O'Keefe	  
et	  al.	  1992;	  Dimitrova	  et	  al.	  1999).	  
Figure	   1.3	  Replication	   timing	   foci	   patters	  
during	   early,	  middle	   and	   late	   S-­‐phase	   of	  
cell	  cycle.	  
Replication	  foci	  were	  visualized	  by	  30	  min	  
pulse-­‐label	   with	   5-­‐bromo-­‐2-­‐deoxyuridine	  
(BrdU)	   and	   immunofluorescence	  
detection.	  DNA	  was	  stained	  with	  Hoechst.	  




In	   every	   multi-­‐cellular	   system	   examined,	   early	   replication	   has	   been	   shown	   to	   correlate	  
strongly	  with	   transcription;	   this	  has	  been	   statistically	   confirmed	   in	  Drosophila,	   human	  and	  
mouse	  cells	  (Schübeler	  et	  al.	  2002;	  Woodfine	  et	  al.	  2004;	  Karnani	  et	  al.	  2007;	  Farkash-­‐Amar	  
et	  al.	  2008;	  Hiratani	  et	  al.	  2008;	  Hiratani	  et	  al.	  2010).	  Early	   replication	  has	  been	   shown	   to	  
also	   correlate	   to	   accessible	   chromatin	   that	   carries	   acetylated	   histones	   (Vogelauer	   et	   al.	  
2002;	  Lin	  et	  al.	  2003;	  Perry	  et	  al.	  2004;	  Ryba	  et	  al.	  2010)	  as	  well	  as	  H3K4me3,	  H3K36me3	  and	  
H4K20me1	  (known	  markers	  of	  active	  transcription)	   (Hiratani	  et	  al.	  2008;	  Ryba	  et	  al.	  2010).	  
Late	  replication	  on	  the	  other	  hand	  has	  been	  shown	  to	  generally	  correlate	  with	  repression	  of	  
transcription,	   however,	   small	   number	   of	   late	   replicating	   (less	   than	   5%	   of	   total	   in	  mouse)	  
genes	  with	  CpG-­‐island	   rich,	   strong	  promoters	  are	  expressed	  and	   thus	   late	   replication	  does	  
not	  preclude	  expression	   (Schübeler	  et	  al.	  2002;	  Woodfine	  et	  al.	  2004;	  Karnani	  et	  al.	  2007;	  
Farkash-­‐Amar	  et	  al.	  2008;	  Hiratani	  et	  al.	  2008;	  Hiratani	  et	  al.	  2010).	  Although	  late	  replication	  
is	   a	   characteristic	   of	   constitutive	   heterochromatin	   and	   some	   facultative	   heterochromatin	  
(Gilbert	   2002;	   Peters	   et	   al.	   2005),	   no	   direct	   correlation	   to	   late	   replication	  was	   found	  with	  
H3K9me3,	  H3K27me3	  or	  H4K20me3	  repressive	  histone	  marks	  (Hiratani	  et	  al.	  2008;	  Ryba	  et	  
al.	   2010).	   Interestingly,	   however,	   data	   from	   a	  mammalian	  model	   system	   of	   PEV	   provides	  
direct	  evidence	  that	  the	  local	  chromosome	  environment	  is	  important	  in	  determining	  timing	  
of	   replication	   (Azuara	   et	   al.	   2003).	   This	   study	   demonstrated	   that	   in	   transgenic	   fibroblasts	  
when	   integrated	   within	   late-­‐replicating	   heterochromatin	   the	   replication	   timing	   of	   a	   λ5	  
transgene	  changed	  to	  roughly	  coincident	  with	  that	  of	  the	  neighbouring	  γ-­‐satellite	  repeats,	  in	  
contrast	   to	   the	   early	   replication	   found	   in	   normal	   fibroblasts,	   notably	   the	   λ5	   gene	   is	   not	  
expressed	  in	  either	  the	  normal	  or	  transgenic	  fibroblasts.	  Many	  expressed	  genes	  do	  replicate	  
early	  and	  examples	  of	  correlation	  of	  replication	  timing	  with	  gene	  expression	  include	  house-­‐
keeping	   genes	   that	   constitutively	   replicate	   early	   in	   S-­‐phase	   whereas	   many	   tissue-­‐specific	  
genes	  only	  replicate	  early	   in	  their	  tissue	  of	  expression	  (Goren	  et	  al.	  2003).	  Furthermore,	   in	  
the	  case	  of	  imprinted	  genes,	  the	  active	  allele	  replicates	  early	  and	  the	  inactive	  late	  during	  S-­‐
phase	  (Simon	  et	  al.	  1999).	  However,	  there	  are	  also	  many	  inactive	  genes	  that	  replicate	  early.	  
These	  include,	  for	  example,	  genes	  involved	  in	  stress	  response	  and	  apoptosis,	  which	  are	  not	  
expressed	  during	  normal	  proliferation	  but	  need	  to	  be	  accessible	  for	  rapid	  transcription	  when	  
necessary,	   as	   well	   as	   lineage-­‐specific	   genes	   that	   are	   not	   expressed	   in	   mES	   cells,	   but	   are	  
upregulated	  upon	  differentiation	   to	   their	   cognate	   lineage.	   It	   is	   therefore	   suggested	   that	   a	  
correlation	   exists	   between	   early	   replication	   timing	   and	   the	   potential	   for	   gene	   expression	  
rather	  than	  actual	  expression	  (Azuara	  et	  al.	  2006;	  Hiratani	  et	  al.	  2008;	  Hiratani	  et	  al.	  2009a;	  
Hiratani	  et	  al.	  2009b;	  Méndez	  2009).	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Of	   all	   the	   histone	   modifications	   examined,	   acetylation	   seems	   to	   correlate	   with	   early	  
replication	   timing	   most	   strongly	   (Méndez	   2009).	   Recent	   experiments	   have	   shown	   that	  
recruitment	   of	   HATs	   to	   the	   human	  β-­‐GLOBIN	   locus	   in	   a	   non-­‐erythroid	   cell	   line,	   where	  β-­‐
GLOBIN	  is	  normally	  not	  expressed,	  would	  change	  its	  replication	  timing	  from	  late	  to	  early	  and	  
conversely	   tethering	   an	   HDAC	   to	   the	   β-­‐GLOBIN	   locus	   in	   an	   erythroid	   cell	   line,	   where	   β-­‐
GLOBIN	   is	  normally	  expressed,	  was	  sufficient	   to	  change	   its	   replication	  timing	   from	  early	   to	  
late	   (Goren	   et	   al.	   2008).	  Use	   of	  HDAC	   inhibitors	   (trichostatin	  A	   and	   sodium	  butyrate)	  was	  
sufficient	  to	  remove	  replication	  imprinting	  signals	  from	  two	  loci	  WT1	  and	  IGF2	  (Bickmore	  et	  
al.	   1995);	   this	   fact	   further	   supports	   the	   correlation	   between	   histone	   acetylation	   and	  
replication	   timing.	  Histone	  acetylation	  has	  been	  hypothesised	   to	   render	   replication	  origins	  
firing	  more	  efficient	  or	  earlier	  at	  the	  affected	  domains	  (Vogelauer	  et	  al.	  2002;	  Aparicio	  et	  al.	  
2004).	   Influence	   of	   other	   histone	  modifications	   remains	   unclear	   and	  may	   be	   restricted	   to	  
specific	   chromatin	   structures,	   such	   as	   repetitive	   satellite	   DNA	   that	   underwent	   replication	  
timing	   changes	   in	   mES	   cells	   lacking	   for	   example	   Dnmt1	   (Jørgensen	   et	   al.	   2007;	   Méndez	  
2009).	  Replication	  timing	  has,	  however,	  been	  found	  to	  be	  correlated	  with	  genomic	  features	  
in	  the	  actual	  DNA	  sequence,	  such	  as	  gene	  density,	  guanine-­‐cytosine	  (GC)-­‐content	  and	   long	  
interspersed	  nuclear	  element	   (LINE)	  density.	   Locus	   specific	  and	  genome-­‐wide	  studies	  have	  
shown	  that	  GC-­‐rich	  and	  gene	  dense	  regions	  tend	  to	  replicate	  early	  in	  S-­‐phase,	  while	  AT-­‐rich,	  
gene-­‐poor	  regions	  with	  high	  LINE	  density	  tend	  to	  replicate	   late	   in	  S-­‐phase	  (Schübeler	  et	  al.	  
2002;	  Hiratani	  et	  al.	  2004;	  Woodfine	  et	  al.	  2004;	  Hiratani	  et	  al.	  2008;	  Ryba	  et	  al.	  2010).	  
Further	  experimental	  evidence	  has	  suggested	  that	  the	  association	  with	  acetylation	  and	  early	  
replication	   is	   not	   just	   a	   passive	   element	   and	   that	   replication	   timing	   might	   play	   a	   role	   in	  
maintaining	  heritable	  epigenetic	  states	  through	  mitosis.	  A	  reporter	  gene	  microinjected	  into	  
early	   S-­‐phase	   nuclei	   was	   assembled	   into	   nucleosomes	   with	   acetylated	   histones	   and	  
expressed	  with	  higher	  efficiency	   than	   the	   same	   reporter	  gene	  microinjected	   into	  nuclei	  of	  
cells	   in	   late	   S-­‐phase,	   which	   was	   preferentially	   assembled	   into	   deacetylated	   nucleosomes	  
(Zhang	   et	   al.	   2002).	   This	   result	   strongly	   suggests	   that	   the	   timing	   of	   replication	   has	   the	  
capacity	   to	   influence	   chromatin	   structure.	   Support	   for	   this	   hypothesis	   comes	   from	   recent	  
studies	   where	   it	   was	   shown	   that	   DNA	   sequences	   originally	   packaged	   into	   nucleosomes	  
containing	  deacetylated	  histones	  during	   late	  S-­‐phase	  become	  reassembled	  with	  acetylated	  
histones	   after	   undergoing	   replication	   in	   early	   S-­‐phase,	   and	   vice	   versa	   (Lande-­‐Diner	   et	   al.	  
2009).	   Consistent	   with	   this	   function	   different	   sets	   of	   chromatin	   assembly	   factors	   and	  
histone-­‐modifying	   enzymes	   are	   present	   at	   the	   replication	   fork	   in	   early	   and	   late	   S-­‐phase	  




and	   chromatin	   structure,	   however	   precisely	   how	   this	   relationship	   operates	   remains	  
unresolved.	   It	   could	   be	   hypothesised	   that	   DNA	   replication	   provides	   a	   means	   to	   inherit	  
chromatin	   states	   that,	   in	   turn,	   regulate	   replication	   timing	   in	   the	   subsequent	   cell	   cycle,	   so	  
that	   once	   a	   timing	   program	   is	   established,	   it	   forms	   a	   self-­‐reinforcing	   auto-­‐regulatory	   loop	  
that	  is	  very	  stable	  for	  many	  generations	  (Hiratani	  et	  al.	  2009a).	  
During	   development	   replication	   timing	   is	   subject	   to	   changes	   across	   different	   loci.	   Studies	  
comparing	   the	   replication	   timing	   of	   a	   panel	   of	   approximately	   50	   tissue-­‐specific	   candidate	  
loci	  in	  mES	  and	  ES-­‐derived	  neuronal	  progenitor	  cells	  demonstrated	  that	  commitment	  to	  the	  
neural	  lineage	  results	  in	  shifts	  of	  replication	  timing	  for	  many	  loci.	  Specifically	  it	  was	  observed	  
that	   many	   ES-­‐associated	   genes	   shifted	   their	   replication	   timing	   towards	   late	   S-­‐phase	   and	  
concurrently	   the	   replication	   timing	   of	   neural	   lineage	   associated	   genes	   was	   advanced	  
towards	   early	   S-­‐phase	   (Hiratani	   et	   al.	   2004;	   Perry	   et	   al.	   2004).	   Furthermore,	   significant	  
deacetylation	  was	  observed	  at	  loci	  that	  underwent	  a	  shift	  from	  early	  to	  late	  replication	  upon	  
differentiation	  from	  ES	  to	  neural	  progenitor	  cells	  (Perry	  et	  al.	  2004).	  A	  subsequent	  candidate	  
based	  study	  compared	   the	   replication	   timing	  of	  a	  panel	  of	   lineage	  specification	  associated	  
loci	   in	  pluripotent	  mES	  cells	  as	  well	  as	  haematopoietic	  stem	  cells	   (HSC)	  and	  T	   lymphocytes	  
(two	   differentiated	   cell	   types)	   (Azuara	   et	   al.	   2006).	  Many	   lineage-­‐specific	   loci	  were	   found	  
replicating	   early	   in	   mES	   cells	   and	   later	   in	   HSC	   and	   T	   cells.	   This	   difference	   was	   observed	  
despite	  the	  fact	  that	  these	  neural-­‐associated	  loci	  were	  not	  expressed	  in	  any	  of	  the	  three	  cell	  
types	  analysed.	  The	  same	  study	  also	  used	  replication	  timing	  analysis	  to	  distinguish	  mES	  cells	  
from	  embryonic	  carcinoma	  (EC)	  cells	  that	  possess	  a	  more	  restricted	  differentiation	  capacity,	  
demonstrating	   that	   the	   replication	   timing	   profiles	   were	   reflective	   of	   the	   potential	   of	   the	  
cells.	   Complementing	   these	   findings,	   further	   genome-­‐wide	   analysis	   confirmed	   similar	   and	  
extensive	  shifts	  in	  replication	  timing	  upon	  stem	  cell	  differentiation,	  as	  seen	  using	  candidate	  
based	   approaches	   (Hiratani	   et	   al.	   2008).	   Taken	   together,	   these	   results	   indicate	   that	  
replication	   timing	   profiling	   can	   be	   used	   to	   identify	   the	   developmental	   stage	   and	   lineage	  
potential	  of	  a	  given	  cell	  population.	  
1.2 Early	  mammalian	  development	  and	  pluripotency	  
1.2.1 Early	  embryo	  development	  
The	  fertilised	  zygote	  has	  the	  potential	  to	  give	  rise,	  via	  intermediate	  cell	  types,	  to	  all	  the	  cells	  
necessary	   to	   form	   an	   adult	   organism.	   During	   normal	   development	   cells	   get	   progressively	  
more	  specialised	  and	  more	  restricted	  in	  their	  potential,	  through	  the	  numerous	  cell	  divisions	  
and	  directed	  differentiation	   to	  specialised	   lineages.	  The	   limited	  availability	  and	  restrictions	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on	  the	  use	  of	  human	  embryos	  and	   in	  vivo	  tissues	  from	  post-­‐implantation	  stages	  mean	  that	  
the	  cellular	  and	  molecular	  mechanisms	  governing	  early	  human	  development	  remain	  poorly	  
understood	  (Niakan	  et	  al.	  2012).	  The	  understanding	  of	  mammalian	  embryology,	  and	  also	  of	  
pluripotent	  stem	  cells,	  is	  based	  mainly	  on	  studies	  in	  the	  mouse	  (Pera	  et	  al.	  2004a),	  however	  
species-­‐specific	  differences	  may	   limit	  the	  extrapolation	  of	  some	  findings	  to	  human	  embryo	  
development	  (Niakan	  et	  al.	  2012).	  
In	  mouse	  development,	  the	  fertilized	  zygote	  undergoes	  a	  series	  of	  cleavage	  divisions	  to	  give	  
rise	   to	   a	   4-­‐cell	   embryo	   at	   day	   2	   of	   embryonic	   development.	   The	   embryo	   then	   develops	  
further	   and	   at	   embryonic	   day	   3	   it	   forms	   a	   compacted	  morula	   (Fig.	   1.4).	   Asymmetrical	   cell	  
divisions	   at	   the	  morula	   stage	   along	   a	   basolateral	   cleavage	   plane	   give	   rise	   to	   two	   distinct	  
subpopulations:	   the	   inner	   cell	   mass	   (ICM)	   and	   trophoectoderm	   (TE).	   Coincident	   with	   the	  
segregation	  of	   the	  TE	  and	   ICM,	   the	  embryo	   cavitates	   to	   form	   the	  blastocyst	   (Arnold	  et	   al.	  
2009).	   Cell	   fate	   studies	   using	   mouse	   chimaeras	   have	   shown	   that	   the	   ICM	   cells	   are	  
pluripotent	   and	   able	   to	   give	   rise	   to	   all	   somatic	   cell	   types	   (Rossant	   2008).	   TE	   cells	   are	  
	  
Figure	  1.4	  Schematic	  representation	  of	  early	  stages	  of	  mouse	  and	  human	  embryo	  development.	  
Prior	   to	   implantation,	   both	   human	   and	   mouse	   embryos	   similarly	   undergo	   cell	   divisions	   culminating	   in	   the	  
development	   of	   a	   blastocyst	   comprising	   a	   discernible	   inner	   cell	   mass	   (ICM)	   and	   trophoectoderm	   (TE).	   The	  
timing	  of	  compaction	  and	  blastocyst	  formation	  differs	  significantly	  between	  mouse	  and	  human	  embryos,	  with	  
human	  embryos	   showing	  delayed	  development	  compared	  with	  mouse	  embryos.	  The	  mouse	  blastocyst	   forms	  
between	  days	  3	  and	  4,	  whereas	  human	  blastocysts	  form	  between	  days	  5	  and	  6.	  Both	  human	  and	  mouse	  pre-­‐
implantation	  blastocysts	  comprise	  an	  outer	  layer	  of	  TE	  cells,	  which	  form	  the	  trophoblast	  lineage	  of	  the	  placenta,	  
and	  an	  ICM	  that	  segregates	  into	  epiblast	  (Epi)	  and	  primitive	  endoderm	  (PrE)	  layers.	  Epiblast	  cells	  eventually	  give	  
rise	  to	  all	  the	  tissues	  of	  the	  future	  foetus,	  whereas	  the	  PrE	  gives	  rise	  to	  extra-­‐embryonic	  endoderm	  (ExEn)	  cells	  
that	  will	  form	  the	  yolk	  sac.	  In	  the	  mouse,	  the	  TE	  gives	  rise	  to	  a	  proliferative	  stem	  cell	  pool	  of	  extra-­‐embryonic	  
ectoderm	  (ExEc)	  cells.	  By	  contrast,	  human	  TE	  gives	  rise	  to	  placental	  villous	  cytotrophoblast	   (VCT)	  cells.	  Figure	  




multipotent,	   only	   being	   able	   to	   contribute	   to	   placental	   tissues,	   including	   the	   extra-­‐
embryonic	   ectoderm	   (ExEc)	   (Arnold	   et	   al.	   2009;	   Niakan	   et	   al.	   2012).	   The	   early	   blastocyst	  
arises	   typically	   at	   embryonic	   day	   3.5	   and	   matures	   to	   the	   late	   blastocyst	   with	   further	  
segregation	   of	   ICM	   cells	   and	   the	   formation	   of	   the	   epiblast	   (Epi)	   and	   primitive	   endoderm	  
(PrE)	   (also	   known	   as	   hypoblast)	   (Fig.	   1.4)	   at	   embryonic	   day	   4.5	   just	   prior	   to	   implantation	  
(Ralston	  et	  al.	  2005;	  Rossant	  et	  al.	  2009).	  The	  cells	  of	  the	  epiblast	   layer	  retain	  pluripotency	  
and	   can	   contribute	   to	   all	   lineages	   of	   the	   adult	   organism,	   as	   shown	   by	   microinjection	  
experiments	   (Gardner	   1998).	   Epiblast	   cells	   in	   the	   pre-­‐implantation	   blastocyst	  mature	   into	  
primed	  epiblast	  of	  the	  post-­‐implantation	  embryo,	  which	  upon	  gastrulation	  gives	  rise	  to	  the	  
three	   germ	   layers	   (ectoderm,	  mesoderm	   and	   endoderm)	   as	   well	   as	   primordial	   germ	   cells	  
(PGCs)	  (Arnold	  et	  al.	  2009).	  Similarly	  to	  the	  TE,	  the	  cells	  from	  the	  PrE	  are	  multipotent,	  giving	  
rise	   to	   the	  parietal	   and	   visceral	   endoderm	   layers	   lining	   the	   yolk	   sac	   (Bielinska	   et	   al.	   1999;	  
Arnold	  et	  al.	  2009).	  In	  addition	  to	  forming	  the	  tissues	  supporting	  the	  developing	  embryo,	  the	  
cells	   of	   the	   TE	   and	   PrE	   lineages	   also	   provide	   signals	   that	   direct	   the	   patterning	   and	  
differentiation	  of	  the	  embryonic	  lineages	  (Rossant	  et	  al.	  2009).	  Human	  and	  mouse	  embryos	  
appear	   morphologically	   similar	   during	   pre-­‐implantation	   development,	   however	   there	   are	  
significant	   differences	   in	   developmental	   timing,	   which	   are	   likely	   caused	   by	   key	  molecular	  
differences	   (Fig.	   1.4)	   (Niakan	   et	   al.	   2012).	   Upon	   implantation	   the	   Epi,	   PrE	   and	   TE	   cells	   in	  
human	  embryos	  give	  rise	  to	  the	  embryo,	  yolk	  sac	  and	  villous	  cytotrophoblast,	  respectively.	  
1.2.2 Embryo-­‐derived	  stem	  cells	  
1.2.2.1 Mouse	  embryo-­‐derived	  stem	  cells	  
A	  number	  of	  different	  types	  of	  stem	  cells	  have	  been	  derived	  from	  the	  mouse	  embryo.	  In	  the	  
pre-­‐implantation	  blastocyst	  three	  lineages	  can	  be	  distinguished,	  namely	  the	  Epi,	  PrE	  and	  TE	  
(Fig.	  1.4).	  Stem	  cells	  have	  been	  derived	  from	  all	  of	  the	  three	  lineages,	  namely	  ES	  cells	  from	  
the	  Epi	  (Evans	  et	  al.	  1981;	  Martin	  1981;	  Brook	  et	  al.	  1997;	  Nichols	  et	  al.	  2009a),	  trophoblast	  
stem	  (TS)	  cells	  from	  the	  TE	  (Tanaka	  et	  al.	  1998)	  and	  extraembryonic	  endoderm	  stem	  (XEN)	  
cells	   from	   the	  PrE	   (Kunath	  et	  al.	   2005).	  These	   three	  different	   cell	   types	   share	   the	  defining	  
features	  of	  stem	  cells,	  i.e.	  being	  able	  to	  self-­‐renew	  without	  differentiating	  and	  thus	  retaining	  
their	  developmental	  potential.	  However,	  they	  display	  distinct	  morphology,	  gene	  expression	  
patterns	  and	  growth	  factor	  requirements,	  reflecting	  their	  lineage	  origins	  (Rossant	  2008).	  All	  
three	  lines	  recapitulate	  the	  lineage	  of	  their	  cognate	  blastocyst	  precursors	  when	  injected	  into	  
blastocysts	   to	   generate	   chimeric	   animals	   (Yamanaka	   et	   al.	   2006).	   Pluripotent	   ES	   cells	   are	  
able	  to	  contribute	  to	  all	  the	  somatic	  lineages	  of	  the	  developing	  foetus,	  but	  only	  poorly	  to	  PrE	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and	   rarely	   to	   TE	   lineages	   (Beddington	   et	   al.	   1989).	   TS	   cells	   are	   only	   able	   to	   contribute	   to	  
trophoblast	   lineages	   (Tanaka	   et	   al.	   1998)	   and	  XEN	   cells	   are	   only	   able	   to	   contribute	   to	   the	  
extra-­‐embryonic	   endoderm	   lineages	   (Kunath	   et	   al.	   2005).	   Key	   transcriptional	   factors	   that	  
regulate	   blastocyst	   lineage	   allocation	   as	   well	   as	   the	   cell	   identity	   of	   embryo-­‐derived	   stem	  
cells	   have	   been	   identified	   and	   these	   include	   Oct4/Sox2/Nanog,	   Cdx2/Eomes/Gata3	   and	  
Gata6/Gata4/Sox17	  in	  Epi	  &	  ES	  cells,	  TE	  &	  TS	  cells	  and	  PrE	  &	  XEN	  cells,	  respectively	  (Ralston	  
et	  al.	  2005;	  Rossant	  2008;	  Home	  et	  al.	  2009;	  Morris	  et	  al.	  2010).	  
Stem	   cells	   have	   also	   been	   isolated	   from	   the	   post-­‐implantation	  mouse	   embryo.	   Embryonic	  
germ	   (EG)	   cells	   were	   derived	   from	   early	   PGC	   cells	   between	   embryonic	   day	   8.5	   and	   11.5	  
(Matsui	   et	   al.	   1992;	   Resnick	   et	   al.	   1992).	   EG	   cells	   are	   pluripotent	   and	   thus	   contribute	   to	  
chimaeras,	   including	   germline	   transmission,	   when	   injected	   into	   blastocysts	   (Matsui	   et	   al.	  
1992;	   Labosky	  et	  al.	  1994).	  More	   recently,	   stem	  cells	  have	  also	  been	  derived	   from	  the	  Epi	  
layer	   of	   post-­‐implantation	   embryonic	   day	   5.5	   to	   6.5	   mouse	   embryos.	   These	   cells,	   named	  
epiblast	   stem	   (EpiS)	   cells,	   are	   pluripotent	   and	   can	   form	  derivatives	   of	   all	   three	   embryonic	  
germ	   layers	   in	   vitro	   and	   in	   vivo	   when	   injected	   into	   immunodeficient	   mice	   to	   form	  
teratocarcinomas.	  However,	  EpiS	  cells	  contribute	  very	  poorly,	  if	  at	  all,	  to	  chimaeras	  and	  the	  
germ	  line	  when	  injected	  into	  blastocysts	  (Brons	  et	  al.	  2007;	  Tesar	  et	  al.	  2007).	  Interestingly,	  
recent	  studies	  have	  demonstrated	  that	  mES	  cells	  can	  be	  converted	  to	  mEpiS	  cells	  and	  vice	  
versa	  by	  genetic	  manipulation	  and	  modification	  of	  the	  culture	  environment,	  highlighting	  the	  
plasticity	   of	   the	   pluripotent	   state	   in	   vitro	   (Bao	   et	   al.	   2009;	   Guo	   et	   al.	   2009;	   Hanna	   et	   al.	  
2009).	  
1.2.2.2 Mouse	  and	  human	  embryonic	  stem	  cells	  
During	  mammalian	  development,	  the	  pluripotent	  state	  exists	  only	  transiently	   in	  vivo	  and	  is	  
lost	  as	   the	  embryo	  develops	  and	   the	  cells	  differentiate	   to	  somatic	   lineages.	   It	   is,	  however,	  
possible	  to	  isolate	  both	  mouse	  and	  human	  pluripotent	  ES	  cells	  ex	  vivo	  under	  defined	  growth	  
conditions	  that	  promote	  proliferation	  of	  the	  pluripotent	  cells	  and	  inhibit	  differentiation	   (Yu	  
et	  al.	  2008).	  
Mouse	   ES	   cells	   were	   first	   derived	   in	   1981	   from	   ICM	   explants	   from	   the	   early	   mouse	  
blastocysts	  that	  were	  grown	   in	  serum-­‐containing	  media	  and	  feeder	  cell	   layers	   (Evans	  et	  al.	  
1981;	  Martin	  1981).	  Under	  appropriate	  culture	  conditions	  mES	  cells	  are	  able	   to	  propagate	  
indefinitely	  in	  a	  self-­‐renewing	  state,	  while	  retaining	  their	  pluripotency.	  If	  injected	  back	  into	  a	  
blastocyst,	  they	  are	  able	  to	  contribute	  to	  all	  tissues	  of	  the	  adult	  organism	  including	  the	  germ	  




single	  blastomeres	  of	  2-­‐	   to	  8-­‐cell	   stage	  mouse	  embryos	   (Eistetter	  1989;	  Chung	  et	  al.	  2006;	  
Wakayama	   et	   al.	   2007).	   It	   is	   thought	   that	   during	   the	   derivation	   process	   the	   isolated	  
blastomeres	  undergo	  cell	  division	  creating	  a	  ‘mini-­‐blastocyst’	  environment,	  from	  which	  mES	  
can	  arise	  (Nichols	  et	  al.	  2011).	  The	  epiblast	  of	  pre-­‐implantation	  embryos	  has	  been	  identified	  
as	  the	  source	  of	  mouse	  ES	  cells,	  and	  it	  is	  thought	  that	  all	  epiblast	  cells	  may	  transiently	  have	  
the	  capacity	  to	  become	  ES	  cells	  (Brook	  et	  al.	  1997;	  Nichols	  et	  al.	  2009a;	  Nichols	  et	  al.	  2011).	  
Derivation	  of	   the	   first	  human	  ES	   cells	   in	  1998	  was	  accomplished	  by	   isolating	   ICM	  explants	  
from	  cultured	  blastocyst	  embryos	  and	  growing	  them	  in	  serum	  containing	  media	  and	  feeder	  
cells,	   in	   a	   similar	   manner	   to	   mES	   cells	   (Thomson	   et	   al.	   1998).	   The	   considerable	   delay	  
between	  the	  successful	  derivation	  of	  mES	  cells	  and	  hES	  cells	  is	  likely	  due	  to	  species-­‐specific	  
ES	  cell	  differences	  and/or	  suboptimal	  human	  embryo	  culture	  media	  (Yu	  et	  al.	  2008).	  Several	  
previous	   attempts	   indeed	   failed	   to	   derive	   hES	   cells.	   For	   example,	   isolation	   of	   human	  
blastocysts	   was	   previously	   reported	   in	   1994	   (Bongso	   et	   al.	   1994),	   but	   their	   subsequent	  
culture	  in	  media	  supplemented	  with	  leukaemia	  inhibitory	  factor	  (LIF)	  and	  serum	  -­‐	  conditions	  
that	   allow	   the	   derivation	   and	   propagation	   of	   mES	   cells	   -­‐	   resulted	   in	   cell	   differentiation.	  
Improvements	  in	  human	  embryo	  culture	  (Gardner	  et	  al.	  1998)	  and	  previous	  experience	  with	  
non-­‐human	   primate	   cell	   lines	   (Thomson	   et	   al.	   1995;	   Thomson	   et	   al.	   1996)	   enabled	   the	  
derivation	  of	  hES	  cells	  in	  1998.	  
Human	  ES	  cells	  maintain	  the	  developmental	  potential	  to	  give	  rise	  to	  derivatives	  of	  all	  three	  
germ	  layers	  even	  after	  prolonged	  undifferentiated	  proliferation	  as	  well	  as	  clonal	  derivation	  
(Amit	  et	  al.	  2000).	  For	  obvious	  ethical	   reasons	   the	  ultimate	  test	   for	  cell	  potency,	  chimaera	  
formation,	  is	  not	  possible	  with	  hES	  cells.	  The	  most	  stringent	  and	  commonly	  used	  alternative	  
is	   the	   injection	   of	   cells	   to	   immunodeficient	   mice	   and	   the	   formation	   of	   teratocarcinomas	  
(Thomson	   et	   al.	   1998).	   Another	   alternative	   is	   in	   vitro	   differentiation	   in	   non-­‐adherent	  
conditions,	  which	  promote	  the	   formation	  of	   three-­‐dimensional	  embryoid	  bodies	   (EBs)	   that	  
mimic	  early	  embryo	  differentiation	  (Vallier	  et	  al.	  2005b).	  In	  addition	  to	  being	  able	  to	  give	  rise	  
to	  the	  three	  germ	  layers,	  and	  in	  contrast	  to	  mES	  cells	  (Beddington	  et	  al.	  1989),	  hES	  cells	  are	  
also	   able	   to	   give	   rise	   to	   extraembryonic	   lineages	   including	   TE	   (Itskovitz-­‐Eldor	   et	   al.	   2000;	  
Reubinoff	  et	  al.	  2000;	  Xu	  et	  al.	  2002)	  as	  well	  as	  PrE	  –like	  cells	  (Pera	  et	  al.	  2004a).	  
In	   the	   same	   way	   as	   mES	   cells,	   human	   ES	   cells	   have	   been	   derived	   from	   morula,	   later	  
blastocyst	  stage	  embryos	  (Stojkovic	  et	  al.	  2004;	  Strelchenko	  et	  al.	  2004),	  single	  blastomeres	  
(Klimanskaya	   et	   al.	   2006)	   and	   parthenogenetic	   embryos	   (Lin	   et	   al.	   2007;	  Mai	   et	   al.	   2007;	  
Revazova	   et	   al.	   2007).	  Whether	   any	  differences,	   especially	  with	   regards	   to	   developmental	  
potential,	  exist	  between	  the	  hES	  cell	   lines	  derived	   from	  these	  various	  sources,	   is	  yet	   to	  be	  
	  
	   	   	  
43	  
determined.	   Recent	   results	   have	   demonstrated	   that	   independently	   derived	   hES	   cell	   lines	  
may	   differ	   significantly	   in	   their	   differentiation	   propensity	   as	   tested	   by	   spontaneous	  
differentiation	  with	  EB	  formation	  or	  directed	  differentiation	  methods	  (Osafune	  et	  al.	  2008).	  
Furthermore,	   recent	   studies	  have	  clearly	   reported	  variability	  between	  hES	  cell	  populations	  
at	   the	   transcriptional	   level	   (Skottman	   et	   al.	   2005;	  Wei	   et	   al.	   2005;	   Adewumi	   et	   al.	   2007;	  
Guenther	  et	  al.	  2010;	  Narva	  et	  al.	  2010;	  Newman	  et	  al.	  2010;	  Amps	  et	  al.	  2011)	  and	  at	  the	  
epigenetic	  level	  (Guenther	  et	  al.	  2010;	  Bruck	  et	  al.	  2011;	  Nazor	  et	  al.	  2012).	  
Although	   the	   evidence	   mentioned	   above	   suggests	   that	   mES	   and	   hES	   cells	   differ	   in	   their	  
developmental	   potency,	   they	   do	   nevertheless	   share	   high	   levels	   of	   alkaline	   phosphatase	  
activity	   (Adewumi	   et	   al.	   2007)	   and	   high	   expression	   of	   key	   TFs	   known	   to	   regulate	   the	  
pluripotent	  state,	  which	  include	  the	  POU-­‐family	  TF	  Oct4	  (Palmieri	  et	  al.	  1994;	  Nichols	  et	  al.	  
1998),	  homeodomain	  DNA-­‐binding	  protein	  Nanog	  (Chambers	  et	  al.	  2003;	  Mitsui	  et	  al.	  2003)	  
and	  the	  SOX-­‐family	  TF	  Sox2	  (Avilion	  et	  al.	  2003;	  Fong	  et	  al.	  2008).	  Mouse	  embryos	  negative	  
for	   Oct4	   are	   unable	   to	   form	   an	   ICM	   and	   consist	   only	   of	   TE	   tissue	   (Nichols	   et	   al.	   1998).	  
Consistently,	  when	  Oct4	  is	  deleted	  from	  mES	  cells,	  they	  convert	  into	  TS-­‐like	  cells	  (Niwa	  et	  al.	  
2000).	  In	  hES	  cells	  knock-­‐down	  of	  OCT4	  expression	  levels	  leads	  to	  differentiation	  towards	  TE	  
phenotype	   (Zaehres	   et	   al.	   2005),	   suggesting	   similar	   function	   in	   both	   mES	   and	   hES	   cells.	  
Mouse	   ES	   cells	   deficient	   for	   Nanog	   are	   still	   able	   to	   self-­‐renew,	   however	   they	   show	   an	  
increased	  propensity	   to	   differentiate	   towards	   XEN-­‐like	   cells	   and	   are	   unable	   to	   give	   rise	   to	  
mature	  germ	  cells	  (Chambers	  et	  al.	  2003;	  Chambers	  et	  al.	  2007).	  In	  hES	  cells	  downregulation	  
of	   NANOG	   causes	   differentiation	   to	   extraembryonic	   lineages	   (Hyslop	   et	   al.	   2005),	   again	  
suggesting	   conserved	   function	   between	   mES	   and	   hES	   cells.	   The	   presence	   of	   maternally	  
derived	  Sox2	  has	  made	  deciphering	  its	  role	  more	  difficult.	  The	  maternal	  contribution	  is	  lost	  
largely	   by	   the	   time	   of	   implantation,	   and	   after	   this	   Sox2	   null	   mouse	   embryos	   generate	  
exclusively	  TE	  and	  PrE	  lineages	  (Avilion	  et	  al.	  2003).	  Similarly	  Sox2	  deletion	  in	  mES	  cells	  also	  
leads	  to	  their	  conversion	  in	  TS-­‐like	  cells	  (Masui	  et	  al.	  2007).	  The	  role	  of	  SOX2	  also	  seems	  to	  
be	   conserved	   in	   hES	   cells,	   as	   knock	   down	   of	   SOX2	   leads	   to	   differentiation	   towards	   a	   TE	  
lineage	  (Fong	  et	  al.	  2008).	  
In	  the	  light	  of	  recent	  evidence	  it	  has	  become	  clear	  that	  mES	  cell	  cultures	  are	  heterogeneous	  
and	   contain	   cells	   in	   different	   interconvertible	   sub-­‐states,	   which	   have	   significant	  
consequences	   on	   their	   behaviour	   and	   differentiation	   ability.	   Expression	   levels	   of	  Rex1	   (an	  
ICM	  related	  marker)	  (Toyooka	  et	  al.	  2008),	  Nanog	  (Chambers	  et	  al.	  2007)	  and	  Stella	  (an	  ICM	  
and	  germ	  cell	  lineage	  related	  marker)	  (Hayashi	  et	  al.	  2008)	  have	  been	  observed	  to	  be	  highly	  




expression	   levels.	   In	   hES	   cell	   cultures	   NANOG	   has	   also	   been	   shown	   to	   have	   variable	  
expression	   levels,	  which	  also	   correlate	  with	   levels	  of,	   for	  example,	  OCT4	   expression	   in	   the	  
same	   cells	   (Fischer	   et	   al.	   2010).	   Furthermore,	   variable	   patterns	   of	   cell	   surface	   marker	  
expression	  in	  pluripotent	  hES	  cells	  also	  points	  to	  the	  existence	  of	  interconvertible	  sub-­‐states	  
of	   the	   stem	   cell	   compartment	   (Enver	   et	   al.	   2005;	   Stewart	   et	   al.	   2006a).	   The	   cell	   surface	  
marker	   stage	   specific	   embryonic	   antigen	  3	   (SSEA3)	  was	  used	   to	   isolate	   SSEA3+	   and	   SSEA3-­‐	  
hES	  sub-­‐populations	   from	  pluripotent	  hES	  cultures,	  and	  subsequent	  analysis	   indicated	  that	  
these	   sub-­‐populations	  have	  different	  phenotypes	  with	   SSEA3+	   cells	   being	   truly	   pluripotent	  
and	  SSEA3-­‐	  possibly	  representing	  culture	  adapted	  cells	  that,	  although	  not	  truly	  pluripotent,	  
retain	   multilineage	   differentiation	   potential	   (Enver	   et	   al.	   2005).	   Moreover,	   similar	  
interconvertible	  sub-­‐states	  have	  also	  been	  identified	  in	  adult	  stem	  cell	  populations	  (Hu	  et	  al.	  
1997;	  Booth	  et	  al.	  2000;	  Jones	  et	  al.	  2007).	  
1.2.3 Extrinsic	   signalling	   pathways	   that	   regulate	   the	   pluripotent	   state	   in	  
vitro	  
Despite	  the	  fact	  that	  both	  mES	  and	  hES	  cells	  are	  pluripotent	  and	  are	  controlled	  by	  the	  same	  
key	   transcription	   factors	   (Oct4,	  Sox2	  and	  Nanog)	   there	  are	  numerous	  differences	  between	  
the	  two	  pluripotent	  cell	  populations.	  Phenotypically	  mES	  cell	  colonies	  are	  round	  and	  dome-­‐
shaped	  whereas	  hES	  cells	   grow	   in	   colonies	   that	  are	   flatter	  and	  often	  display	  more	  distinct	  
colony	  borders	  (Pera	  et	  al.	  2004b).	  The	  initial	  derivation	  of	  both	  mouse	  and	  human	  ES	  cells	  
was	   done	   in	   serum	   containing	   media	   with	   mitotically	   inactivated	   fibroblast	   feeder	   cells	  
(Evans	  et	  al.	  1981;	  Martin	  1981;	  Thomson	  et	  al.	  1998).	  The	  fact	  that	  fibroblast	  feeder	  layers	  
support	   both	   mouse	   and	   human	   ES	   cells,	   however,	   now	   appears	   largely	   to	   be	   a	   lucky	  
coincidence,	  as	  the	  specific	  factors	  used	  to	  sustain	  mouse	  ES	  cells	  do	  not	  support	  human	  ES	  
cells	  (Yu	  et	  al.	  2008).	  
Undifferentiated	  mES	  cells	  can	  be	  maintained	  self-­‐renewing	   in	  media	  containing	  foetal	  calf	  
serum	   (FCS)	   supplemented	   with	   the	   cytokine	   LIF,	   which	   was	   identified	   from	   media	  
conditioned	  with	   feeder	   cells	   (Smith	   et	   al.	   1988;	  Williams	   et	   al.	   1988).	   LIF	   and	   its	   related	  
cytokines	  act	  via	  the	  gp130	  and	  LIF	  receptors	  (Yoshida	  et	  al.	  1994).	  Binding	  of	  LIF	  leads	  to	  the	  
heterodimerisation	   of	   gp130	   and	   LIF	   receptors	   and	   the	   subsequent	   activation	   of	   the	   JAK-­‐
STAT3	  pathway	   (Yoshida	  et	  al.	  1994;	  Niwa	  et	  al.	  1998).	  Activated	  Stat3	   translocates	   to	   the	  
nucleus	  and	  regulates	  the	  levels	  of	  genes	  essential	  for	  mES	  pluripotent	  identity	  (Niwa	  et	  al.	  
1998;	  Raz	  et	  al.	  1999).	  Mouse	  ES	  cells	  that	  have	  been	  transfected	  with	  constitutively	  active	  
Stat3	   are	   rendered	   LIF	   independent	   (Matsuda	   et	   al.	   1999),	   whereas	   withdrawal	   of	   LIF	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supplementation	   from	   normal	   mES	   cultured	   with	   media	   containing	   FCS	   leads	   to	  
differentiation	  to	  a	  mixture	  of	  lineages	  (Nichols	  et	  al.	  2001).	  When	  mES	  cells	  are	  cultured	  in	  
serum	   free	   media,	   LIF	   alone	   is	   not	   sufficient	   to	   prevent	   differentiation,	   however	   in	  
combination	  with	  supplementation	  by	  bone	  morphogenetic	  protein	  [BMP;	  a	  member	  of	  the	  
transforming	   growth	   factor-­‐β	   (TGF-­‐β)	   family]	   the	   pluripotent	   identity	   of	   mES	   cells	   is	  
sustained	   (Ying	   et	   al.	   2003).	   BMPs	   induce	   expression	   of	   inhibitor	   of	   differentiation	   (Id)	  
proteins	  via	  the	  activation	  of	  Smad1/5/8	  pathway.	  The	  LIF/Stat3	  and	  BMP/Id	  signalling	  act	  in	  
combination	  to	  prevent	  differentiation	  towards	  mesoderm	  &	  endoderm	  and	  neuroectoderm	  
respectively	  and	  thus	  maintain	  undifferentiated	  mES	  cells	  (Ying	  et	  al.	  2003).	  More	  recently	  it	  
has	   been	   shown	   that	   mES	   cells	   can	   be	   efficiently	   derived	   and	   maintained	   in	   an	  
undifferentiated	   state	   in	   serum	   free	  medium	   by	   use	   of	   small	  molecules	   to	   inhibit	   specific	  
kinases.	   The	   combination	   of	   two	   specific	   inhibitors	   (2i),	   PD184352	   and	   CHIR99021,	   which	  
target	  MEK/Erk	  and	  Gsk3	  signalling	  pathways,	  respectively	  (Ying	  et	  al.	  2008)	  allows	  for	  mES	  
culture	   in	   the	  absence	  of	   cytokine	   supplementation.	   In	  essence,	   the	   inhibition	  of	  MEK/Erk	  
signalling	   in	   the	  developing	  mouse	  embryo	  abrogates	  the	  pro-­‐differentiation	  activities	   that	  
are	  promoted	  during	  normal	  development	   (Nichols	  et	  al.	  2009a).	  Gsk3	   inhibition	  enhances	  
the	  expansion	  of	  the	  mES	  cultures,	  but	  the	  mechanism	  for	  this	  remains	  unclear,	  although	  it	  
is	  known	  to	  lead	  to	  the	  activation	  of	  the	  Wnt/β-­‐catenin	  pathway	  (Sato	  et	  al.	  2004;	  Ying	  et	  al.	  
2008).	   It	   has	   been	   suggested	   that	   mES	   cells	   maintained	   in	   serum-­‐free	   conditions	   with	   2i	  
might	   represent	   the	   ‘ground-­‐state’	  of	  pluripotency	  that	  exists	   transiently	   in	   the	  epiblast	  of	  
pre-­‐implantation	   blastocysts	   (Ying	   et	   al.	   2008;	   Nichols	   et	   al.	   2009a;	   Nichols	   et	   al.	   2009b;	  
Nichols	  et	  al.	  2011).	  
Human	  ES	  cells	  are	  not	  responsive	  to	  LIF	  signalling	  and	  media	  containing	  serum	  and	  LIF	  fails	  
to	   support	   undifferentiated	   hES	   cultures	   (Thomson	   et	   al.	   1998;	   Daheron	   et	   al.	   2004).	   In	  
addition	   to	   this,	   BMPs	   induce	   hES	   cultures	   to	   differentiate	   towards	   TE	   (Xu	   et	   al.	   2002;	  
Gerami-­‐Naini	  et	  al.	  2004;	  Pera	  et	  al.	  2004a).	  In	  contrast	  to	  mES	  cells,	  fibroblast	  growth	  factor	  
(FGF)	   and	   TGF-­‐β/Activin	   signalling	   are	   central	   to	   the	   maintenance	   of	   hES	   cell	  
undifferentiated	   phenotype	   (Yu	   et	   al.	   2008).	   Initial	   experiments	   indicated	   that	  
supplementation	   by	   FGF2	   was	   necessary	   for	   extended	   culture	   and	   maintenance	   of	  
undifferentiated	  hES	   colonies	  on	   feeder	   cells	   (Amit	  et	  al.	   2000).	   Further	   research	   revealed	  
that	   used	   at	   an	   increased	   concentration	   FGF2	   allows	   for	   feeder-­‐independent	   culture	   of	  
undifferentiated	  hES	  cells	  in	  serum	  replacement	  medium	  (Wang	  et	  al.	  2005;	  Xu	  et	  al.	  2005;	  
Levenstein	  et	  al.	  2006).	  The	  mechanisms,	  by	  which	  FGF2	  action	  is	  conferred	  in	  hES	  cultures,	  




been	   proposed	   for	   this	   growth	   factor.	   FGF2	   was,	   for	   example,	   shown	   to	   suppress	   BMP	  
activity	  present	  in	  serum	  and	  serum	  replacement	  medium	  that	  can	  induce	  differentiation	  in	  
hES	   cells	   (Xu	   et	   al.	   2005).	   FGF2	   has	   also	   been	   reported	   to	   promote	   the	   expression	   of	  
members	  of	  the	  TGF-­‐β	   family	   in	  hES	  cells,	  and	  also	  feeder	  cells,	  which	  can	  in	  turn	  enhance	  
self-­‐renewal	  (Greber	  et	  al.	  2007).	  To	  promote	  hES	  self-­‐renewal,	  FGF2	  signalling	  has	  also	  been	  
shown	  to	  co-­‐operate	  with	  insulin-­‐like	  growth	  factor	  (IGF)	  produced	  in	  a	  paracrine	  manner	  by	  
fibroblast-­‐like	   cells	  within	   the	  hES	   cell	   cultures	   (Bendall	   et	   al.	   2007).	   IGF	   signalling	   cannot,	  
however,	   substitute	   FGF2	   signalling	   to	   support	   self-­‐renewal	   in	   hES	   cells,	   and	   it	   has	   been	  
shown	   that	   withdrawal	   of	   FGF2	   promotes	   apoptosis	   in	   addition	   to	   differentiation	   in	   hES	  
cultures	  (Wang	  et	  al.	  2009a).	  
Both	  TGF-­‐β	  and	  Activin	  have	  strong	  positive	  effects	  on	  undifferentiated	  proliferation	  of	  hES	  
cells	   in	   the	   presence	   of	   low	   or	   modest	   concentrations	   of	   FGF2,	   and	   based	   on	   inhibitor	  
studies,	   it	   has	   been	   suggested	   that	   this	   signalling	   pathway	   is	   essential	   for	   hES	   cell	   self-­‐
renewal	  and	  pluripotency	  (Beattie	  et	  al.	  2005;	  James	  et	  al.	  2005;	  Vallier	  et	  al.	  2005a;	  Xiao	  et	  
al.	   2006).	   Signalling	   from	   the	   TGF-­‐β/Activin	   pathway	   acts	   via	   phosphorylated	   SMAD2/3	  
(Schmierer	   et	   al.	   2007).	   Inhibiting	   TGF-­‐β/Activin	   signalling	   in	   hES	   cells	   with	   a	   chemical	  
inhibitor	   SB431542	   leads	   to	   a	   reduction	   in	   the	   levels	   of	   phosphorylated	   SMAD2/3	   and	  
induces	   differentiation	   (James	   et	   al.	   2005;	   Vallier	   et	   al.	   2005a;	   Xiao	   et	   al.	   2006).	   Recent	  
evidence	  has	  shown	  that	  SMAD2/3	  directly	  binds	  the	  NANOG	  proximal	  promoter	  in	  hES	  cells	  
and	   regulates	   the	   levels	   of	   its	   expression	   (Xu	   et	   al.	   2008;	   Vallier	   et	   al.	   2009a).	   Other	  
signalling	   pathways	   have	   been	   implicated	   in	   the	   regulation	   of	   hES	   self-­‐renewal,	   however	  
remain	   less	   well	   defined.	   Previously	   it	   has	   been	   reported	   that	   Wnt/β-­‐catenin	   signalling	  
would	   be	   beneficial	   for	   hES	   self-­‐renewal	   (Sato	   et	   al.	   2004),	   however	   recent	   data	   from	  
experiments	  inhibiting	  the	  Wnt/β-­‐catenin	  pathway	  in	  hES	  showed	  no	  effect	  on	  self-­‐renewal	  
(Davidson	   et	   al.	   2012).	   The	   PI3K/Akt	   pathway	   has	   recently	   also	   been	   implicated	   in	  
maintenance	   of	   hES	   pluripotency.	   PI3K/Akt	   signalling	   has	   been	   shown	   to	   modulate	   the	  
activity	   of	   TGF-­‐β/Activin	   signalling	   in	   promotion	   of	   self-­‐renewal	   in	   crosstalk	  with	  MEK/Erk	  
and	  Wnt/β-­‐catenin	   signalling	   (Chen	  et	  al.	  2012;	  Singh	  et	  al.	  2012).	  Hence,	   coordinated	  yet	  
complicated	   interactions	   between	   signalling	   networks	   are	   likely	   to	   govern	   the	   balance	  
between	   self-­‐renewal	   and	   differentiation	   in	   hES	   cells.	   Defining	   the	   exact	   mechanisms	  
regulating	   these	   decisions	   will	   be	   of	   great	   importance	   for	   possible	   future	   applications	   in	  
regenerative	  medicine.	  
Mouse	  EpiS	  cells	  derived	  from	  post-­‐implantation	  embryos	  are	  maintained	  self-­‐renewing	  in	  a	  
pluripotent	   state	   by	   Fgf2	   and	   Activin	   A	   supplementation	   (Brons	   et	   al.	   2007;	   Tesar	   et	   al.	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2007);	  the	  key	  signalling	  pathways	  also	  implicated	  in	  maintenance	  of	  hES	  pluripotent	  state.	  
TGF-­‐β/Activin	   signalling	   promotes	   the	   expression	   of	   Nanog	   via	   the	   SMAD2/3	   pathway,	  
which,	   in	   turn,	   maintains	   a	   self-­‐renewing	   mEpiS	   state	   (Greber	   et	   al.	   2010),	   in	   a	   similar	  
manner	   to	   hES	   cells.	   Moreover,	   blocking	   TGF-­‐β/Activin	   signalling	   induces	   differentiation	  
towards	  the	  neural	  lineage	  in	  mEpiS	  cells	  and	  in	  hES	  cells	  (Vallier	  et	  al.	  2009a;	  Greber	  et	  al.	  
2010).	  Interestingly,	  Fgf2	  signalling	  in	  mEpiS	  cells	  has	  a	  role	  in	  maintaining	  the	  EpiS-­‐identity,	  
as	   blocking	   Fgf2	   signalling	   in	  mEpiS	   cells	   leads	   to	   the	   spontaneous	   generation	   of	  mES-­‐like	  
colonies	  (Greber	  et	  al.	  2010).	  The	  effect	  of	  Fgf2	  signalling	  maintaining	  a	  mEpiS-­‐identity	  can	  
be	  overcome,	  however,	   by	   constitutive	   activation	  of	   JAK-­‐STAT3	  pathway,	  which	  allows	   for	  
reversion	  of	  mEpiS	  cells	   to	  mES	  cell	   like	  naïve	  pluripotent	   identity	  even	   in	  the	  presence	  of	  
Fgf2	  and	  Activin	  A	  supplementation	  (van	  Oosten	  et	  al.	  2012).	  
1.2.4 Transcriptional	  networks	  that	  control	  pluripotency	  
In	  both	  mouse	  and	  human	  ES	  cells	  the	  key	  transcription	  factors	  Oct4,	  Sox2	  and	  Nanog	  are	  at	  
the	  centre	  of	  a	  regulatory	  network	  crucial	  for	  the	  maintenance	  of	  pluripotency	  (Boyer	  et	  al.	  
2005;	  Loh	  et	  al.	  2006;	  Kim	  et	  al.	  2008;	  Mathur	  et	  al.	  2008;	  Kunarso	  et	  al.	  2010).	  The	  same	  
network	   has	   also	   been	   shown	   to	   be	   critical	   for	   the	   development	   of	   the	   transiently	  
pluripotent	  cell	  population	  in	  vivo.	  Data	  from	  genome-­‐wide	  studies	  demonstrated	  that	  Oct4,	  
Sox2	   and	   Nanog	   bind	   together	   at	   their	   own	   promoters	   forming	   interconnected	   auto-­‐
regulatory	   loops	  that	  maintain	  the	  expression	  of	  these	  key	  factors	   in	  ES	  cells.	  Furthermore	  
the	   three	   factors	   often	   co-­‐occupy	   common	   target	   genes	   including	   important	   self-­‐renewal	  
regulators	   that	   are	   strongly	   expressed	   in	   ES	   cells	   as	  well	   as	   somatic	   lineage-­‐specific	   genes	  
that	   are	   inactive	   but	   poised	   for	   future	   activation	   in	   ES	   cells	   (Jaenisch	   et	   al.	   2008;	   Young	  
2011).	   These	   findings	   together	   suggest	   that	  Oct4,	   Sox2	   and	  Nanog	   are	   so-­‐called	   ‘master	  
regulators’	   of	   the	   pluripotent	   stem	   cell	   identity	   (Spivakov	   et	   al.	   2007).	   However,	   it	   is	  
important	  to	  note	  that	  the	  pluripotency	  network	  is	  very	  complex	  and	  involves	  an	  extending	  
number	   of	   new	   effector	   proteins,	   such	   as	   nuclear	   receptor	   Esrrb	   and	   co-­‐activator	   Ncoa3	  
(Zhang	  et	  al.	  2008;	  Percharde	  et	  al.	  2012).	  
1.2.5 	  Epigenetic	  regulation	  of	  pluripotency	  
Recent	   studies	   have	   indicated	   that	   ES	   cell	   chromatin	   exists	   in	   an	   ‘open’	   state,	   which	   is	  
transcriptionally	   ‘permissive’	   and	   is	   proposed	   to	   allow	   the	   transcriptional	   programme	   to	  
switch	  rapidly	  upon	  differentiation	  (Meshorer	  et	  al.	  2006;	  Efroni	  et	  al.	  2008;	  Gaspar-­‐Maia	  et	  
al.	   2009;	   Gaspar-­‐Maia	   et	   al.	   2011).	   Interestingly,	   genome-­‐wide	   analysis	   of	   the	   repressive	  




methylation	   covering	   between	   10%	   and	   46%	   of	   the	   genome	   depending	   on	   the	   specific	  
tissue,	   in	   contrast,	   pluripotent	   ES	   cells	   were	   shown	   to	   only	   have	   H3K9me2	   enriched	   only	  
through	  4%	  of	  the	  genome	  (Wen	  et	  al.	  2009).	  Analysis	  of	  tissue-­‐specific	  genes	  in	  pluripotent	  
ES	  cells	  has	  revealed	  that	  many	  of	  them	  are	  not	  actively	  transcribed	  or	  repressed,	  but	  poised	  
for	   transcription.	   Promoters	   of	   such	   poised	   genes	   carry	   both	   repressive	   (H3K27me3)	   and	  
active	   (H3K4me3)	   histone	   modifications,	   forming	   so	   called	   bivalent	   chromatin	   domains	  
(Azuara	   et	   al.	   2006;	   Bernstein	   et	   al.	   2006).	   These	   domains	   are	   thought	   to	   prime	   tissue-­‐
specific	  genes	  for	  future	  activation	  (or	  repression)	  upon	  ES	  cell	  differentiation,	  yet	  preclude	  
their	   premature	   expression	   through	   PRC2-­‐mediated	   repression	   (Giadrossi	   et	   al.	   2007;	  
Spivakov	  et	  al.	  2007).	  Consistent	  with	  gene	  priming,	  bivalently	  marked	  promoters	  have	  also	  
been	  shown	  to	  assemble	  RNA	  polymerase	   II	   complexes,	  preferentially	  harbouring	  a	  poised	  
conformation	   that	   is	   enforced	   by	   the	   presence	   of	   PRC1	   complexes	   (Stock	   et	   al.	   2007;	  
Brookes	  et	  al.	  2012).	  Upon	  genetic	  disruption	  of	  the	  PRC2	  components	  Eed	  or	  Suz12	  (Azuara	  
et	  al.	  2006;	  Boyer	  et	  al.	  2006;	  Lee	  et	  al.	  2006)	  or	  the	  PRC1	  component	  Ring1B	  (Jørgensen	  et	  
al.	   2006;	   Stock	   et	   al.	   2007),	  many	   developmental	   PcG	   target	   genes	   become	   derepressed,	  
demonstrating	  the	   importance	  of	  polycomb-­‐mediated	  gene	  silencing	   in	  ES	  cells.	   It	  has	  also	  
been	  shown	  that	  bivalent	  domains	  generally	  become	  resolved	  at	  lineage-­‐specific	  genes	  upon	  
differentiation	   of	   ES	   cells,	   with	   lineage-­‐specific	   genes	   retaining	   the	   active	   H3K4me3	  mark	  
and	  losing	  the	  repressive	  H3K27me3	  in	  their	  cognate	  lineage	  and	  vice	  versa	  in	  other	  lineages	  
(Bernstein	  et	  al.	  2006;	  Mikkelsen	  et	  al.	  2007).	  
1.2.6 The	   in	   vivo	   equivalence	   of	   mouse	   and	   human	   ES	   cells	   –	   a	  
developmental	  paradox	  
Both	   mouse	   and	   human	   ES	   cells	   can	   be	   derived	   from	   ICM	   explants	   of	   pre-­‐implantation	  
embryos,	   and	   both	   cell	   populations	   are	   pluripotent	   and	   under	   the	   regulation	   of	   the	   key	  
transcription	  factors	  Oct4,	  Sox2	  and	  Nanog.	  However,	  clear	  differences	  exist	  between	  these	  
two	  types	  of	  pluripotent	  cells	  (Rossant	  2011).	  As	  mentioned	  before,	  mES	  and	  hES	  cells	  grow	  
in	  morphologically	  different	   colonies,	  with	  mES	   cells	   growing	  as	   three-­‐dimensional,	   dome-­‐
shaped	  colonies	  whereas	  hES	  cells	  grow	  in	  colonies	  as	  thin	  and	  flat	  layers.	  The	  two	  cell	  types	  
also	   differ	   in	   their	   expression	   of	   cell-­‐surface	   markers,	   with	   SSEA1	   and	   SSEA3/4	   being	  
specifically	  expressed	  in	  undifferentiated	  mES	  and	  hES	  cells,	  respectively	  (Pera	  et	  al.	  2004a;	  
Pera	  et	  al.	  2010).	  Further	  evidence	  of	  the	  divergent	  nature	  of	  mouse	  and	  human	  pluripotent	  
ES	   cells	   comes	   from	   the	   low	   overlap	   of	   target	   genes	   regulated	   by	   the	   Oct4/Sox2/Nanog	  
transcriptional	   network	   (Boyer	   et	   al.	   2005;	   Loh	   et	   al.	   2006),	   which	   suggests	   that	   the	  
pluripotent	  states	  differ	  between	  mES	  and	  hES	  cells.	  It	  has	  to	  be	  noted,	  however,	  that	  these	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studies	   were	   performed	  with	   different	   technology	   platforms,	   which	   is	   likely	   to	   explain	   at	  
least	  some	  of	  the	  lack	  of	  overlap	  (Rossant	  2008).	  
One	  interesting	  difference	  between	  mES	  and	  hES	  cells	  is	  that	  hES	  cells	  are	  able	  to	  give	  rise	  to	  
extra-­‐embryonic	   tissues	   (Itskovitz-­‐Eldor	   et	   al.	   2000;	   Reubinoff	   et	   al.	   2000;	   Xu	   et	   al.	   2002)	  
whereas	   this	   has	   not	   been	   reported	   for	   mES	   cells.	   One	   possible	   explanation	   for	   this	  
discrepancy	   could	   be	   that	   hES	   cells	   are	   in	   a	   pre-­‐epiblast	   stage	   of	   commitment,	   where	   all	  
lineage	  options	   including	  TE	  are	   still	   open,	  whereas	  mES	  cells	  might	   represent	   the	  already	  
lineage-­‐restricted	  epiblast	  progenitor	  of	  the	  blastocyst.	  This	  could	  relate	  to	  the	  slower	  pace	  
of	  lineage	  restriction	  in	  the	  early	  stages	  of	  human	  development	  compared	  with	  mouse	  (See	  
Fig.	   1.4)	   (Pera	   et	   al.	   2004a;	   Niakan	   et	   al.	   2012).	   However,	   the	   recent	   derivation	   of	  mEpiS	  
cells,	   a	   pluripotent	   stem	   cell	   population	   derived	   from	   post-­‐implantation	   mouse	   embryos	  
(Brons	   et	   al.	   2007;	   Tesar	   et	   al.	   2007),	  which	   have	   properties	   closely	   resembling	   hES	   cells,	  
contradicts	   such	   interpretation.	   Both	   hES	   and	  mEpiS	   cells	   are	  maintained	   in	   a	   pluripotent	  
state	  with	  FGF	  and	  TGF-­‐β/Activin	  signalling,	  in	  contrast	  to	  the	  LIF/BMP	  signalling	  required	  for	  
mES	  pluripotency	  (Brons	  et	  al.	  2007;	  Tesar	  et	  al.	  2007)	  and	  interestingly	  recent	  genome-­‐wide	  
DNA	  replication	  timing	  studies	  have	  indicated	  that	  hES	  replication	  timing	  profiles	  align	  more	  
closely	   to	   those	   of	  mEpiS	   than	   of	  mES	   cells	   (Ryba	   et	   al.	   2010).	   However,	   there	   are	  many	  
crucial	   differences	   between	   hES	   and	   mEpiS	   cells	   (reviewed	   in	   Pera	   and	   Tam,	   2010).	   For	  
example,	  hES	  cells	  express	  genes	  such	  as	  DPPA3,	  KLF4	  and	  REX1,	  which	  are	  not	  expressed	  in	  
mEpiS	  cells	  and	  conversely	  hES	  cells	  lack	  expression	  of	  FGF5,	  a	  marker	  of	  mEpiS	  cells	  (Pera	  et	  
al.	  2010).	  
As	   already	   mentioned	   before	   mES	   cell	   cultures	   are	   heterogeneous	   and	   contain	   cells	   in	  
different	   interconvertible	   sub-­‐states.	  Mouse	  ES	   cells	   expressing	  high	   levels	  of	  Nanog	  were	  
found	   to	   have	   higher	   self-­‐renewal	   capabilities	   as	   compared	   to	   cells	   with	   low	   Nanog	  
expression,	  which	  are	  prone	  to	  differentiate	  (Chambers	  et	  al.	  2007).	  In	  similar	  analysis,	  mES	  
cells	   with	   high	   expression	   of	   Stella	   were	   found	   correlate	   with	   an	   ICM-­‐like	   phenotype	   in	  
contrast	   to	   Stella-­‐negative	   cells,	   which	   were	   more	   like	   the	   post-­‐implantation	   epiblast	  
derived	  mEpiS	  cells	   (Hayashi	  et	  al.	  2008).	  Recently	   it	  has	  been	  shown	   that	  mEpiS	  cells	   can	  
also	  be	  isolated	  from	  pre-­‐implantation	  mouse	  embryos	  alongside	  mES	  cells	  when	  derived	  in	  
specific	  culture	  conditions	  in	  the	  absence	  of	  any	  growth	  factor	  additives	  (Najm	  et	  al.	  2011).	  
In	   addition	   to	   this,	   early	   and	   late	   pre-­‐gastrulation	   epiblast	   like	   stages	   could	   be	   delineated	  
within	  mEpiS	  cell	  cultures,	  using	  an	  Oct4-­‐green	  fluorescent	  protein	  (GFP)	  reporter,	  forming	  
different	  subpopulations	  (Han	  et	  al.	  2010).	  Notably,	  the	  Oct4-­‐GFP	  positive	  early	  epiblast-­‐like	  




epiblast-­‐like	  cells.	  These	  data	  strongly	  suggest	  that	  the	  pluripotent	  state	  in	  mouse	  cells	  exists	  
in	  a	  continuum	  of	  phenotypically	  and	  functionally	  distinct	  states.	  
One	  hypothesis	  to	  explain	  the	  similarity	  between	  mEpiS	  and	  hES	  cells	  could	  be	  that	  during	  
the	  process	  of	  derivation	  from	  the	  ICM	  explant	  hES	  cells,	  would	  continue	  to	  develop	  and	  the	  
cells	   isolated	   preferentially	   adopt	   a	   primed	  mEpiS-­‐like	   pluripotent	   state	   in	   culture,	   rather	  
than	   ground-­‐state	  mES-­‐like	   pluripotency	   (Nichols	   et	   al.	   2011).	   Recent	   studies	   tracking	   the	  
derivation	  process	  of	  hES	  cells,	  have	  identified	  a	  post-­‐ICM	  intermediate	  (PICMI),	  a	  transient	  
morphologically	   distinct	   epiblast-­‐like	   structure,	   which	   is	  OCT4	   and	  NANOG	   positive	   and	   is	  
both	  necessary	  and	  sufficient	  for	  hES	  derivation	  (O'Leary	  et	  al.	  2012).	  This	  study,	  however,	  
did	   not	   find	   a	   correlation	  with	   the	   PICMI	   and	  mES-­‐like	   naïve	   pluripotent	   state.	   Human	   ES	  
cells	   with	   properties	   similar	   to	   mES	   cells	   have	   been	   derived	   via	   the	   ectopic	   induction	   of	  
OCT4,	  KLF2	  and	  KLF4	   (Hanna	  et	  al.	  2010a),	  however	  these	  cells	  are	  metastable	  and	  remain	  
dependent	  on	  transgene	  expression.	  The	  true	  embryological	  equivalence	  of	  hES	  cells	  to	  mES	  
or	  mEpiS	  cells	  pluripotent	  state	  remains	  largely	  unresolved	  and	  further	  research	  is	  needed	  to	  
determine	   whether	   similar	   continuum	   of	   pluripotency	   exists	   in	   humans	   as	   has	   been	  
identified	  in	  mouse.	  
1.2.7 Reprogramming	  to	  pluripotency	  
The	  gene	  expression	  patterns	  that	  give	  each	  cell	  type	  its	  identity	  are	  governed	  by	  epigenetic	  
mechanisms,	  which	  during	  development	  allow	  for	  the	  stable	  inheritance	  of	  a	  differentiated	  
phenotype	   in	   lineage	   committed	   cells.	   Under	   certain	   conditions,	   differentiated	   cells	   can,	  
however,	  revert	   into	  a	   less	  differentiated	  state,	  a	  process	  termed	  ‘nuclear	  reprogramming’	  
(Hochedlinger	   et	   al.	   2009).	   Reprogramming	   cells	   to	   pluripotency	   offers	   unprecedented	  
potential	  for	  disease	  research,	  drug	  screening,	  toxicology	  and	  regenerative	  medicine	  via	  the	  
possibility	   of	   generating	   disease	   specific	   cell	  models	   and	   possible	   patient	   specific	   cells	   for	  
grafting	   (Yamanaka	   2009).	   Different	   experimental	   strategies	   for	   nuclear	   reprogramming	  
have	  been	   created	   including	   somatic	   cell	   nuclear	   transfer	   (SCNT)	   (Gurdon	  1962),	   fusion	  of	  
different	   cell	   types	   (Miller	   et	   al.	   1976)	   and	   induction	   by	   specific	   factors	   (Takahashi	   et	   al.	  
2006).	  
Initial	  experiments	  on	  SCNT	  were	  developed	  to	  assess	  whether	  the	  nuclei	  of	  differentiated	  
cells	   retain	  all	   the	  genetic	   information	   required	   for	   the	  development	  of	   a	  whole	  organism	  
(Hochedlinger	  et	  al.	  2009).	  These	  were	  also	  the	  first	  experiments	  of	  nuclear	  reprogramming.	  
The	   transfer	   of	   a	   differentiated	   cell	   nucleus	   into	   an	   enucleated	   oocyte	   was	   able	   to	  
reprogram	   the	   differentiated	   nucleus	   to	   the	   state	   of	   a	   zygote,	   indicating	   that	   the	   oocyte	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contains	   factors	   able	   to	   induce	   reprogramming.	   Initial	   experiments	   were	   conducted	   in	  
amphibians	  (Gurdon	  1962),	  and	  only	  much	  later	  this	  was	  also	  repeated	  in	  mammals	  (Wilmut	  
et	   al.	   1997;	  Hochedlinger	  et	   al.	   2002).	  Only	   very	   recently	   SCNT	  has	  been	  achieved	   in	  non-­‐
human	   primates	   (Byrne	   et	   al.	   2007),	   indicating	   the	   challenging	   nature	   of	   this	   technique.	  
Similar	   successful	   SCNT	   has	   yet	   to	   be	   reported	   for	   human	   cells,	   however	   it	   was	   recently	  
reported	  that	  injection	  of	  a	  somatic	  genome	  into	  a	  human	  oocyte	  that	  was	  not	  enucleated	  
allows	   for	   embryonic	   development	   up	   to	   the	   blastocyst	   stage	   through	   the	   formation	   of	   a	  
triploid	  embryo	  (Noggle	  et	  al.	  2011).	  Due	  to	  the	  very	  low	  efficiency	  and	  numerous	  technical	  
challenges	   as	  well	   as	   the	  ethical	   questions	  with	   regards	   to	   the	  use	  of	   human	  oocytes	   and	  
development	  of	  cloned	  embryos,	  SCNT	  is	  unlikely	  to	  be	  practical	  for	  widespread	  clinical	  use.	  
Nuclear	   reprogramming	   can	   also	   occur	   upon	   cell	   fusion,	   as	   first	   achieved	   using	  mouse	   EC	  
cells	   and	   thymocytes	   (Miller	   et	   al.	   1976).	  Cell	   fusion	   creates	   cells	  harbouring	   two	  or	  more	  
nuclei	   sharing	   the	   same	   cytoplasm,	   termed	   heterokaryon	   if	   the	   fused	   cells	   originate	   from	  
different	   tissues	   or	   species.	   If	   heterokaryons	   are	   maintained	   in	   culture	   for	   several	   days,	  
hybrids	   will	   form	   upon	   cell	   division	   and	   nuclear	   fusion	   (Kikyo	   et	   al.	   2000).	   In	   most	   cell	  
hybrids,	  the	  phenotype	  of	  the	  less	  differentiated	  cell	  is	  dominant	  over	  the	  phenotype	  of	  the	  
more	  differentiated	  fusion	  partner.	  This	  was	  evident	  in	  the	  first	  fusions	  between	  mouse	  EC	  
cells	   and	   thymocytes	   and	   further	   confirmed	   with	   fusions	   between	   mouse	   myoblasts	   and	  
human	   lymphocytes,	   where	   the	   myoblast	   phenotype	   was	   dominant,	   and	   with	   fusions	  
between	  ES	  cells	  and	  various	  somatic	  cell	  types	  with	  both	  mouse	  and	  human	  ES	  cells	  (Miller	  
et	  al.	  1976;	  Tada	  et	  al.	  2001;	  Ying	  et	  al.	  2002;	  Cowan	  et	  al.	  2005;	  Terranova	  et	  al.	  2005;	  Yu	  et	  
al.	   2006).	   The	   reason	   why	   the	   less	   differentiated	   phenotype	   dominates	   in	   heterokaryons	  
remains	   largely	   unknown.	   Cell	   fusion	   experiments	   and	   heterokaryon	   formation,	   however,	  
provide	  a	  powerful	  in	  vitro	  system	  to	  further	  study	  the	  contribution	  of	  specific	  factors	  to	  the	  
reprogramming	  process	  (Piccolo	  et	  al.	  2011).	  Nevertheless,	  this	  approach	  is	  also	  unlikely	  to	  
be	   of	   use	   for	   customised	   cell	   therapy	   due	   to	   low	   efficiency	   and	   the	   tetraploidy	   of	   the	  
reprogrammed	  cells	  (Jaenisch	  et	  al.	  2008).	  
Ground-­‐breaking	   experiments	   in	   2006	   demonstrated	   that	   mouse	   fibroblasts	   can	   be	  
reprogrammed	  to	  become	  iPS	  cells	  by	  viral	  transfection	  of	  four	  TFs,	  Oct4,	  Sox2,	  Klf4	  and	  c-­‐
Myc	  (Takahashi	  et	  al.	  2006).	  This	  was	  then	  repeated	  with	  human	  fibroblasts	  using	  the	  same	  
four	   factors	   (Takahashi	   et	   al.	   2007),	   as	  well	   as	  with	   a	   different	   set	   of	   factors	   that	   include	  
OCT4,	  SOX2,	  NANOG	  and	  LIN-­‐28	   (Yu	  et	  al.	  2007).	   Induced	  pluripotent	  stem	  cells	  have	  since	  
been	   derived	   from	   many	   different	   cell	   types	   including	   keratinocytes	   (Aasen	   et	   al.	   2008),	  




Induced	  pluripotent	   stem	  cells	  offer	  an	  opportunity	   to	   study	  many	  diseases	   in	   cell	  models	  
and	   hence	   disease-­‐specific	   iPS	   cells	   have	   been	   generated	   for	   many	   disorders	   (Park	   et	   al.	  
2008a).	   Numerous	   improvements	   in	   the	   delivery	   methods	   of	   the	   reprogramming	   factors,	  
and	   identification	   of	   additional	   factors	   or	   small	   molecules	   that	   improve	   reprogramming	  
efficiency	   have	   been	   made	   to	   the	   technology	   as	   reviewed	   in	   (González	   et	   al.	   2011).	  
Interestingly,	   it	  has	  been	  shown,	   for	  example,	   that	   reprogramming	  can	  also	  be	   induced	  by	  
delivery	  of	  recombinant	  proteins	  (Zhou	  et	  al.	  2009).	  
Mouse	  iPS	  cells	  are	  maintained	  by	  LIF/BMP	  signalling	  (Takahashi	  et	  al.	  2006)	  and	  by	  contrast	  
human	   iPS	   cells	   by	   FGF2/Activin	   signalling	   (Park	   et	   al.	   2008b).	   Interestingly,	   derivation	   of	  
induced	   EpiS	   cells	   was	   recently	   reported	   by	   introducing	   Oct4,	   Sox2,	   Klf4	   and	   c-­‐Myc	   and	  
derivation	   under	   mEpiS	   culture	   conditions	   (Han	   et	   al.	   2011)	   This	   suggests	   that	   distinct	  
pluripotent	   states	   can	   be	   reached	   by	   reprogramming	   as	   found	   in	   ‘native’	   developmental	  
context.	   The	   equivalence	   of	   ES	   cells	   and	   iPS	   cells	   remains,	   nevertheless,	   a	   question	   of	  
debate.	  Induced	  pluripotent	  cells	  are	  very	  similar	  to	  ES	  cells	  (Hanna	  et	  al.	  2010b),	  and	  have	  
been	   conclusively	   shown	   to	   be	   pluripotent	   via	   the	   generation	   of	   chimaeras	   and	   germline	  
transmission,	  as	  well	  as	  generation	  of	  adult	  mice	  via	  tetraploid	  complementation	  (Maherali	  
et	  al.	  2007;	  Okita	  et	  al.	  2007;	  Wernig	  et	  al.	  2007;	  Boland	  et	  al.	  2009).	  However,	  the	  somatic	  
cell	  type	  used	  in	  reprogramming	  protocol	  influences	  the	  molecular	  and	  functional	  properties	  
of	   the	  generated	   iPS	  cells	  with	  somatic	   specific	  DNA	  methylation	  and	  histone	  modification	  
patterns	  being	  retained	  in	  iPS	  cells,	  referred	  to	  as	  ‘epigenetic	  memory’	  (Polo	  et	  al.	  2010;	  Ohi	  
et	   al.	   2011).	   Recent	   reports	   have	   highlighted	   the	   existence	   of	   somatic	   coding	   mutations,	  
copy	  number	  variation	  and	  hotspots	  of	  aberrant	  epigenomic	   reprogramming	   in	  human	   iPS	  
cells	   (Gore	   et	   al.	   2011;	   Hussein	   et	   al.	   2011;	   Lister	   et	   al.	   2011),	   however	   whole	   genome	  
sequencing	   of	   mouse	   and	   human	   iPS	   clones	   and	   their	   parental	   cells	   suggests	   that	  
background	  mutations	  in	  parental	  cells	  account	  for	  most	  of	  the	  genetic	  heterogeneity	  found	  
in	  iPS	  cells	  (Abyzov	  et	  al.	  2012;	  Young	  et	  al.	  2012).	  The	  differences	  between	  iPS	  and	  ES	  cells,	  
as	  well	  as	  those	  among	  iPS	  cells,	  might	  hence	  have	  consequences	  for	  the	  use	  of	  these	  cells	  in	  
research,	   disease	  modelling	   and	   therapeutics	   (Robinton	   et	   al.	   2012),	   and	   this	   needs	   to	   be	  
taken	  into	  consideration	  when	  research	  is	  taken	  forwards.	  
1.3 Aims	  of	  this	  study	  
A	  growing	  panel	  of	  different	  mouse	  and	  human	  pluripotent	  stem	  cell	  lines	  has	  been	  derived	  
from	   the	   developing	   early	   embryo	   as	   well	   as	   via	   somatic	   cell	   reprogramming.	   The	   exact	  
relationship	   between	   each	   other	   of	   these	   lines	   and	  whether	   they	   correspond	   to	   different	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pluripotent	   states	   with	   distinct	   developmental	   potencies	   and	   affiliations	   in	   vivo	   remain,	  
however,	   unclear.	   The	  overall	   aim	  of	   this	   project	   is	   to	   assess	   the	  developmental	   status	  of	  
embryo-­‐derived	   pluripotent	   cell	   lines	   using	   a	   chromatin-­‐based	   approach.	   Here	   a	   DNA	  
replication	   timing	   assay	   is	   used	   as	   a	   tractable	   approach	   to	   investigate	   whether	   and	   how	  
variations	  in	  a	  cell’s	  chromatin	  status	  can	  reliably	  define	  different	  pluripotent	  cell	  identities.	  
For	   this	   purpose,	   a	   comparison	   of	   the	   replication	   timing	   status	   of	   a	   large	   panel	   of	   key	  
developmental	   genes	   in	   several	   hES	   and	   hiPS	   cell	   lines	   alongside	   mES	   and	   mEpiS	   cells	   is	  
initially	   conducted	   to	   determine	   whether	   distinct	   pluripotent	   states	   can	   indeed	   be	  
delineated	  at	  this	  level.	  The	  impact	  of	  different	  growth	  culture	  conditions	  on	  modulating	  hES	  
cell’s	   epigenetic	   and	   pluripotent	   identity	   will	   then	   be	   investigated	   and	   the	   underlying	  
molecular	   and	   epigenetic	   mechanisms	   explored	   further.	   In	   particular,	   the	   role	   of	   TGF-­‐
β/Activin	  signalling	  axis	  in	  favouring	  a	  self-­‐renewing	  and	  epigenetically	  stable	  state	  as	  well	  as	  
the	  role	  of	  the	  pluripotent	  marker	  REX1	  will	  be	  subsequently	  assessed	  in	  this	  thesis.	  
This	   study	  might	   advance	   current	   understanding	   of	   early	   development	   and	   could	   also	   be	  
beneficial	  for	  developing	  stem	  cell-­‐based	  therapies	  for	  regenerative	  medicine,	  as	  responses	  
to	  directed	  differentiation	  are	   likely	  to	  vary	  depending	  on	  the	  initial	  position	  of	  cells	   in	  the	  
developmental	  hierarchy.	  
	  




Chapter	  2 Materials	  and	  Methods	  
2.1 Materials	  
2.1.1 Primary	  antibodies	  
β-­‐actin	   Rabbit	   polyclonal	   anti-­‐β-­‐actin	   antibody	   (ab8227;	   Abcam	   Ltd.,	   Cambridge,	  
UK).	  Used	  for	  western	  blot	  (WB)	  at	  1:5000	  dilution.	  
BrdU	   Mouse	   monoclonal	   anti-­‐BrdU	   antibody	   (347580;	   Becton	   Dickinson	  
Biosciences,	   San	   Jose,	   CA).	   Used	   for	   replication	   timing	   at	   80	   µl/reaction	  
dilution	  and	  for	  analysis	  of	  DNA	  content	  at	  5	  µg/ml.	  
H3	   Rabbit	   polyclonal	   anti-­‐histone	  3	   carboxy	   terminal	   (ab1791;	  Abcam).	  Used	  
for	   WB	   at	   1:2500	   and	   chromatin	   immunoprecipitation	   (ChIP)	   at	   5	  
µg/immunoprecipitation	  (IP)	  dilution.	  
H3Ac	   Rabbit	   polyclonal	   anti-­‐histone	   3	   acetylation	   (17-­‐615;	   Upstate	  
Biotechnology	   /Millipore,	   Lake	   Placid,	   NY).	   Used	   for	  WB	   at	   1:10	   000	   and	  
ChIP	  at	  5	  µg/IP	  dilution.	  
H3K9Ac	   Rabbit	   polyclonal	   anti-­‐histone	   3	   lysine	   9	   acetylation	   (07-­‐352;	   Upstate).	  
Used	  for	  WB	  at	  1:2	  500	  and	  ChIP	  at	  5	  µg/IP	  dilution.	  
H3K18Ac	   Rabbit	   polyclonal	   anti-­‐histone	   3	   lysine	   18	   acetylation	   (07-­‐354;	   Upstate).	  
Used	  for	  WB	  at	  1:10	  000	  and	  ChIP	  at	  5	  µg/IP	  dilution.	  
H3K56Ac	   Rabbit	  monoclonal	  anti-­‐histone	  3	  lysine	  56	  acetylation	  (2134-­‐1;	  Epitomics,	  
Inc.,	  Burlingame,	  CA).	  Used	  for	  WB	  at	  1:750	  and	  ChIP	  at	  10	  µg/IP	  dilution.	  
H3K27me3	   Rabbit	  polyclonal	  anti-­‐histone	  3	  lysine	  27	  trimethylation	  (07-­‐449;	  Upstate).	  
Used	  for	  WB	  at	  1:2500	  dilution.	  
H3K4me2	   Rabbit	   polyclonal	   anti-­‐histone	  3	   lysine	  4	  dimethylation	   (07-­‐030;	  Upstate).	  
Used	  for	  WB	  at	  1:5000	  dilution.	  
H4	   Rabbit	  monoclonal	  anti-­‐histone	  4	  pan	  (05-­‐858;	  Upstate).	  Used	  for	  ChIP	  at	  5	  
µg/IP	  dilution.	  
H4Ac	   Rabbit	   polyclonal	   anti-­‐histone	   4	   acetylation	   (06-­‐866;	   Upstate).	   Used	   for	  
ChIP	  at	  5	  µg/IP	  dilution.	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IgG	   Rabbit	  anti-­‐IgG	  (whole	  molecule)	  fraction	  of	  antiserum	  antibody	  (M-­‐7023;	  
Sigma	  Aldrich	  Company	  Ltd.,	  Gillingham,	  UK).	  Used	  for	  ChIP	  at	  5	  µg/IP	  and	  
replication	  timing	  35	  µg/reaction	  dilution.	  
Methyl-­‐C	   Mouse	   monoclonal	   anti-­‐5-­‐methylcytidine	   (33D3;	   Eurogenetec,	   Belgium).	  
Used	   for	  methylated	  DNA	   immunoprecipitation	   (MeDIP)	  at	  10	  µl/reaction	  
dilution.	  
Musashi	   Rabbit	   polyclonal	   anti-­‐Musashi	   (AB5977;	   Chemicon/Millipore).	   Used	   for	  
immunofluorescence	  (IF)	  at	  1:200	  dilution.	  
Nanog	   Rabbit	   polyclonal	   anti-­‐human	   Nanog	   (ab21624;	   Abcam).	   Used	   for	   IF	   at	  
1:500	   and	   WB	   at	   1:1000	   dilution.	   Rabbit	   polyclonal	   anti-­‐mouse	   Nanog	  
(REC-­‐RCAB0002P-­‐F;	   Cosmo	   Bio	   Co.,	   Ltd.,	   Japan)	   used	   for	   IF	   at	   1:500,	  
fluorescence-­‐activated	   cell	   sorting	   (FACS)	   at	   1	   µg/1x106	   cells	   and	  WB	   at	  
1:1000	  dilution.	  
Nestin	   Mouse	  monoclonal	   anti-­‐Nestin	   (MAB5326;	  Chemicon/Millipore).	  Used	   for	  
IF	  at	  1:500	  dilution.	  
Oct4	   Goat	   polyclonal	   anti-­‐Oct4	   (N19	   sc-­‐8628;	   Santa	   Cruz	   Biotechnology	   Inc.,	  
Santa	  Cruz,	  CA).	  Used	  for	   IF	  at	  1:100,	  FACS	  at	  1	  µg/1x106	  cells	  and	  WB	  at	  
1:1000	  dilution.	  
P300/CBP	   Rabbit	  polyclonal	  anti-­‐P300/CBP	  (C-­‐20	  sc-­‐585;	  Santa	  Cruz).	  Used	  for	  WB	  at	  
1:1000	  and	  ChIP	  at	  2	  µg/IP	  dilution.	  
Pax6	   Rabbit	   polyclonal	   anti-­‐Pax6	   (AB5409;	   Chemicon/Millipore).	   Used	   for	   IF	   at	  
1:1000	  dilution.	  
P-­‐Smad2/3	   Rabbit	   monoclonal	   anti-­‐Phospho	   Smad2/3	   (serines	   465/467)	   (3108;	   Cell	  
Signalling	  Technology,	   Inc.,	  Boston,	  MA).	  Used	  for	  WB	  at	  1:1000	  and	  ChIP	  
at	  10	  µl/IP	  dilution.	  
Sirt1	   Rabbit	   monoclonal	   anti-­‐Sirt1	   (ab32441;	   Abcam).	   Used	   for	   WB	   at	   1:1000	  
dilution.	  
Smad2/3	   Rabbit	  polyclonal	  anti-­‐Smad2/3	  (3102;	  Cell	  Signalling	  Technology).	  Used	  for	  
WB	  at	  1:1000	  and	  ChIP	  at	  10	  µl/IP	  dilution.	  
Sox2	   Rabbit	   polyclonal	   anti-­‐Sox2	   (ab15830;	  Abcam).	  Used	   for	   IF	   at	   1:1000	   and	  




SSEA1	   Allophycocyanin	   (APC)	   –conjugated	   mouse	   monoclonal	   anti-­‐SSEA1	  
(FAB2155A;	   R&D	   Systems	   Inc.	   Minneapolis,	   MN).	   Used	   for	  
immunofluorescence	   (IF)	  and	   fluorescence	  activated	  cell	   sorting	   (FACS)	  at	  
1:200	  dilution.	  
SSEA4	   Mouse	   monoclonal	   anti-­‐SSEA4	   (MC-­‐813-­‐70;	   Developmental	   Hybridoma	  
Studies	  Bank,	  Iowa	  City,	  IA).	  Used	  for	  IF	  and	  FACS	  at	  1:3	  dilution.	  
TRA-­‐1-­‐60	   Mouse	  monoclonal	   anti-­‐Tumour	   rejection	   antigen	   (TRA)-­‐1-­‐60	   (MAB4360;	  
Chemicon/Millipore,	  Temecula,	  CA).	  Used	  for	  IF	  and	  FACS	  at	  1:12	  dilution.	  
TRA-­‐1-­‐81	   Mouse	  monoclonal	  anti-­‐TRA-­‐1-­‐81	  (MAB4381;	  Chemicon).	  Used	  for	  FACS	  at	  
1:20	  dilution.	  
2.1.2 Secondary	  antibodies	  
Alexa	  488	   Goat	   anti-­‐mouse	   IgG	   (A11029;	  Molecular	   Probes	   Invitrogen,	   Ltd.,	   Paisley,	  
UK).	  Used	  for	  IF	  at	  1:500	  and	  FACS	  at	  1:1000	  dilution.	  
Alexa	  488	   Goat	  anti-­‐rabbit	  IgG	  (A11034;	  Molecular	  Probes).	  Used	  for	  IF	  at	  1:500	  and	  
FACS	  at	  1:1000	  dilution.	  
Alexa	  568	   Goat	   anti-­‐mouse	   IgG	   (A11031;	   Molecular	   Probes).	   Used	   for	   IF	   at	   1:500	  
dilution.	  
Alexa	  568	   Goat	   anti-­‐rabbit	   IgG	   (A11036;	   Molecular	   Probes).	   Used	   for	   IF	   at	   1:500	  
dilution.	  
FITC	   Goat	   anti-­‐mouse	   IgM	   (F9259;	   Sigma).	   Used	   for	   IF	   at	   1:200	   and	   FACS	   at	  
1:500	  dilution.	  
FITC	   Goat	  anti-­‐rat	  IgM	  (F6258;	  Sigma).	  Used	  for	  IF	  at	  1:100	  dilution	  and	  FACS	  at	  
1:500	  dilution.	  
HRP-­‐conjugated	   Goat	   anti-­‐mouse	   IgG	   HRP	   (sc-­‐2005,	   Santa	   Cruz).	   Used	   for	   WB	   at	   1:2000	  
dilution.	  
HRP-­‐conjugated	   Goat	   anti-­‐rabbit	   IgG	   HRP	   (sc-­‐2004,	   Santa	   Cruz).	   Used	   for	   WB	   at	   1:5000	  
dilution.	  
	  
	   	   	  
57	  
2.1.3 Cell	  lines	  
B6	  	   Mouse	  ES	  cell	  line	  (Kontgen	  et	  al.	  1993);	  feeder-­‐dependent;	  C57BL/6	  genetic	  
background;	   a	   gift	   from	   Dr	   Colin	   Steward	   (National	   Cancer	   Institute,	  
Frederick,	  Maryland,	  USA).	  
CD34+	   Human	   CD34+	   stem	   cells	   isolated	   from	   peripheral	   blood	   of	   3	   healthy	  
volunteers	  following	  informed	  consent.	  These	  cells	  were	  kindly	  provided	  by	  
Dr	  Catherine	  Flores	  (Department	  of	  Haematology,	  Imperial	  College	  London,	  
UK).	  
Dc7	   Mouse	  ES	  cell	  line	  newly	  derived;	  feeder-­‐independent;	  129/castaneus	  mixed	  
genetic	  background;	  a	  gift	  from	  Dr	  Tatyana	  Nesterova	  (MRC	  Clinical	  Sciences	  
Centre,	  London,	  UK).	  
E14tg2A	   Hprt	   deficient	   mouse	   ES	   cell	   line	   derived	   from	   Lesch-­‐Nyhan	   embryos	  
(Hooper	  et	  al.	  1987);	  feeder-­‐independent;	  129	  genetic	  background.	  
EpiS	  129	   Mouse	   EpiS	   cell	   line	   derived	   from	   the	   dissection	   of	   the	   late-­‐epiblast	   layer	  
from	   pre-­‐gastrula	   E6.5	   embryos	   (Vallier	   et	   al.	   2009a);	   129	   genetic	  
background;	   a	   gift	   from	   Dr	   Ludovic	   Vallier	   (Department	   of	   Surgery	   and	  
Laboratory	  for	  Regenerative	  Medicine,	  University	  of	  Cambridge,	  UK).	  
EpiS	  B6/CBA	   Mouse	   EpiS	   cell	   line	   derived	   from	   the	   dissection	   of	   the	   late-­‐epiblast	   layer	  
from	   pre-­‐gastrula	   E5.75	   embryos	   (Brons	   et	   al.	   2007);	   B6/CBA	   F1	   genetic	  
background;	   a	   gift	   from	   Dr	   Ludovic	   Vallier	   (Department	   of	   Surgery	   and	  
Laboratory	  for	  Regenerative	  Medicine,	  University	  of	  Cambridge,	  UK).	  
EpiS	  NOD	   Mouse	   EpiS	   cell	   line	   derived	   from	   the	   dissection	   of	   the	   late-­‐epiblast	   layer	  
from	   pre-­‐gastrula	   E6.5	   embryos	   (Brons	   et	   al.	   2007);	   NOD	   genetic	  
background;	   a	   gift	   from	   Dr	   Ludovic	   Vallier	   (Department	   of	   Surgery	   and	  
Laboratory	  for	  Regenerative	  Medicine,	  University	  of	  Cambridge,	  UK).	  
H1	  (WA-­‐01)	   Male	  human	  ES	  cell	  line	  (Thomson	  et	  al.	  1998);	  grown	  in	  collaboration	  with	  
Dr	  Wei	  Cui	  (IRDB,	  Imperial	  College	  London,	  UK).	  
H1-­‐BH1	   Male	  human	  ES	  cell	  line	  clonally	  derived	  from	  H1	  cells.	  Cell	  number	  passages	  
with	   ≥	   100	   are	   karyotypically	   abnormal.	   Cells	   were	   grown	   and	   kindly	  
provided	   by	   Dr	   Peter	   Andrews’s	   laboratory	   (Centre	   for	   Stem	   Cell	   Biology,	  




H7	  (WA-­‐07)	   Female	   human	   ES	   cell	   line	   (Thomson	   et	   al.	   1998);	   grown	   in	   collaboration	  
with	  Dr	  Wei	  Cui	  (IRDB,	  Imperial	  College	  London,	  UK).	  
H9	  (WA-­‐09)	   Female	   human	   ES	   cell	   line	   (Thomson	   et	   al.	   1998);	   grown	   in	   collaboration	  
with	  Dr	  Wei	  Cui	  (IRDB,	  Imperial	  College	  London,	  UK).	  
H9	  GFP	  OE	   Female	   human	   ES	   cell	   line	   (Thomson	   et	   al.	   1998)	   with	   constitutive	  
expression	   of	   GFP	   (Vallier	   et	   al.	   2009a),	   a	   gift	   from	   Dr	   Ludovic	   Vallier	  
(Department	   of	   Surgery	   and	   Laboratory	   for	   Regenerative	   Medicine,	  
University	  of	  Cambridge,	  UK).	  
H9	  NANOG	  KD	   Female	   human	   ES	   cell	   line	   (Thomson	   et	   al.	   1998)	   with	   constitutive	  
knockdown	   of	  NANOG	   (Vallier	   et	   al.	   2009a),	   a	   gift	   from	  Dr	   Ludovic	   Vallier	  
(Department	   of	   Surgery	   and	   Laboratory	   for	   Regenerative	   Medicine,	  
University	  of	  Cambridge,	  UK).	  
H9	  NANOG	  OE	   Female	   human	   ES	   cell	   line	   (Thomson	   et	   al.	   1998)	   with	   constitutive	  
expression	   of	  NANOG	   (Vallier	   et	   al.	   2009a),	   a	   gift	   from	   Dr	   Ludovic	   Vallier	  
(Department	   of	   Surgery	   and	   Laboratory	   for	   Regenerative	   Medicine,	  
University	  of	  Cambridge,	  UK).	  
H9	  shSCR	   Female	  human	  ES	   cell	   line	   (Thomson	  et	   al.	   1998)	   expressing	  non-­‐targeting	  
scramble	   shRNA	   (Vallier	   et	   al.	   2009a;	   Brown	   et	   al.	   2011),	   a	   gift	   from	   Dr	  
Ludovic	   Vallier	   (Department	   of	   Surgery	   and	   Laboratory	   for	   Regenerative	  
Medicine,	  University	  of	  Cambridge,	  UK).	  
H9	  SMAD2	  KD	   Female	  human	  ES	  cell	   line	  (Thomson	  et	  al.	  1998)	  with	  stable	  knockdown	  of	  
SMAD2	   (Brown	   et	   al.	   2011),	   a	   gift	   from	  Dr	   Ludovic	   Vallier	   (Department	   of	  
Surgery	  and	  Laboratory	  for	  Regenerative	  Medicine,	  University	  of	  Cambridge,	  
UK).	  
iPS	  40	   Human	   iPS	   cell	   line	   (Vallier	   et	   al.	   2009b)	   derived	   from	   neonatal	   foreskin	  
fibroblasts	   by	   retroviral	   infection	   and	   expression	   of	   four	   reprogramming	  
factors	   (OCT4,	   SOX2,	  C-­‐MYC	  and	  KLF4).	   These	   cells	  were	  obtained	   from	  Dr	  
Ludovic	   Vallier	   (Laboratory	   for	   regenerative	   medicine,	   University	   of	  
Cambridge,	  UK).	  
NP7	   Human	   neural	   progenitor	   cells	   derived	   from	   H7	   ES	   cells	   (Gerrard	   et	   al.	  
2005a).	  
MEFs	   Mouse	  embryonic	  fibroblasts	  isolated	  from	  wild	  type	  CF-­‐1	  embryos	  (E13.5).	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ReNcell	  VM	   Human	   immortalized	   neural	   stem	   cell	   line	   derived	   from	   a	   10-­‐week	   foetal	  
brain	  (SCC008;	  Chemicon/Millipore).	  
2.2 Methods	  
2.2.1 Cell	  culture	  
All	   tissue	   culture	   reagents	   used	   were	   from	   LifeTechnologies	   (Paisley,	   UK)	   and	   all	   plastics	  
from	   Corning	   Inc.	   (NY,	   USA)	   unless	   otherwise	   stated.	   H1,	   H7	   and	   H9	   hES	   cell	   lines	   were	  
cultured	   under	   feeder-­‐free	   conditions	   on	   matrigel-­‐coated	   6	   well	   plates	   as	   previously	  
described	   (Xu	   et	   al.	   2001).	   According	   to	   these	   conditions,	   cells	   were	   maintained	   in	   an	  
undifferentiated	  state	   in	  mitotically	   inactivated	  primary	  mouse	  embryonic	   fibroblast	   (MEF)	  
cells-­‐conditioned	   medium	   (CM)	   [Knockout™	   Dulbecco's	   Modified	   Eagle	   Medium	   (DMEM)	  
medium	   supplemented	   with	   20%	   (v/v)	   Knockout™	   Serum	   Replacement	   (KSR),	   1	   mM	   L-­‐
glutamine,	   non-­‐essential	   amino	   acids	   (NEAA)	   and	   0.1	   mM	   β-­‐mercaptoethanol]	  
supplemented	  with	  8	  ng/ml	  basic	  fibroblast	  growth	  factor	  (FGF2)	  (R&D	  Systems	  Europe	  Ltd,	  
Abingdon,	   UK).	   CM	  was	   prepared	   by	   incubating	   hES	   cells	   medium	   on	   flasks	   (0.5	  ml/cm2)	  
with	  40	  grays	  irradiated	  MEFs	  at	  56	  000	  cells/cm2	  during	  24	  hours.	  The	  CM	  was	  filtered	  (0.2	  
µm)	   and	   stored	   at	   -­‐20°C.	  MEFs	   were	   cultured	   in	   high-­‐glucose	   DMEM	   supplemented	   with	  
10%	  foetal	  bovine	  serum	  (FBS;	  Globepharm,	  Esher,	  UK)	  and	  2	  mM	  L-­‐glutamine,	  grown	  until	  
80-­‐85%	   confluence,	   dissociated	   with	   trypsin	   ethylene-­‐dinitrilo	   tetraacetic	   acid	   (EDTA)	  
(0.05%/0.02%)	   (PAA	   Laboratories,	   Yeovil,	   UK)	   before	   irradiation	   and	   plated	   onto	   0.1%	  
gelatine-­‐coated	  surfaces	  (Sigma-­‐Aldrich,	  Gillingham,	  UK).	  
For	  feeder	  and	  Serum	  Replacer	  free	  culture,	  H1	  and	  H9	  hES	  cell	  lines	  were	  transferred	  from	  
CM	  conditions	   to	  a	   chemically	  defined	  medium	   (CDM)	   (Johansson	  et	   al.	   1995;	  Wiles	  et	   al.	  
1999)	  supplemented	  with	  10	  ng/ml	  Activin	  A	  (R&D	  Systems	  Europe	  Ltd)	  and	  12	  ng/ml	  FGF2	  
as	  previously	  described	  (Vallier	  et	  al.	  2005a)	  (CDMactivin).	  The	  composition	  of	  CDM	  was	  50%	  
Iscove's	  Modified	  Dulbecco's	  Medium	  plus	  50%	  F12	  NUT-­‐MIX,	  supplemented	  with	  7	  µg/ml	  of	  
insulin	   (Roche	   Ltd,	   West	   Sussex,	   UK),	   15	   µg/ml	   of	   transferrin	   (Roche	   Ltd),	   450	   µM	   of	  
monothioglycerol	   (Sigma-­‐Aldrich),	   1%	   chemically	   defined	   lipid	   concentrate	   100x	   and	   5	  
mg/ml	  of	  batch	  tested	  bovine	  serum	  albumin	  (BSA)	  fraction	  V	  (PAA	  Laboratories).	  To	  allow	  
hES	  cells	  adhesion	  in	  CDM,	  plates	  were	  pre-­‐coated	  with	  0.1%	  gelatine	  followed	  by	  a	  coating	  
with	  adhesion	  media	  (Knockout™	  DMEM	  medium	  supplemented	  with	  10%	  batch	  tested	  FBS	  
and	  2	  mM	  L-­‐glutamine),	  for	  24	  hours	  at	  37°C	  and	  then	  washed	  twice	  in	  phosphate	  buffered	  




curcumin	   (a	   gift	   from	   Dr	   Matthew	   J	   Fuchter,	   Department	   of	   Chemistry,	   Imperial	   College	  
London,	   UK)	   or	   c646	   (R&D	   Systems	   Europe	   Ltd)	   dissolved	   in	   dimethyl	   sulfoxide	   (DMSO)	  
(Sigma-­‐Aldrich)	  was	   added	   to	  CM	  or	  CDM	  media	  of	  H1	  hES	   cells	  when	   indicated.	  Medium	  
was	   changed	   daily	   and	   cells	   routinely	   passaged	   at	   a	   1:3	   split	   ratio	   by	   treatment	  with	   200	  
units	   (U)/ml	  collagenase	   type	   IV	   in	  Knockout™	  DMEM	  followed	  by	  mechanical	  dissociation	  
with	  5	  ml	  pipette	   in	  both	  CM	  and	  CDM	  conditions.	  Nomenclature	   for	  culture	  conditions	   is	  
according	   to	   the	   following	   convention:	   cell	   line,	   number	   of	   passages	   in	   CM	   culture,	   plus	  
additional	   passages	   in	   CDM	   conditions,	   plus	   number	   of	   passages	   of	   cells	   returned	   to	   CM	  
here	   labelled	   as	   re-­‐swapped	   (RS)	   cells,	   if	   applied.	   Thus,	   H1p40(CDM6;RS5)	   would	   be	   H1	  
grown	  for	  51	  passages	  overall,	  40	  initial	  passages	  were	  in	  CM,	  passages	  41-­‐46	  were	  in	  CDM	  
and	  passages	  47-­‐51	  were	  again	   in	  CM.	  Since	  hES	  cells	  are	  susceptible	  to	  genetic	  anomalies	  
on	  prolonged	  passages	   (Draper	  et	  al.	  2004),	  where	  possible	  only	  hES	  cells	  earlier	  passages	  
(p30-­‐p80)	  were	  used	  for	  these	  experiments.	  
Human	   iPS	   40	   cells	   (Vallier	   et	   al.	   2009b)	   were	   grown	   under	   CM	   or	   CDM	   conditions	   as	  
described	  for	  hES	  cells.	  
Hela	  cells	  were	  cultured	   in	  high	  glucose	  DMEM	  supplemented	  with	  10%	  FBS	  and	  passaged	  
using	  trypsin	  EDTA.	  
Mouse	   ES	   cells	   were	   grown	   and	   maintained	   in	   an	   undifferentiated	   state	   either	   on	   0.1%	  
gelatin-­‐coated	   surfaces	   (E14tg2A)	   or	   on	   irradiated	   MEF	   feeder	   layers	   (B6	   and	   Dc7),	   and	  
dissociated	  with	  trypsin-­‐EDTA.	  With	  the	  exception	  of	  the	  newly	  derived	  Dc7	  cell	  line,	  all	  mES	  
cells	  were	  grown	  in	  Minimal	  Eagle	  medium	  (GMEM-­‐BHK	  21)	  supplemented	  with	  15%	  batch	  
tested	  FBS	  (Sigma),	  1x	  NEAA,	  1	  mM	  sodium	  pyruvate,	  0.075%	  sodium	  bicarbonate,	  0.1	  mM	  
β-­‐mercaptoethanol,	   2	   mM	   L-­‐glutamine,	   antibiotics,	   and	   1000	   U/ml	   of	   LIF	   (ESGRO-­‐LIF,	  
Chemicon/Millipore).	   Dc7	   cells	   were	   cultured	   and	   analysed	   in	   derivation	   medium	   with	  
DMEM	   supplemented	   with	   5%	   batch	   tested	   FBS	   (Sigma),	   15%	   KSR,	   1x	   NEAA,	   50	   µM	   β-­‐
mercaptoethanol,	  2	  mM	  L-­‐glutamine	  and	  2000	  U/ml	  LIF.	  	  
Mouse	  EpiS	  cell	   lines	  (129,	  B6/CBA	  and	  NOD)	  were	  cultured	  as	  previously	  described	  (Brons	  
et	  al.	  2007)	  in	  CDM	  media	  supplemented	  with	  20	  ng/ml	  Activin	  A	  and	  12	  ng/ml	  FGF2	  on	  pre-­‐
coated	   adhesion	  medium	   plates	   in	   the	   same	   way	   that	   hES	   cells	   in	   CDM	   conditions.	   Cells	  
were	   propagated	   as	   small	   clumps	   by	   scraping	  with	   5	  ml	   pipette	   after	   incubation	  with	   1%	  
collagenase	   type	   IV	   in	   Knockout™	   DMEM	   using	   1:5	   to	   1:15	   split	   ratios	   depending	   on	  
proliferation	  ratio.	  Unless	  otherwise	  stated	  all	  cells	  were	  maintained	  at	  37°C	  and	  5%	  CO2.	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2.2.2 Cloning	  and	  delivery	  of	  DNA	  into	  hES	  cells	  
2.2.2.1 	  Engineering	  of	  protein	  expression	  constructs	  
The	  REX1	   open	   reading	   frame	   (ORF)	  was	   amplified	   from	  hES	   complementary	  DNA	   (cDNA)	  
(prepared	  according	  to	  section	  2.2.5.1.)	  by	  reverse	  transcription	  polymerase	  chain	  reaction	  
(RT-­‐PCR)	   using	   linker	   primers	   5’-­‐	   ATTCCCTCGAGATGAGCCAGCAACTG	   -­‐3’	   and	   5’-­‐	  
CGCGGTTAATTAACTACTTTCCCTCTTG	  -­‐3’,	  which	  introduced	  flanking	  restrictions	  sites	  for	  XhoI	  
and	   PacI	   (underlined)	  
respectively)	   using	  
PFUTurbo	   (Agilent	  
Technologies,	   La	   Jolla,	  
CA).	   Briefly	   the	   RT-­‐PCR	  
reaction	   contained	   2	   µl	  
cDNA,	   1	   µl	   forward	  
primer,	   1	   µl	   reverse	  
primer,	  1	  µl	  10nM	  dNTP,	  
5	   µl	   10x	   buffer,	   1	   µl	  
PFUTurbo	   and	   dH2O	   up	  
to	   50	   µl.	   The	   reaction	  
was	   heated	   to	   95°C	   for	  
4	  min,	  then	  kept	  at	  95°C	  
for	   1	   min,	   30	   sec	   at	  
60°C,	   1	   min	   15	   sec	   at	  
72°C	  then	  cycled	  back	  to	  
step	   two	   for	   40	   times,	  
then	   incubated	   at	   72°C	  
for	   10	   min.	   The	  
amplified	  REX1	  with	   the	  
restriction	   sites	   (Fig.	  
2.1a)	   was	   ligated	   into	  
pGEM-­‐T	   Easy	   vector	  
(Promega	   Corporation,	  
Madison,	   WI)	   and	  
sequence	   was	   verified	  
Figure	  2.1	  Transgenes	  and	  expression	  vector	  used	  in	  this	  study	  
(a)	   Schematic	   representation	  of	   human	  REX1	   coding	   sequence	   cloned	   for	   this	  
study.	   Indicated	   are	   the	   restriction	   sites	   and	   primer	   pairs	   used	   for	   PCR	  
amplification	   as	   well	   as	   FLAG-­‐tag	   added	   in	   one	   construct.	   (b)	   Vector	   map	   of	  
pPyfloxed	  expression	  vector	  with	   insert.	   Expression	  of	   the	   transgene	   is	  driven	  
by	   the	   CAG	   promoter.	   Indicated	   are	   loxP	   sites,	   which	   allow	   the	   creation	   of	  
revertant	  clones	  by	  Cre-­‐Lox	  excision,	   restriction	  sites,	   internal	   ribosomal	  entry	  
site	   (IRES),	  puromycin	   resistance	  gene	   (puroR),	   synthetic	  polyA	  site,	  enhanced	  
green	   fluorescent	   protein	   (EGPP)	   coding	   sequence,	   which	   will	   be	   active	   in	  





(MRC	   Clinical	   Sciences	   Centre	   sequencing	   facility).	   To	   generate	   a	   eukaryotic	   expression	  
construct	  the	  REX1	  was	  then	  subcloned	  into	  pPyfloxed	  expression	  vector	  (a	  kind	  gift	  Prof	  Ian	  
Chambers)	  using	  XhoI–PacI	   sites	   (Fig.	   2.1b).	  Details	  of	   cloning	  procedures	   are	  described	   in	  
section	   2.2.2.3.	   In	   the	   pPyfloxed	   vector	   expression	   was	   driven	   by	   the	   CAG-­‐promoter	   and	  
selection	  enabled	  by	  the	  puromycin	  resistance	  gene.	  
The	   FLAG-­‐Rex1	   construct	   was	   RT-­‐PCR	   amplified	   from	   the	   pPyfloxed-­‐REX1	   plasmid	   using	  
linker	   primers	   5’-­‐CTCGAGATGGACTACAAGGACGACGATGACAAGAGCCAGCAACTGAAGAAA	  
CGGGCA-­‐3’	   and	   5’-­‐	   CGCGGTTAATTAACTACTTTCCCTCTTG	   -­‐3’,	   which	   introduced	   flanking	  
restrictions	   sites	   for	   XhoI	   and	   PacI	   (underlined)	  
respectively	  and	  the	  FLAG	  sequence	  (bold)	  using	  
Phusion	  DNA	  polymerase	  (New	  England	  Biolabs,	  
Ipswich,	   MA).	   Briefly	   the	   RT-­‐PCR	   reaction	  
contained	  2	  µl	  cDNA,	  2.5	  µl	   forward	  primer,	  2.5	  
µl	  reverse	  primer,	  1	  µl	  10nM	  dNTP,	  10	  µl	  5x	  GC	  
buffer,	  0.5	  µl	  Phusion,	  1.5	  µl	  DMSO	  and	  dH2O	  up	  
to	  50	  µl.	  The	  reaction	  was	  heated	  to	  98°C	  for	  30	  
sec,	  then	  kept	  at	  98°C	  for	  10	  sec,	  30	  sec	  at	  68°C,	  
30	  sec	  at	  72°C	  then	  cycled	  back	  to	  step	  two	  for	  
35	  times,	  then	  incubated	  at	  72°C	  for	  10	  min.	  The	  
amplified	   FLAG-­‐REX1	   was	   ligated	   into	   pGEM-­‐T	  
Easy	   vector	   and	   subcloned	   into	   pPyfloxed	  
expression	   vector	   as	   described	   above	   for	   REX1	  
(Fig.	  2.1a	  and	  b).	  
2.2.2.2 Preparation	  and	  selection	  of	  shRNA	  constructs	  
Five	   individual	  MISSION®	  short	  hairpin	   loop	  RNA	  (shRNA)	  constructs	  targeting	  human	  P300	  
and	   a	   non-­‐targeting	   control	   shRNA	  were	   ordered	   from	   Sigma-­‐Aldrich	   in	   bacterial	   glycerol	  
stocks.	  The	  bacteria	  were	  picked	  according	   to	  manufacturer’s	   instructions	  and	  plated	  onto	  
Lysogeny	   Broth	   (LB)	   agar	   [LB-­‐Broth	   Lennox	   20	   g/l	   (BD)	   and	   L-­‐agar	   15	   g/l	   (Sigma)	   in	   dH2O]	  
with	  100	  µg/µl	  ampicillin	  and	  incubated	  overnight.	  Individual	  colonies	  were	  picked	  into	  low	  
salt	  LB	  [LB-­‐Broth-­‐Lennox	  10	  g/l,	  Peptone	  5	  g/l	  and	  Yeast	  Extract	  2.5	  g/l	  (all	  from	  BD)	  in	  dH2O]	  
supplemented	  with	   100	  µg/µl	   ampicillin	   and	   incubated	  overnight	   at	   37°C	  under	   agitation.	  
Plasmid	  DNA	  was	  extracted	  from	  exponentially	  growing	  cultures	  with	  Purelink	  Plasmid	  Mini	  
and	   Midiprep	   kits	   (LifeTechnologies)	   according	   to	   manufacturer’s	   instructions.	   Final	   DNA	  
Figure	   2.2	   Vector	   used	   for	   stable	   expression	   of	  
shRNA	  
Vector	   map	   of	   pLKO.1-­‐puro	   shRNA	   expression	  
vector.	  Expression	  of	  the	  shRNA	  is	  driven	  by	  hU6	  
promoter.	   Indicated	   are	   human	  
phosphoglycerate	   kinase	   eukaryotic	   promoter	  
(hPGK),	   puromycin	   resistance	   gene	   (puroR)	   and	  
ampicillin	  resistance	  gene	  (AmpR).	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product	   was	   resuspended	   in	   double	   distilled	   H2O.	   Figure	   2.2	   shows	   a	   schematic	  
representation	  of	  the	  pLKO.1-­‐puro	  shRNA	  vector	  used	  for	  the	  expression	  of	  the	   interfering	  
RNAs.	  
All	   five	   P300	   shRNAs	   were	   tested	   by	  
transforming	  Hela	   cells	  with	   each	   individual	  
shRNA	   and	   comparing	   them	   to	   the	   non-­‐
targeting	   shRNA,	   using	   Lipofectamine	   2000	  
(LifeTechnologies),	   according	   to	  
manufacturer’s	   instructions.	   Analysis	   of	  
knockdown	   of	   P300	   expression	   was	   done	  
with	   evaluating	   gene	   expression	   levels	   by	  
real-­‐time	   quantitative	   PCR	   (qRT-­‐PCR)	   and	  
protein	   expression	   levels	   by	   western	  
blotting,	   samples	   were	   collected	   48	   hours	  
after	   transfection.	   Results	   of	   these	   analyses	  
are	  summarised	  in	  Figure	  2.3.	  Knockdown	  of	  
P300	  was	  most	  efficient	  with	  shRNAs	  3	  and	  4	  
with	   approximately	   70%	   reduction	   of	  
relative	   gene	   expression	   and	   nearly	  
complete	   knockdown	   of	   protein	   expression	  
as	   compared	   to	   the	   non-­‐targeting	   scramble	  
shRNA	   (scr)	   transformed	   sample	   and	   these	   were	   selected.	   ShRNA	   3	   5’-­‐	  
CCGGCAATTCCGAGACATCTTGAGACTCGAGTCTCAAGATGTCTCGGAATTGTTTTTG	   -­‐3’	   and	  
shRNA	   4	   5’-­‐	   CCGGTACACTAGAGACACCTTGTATCTCGAGATACAAGGTGTCTCTAGTGTA	  
TTTTTG	   -­‐3’	   and	   the	   scr	   5’-­‐	  
CCGGCAACAAGATGAAGAGCACCAACTCGAGTTGGTGCTCTTCATCTTGTTGTTTTT	   -­‐3’	   were	   used	  
in	  the	  experiments	  with	  hES	  cells.	  Expression	  of	  the	  shRNA	  was	  driven	  by	  hU6	  promoter	  and	  
selection	  of	  clones	  was	  enabled	  by	  puromycin	  resistance	  gene	  (Fig.	  2.2).	  
2.2.2.3 Plasmid	  construction	  and	  bacterial	  transformation	  
All	   reagents	  used	  were	   from	  New	  England	  Biolabs,	  unless	  otherwise	   stated.	  PCR-­‐amplified	  
fragments	  were	  run	  on	  a	  1%	  agarose	  (Sigma-­‐Aldrich)	  gel	  along	  with	  a	  2-­‐log	   ladder.	  Correct	  
sized	   fragments	   were	   isolated	   using	   QIAquick	   Gel	   Extraction	   Kit	   (Qiagen)	   according	   to	  
manufacturer’s	   instructions.	  Isolated	  DNA	  fragments	  were	  TA-­‐tailed	  by	  incubating	  different	  
amounts	   of	   DNA	   with	   1µl	   of	   Taq-­‐polymerase	   (LifeTechnologies),	   1µl	   Taq	   PCR	   –buffer	  
Figure	  2.3	  Selection	  of	  effective	  P300	  shRNAs.	  
P300	  specific	  shRNAs	  (sh2,	  sh3,	  sh4,	  sh5	  and	  sh6)	  were	  
transfected	   in	   HELA	   cells	   alongside	   non-­‐targeting	  
scramble	   shRNA.	   Samples	   were	   analysed	   for	   the	  
efficiency	   of	  P300	   knockdown	  by	   (a)	   qRT-­‐PCR	   analysis	  




(LifeTechnologies),	  0.3	  µl	  of	  50	  mM	  MgCl2	  and	  0.2	  µl	  of	  10	  mM	  dNTP	  (LifeTechnologies)	  in	  10	  
µl	   reaction	   volume	  with	  dH2O	   for	   20	  min	   at	   70°C.	  After	   TA-­‐tailing	   various	   amounts	  of	   the	  
DNA	   fragments	  were	   ligated	  with	  pGEM-­‐T	  Easy	  vector	   in	  a	  20	  µl	   reaction	  with	  10	  µl	  of	  2x	  
rapid	   ligation	   buffer	   (Promega)	   and	   T4	   DNA	   ligase	   (Promega).	   Ligations	   were	   incubated	  
overnight	  at	  4°C.	  
The	   ligation	  products	  were	  used	   to	   transform	  RapidTrans™	  TAM1	  competent	  E.coli	   (Active	  
Motif)	  according	  to	  manufacturer’s	  instructions.	  Briefly,	  5	  µl	  of	  plasmid	  product	  was	  added	  
to	  50	  µl	   of	  bacteria	   and	  mixed	  gently.	   Transformations	  were	   incubated	  on	   ice	   for	  30	  min,	  
then	  heat	  shocked	  by	  immersing	  in	  42°C	  water	  for	  30	  s	  and	  then	  immediately	  returned	  to	  ice	  
for	  2	  min.	  250	  µl	  of	  SOC-­‐medium	  was	  added	  to	  the	  reaction	  and	  the	  bacteria	  were	  incubated	  
shaking	  at	  37°C	  for	  one	  hour.	  40	  µl	  of	  X-­‐Gal	  (to	  enable	  blue/white	  screening	  of	  colonies	  by	  β-­‐
galatosidase	  activity)	  was	  added	  to	  each	  reaction	  and	  an	  aliquot	  of	  the	  transformed	  bacteria	  
was	   plated	   onto	   LB-­‐agar	   plates	   supplemented	   with	   100	   µg/µl	   ampicillin.	   Plates	   were	  
incubated	  overnight	  at	  37°C	  and	  the	  next	  day	  individual	  white	  colonies	  were	  picked	  into	  LB-­‐
broth	   (LB-­‐Broth	   Lennox	   20	   g/l	   in	   dH2O)	   supplemented	   with	   100	   µg/µl	   ampicillin	   and	  
incubated	  overnight	  at	  37°C	  under	  agitation.	  Plasmid	  DNA	  was	  extracted	  from	  exponentially	  
growing	  cultures	  with	  Purelink	  Plasmid	  Mini	  and	  Midiprep	  kits	  (LifeTechnologies)	  according	  
to	  manufacturer’s	   instructions.	  Final	  DNA	  product	  was	  resuspended	  in	  double	  distilled	  H2O	  
and	  insertion	  of	  correct	  DNA	  fragment	  was	  confirmed	  by	  sequencing.	  
4	  µg	  of	  insert	  (REX1	  or	  FLAG-­‐REX1)	  and	  4	  µg	  of	  vector	  (pPyfloxed)	  were	  digested	  in	  a	  20	  µl	  
reaction	  with	  1	  µl	  of	  PacI,	  1µl	  of	  XhoI	  and	  2	  µl	  of	  10x	  buffer,	   incubated	  at	  37°C	  overnight.	  
Digestion	  products	  were	  ran	  on	  a	  1%	  agarose	  gel	  with	  the	  2-­‐log	  ladder	  and	  bands	  of	  correct	  
sizes	  were	   isolated	  with	  QIAquick	  Gel	   Extraction	   Kit	   (Qiagen)	   according	   to	  manufacturer’s	  
instructions.	  Digested	  pPyfloxed	  vector	  was	  dephosphorylated	  with	  Antarctic	  phosphatase	  in	  
a	  40	  µl	  reaction	  with	  4	  µl	  of	  4x	  buffer	  and	  1	  µl	  of	  phosphatase	  incubated	  at	  37°C	  for	  30	  min.	  
50	  ng	  of	  vector	  and	  three-­‐molar	  excess	  of	  insert	  were	  ligated	  in	  a	  20	  µl	  reaction	  with	  2	  µl	  of	  
10x	  buffer	  and	  1	  µl	  of	  T4	  ligase	  (400	  U)	  incubated	  overnight	  at	  16°C.	  	  
The	   ligation	  products	  were	  used	   to	   transform	  RapidTrans™	  TAM1	  competent	  E.coli	   (Active	  
Motif)	   according	   to	  manufacturer’s	   instructions	   and	   cultures	  were	   expanded	   as	   described	  
above	   for	   pGEM-­‐T	   Easy	   ligations,	   with	   the	   exception	   of	   no	   X-­‐Gal	   added	   and	   blue/white	  
screening	   done.	   Plasmid	   DNA	   was	   extracted	   from	   exponentially	   growing	   cultures	   with	  
Purelink	   Plasmid	   Mini	   and	   Midiprep	   kits	   (LifeTechnologies)	   according	   to	   manufacturer’s	  
	  
	   	   	  
65	  
instructions.	   Final	   DNA	   product	   was	   resuspended	   in	   double	   distilled	   H2O	   and	   insertion	   of	  
correct	  DNA	  fragment	  was	  confirmed	  by	  sequencing.	  
2.2.2.4 DNA	  delivery	  into	  hES	  cells	  
H1	   and	   H9	   hES	   cells	   were	   transfected	   with	   the	   appropriate	   overexpression	   on	   shRNA	  
constructs	   using	   Lipofectamine	   2000	   according	   to	   manufacturer’s	   instructions	   with	   some	  
adjustments.	  Briefly,	  hES	  cells	  were	  seeded	  in	  high	  density	  of	  small	  colonies	  onto	  six	  wells	  of	  
a	  six	  well	  plate.	  Cells	  were	  maintained	  in	  CDM	  media	  without	  antibiotics	  for	  two	  days	  after	  
which	  they	  were	  transfected.	  4	  µg	  of	  plasmid	  DNA	  was	  diluted	  in	  250	  µl	  of	  OPTIMEM	  media	  
(LifeTechnologies)	  and	  10	  µl	  of	  Lipofectamine	  was	  diluted	   in	  250	  µl	  of	  OPTIMEM,	  per	  each	  
well	   transfected.	   Lipofectamine	   mix	   was	   incubated	   at	   room	   temperature	   (RT)	   for	   5	   min	  
before	  mixing	  carefully	  with	   the	  plasmid	  DNA	  mix	  and	   further	   incubated	   for	  20	  min	  at	  RT.	  
Medium	   on	   cells	   to	   be	   transfected	   was	   changed	   to	   1	   ml	   of	   OPTIMEM	   without	   any	  
supplements.	  After	  the	  incubation	  Lipofectamine/DNA	  mix	  was	  added	  at	  a	  dropwise	  manner	  
to	  the	  wells.	  The	  plates	  were	  then	  briefly	  shaken	  and	  placed	  back	  into	  the	  cell	  incubator.	  The	  
following	  day	  media	  was	  changed	  back	  to	  CDMactivin	  and	  then	  maintained	  in	  the	  media	  until	  
approximately	   day	   seven	   after	   transfection.	   Once	   the	   cells	   had	   reached	   confluence	   at	  
around	  day	   seven,	   selection	  was	   started	  by	   adding	   1	  µg/ml	   of	   puromycin	   in	   the	  CDMactivin	  
culture	  medium.	  Cells	  were	  maintained	  under	  selection	  for	  a	  further	  two	  to	  three	  weeks	  at	  
which	   point	   individual	   colonies	  were	   picked	   and	   seeded	   onto	   12	   –well	   plates	   to	   establish	  
lines.	   Overexpression	   or	   knockdown	  was	   confirmed	   by	   qRT-­‐PCR	   and	   positive	   clones	   were	  
used	  for	  downstream	  analysis.	  
2.2.3 Small	  interfering	  RNA	  induced	  knockdown	  in	  hES	  cells	  
ON-­‐TARGETPlus	   non-­‐targeting	   control	   pool	   (siSCR)	   small	   interfering	   RNA	   (siRNA)	   and	   ON-­‐
TARGETPlus	   siP300	   pool	   (siP300)	  were	   purchased	   from	   ThermoScientific	   (Cambridge,	   UK).	  
Sequences	   for	   the	   four	   siRNAs	   in	   the	   siP300	   pool	   are	   as	   follows:	   1;	   5’-­‐
CGACAGGGAUGCAGUAACA-­‐3’,	   2;	   5’-­‐GUUCAAUAAUGCCUGGUUA-­‐3’,	   3;	   5’-­‐
GACAAGGGAUAAUGCCUAA-­‐3’	   and	   4;	   5’-­‐GGACUACCCUAUCAAGUAA-­‐3’.	   The	   siRNAs	   were	  
resuspended	   at	   100	   µM	   for	   stock	   solution	   in	   deoxyribonuclease	   (DNase)/ribonuclease	  
(RNase)	  free	  dH2O.	  For	  P300	  knockdown	  hES	  cells	  were	  double	  transfected	  with	  siP300	  and	  
compared	   to	   cells	   transfected	  with	   siSCR.	   Briefly,	   for	   transfection	   in	   6-­‐well	   plates	   and	   for	  
each	  transfected	  well,	  siRNA	  was	  diluted	  at	  a	  25	  nm	  final	  concentration	  into	  15	  µl	  of	  dH2O	  
(total	   final	   transfection	  volume	   is	  1.5	  ml).	  12	  µl	   of	  HiPerfect	   transfection	   reagent	   (Qiagen)	  




and	  the	  media	  with	  the	  transfection	  reagent	  were	  added	  into	  the	  well	  and	  left	  incubating	  for	  
approximately	   30	  min	   at	   RT.	   Following	   the	   30	  min	   incubation,	   hES	   cells	   to	   be	   transfected	  
were	   plated	   in	   small	   clumps	   on	   top	   of	   the	   siRNA/medium	   in	   1.2	  ml	   of	  OPTIMEM	  used	   to	  
passage	   the	   cells.	   Cells	  were	   then	   returned	   to	   the	   incubator	   and	   left	   overnight	  when	   the	  
medium	  was	  changed	   to	  CDMactivin.	  On	   the	   second	  day	  after	   the	   first	   transfection	   the	  cells	  
were	  re-­‐transfected	  with	  siRNA.	  Media	  on	  the	  cells	  was	  changed	  to	  1.2	  ml	  of	  OPTIMEM.	  25	  
nM	  final	  concentration	  of	  siRNA	  and	  12	  µl	  of	  HiPerfect	  were	  diluted	  in	  300	  µl	  of	  OPTIMEM.	  
After	  incubation	  at	  RT	  for	  30	  min	  the	  siRNA	  mixture	  was	  added	  dropwise	  onto	  the	  cells.	  Cells	  
were	   returned	   to	   the	   incubator	   and	   medium	   changed	   to	   CDMactivin	   the	   following	   day.	   All	  
analysis	  for	  the	  siRNA	  transfections	  was	  done	  after	  day	  four	  of	  treatment.	  
2.2.4 Human	  ES	  cell	  differentiation	  
2.2.4.1 	  Embryoid	  body	  formation	  
Human	  ES	  cells	  differentiation	  was	  achieved	  by	  promoting	  embryoid	  body	  (EB)	  outgrowths	  
from	  hES	  cells	  CM	  and	  CDM	  conditions,	  as	  previously	  described	  (Xu	  et	  al.	  2001;	  Osafune	  et	  
al.	  2008).	  Briefly,	  1	  well	   from	  a	  6	  well	  plate	  of	  hES	  cells	  at	  80-­‐90%	  confluence	  were	  rinsed	  
with	  PBS	  and	  treated	  with	  1	  mg/ml	  collagenase	  type	  IV	  in	  Knockout™	  DMEM	  for	  10	  min	  at	  
37	   °C.	   The	   collagenase	  was	   rinsed	   away	  with	   PBS	   and	   replaced	  with	   EB	  media	   containing	  
Knockout™	  DMEM	  supplemented	  with	  20%	  FBS,	  0.1	  mM	  NEAA,	  2	  mM	  L-­‐glutamine	  and	  0.55	  
mM	   β-­‐mercaptoethanol.	   Cells	   were	   then	   scraped	   off	   with	   a	   cell	   scraper,	   dissociated	   by	  
pipetting,	  and	  distributed	  into	  1	  well	  of	  an	  ultra-­‐low	  attachment	  6	  well	  plate	  (Corning	  Inc.).	  
On	   day	   10,	   EBs	   were	   transferred	   back	   to	   0.1%	   gelatinized-­‐tissue	   culture	   plates,	   which	  
allowed	  the	  cells	  to	  adhere	  and	  further	  differentiate	  into	  different	  cell	   lineages.	  Media	  was	  
changed	   every	   3	   days	   and	   EBs	   were	   collected	   for	   real-­‐time	   quantitative	   PCR	   analysis	   at	  
culture	  day	  3,	  6,	  9	  and	  30.	  Primer	  pairs	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  Table	  
A1.	  
2.2.4.2 Neural	  progenitor	  cell	  differentiation	  
Human	   ES	   cells	   were	   differentiated	   to	   neural	   progenitor	   cells	   according	   an	   established	  
protocol	   (Smith	  et	  al.	  2008),	  with	  slight	  modifications.	  Briefly	  hES	  cells	  were	  maintained	   in	  
CDM	   conditions	   as	   described	   above.	   Following	   48h	   after	   splitting	   the	   cells	   neural	  
differentiation	   was	   induced	   by	   culturing	   the	   cells	   in	   CDM	  media	   supplemented	   with	   100	  
ng/ml	  of	  Noggin	  (R&D	  Systems	  Europe	  Ltd),	  10	  µM	  SB431542	  (Sigma-­‐Aldrich)	  and	  12	  ng/ml	  
of	  FGF2.	  Media	  was	  changed	  daily	  and	  cells	  collected	  for	  real-­‐time	  quantitative	  PCR	  on	  days	  
0,	  2,	  4,	  6,	  8	  and	  10.	  Primer	  pairs	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  Table	  A1.	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Human	   neural	   progenitor	   (NP)	   cells	   derived	   from	   undifferentiated	   H7	   cells	   from	   CM	  
conditions	  were	  derived	  according	  to	  Gerrard	  et	  al.	  (Gerrard	  et	  al.	  2005a).	  Briefly,	  confluent	  
hES	  cells	  were	  split	  with	  0.5	  mM	  EDTA/PBS	  in	  1:5	  ratios	  into	  culture	  dishes	  coated	  with	  poly-­‐
L-­‐lysine/laminin	   and	   cultured	   in	   N2B27	  medium	   (as	   described	   above),	   supplemented	  with	  
100	   ng/ml	  mouse	   recombinant	   noggin	   (R&D	   Systems).	   Cells	   were	   consistently	   split	   at	   1:3	  
ratios	   by	   collagenase	   into	   small	   clumps,	   similar	   to	   hES	   cells	   CM	   culture.	   After	   24	   days	   in	  
culture	   cells	   were	   disassociated	   into	   single	   cells	   by	   TrypLE	   express,	   and	   noggin	   was	  
withdrawn	   from	   N2B27	   medium,	   while	   20	   ng/ml	   FGF2	   and	   20	   ng/ml	   epidermal	   growth	  
factor	  were	  added	  after	  an	  extra	  8	  days	  in	  culture.	  NP	  cells	  were	  plated	  at	  1x105	  cells/cm2	  in	  
6	  well	  culture	  plates.	  Media	  was	  changed	  every	  2	  days.	  
2.2.5 Replication	  timing	  analysis	  
2.2.5.1 BrdU	  labelling	  and	  cell	  cycle	  fractionation	  by	  flow	  cytometry	  
All	   reagents	   used	   in	   this	   analysis	   were	   from	   Sigma-­‐Aldrich	   unless	   otherwise	   stated.	   The	  
replication	   timing	   of	   individual	   loci	   was	   assessed	   using	   a	   previously	   described	   method	  
(Azuara	  2006).	  Exponentially	  growing	  non-­‐synchronized	  cells	  were	  incubated	  with	  50	  µM	  5-­‐
bromo-­‐2-­‐deoxyuridine	   (BrdU)	   for	   90	   min	   at	   37°C,	   washed	   in	   cold	   PBS	   (PAA	   laboratories)	  
without	  calcium	  and	  magnesium,	   fixed	   in	  70%	  ethanol	  and	  stored	  at	  4°C	   in	  the	  dark	   for	  at	  
least	  24	  hours.	  Ethanol	  was	  removed	  by	  washing	  the	  cells	   twice	  with	  PBS	  and	  collected	  by	  
centrifugation	  at	  1700	  rotations	  per	  minute	  (rpm)	  for	  10	  min,	  4°C.	  BrdU-­‐labelled	  cells	  were	  
resuspended	   in	   staining	   buffer	   (40	   mM	   (hydroxymethyl)methylamine	   (Tris)	   pH	   7.4,	   0.8%	  
NaCl,	   21	  mM	  MgCl2	   and	   0.05%	  NP-­‐40)	  with	   50	   µg/ml	   propidium	   iodide	   (PI)	   and	   1	  mg/ml	  
RNase	  A,	   carefully	  disaggregated	  with	   the	  help	  of	  a	  40	  µm	  cell	   strainer	   (Becton	  Dickinson,	  
Oxford,	  UK)	  and	  allowed	  to	  stain	  on	  ice,	  in	  the	  dark	  for	  20	  min	  prior	  to	  separation	  on	  a	  FACS	  
Vantage	  flow	  cytometer,	  Diva.	  Equal	  numbers	  of	  cells	  (ranging	  from	  20	  000	  to	  50	  000)	  were	  
collected	  for	  each	  of	  six	  fractions	  (G1,	  S1,	  S2,	  S3,	  S4	  and	  G2)	  into	  Lysis	  buffer	  I	  [1	  M	  NaCl,	  10	  
mM	   EDTA,	   50	   mM	   Tris-­‐HCL	   pH	   8.0,	   0.5%	   sodium	   dodecyl	   sulphate	   (SDS),	   0.2	   mg/ml	  
proteinase	   K	   (PK),	   0.25	  mg/ml	   salmon	   sperm	  DNA	   (LifeTechnologies)]	   and	   stored	   at	   -­‐20°C	  
following	  incubation	  for	  2	  hours	  at	  50°C.	  
2.2.5.2 Isolation	  of	  newly-­‐replicated	  DNA	  by	  immunoprecipitation	  
Equal	   amounts	   of	   Drosophila	   melanogaster	   S2	   BrdU-­‐labelled	   DNA	   were	   added	   to	   each	  
sorted	   cell	   cycle	   fraction	   (7.5	   ng	   per	   104	   sorted	   cells).	   DNA	  was	   then	   purified	   by	   phenol,	  
chloroform/isoamylalcohol	   extraction	   and	   ethanol	   precipitation.	   Precipitated	   DNA	   was	  




37°C	   for	   1	   hour	   in	   the	   dark.	   Samples	  were	   then	   sonicated	   45	   sec	   on	   a	   Vibra-­‐Cell™	  VC130	  
(Sonics	  &	  Material	   Inc.,	  Newtown,	  USA)	   (130W,	  30Hz)	  using	  a	  microtip	  ultrasonic	  probe	   in	  
order	   to	  generate	   fragments	  of	  an	  average	  size	  of	  700	  bp.	  After	  denaturation	   for	  5	  min	  at	  
95°C	  and	  cooling	  down	  on	  ice	  for	  2	  min,	  50	  µl	  of	  Adjusting	  buffer	  [10	  mM	  sodium	  phosphate	  
(pH	  7),	  0.14	  M	  NaCl,	  and	  0.05%	  Triton	  X-­‐100]	  was	  added	  to	  each	  fraction	  and	  incubated	  with	  
80	  µl	  anti-­‐BrdU	  antibody	  for	  30	  min	  at	  room	  temperature	  with	  constant	  rotation.	  Secondary	  
antibody	   (rabbit	   anti-­‐mouse	   IgG)	   was	   added	   (35	   µg)	   and	   incubated	   at	   room	   temperature	  
with	   constant	   rotation	   for	   additional	   30	   min.	   DNA-­‐protein	   complexes	   were	   collected	   by	  
centrifugation	   at	   15	   300	   rpm	   for	   20	  min,	   4°C,	  washed	   once	  with	  Washing	   buffer	   (10	  mM	  
sodium	  phosphate	  buffer	  pH	  7.0,	  0.14	  M	  NaCl,	  0.05%	  Triton	  X-­‐100)	  and	  resuspended	  in	  200	  
µl	   Lysis	   buffer	   II	   (50	   mM	   Tris-­‐HCL	   pH	   8,	   10	   mM	   EDTA,	   0.5%	   SDS,	   0.25	   mg/ml	   PK)	   and	  
incubated	   2	   hour,	   55°C.	   BrdU-­‐labelled	   DNA	   was	   then	   extracted	   by	  
phenol/chloroform/isoamyl	   alcohol	   and	   ethanol	   precipitation	   before	   resuspension	   in	   Tris-­‐
EDTA	  (TE;	  10	  mM	  Tris-­‐HCl	  pH	  8.0,	  1	  mM	  EDTA)	  at	  a	  concentration	  of	  200	  cells	  per	  microliter.	  
The	  abundance	  of	  newly	  replicated	  DNA	  in	  each	  cell-­‐cycle	  fraction	  was	  determined	  by	  real-­‐
time	  quantitative	  PCR.	  Primer	  pairs	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  Table	  A3.	  
2.2.6 Reverse	  transcription	  polymerase	  chain	  reaction	  
2.2.6.1 RNA	  extraction	  and	  cDNA	  synthesis	  
RNA	   extraction	   was	   performed	   using	   RNeasy	   protect	   mini	   kit	   (Qiagen,	   Valencia,	   CA)	   and	  
residual	   DNA	   was	   eliminated	   using	   the	   RNase-­‐free	   DNase	   kit	   (Qiagen)	   according	   to	  
manufacturer’s	   instructions.	   RNA	   was	   then	   reverse	   transcribed	   using	   Superscript™	   First-­‐
Strand	  Synthesis	  system	  (LifeTechnologies).	  0.5	  -­‐	  1	  µg	  of	  total	  RNA	  was	  supplemented	  with	  1	  
µl	  of	  10	  mM	  dNTP	  mix	   (LifeTechnologies)	  and	  1	  µl	  of	  oligo	   (dT)12-­‐18	  and	  diluted	   in	  RNase	  
free	  water	  to	  a	  final	  volume	  of	  12	  µl.	  The	  mixture	  was	  incubated	  at	  65°C	  for	  5	  min	  and	  put	  
on	   ice	   for	   2	  min,	   when	   2	   µl	   of	   0.1	  M	   dithiothreiol,	   4	   µl	   of	   5X	   first	   strand	   buffer,	   1	   µl	   of	  
RnaseOUT	  (LifeTechnologies)	  were	  added	  before	  being	  further	   incubated	  at	  42°C	  for	  2	  min	  
and	  1	  µl	  of	  200	  U/µl	  Superscript	  II	  was	  added.	  A	  reaction	  mixture	  without	  the	  enzyme	  was	  
also	  set	  up	  as	  a	  control	  (designated	  “-­‐RT”).	  The	  mixture	  was	  incubated	  at	  42°C	  for	  1	  h	  and	  at	  
70°C	  for	  15	  min	  to	  stop	  the	  reaction.	  380	  µl	  of	  RNase-­‐free	  water	  was	  added	  and	  cDNAs	  of	  
interest	  were	  then	  detected	  by	  quantitative	  real-­‐time	  PCR.	  
2.2.6.2 Primer	  design	  and	  testing	  for	  quantitative	  PCR	  
Primers	   for	   ChIP,	   replication	   timing	   and	   gene	   expression	   analysis	   were	   designed	  with	   the	  
NCBI	   (National	   Centre	   for	   Biotechnology	   Information)	   primer	   blast	   search	   engine	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(http://www.ncbi.nlm.nih.gov/tools/primer-­‐blast/).	  The	  following	  design	  criteria	  were	  used:	  
amplicon	   size	   of	   100-­‐250	   bp,	   GC	   content	   of	   45-­‐55%,	   melting	   temperature	   57-­‐63°C	   and	  
primer	   size	   15-­‐27	   bp.	   Additionally	   for	   gene	   expression	   analysis	   one	   of	   the	   primers	   was	  
required	  to	  span	  an	  exon-­‐exon	  junction.	  All	  primer	  pairs	  were	  tested	  for	  predicted	  products	  
within	   the	   mouse	   and	   human	   genome	   using	   in	   silico	   PCR	   UCSC	   genome	   browser	  
(http://genome.ucsc.edu).	  Primers	  yielding	  a	  single	  predicted	  PCR	  product	  of	  the	  correct	  size	  
were	   ordered	   from	   Sigma	   Genosys	   (the	   primers	   sequences	   are	   shown	   in	   their	   5’	   to	   3’	  
orientation).	   The	   efficiency	   of	   amplification	   for	   each	   primer	   pair	   was	   tested	   by	   qRT-­‐PCR	  
analysis	   with	   sequential	   2-­‐fold	   dilutions	   of	   genomic	   DNA	   or	   cDNA	   (Pfaffl	   2001).	   Primers	  
yielding	   poor	   linear	   fits	   of	   the	   threshold	   cycle	   [C(T)]	   versus	   logarithm	   of	   concentration	  
(R2<0.98)	  or	  efficiencies	  lower	  than	  1.8	  or	  greater	  than	  2.2	  were	  discarded.	  All	  primers	  are	  
listed	  in	  Appendix	  I,	  Table	  A1.	  
2.2.6.3 Real-­‐time	  quantitative	  PCR	  analysis	  
Real-­‐time	  PCR	  analysis	  was	  carried	  out	  in	  20	  µl	  reaction	  volume	  with	  Jumpstart	  Sybr-­‐Green	  
PCR	  Mastermix	   (Sigma-­‐Aldrich),	   300nM	   primers	   and	   2	  µl	   of	   template.	   A	   reaction	  without	  
DNA	  was	  included	  to	  control	  for	  the	  formation	  of	  primer	  dimers	  and	  each	  measurement	  was	  
performed	   in	   duplicate.	   PCR	   reactions	   were	   performed	   on	   a	   DNA	   Engine	   Opticon™	   using	  
Opticon	  Monitor	  3	  software	  (Bio-­‐Rad	  Laboratories	  Inc.,	  Hercules,	  CA),	  running	  the	  following	  
program:	  an	  initial	  denaturing	  step	  at	  95°C	  for	  15	  min,	  40	  cycles	  of	  denaturation	  at	  94°C	  for	  
15	   sec,	   annealing	   at	   60°C	   for	   30	   sec,	   elongation	   at	   72°C	   for	   30	   sec	   at	   which	   point	   the	  
fluorescence	  was	  read	  at	  72°C,	  75°C,	  78°C	  and	  83°C.	  The	  melting	  curve	  was	  determined	  from	  
70°C	   to	  90°C,	  at	  0.2°C	   intervals.	  The	  analysis	  of	   the	  qRT-­‐PCR	  data	  was	  performed	  with	   the	  
Opticon	  Monitor	  3	  software	  and	  the	  relative	  abundance	  of	  sequences	  was	  calculated	  using	  
the	  ΔΔC(T)	  method	  (Livak	  et	  al.	  2001;	  Pfaffl	  2001).	  When	  the	  amplification	  efficiency	  is	  close	  
to	  2,	  the	  relative	  amount	  of	  PCR	  products	  between	  reactions	  1	  and	  2	  can	  be	  calculated	  as	  2-­‐
ΔC(T)1/2-­‐ΔC(T)2,	  being	  C(T)	  the	  threshold	  cycle	  at	  which	  fluorescence	  due	  to	  PCR	  products	  
becomes	   detectable	   above	   background.	   Gene	   expression	   data	   was	   normalized	   to	   the	  
average	   of	   two	   housekeeping	   genes	   as	   previously	   described	   (Vandesompele	   et	   al.	   2002).	  
Briefly,	   the	   relative	   expression	   levels	   of	   target	   genes	   were	   normalised	   to	   the	   average	  
expression	   levels	   of	  HPRT	   and	  GAPDH	   in	   each	   specific	   sample.	   These	   housekeeping	   genes	  




2.2.6.4 Semi-­‐quantitative	  PCR	  analysis	  
Semi-­‐quantitative	   PCR	   analysis	   was	   performed	   in	   50	   µl	   reaction	   volume	   with	   1.25	   U	   of	  
HotStarTaqTM	   DNA	   polymerase	   (Qiagen)	   using	   0.4	   µM	   specific	   primers,	   with	   the	   following	  
program:	  95°C	  for	  15	  min,	   then	  cycles	  of	  94°C	  for	  15	  sec,	  60°C	  for	  30	  sec,	  72°C	  for	  30	  sec.	  
PCR	   products	   were	   separated	   by	   electrophoresis	   on	   1.5%	   agarose	   (Invitrogen)	   gels	   and	  
visualised	  by	  ethidium	  bromide	  staining.	  β-­‐ACTIN	  was	  used	  to	  normalize	  input.	  The	  primers	  
and	  conditions	  used	  for	  this	  analysis	  can	  be	  found	  in	  Appendix	  I,	  Table	  A2.	  For	  each	  reaction	  
of	  PCR	  amplification,	  conditions	  were	  maintained	  within	  the	  dynamic	  range.	  
2.2.7 Immunofluorescence	  analysis	  and	  alkaline	  phosphatase	  activity	  
Undifferentiated	  hES	  cells	  were	  cultured	  on	  coated	  glass	  coverslips	  according	  to	  their	  growth	  
conditions	   for	  at	   least	  24	  hours.	  Coverslips	  were	   removed,	  washed	   in	  PBS	  and	   fixed	   in	  4%	  
paraformaldehyde	  (PFA)	  (Sigma)	  in	  PBS	  for	  15	  min.	  Fixed	  samples	  were	  washed	  in	  PBS	  and,	  
for	   intracellular	   staining,	   permeabilised	   with	   0.4%	   Triton	   X-­‐100	   for	   15	   min	   at	   room	  
temperature.	   Samples	   were	   incubated	   sequentially	   in	   blocking	   solution	   [2.5%	   BSA,	   0.05%	  
Tween20,	   10%	   Normal	   Goat	   Serum	   (Sigma)	   in	   PBS]	   for	   30	   min	   and	   in	   primary	   antibody	  
diluted	  in	  blocking	  solution	  overnight	  at	  4°C	  in	  a	  humid	  chamber.	  Coverslips	  were	  washed	  in	  
wash	   buffer	   (0.2%	  BSA,	   0.05%	   Tween20	   in	   PBS;	   3	   x	   5	  min)	   and	   incubated	  with	   secondary	  
antibodies	   coupled	  with	   appropriate	   fluorophores	   diluted	   in	   blocking	   solution	   for	   45	  min.	  
Finally,	  cells	  were	  washed	  twice	  in	  wash	  buffer	  (5	  min),	  once	  in	  PBS	  (3	  min)	  and	  mounted	  in	  
Vectashield	   (Vector)	   with	   4,6-­‐diamidino-­‐2-­‐phenylindole	   (DAPI)	   (1	   μg/ml).	   A	   list	   of	   primary	  
and	  secondary	  antibodies	  used	  for	  IF	  as	  well	  as	  quantities	  and	  suppliers	  is	  shown	  in	  section	  
2.1.1	  and	  2.1.2	  
Alkaline	  Phosphatase	  staining	  was	  carried	  out	  on	  cells	  grown	  for	  at	  least	  2	  days	  under	  their	  
standard	   culture	   conditions,	   using	   a	   kit	   from	   Sigma	   (86R-­‐1KT)	   according	   to	   the	  
manufacturer’s	  instructions.	  
Samples	  were	  visualised	  using	  a	  Nikon	  Eclipse	  TE2000-­‐U	  microscope	  and	  images	  processed	  
using	  QCapture	  Pro	  software,	  or	  Nikon	  Eclipse	  TS100	  and	  Nikon	  D5100	  digital	  camera	  or	  a	  
TCS	   SP5	   Leica	   laser-­‐scanning	   confocal	   microscope	   using	   the	   Leica	   Confocal	   software.	   All	  
images	  were	  processed	  using	  Adobe	  Photoshop	  CS5.	  Microscope	   settings	  and	   laser	  power	  
were	  kept	  constant	  between	  the	  controls	  and	  samples.	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2.2.8 	  Fluorescence	  activated	  cell	  sorting	  analysis	  
The	   analysis	   of	   cell	   surface	   antigens	   (SSEA4,	   SSEA3,	   SSEA1,	   Tra-­‐1-­‐60	   and	   Tra-­‐1-­‐81)	   was	  
performed	  as	   follows:	   cells	  were	  harvested	  by	   trypsinisation	   and	  5x106	   cells	  were	  washed	  
twice	   in	   FACS	   buffer	   (PBS,	   2%	   FBS,	   2	  mM	   EDTA),	   resuspended	   in	   50	  µl	   of	   blocking	   buffer	  
(PBS,	  2%	  FBS,	  2	  mM	  EDTA	  and	  40%	  normal	  goat	  serum)	  and	  incubated	  for	  15	  min	  on	  ice	  to	  
block	  no-­‐specific	  binding.	  Primary	  antibody	  was	  then	  added	  at	  an	  appropriate	  dilution	  and	  
incubated	  30	  min	   at	   4ºC.	   The	   cells	  were	   then	  washed	  and	   resuspended	   in	  100	  µl	   of	   FACS	  
buffer	  with	  appropriate	   secondary	  antibody	  and	   incubated	   for	  an	  additional	  30	  min	   in	   the	  
dark	  on	  ice.	  Finally,	  cells	  were	  washed	  and	  then	  resuspended	  in	  1	  ml	  of	  PBS	  with	  2	  mM	  EDTA	  
for	  analysis.	  For	  SSEA1	  staining,	  cells	  were	  incubated	  with	  APC-­‐coupled	  anti-­‐SSEA1	  antibody,	  
washed	   twice	   and	   resuspended	  directly	   in	   100	  μl	   of	   FACS	  buffer.	   For	   intracellular	   staining	  
(Oct4	  and	  Nanog)	  cells	  were	  harvested	  by	  trypsinisation,	  washed	  in	  FACS	  buffer	  and	  1.5x106	  
cells	  fixed	  (10	  min,	  37°C)	  with	  0.1%	  PFA	  in	  PBS.	  Cells	  were	  then	  washed	  and	  permeabilised	  
(30	  min,	  4°C)	  with	  cold	  90%	  methanol.	  After	  washing	  once,	  cells	  were	  incubated	  for	  30	  min	  
at	  room	  temperature	  with	  primary	  antibody	  diluted	  in	  FACS	  buffer	  with	  0.1%	  Triton	  X-­‐100.	  
Cells	  were	  again	  washed	  twice	  before	  incubating	  for	  30	  min	  with	  secondary	  antibody	  diluted	  
in	  FACS	  buffer	  with	  0.5%	  Triton	  X-­‐100.	  The	  cells	  were	  finally	  washed	  twice	  and	  resuspended	  
in	  600	  μl	  of	   FACS	  buffer	  before	  analysis	  on	  a	  FACScalibur	   flow	  cytometer	   (BD	  Biosciences)	  
with	  CellQuest	   software.	   The	  profile	   of	   stained	   cells	  was	   compared	   to	  unstained	   cells	   and	  
cells	   stained	  with	   the	   secondary	   antibody	   only	   or	   to	   cells	   stained	  with	   an	   isotype	   control	  
antibody.	  A	  list	  of	  primary	  and	  secondary	  antibodies	  used	  for	  FACS	  as	  well	  as	  quantities	  and	  
suppliers	  is	  shown	  in	  section	  2.1.1	  and	  2.1.2.	  
2.2.9 Protein	  analysis	  by	  western	  blotting	  
Whole	   cell	   extracts	   were	   prepared	   by	   direct	   lysis	   of	   cells	   with	   cold	   Radio	   Immuno	  
Precipitation	  Assay	  buffer	   [150	  mM	  NaCl,	  50	  mM	  Tris	  pH	  8.0,	  0.5%	  Deoxycholic	  acid,	  0.1%	  
sodium	  dodecyl	  sulphate	  (SDS),	  1%	  NP-­‐40	  plus	  protease	  inhibitors].	  Cells	  were	  scraped	  from	  
the	  plates,	  incubated	  under	  rotation	  at	  4°C	  for	  20	  min	  and	  centrifuged	  at	  13	  000	  rpm	  for	  20	  
min	  at	  4˚C	  and	  the	  supernatant	  collected.	  The	  protein	  solution	  was	  quantified	  by	  Pierce	  BCA	  
Protein	  assay	  (ThermoScientific)	  and	  stored	  at	  -­‐80°C.	  
20-­‐40	  µg	  of	  protein	  sample	  was	  diluted	  1:1	  with	  Laemmli	  sample	  buffer	  (BioRad)	  with	  5%	  β-­‐
mercaptoethanol	   and	   heated	   at	   95˚C	   for	   5	  min.	   Cell	   lysates	  were	   resolved	   on	   8-­‐14%	   SDS	  
polyacrylamide	   gel	   electrophoresis	   (SDS-­‐PAGE)	   gels	   with	   5	   µl	   PageRuler™	   protein	   ladder	  




membranes	   (Millipore)	   using	   either	   a	   wet-­‐transfer	   method	   for	   large	   proteins	   [>	   100	  
kiloDalton	   (kDa)]	   in	   a	   transfer	   tank	   at	   100	   V	   for	   1	   hour	   in	   transfer	   buffer	   (48	  mM	  Trizma	  
base,	  39	  mM	  glycine,	  0.037%	  SDS	  and	  10%	  methanol)	  in	  4°C	  or	  semi-­‐dry	  transfer	  method	  for	  
smaller	   proteins	   (<	   100	   kDa)	   between	   transfer	   plates	   soaked	   in	   transfer	   buffer	   (48	   mM	  
Trizma	  base,	   39	  mM	  glycine,	   0.037%	  SDS	   and	  20%	  methanol).	   The	  membranes	  were	   then	  
blocked	  with	  5%	  skimmed	  milk	  (Sigma)	  or	  5%	  BSA	  in	  Tris-­‐Buffered	  Saline	  with	  0.5%	  Tween20	  
(TBS-­‐T)	  for	  1	  hour	  at	  room	  temperature,	  followed	  by	  primary	  antibody	  incubation	  diluted	  in	  
blocking	   buffer	   with	   5%	   milk	   or	   BSA,	   overnight	   at	   4˚C,	   with	   agitation.	   Membranes	   were	  
washed,	   to	   remove	   any	   excess	   antibody,	   for	   10	  min	   three	   times	   in	   TBS-­‐T	   under	   agitation	  
before	   incubating	   with	   the	   appropriate	   HRP-­‐conjugated	   secondary	   antibody	   in	   blocking	  
buffer,	   for	  1	  hour	  at	   room	   temperature.	   Excess	   secondary	  antibody	  was	   then	   removed	  by	  
washing	  the	  membrane	  for	  10	  min	  three	  times	  in	  TBS-­‐T	  buffer	  under	  agitation.	  The	  blot	  was	  
treated	   by	   either	   Pierce	   ECL	   western	   blotting	   substrate	   (ThermoScientific)	   or	   ECL	   prime	  
western	   blotting	   detection	   reagents	   (GE	   Healthcare	   Life	   Sciences,	   Little	   Chalfont,	   UK)	   for	  
HRP-­‐conjugated	   antibody	   detection	   before	   being	   exposed	   to	   X-­‐ray	   films	   (CL-­‐XPosure	   Film,	  
ThermoScientific)	   and	   using	   the	   OPTIMAX	   IGP	   developer,	   or	   by	   using	   GE	   LAS4000	  
chemiluminescence	  imager.	  A	  list	  of	  primary	  and	  secondary	  antibodies	  used	  for	  WB	  as	  well	  
as	  quantities	  and	  suppliers	  is	  shown	  in	  sections	  2.1.1	  and	  2.1.2.	  
2.2.10 	  Colony	  formation	  assay	  
H1	   and	   H9	   hES	   cells	   were	   trypsinised	   to	   a	   single	   cells	   suspension	   and	   seeded	   on	   12-­‐well	  
plates	  at	  a	  density	  of	  5000	  cells	  per	  cm2	  in	  either	  normal	  CDMactivin	  or	  in	  CDM	  media	  without	  
Activin	  A	  supplementation.	  After	  eight	  days	  of	  culture	  the	  cells	  were	  fixed	  and	  assayed	  for	  
alkaline	   phosphatase	   activity	   as	   described	   in	   section	   2.2.7.	   The	   resulting	   colonies	   were	  
classified	   as	   undifferentiated,	  mixed	   or	   differentiated	   (See	   Fig.	   5.5	   for	   examples),	   and	   the	  
amount	   of	   each	   class	   in	   the	   plates	  was	   counted	   and	   represented	   as	   a	   proportion	   of	   total	  
number	  of	  colonies.	  
2.2.11 Chromatin	  immunoprecipitation	  analysis	  
2.2.11.1 ChIP	  for	  histone	  modifications	  
All	   reagents	   used	   were	   from	   Sigma	   unless	   stated	   otherwise.	   Approximately	   0.5-­‐1x108	  
exponentially	  growing	  cells	  were	  harvested,	  washed	  twice	  in	  PBS	  (PAA)	  and	  cross	  linked	  with	  
1%	   PFA	   for	   10	   min	   at	   room	   temperature.	   After	   quenching	   of	   PFA	   with	   glycine	   at	   a	   final	  
concentration	  of	  125	  mM,	  cells	  were	  washed	  twice	  with	  ice-­‐cold	  PBS	  and	  lysed	  in	  1	  ml	  of	  ice-­‐
cold	   lysis	   buffer	   (50	   mM	   Tris-­‐HCL	   pH	   8.1,	   10	   mM	   EDTA	   pH	   8.0,	   1%	   SDS)	   with	   protease	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inhibitor	  cocktail	   tablets	   (Roche).	  Using	  a	  BioruptorTM	  200	   (Diagenode,	  SA,	  Liège,	  Belgium),	  
the	   chromatin	   was	   sonicated	   to	   an	   average	   size	   of	   300	   to	   1000	   bp	   as	   analysed	   on	   1.5%	  
agarose	  gels.	   Insoluble	  proteins	  were	  discarded	  after	  centrifugation	  of	  the	  lysate	  at	  14	  000	  
rpm	   for	   15	  min	   at	   18°C	   and	   DNA	   concentration	   quantified	   using	   a	   NanoDrop	   ND-­‐1000.	  
100-­‐150	  µg	  of	  fragmented	  chromatin	  was	  diluted	  1/10	  in	  dilution	  buffer	  (1%	  Triton	  X-­‐100,	  2	  
mM	   EDTA	   pH	   8.0,	   150	   mM	   NaCl,	   20	   mM	   Tris-­‐HCL	   pH	   8.1)	   with	   protease	   inhibitors	   and	  
incubated	  at	  4°C	  for	  2	  hours,	  with	  30	  µl	  of	  blocked	  protein	  A-­‐sepharose	  beads	  to	  pre-­‐clear	  
the	   solution	   of	   any	   non-­‐specific	   binding.	   Beads	  were	   blocked	   overnight	   at	   4°C	   in	   dilution	  
buffer	   supplemented	  with	  10	  µl	  of	  BSA	   (New	  England	  Biolabs,	  10	  mg/ml)	  and	  4	  µl	   salmon	  
sperm	  DNA	  (10	  mg/ml)	  (LifeTechnologies)	  and	  then	  resuspended	  in	  dilution	  and	  lysis	  buffer	  
in	   a	   10:1	   ratio.	   Pre-­‐cleared	   chromatin	  was	   then	   immunoprecipitated	   (4°C,	   overnight)	  with	  
primary	  antibodies	  for	  histone’s	  modification,	  a	  negative	  anti-­‐IgG	  control	  and	  an	  anti-­‐H3	  or	  -­‐
H4	  total	  antibody	  for	  data	  normalisation,	  under	  rotation.	  A	  list	  of	  antibodies	  used	  for	  ChIP	  as	  
well	  as	  quantities	  and	  suppliers	  is	  shown	  in	  section	  2.1.1.	  Immune-­‐complexes	  were	  collected	  
by	   adding	   30	  μl	   of	   blocked	  beads	   once	   again	   and	   left	   immunoprecipitating	   2	   hours	   under	  
rotation,	   at	   4°C.	  Unbound	   chromatin	  was	   removed	   by	  washing	   four	   times	   in	   1	  ml	   of	   cold	  
wash	  buffer	  (0.1%	  SDS,	  1%	  Triton	  X-­‐100,	  2	  mM	  EDTA,	  150	  mM	  NaCl,	  20	  mM	  Tris-­‐HCl	  pH	  8.1	  
and	  protease	  inhibitors)	  and	  once	  in	  final	  high	  salt	  wash	  buffer	  (0.1%	  SDS,	  1%	  Triton	  X-­‐100,	  2	  
mM	   EDTA,	   150	   mM	   NaCl,	   20	   mM	   Tris-­‐HCl	   pH	   8.1	   and	   protease	   inhibitors).	   After	   adding	  
elution	   buffer	   (1%	   SDS,	   0.1	   M	   NaHCO3)	   to	   elute	   the	   immunocomplexes	   from	   the	   beads,	  
these	  were	  treated	  with	  100	  µg/ml	  RNase	  A	  and	  500	  µg/ml	  PK,	  2	  hours	  at	  37°C	  and	  6	  hours	  
of	  incubation	  at	  65°C	  to	  reverse	  the	  cross-­‐links.	  Finally,	  the	  DNA	  was	  sequentially	  extracted	  
with	   phenol/chloroform/Isoamylalcohol	   and	   precipitated	   in	   50%	   isopropanol	   containing	   5	  
mM	  NaAc	   and	  20	  µg	  of	   glycogen	   carrier	   (Glycoblue,	  Ambion).	   After	   purification,	  DNA	  was	  
resuspended	   in	   100	  µl	   of	   TE	  buffer.	  Histone’s	  modification	   levels	  were	  normalised	   against	  
total	  H3	  or	  H4	  detected,	  and	  the	  ratio	  of	  DNA	  bound	  to	  modified-­‐H3	  or	  -­‐H4	  to	  total	  H3	  or	  H4	  
was	   denoted	   as	   “relative	   abundance”.	   Quantification	   of	   precipitated	   DNA	  was	   performed	  
using	  qRT-­‐PCR	  amplification	  and	  the	  primers	  listed	  on	  Appendix	  I,	  Table	  A3.	  
2.2.11.2 ChIP	  for	  P300	  
The	  protocol	  used	  with	  minor	  modifications	  has	  previously	  been	  described	  in	  detail	  by	  (Stock	  
et	  al.	  2007).	  Briefly,	  cells	  were	  treated	  with	  1%	  formaldehyde	  (37°C,	  10	  min)	  and	  quenched	  
with	   125	   mM	   glycine.	   Cells	   were	   washed	   in	   ice-­‐cold	   PBS	   and	   lysed	   at	   4°C	   for	   10	   min	   in	  
swelling	  buffer	   (25	  mM	  4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid	   (HEPES)	  pH	  7.9,	  




extracted	  by	  homogenization,	  resuspended	  in	  sonication	  buffer	  (50	  mM	  HEPES	  pH	  7.9,	  140	  
mM	  NaCl,	  1	  mM	  EDTA,	  1%	  Triton	  X-­‐100,	  0.1%	  Na-­‐deoxycholate	  and	  0.1%	  SDS)	  and	  sonicated	  
to	  produce	  chromatin	   fragments	  with	   less	   than	  1.6	  kb	   in	   length.	  500-­‐600	  µg	  of	   solubilised	  
chromatin	   was	   pre-­‐cleared	   with	   blocked	   Protein-­‐A	   (rabbit	   antibodies)	   or	   Protein-­‐G-­‐
sepharose	  beads	  (mouse	  antibodies)	  and	  incubated	  overnight	  at	  4˚C	  with	  primary	  antibody	  
on	  a	  rotating	  wheel.	  A	  list	  of	  antibodies	  used	  for	  ChIP	  as	  well	  as	  quantities	  and	  suppliers	   is	  
shown	   in	   section	  2.1.1.	  Antibody-­‐chromatin	   complexes	  were	   collected	  with	  blocked	  beads	  
for	   3	   hours	   at	   4˚C	   before	   sequential	   washes:	   1x	   sonication	   buffer,	   1x	   sonication	   buffer	  
containing	  500	  mM	  NaCl,	  1x	  with	  20	  mM	  Tris	  pH	  8.0,	  1	  mM	  EDTA,	  250	  mM	  LiCl,	  0.5%	  NP-­‐40	  
and	  0.5%	  Na-­‐deoxycholate,	  and	  2x	  TE	  buffer.	  All	  buffers	  were	  supplemented	  with	  5	  mM	  NaF,	  
2	   mM	   Na3VO4,	   1	   mM	   phenylmethylsulphonyl	   fluoride,	   and	   protease	   inhibitor	   cocktail.	  
Immunoprecipitated	   chromatin	   was	   eluted	   and	   DNA	   recovered	   by	  
phenol/chloroform/Isoamylalcohol	   extraction	   and	   ethanol	   precipitation	   as	   previously	  
described	   in	   2.2.9.1.	   Final	  DNA	   concentrations	  were	   determined	  by	   PicoGreen	   fluorimetry	  
(Molecular	  Probes,	   Invitrogen)	  and	   the	  amount	  of	  DNA	  precipitated	  by	  each	  antibody	  was	  
normalised	   against	   the	   total	   input	   material.	   Quantification	   of	   precipitated	   DNA	   was	  
performed	  using	  qRT-­‐PCR	  amplification	  and	  the	  primers	  listed	  on	  Appendix	  I,	  Table	  A3.	  
2.2.12 Analysis	  of	  DNA	  content	  and	  BrdU	  incorporation	  via	  acid	  denaturation	  
of	  DNA	  
All	   reagents	   used	   in	   this	   analysis	  were	   from	   Sigma	   unless	   otherwise	   stated.	   Exponentially	  
growing	  non-­‐synchronized	  H9	  cells	  were	  incubated	  with	  30	  µg/ml	  BrdU	  for	  60	  min	  at	  37°C.	  
Cells	   were	   collected	   from	   plates	   by	   trypsinisation,	   pooled	   with	   the	   floating	   cells	   in	   the	  
medium	   and	   resuspended	   in	   room	   temperature	   PBS	   at	   1x106	   cells/ml.	   With	   a	   Pasteur	  
pipette	  1	  ml	  aliquots	  of	   the	  cell	   suspension	  were	   transferred	   into	   tubes	  with	  10	  ml	  of	   ice-­‐
cold	   70%	   ethanol	   and	   fixed	   overnight	   at	   4°C,	   in	   the	   dark.	   Cells	   were	   collected	   by	  
centrifugation	   (1200	  rpm,	  5	  min)	  and	  pellets	   incubated	   in	  250	  µl	  of	  2	  M	  HCl	   for	  20	  min	  at	  
room	  temperature.	  After	  this	  5	  ml	  of	  phosphate/citric	  acid	  buffer,	  pH	  7.4	  (182	  mM	  Na2HPO4	  
and	  9	  mM	  citric	  acid)	  was	  added	   to	   the	   suspension,	   cells	  were	  centrifuged	  and	  washed	   in	  
another	   5	   ml	   of	   phosphate/citric	   acid	   buffer,	   pH	   7.4.	   Cells	   were	   resuspended	   in	   100	   µl	  
antibody	  dilution	  buffer	   (0.1%	  Triton	  X-­‐100,	  1	  %	  BSA	   in	  PBS)	  with	  0.5	  µg	  mouse	  anti-­‐BrdU	  
antibody,	  gently	  vortexed	  and	  incubated	  30	  min,	  room	  temperature.	  Cells	  were	  then	  washed	  
once	  with	  5	  ml	  antibody	  dilution	  buffer	  and	  resuspended	  in	  100	  µl	  antibody	  dilution	  buffer	  
with	   1	   µg	   Alexa	   488	   goat	   anti-­‐mouse	   antibody,	   gently	   vortexed	   and	   incubated	   60	  min	   at	  
	  
	   	   	  
75	  
room	   temperature	   and	   5	  min	   on	   ice.	   After	  washing	   once,	   cells	  were	   finally	   stained	   in	   the	  
dark	  with	  2	  ml	  PI	  staining	  solution	  (100	  µg	  PI,	  1	  mg	  RNase	  A	  and	  10	  ml	  PBS)	  for	  30	  min	  prior	  
to	   FACS	   analysis.	   Cells	   that	   were	   not	   incubated	   with	   BrdU	   and	   cells	   incubated	   only	   with	  
secondary	  antibody	  were	  used	  as	  a	  negative	  control.	  




Chapter	  3 Characterisation	   of	   replication	   timing	   profiles	   in	  
hES	  cell	  lines	  alongside	  mES	  and	  mEpiS	  cell	  lines	  
3.1 Introduction	  
Chromatin	  profiles	  are	   increasingly	  being	  used	  as	  a	  valuable	   signature	   for	  defining	   the	  cell	  
identity	  and	  developmental	  state	  of	  a	  given	  cell	  population.	  One	  approach	  has	  been	  to	  assay	  
the	  timing	  of	  DNA	  replication	  across	  a	  panel	  of	  candidate	  loci,	  as	  an	  indicator	  of	  chromatin	  
accessibility.	  Acetylated	  histones,	  which	  are	  associated	  with	  accessible	  chromatin,	  have	  been	  
demonstrated	  to	  be	  highly	  correlated	  with	  early	  replication,	  and	  conversely	  late	  replication	  
has	  been	  correlated	  with	  inaccessible	  heterochromatin	  (Gilbert	  2002;	  Vogelauer	  et	  al.	  2002;	  
Peters	  et	  al.	  2005;	  Ryba	  et	  al.	  2010).	  Remarkably,	  this	  replication	  timing	  profiling	  allowed	  the	  
distinction	  of	  pluripotent	  mES	  cells	  from	  cells	  with	  a	  more	  restricted	  differentiation	  capacity,	  
including	  mouse	  EC	  cells	  (Perry	  et	  al.	  2004;	  Azuara	  et	  al.	  2006;	  Hiratani	  et	  al.	  2008).	  
Despite	   being	   called	   embryonic	   stem	   cells,	   hES	   cells	   differ	   from	  mES	   cells	   in	   a	   number	   of	  
ways,	   and	   have	   been	   suggested	   to	   be	   more	   closely	   affiliated	   with	   mEpiS	   cells.	   In	   vivo	  
determination	  of	  hES	  lineage	  potential	  is	  not	  possible,	  due	  to	  ethical	  reasons,	  and	  their	  exact	  
developmental	   affiliation	   remains	   unclear.	   As	   mentioned	   above	   chromatin	   profiling	   has	  
been	  successfully	  used	  to	  distinguish	  closely	  related	  pluripotent	  mouse	  cell	  populations	  with	  
different	   differentiation	   potentials.	   Here,	   human	   and	   mouse	   pluripotent	   stem	   cell	  
populations	  derived	   from	   the	  early	  embryo,	  namely	  hES	   (H1,	  H7	  &	  H9),	  mES	   (E14tg2A,	  B6	  
and	   Dc7)	   and	   mEpiS	   (129,	   B6/CBA	   and	   NOD)	   cell	   lines	   derived	   from	   different	   genetic	  
backgrounds	  (see	  section	  2.1.3.	  for	  details	  of	  cell	  lines	  used),	  are	  analysed	  and	  compared	  to	  
each	  other	   using	  DNA	   replication	   timing	   profiling.	   This	   is	  with	   the	   aim	  of	   determining	   the	  
embryonic	  affiliation	  of	  hES	  cells.	  
3.2 Epigenetic	  profiling	  of	  hES,	  mES	  and	  mEpiS	  using	  a	  PCR-­‐based	  DNA	  
replication	  timing	  assay	  
Human	   ES,	  mES	   and	  mEpiS	   cells	   are	   all	   types	   of	   pluripotent	   cells	   that	   can	   be	   propagated	  
undifferentiated	   for	   an	   unlimited	   period	   of	   time	   under	   appropriate	   conditions	   and	  
commonly	  share	  the	  expression	  of	  key	  pluripotency	  markers	  such	  as	  Oct4,	  Sox2	  and	  Nanog	  
(Yu	  et	  al.	  2008).	  As	  Figure	  3.1a	  illustrates	  Oct4	  and	  Nanog	  expression	  was	  confirmed	  in	  the	  
three	  cell	   types	  analysed.	  Despite	   these	   similarities,	   several	  differences	  between	  mES,	  hES	  
and	  mEpiS	  cells	  have	  been	  reported	  especially	  	  with	  	  regards	  	  to	  	  surface	  	  antigen	  	  expression	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and	   cell	  morphology	   (Pera	   et	   al.	   2004b;	   Pera	   et	   al.	   2010).	   As	   can	   be	   seen	   in	   Figure	   3.1b,	  
undifferentiated	  mES	   cells	   grow	   in	   small	   and	   domed	   colonies.	   In	   contrast	   hES	   and	  mEpiS	  
form	   larger	   flattened	   colonies	   that	   grow	   as	   a	   monolayer.	   Expression	   of	   the	   cell	   surface	  
marker	  SSEA1	  is	  restricted	  to	  undifferentiated	  mES	  and	  mEpiS	  cells,	  whereas	  only	  mES	  and	  
hES	  cells	  stain	  positive	  for	  alkaline	  phosphatase	  (AP)	  activity	  (Fig.	  3.1a	  &	  c).	  Moreover,	  a	  key	  
difference	   between	   mES	   and	   hES	   cells	   is	   the	   extrinsic	   signalling	   that	   enables	   their	   self-­‐
renewal.	   Undifferentiated	   mES	   cells	   require	   LIF/BMP	   signalling	   to	   remain	   self-­‐renewing,	  
whereas	  hES	  cells	  do	  not	  respond	  to	  LIF/BMP	  signalling	  but	  instead	  require	  signals	  through	  
the	  Activin/FGF	  pathway.	   Interestingly	  undifferentiated	  mEpiS	   cells	  also	   strictly	  depend	  on	  
Activin/FGF	   signalling	   (Yu	  et	  al.	   2008).	   Taken	   together,	   this	   raises	   the	  question	  of	   the	   true	  
lineage	   affiliation	   of	   hES	   cells,	   a	   developmental	   paradox.	   Are	   the	   differences	   observed	  
between	   mES	   and	   hES	   cells	   due	   to	   species	   divergence	   or	   directly	   reflect	   the	   embryonic	  
development	   stage	   from	   which	   the	   cells	   arise?	   Using	   DNA	   replication	   timing,	   this	   study	  
sought	  to	  revisit	  this	  developmental	  paradox,	  by	  investigating	  the	  cell	  and	  chromatin	  status	  
of	  mES,	  hES	  and	  mEpiS	  cells.	  
Figure	  3.1	  Phenotypic	  similarities	  and	  differences	  between	  undifferentiated	  mES,	  hES	  and	  mEpiS	  cells.	  
(a)	  Mouse	  ES	   (E14tg2A	   line,	   top	  panel),	   hES	   (H1	   line,	  middle	  panel)	   and	  mEpiS	   (129	   line,	  bottom	  panel)	   cells	  
were	  analysed	  by	  immunofluorescence	  for	  the	  expression	  of	  Nanog	  (green),	  Oct4	  (red)	  and	  SSEA1	  (red).	  Nanog	  
and	  Oct4	  are	  highly	  expressed	   in	  mES,	  hES	  and	  mEpiS	  cells,	  while	  SSEA1	   is	  not	  expressed	   in	  hES	  cells.	   Images	  
overlaid	   with	   DAPI	   staining	   (blue)	   showing	   nuclei.	   (b)	   Bright	   field	   (BF)	   pictures	   of	   representative	  
undifferentiated	  mES,	   hES	   and	  mEpiS	   cell	   colonies.	  Mouse	   ES	   cells	   typically	   grow	   in	   small,	   compact,	   domed	  
colonies;	  while	  hES	  and	  mEpiS	  cell	  colonies	  are	   larger	  and	  flat	  growing	  as	  a	  monolayer.	   (c)	  Both	  hES	  and	  mES	  
cells	   stain	  positive	   for	   alkaline	  phosphatase	   (AP)	   enzymatic	   activity	   (pink),	   however	  mEpiS	   cells	   do	  not.	   Scale	  




Table	  1	  -­‐	  Candidate	  genes	  selected	  for	  the	  replication	  timing	  analysis.	  
 Loci Chromosome location   Mouse Human 
Controls α-globin 11  16.0 cM 16p13.3 
 
Amylase 3  50.0 cM  1p21 
       
    Inner Cell Mass Cripto 9  60.0 cM  3p21.31  
 
Dnmt3b 2  A2-A3  20q11.2 
 
Dppa4 16  B5  3q13.13  
 
Gbx2 1  65.0 cM 2q37 
 
Gdf3 6  60.6 cM  12p13.1 
 
Nanog 6  F2  12p13.31  
 
Oct4/Pou5f1 17  19.23 cM  6p21.31  
 
Rex1/Zfp42  8  24.0 cM  4q35.2  
 
Sox2 3  15.0 cM  3q26.3-q27  
 
Tert 13  43.0 cM  5p15.33 
 
Tle1 4 9q21.32  
       
    Epiblast Fgf5 5  55.0 cM 4q21 
 
Prce/Espl1 15 F3 12q 
 
Psc1/Rbm27 18 B3 5q32 
       
    Trophectoderm Cdx2 5  82.0 cM  13q12.3 
 
Cga 4  10.5 cM  6q12-q21  
 
Eomes 9  67.0 cM  3p21.3-p21.2 
 
Esxl1 X  57.0 cM  Xq22.1 
       
    Germ cells Dazl 17  25.6 cM  3p24.3 
 
Sycp1 3  A3  1p13-p12  
 
Tekt1 11  B4  17p13.2 
       
    Somatic lineages Bmp4 14  15.0 cM  14q22-q23  
 
Cxcr4 1  67.4 cM  2q21 
 
Ebf 11  20.0 cM  5q34 
 
Foxa2 2  84.0 cM  20p11  
 
Gata4 14  28.0 cM  8p23.1-p22  
 
Gata6 18  3.0 cM  18q11.1-q11.2 
 
Hoxb1 11  56.08 cM  17q21.3  
 
Ikaros 11  6.0 cM  7p13-p11.1 
 
Mash1  10  C1  12q22-q23  
 
Mixl1 1  H4  1q42.12  
 
Myf5 10  59.0 cM  12q21 
 
Nestin 3  42.5 cM  1q23.1 
 
NeuroD 2  46.0 cM  2q32 
 
Neurog1 13  35.0 cM  5q23-q31  
 
Pax6 2  58.0 cM  11p13 
 
Pdx1 5  82.0 cM  13q12.1 
 
Sox1 8  4.0 cM 13q34 
 
Sox17 1  7.0 cM  8q11.23 
 
Sox3 X  24.5 cM  Xq27.1 
 
Sox7 14  C3  8 
 
Wnt3 11  63.0 cM  17q21  
 
Zic1 9  61.0 cM  3q24 
           The chromosomal location for each locus is according to the National Center for  
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/ ). 
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A	   panel	   of	   45	   key	   transcriptional	   regulatory	   genes	   (mostly	   encoding	   human	   and	   mouse	  
homologs)	  was	  selected	  for	  this	  analysis.	  These	  genes	  are	  selectively	  expressed	  in	  embryonic	  
(pluripotent)	   and	   extra-­‐embryonic	   (trophectoderm)	   tissues	   of	   the	   early	   embryo	   or	   are	  
involved	  in	  specifying	  ectoderm,	  mesoderm,	  endoderm	  or	  germ-­‐line	  lineages	  (Table	  1).	  The	  
POU	  TF	  Oct4	  (Nichols	  et	  al.	  1998;	  Reubinoff	  et	  al.	  2000;	  Brons	  et	  al.	  2007;	  Tesar	  et	  al.	  2007)	  
and	  the	  homeobox	  gene	  Nanog	  (Chambers	  et	  al.	  2003;	  Clark	  et	  al.	  2004;	  Brons	  et	  al.	  2007;	  
Tesar	  et	  al.	  2007)	  are	  key	  pluripotency-­‐associated	  genes	  in	  both	  human	  and	  mouse	  stem	  cell	  
populations.	  Other	  loci	  showing	  differential	  gene	  expression	  between	  ICM/ES	  cells	  (Rex1	  and	  
Gbx2)	  (Rogers	  et	  al.	  1991;	  Chapman	  et	  al.	  1997)	  and	  epiblast/EpiS	  cells	  (Fgf5,	  Psc1	  and	  Prce)	  
(Haub	  et	  al.	  1991;	  Hebert	  et	  al.	  1991;	  Pelton	  et	  al.	  2002;	  Brons	  et	  al.	  2007;	  Tesar	  et	  al.	  2007)	  
were	  also	   included	   in	   this	  analysis.	  Note	  that	   the	  selection	  of	   these	  markers	  could	  only	  be	  
based	  on	  expression	  analysis	  of	  mouse	  embryos,	  as	  equivalent	  information	  was	  not	  available	  
in	   human	   embryos.	   Genes	   involved	   in	   the	   trophectoderm	   lineage	   specification	   in	   both	  
human	  and	  mouse	  embryos	  include	  the	  caudal-­‐related	  gene	  Cdx2	  (Beck	  et	  al.	  1995;	  Hay	  et	  
al.	  2004)	  and	  the	  T-­‐box	  gene	  Eomes	  (Ciruna	  et	  al.	  1999;	  Russ	  et	  al.	  2000;	  Babaie	  et	  al.	  2007).	  
While	  Dazl	   (Ruggiu	  et	  al.	  1997)	  and	  Sycp1	   (Meuwissen	  et	  al.	  1992)	  are	   typical	  examples	  of	  
selected	   germ	   cell	  markers.	   22	   additional	   genes	   implicated	   in	   the	   specification	   of	   somatic	  
lineages	  were	  also	   included	  among	  which	  are	   the	  ectoderm,	  neuronal-­‐specific	  genes,	  Sox1	  
(Collignon	  et	  al.	  1996;	  Malas	  et	  al.	  1997)	  and	  Sox3	   (Stevanovlć	  et	  al.	  1993;	  Collignon	  et	  al.	  
1996)	   and	   the	   mesoderm,	   myogenic	   or	   haematopoietic	   genes	  Myf5	   (Braun	   et	   al.	   1989;	  
Rudnicki	  et	  al.	  1993)	  and	   Ikaros	  (Georgopoulos	  et	  al.	  1992),	  respectively.	  The	  zinc-­‐finger	  TF	  
Gata6	   (Morrisey	   et	   al.	   1998;	   Koutsourakis	   et	   al.	   1999)	   is	   known	   to	   be	   involved	   in	   PrE	  
development	   while	   the	   pancreatic	   Pdx1	   (Ahlgren	   et	   al.	   1996;	   Stoffers	   et	   al.	   1997)	   is	   an	  
example	   of	   definitive	   endoderm	   marker.	   The	   full	   list	   of	   selected	   loci	   as	   well	   as	   their	  
chromosomal	  locations	  on	  mouse	  and	  human	  genomes	  is	  summarized	  in	  Table	  1.	  
The	  replication	  timing	  of	  individual	  candidate	  loci	  was	  assessed	  using	  a	  previously	  described	  
method	  (Hansen	  et	  al.	  1993;	  Azuara	  et	  al.	  2003;	  Azuara	  2006)	  a	  schematic	  representation	  of	  
this	  assay	  is	  shown	  in	  Figure	  3.2.	  Briefly,	  non-­‐synchronised	  exponentially	  growing	  cells	  were	  
pulse-­‐labelled	  with	  5-­‐bromo-­‐2-­‐deoxyuridine	  (BrdU),	  a	  thymidine	  analogue	  that	  is	  selectively	  
incorporated	  into	  newly	  replicating	  DNA.	  Following	  this	  the	  cells	  were	  stained	  with	  the	  DNA-­‐
binding	   dye	   propidium	   iodide	   (PI)	   and	   fractionated	   by	   flow	   cytometry	   into	   six	   cell	   cycle	  
fractions	  according	  to	  DNA	  content.	  The	  first	   fraction	   included	  cells	   in	  G0	  and	  G1,	  while	  S-­‐
phase	   was	   represented	   by	   four	   fractions	   (designated	   as	   S1	   to	   S4)	   and	   the	   G2	   fraction	  




mES	   cells	   is	   shown	   in	   figure	  
3.2,	   where	   the	   non-­‐
overlapping	   gates	   used	   to	   sort	  
the	   six	   cell	   cycle	   fractions	   are	  
indicated.	   After	   DNA	   isolation	  
and	   sonication,	   newly	  
synthesised	   BrdU-­‐labelled	  
DNA,	  from	  an	  equal	  number	  of	  
sorted	   cells,	   was	   purified	   by	  
immunoprecipitation	  with	  anti-­‐
BrdU	  antibodies.	  Locus-­‐specific	  
sequences	   were	   then	  
quantified	   by	   real-­‐time	  
quantitative	   PCR	   (qRT-­‐PCR)	  
using	   primers	   amplifying	   the	  
regions	   around	   600	   bp	  
upstream	   of	   the	   transcription	  
start	   sites	   of	   the	   selected	  
genes.	   The	   relative	   abundance	  
of	   newly	   synthesized	   locus-­‐
specific	   DNA	   present	   in	   each	  
sorted	   cell	   cycle	   fraction	   was	  
represented	  as	  a	  percentage	  of	  
the	   total.	   Importantly,	   the	  
replication	   timing	   of	   each	   45	  
candidate	   genes	   and	   controls	   were	   analysed	   in	   parallel	   using	   the	   same	   cell	   cycle	   sorted,	  
BrdU-­‐labelled	  DNA	  template.	  
Controls	   for	   replication	   timing	   analysis	   included	   the	  α-­‐globin	   locus,	   a	   constitutively	   early-­‐
replicating	   gene	   (Smith	   et	   al.	   1999)	   and	   pancreatic	  Amylase,	   a	   tissue-­‐specific	   gene,	  which	  
was	  consistently	  shown	  to	  replicate	  late	  in	  S-­‐phase	  in	  several	  different	  cell	  types	  (Hatton	  et	  
al.	  1988;	  Mileham	  et	  al.	  1996;	  Azuara	  et	  al.	  2003).	   In	  agreement	  with	  previously	  published	  
data,	   the	   early	   replicating	   control	   α-­‐globin	   showed	   peak	   abundance	   in	   S1/S2	   fractions	  
isolated	   from	  hES,	  mES	  and	  mEpiS	   cells,	  whereas	   the	   late	   replicating	   control	  Amylase	  was	  
abundant	  in	  S3	  and	  peaked	  in	  the	  S4	  fractions	  (Fig.	  3.3).	  To	  ensure	  equivalent	  precipitation	  
Figure	   3.2	   Schematic	   representation	   of	   DNA	   replication	   timing	  
analysis.	  
Asynchronously	   growing	   cells	   are	   pulse-­‐labelled	   with	   5-­‐bromo-­‐2-­‐
deoxyuridine	   (BrdU),	   which	   is	   incorporated	   into	   replicating	   DNA.	   Cells	  
are	   sorted	   according	   to	   DNA	   content	   into	   six	   cell	   cycle	   fractions	  
(designated	   as	  G1,	   S1-­‐S4	   and	  G2)	   using	  propidium	   iodide	   (PI)	   staining.	  
DNA	   is	   then	   isolated	  from	  each	  of	   the	  sorted	  fractions	  and	  sheared	  by	  
sonication.	   Newly	   synthesised	   BrdU-­‐labelled	   DNA	   is	   recovered	   by	  
immunoprecipitation	   using	   anti-­‐BrdU	   antibodies	   and	   the	   relative	  
abundance	  of	  locus-­‐specific	  sequences	  analysed	  by	  qRT-­‐PCR.	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of	   BrdU-­‐labelled	   DNA,	   each	   cell	   cycle	   fraction	   was	   spiked	   with	   a	   constant	   amount	   of	  
Drosophila	   S2	   BrdU-­‐labelled	   DNA	   prior	   to	   immunoprecipitation.	   The	   detection	   of	   similar	  
levels	  of	  Drosophila	  EMC	  PCR	  products	  in	  each	  fraction	  confirmed	  uniform	  recovery	  of	  BrdU-­‐
labelled	  DNA	  (Fig.	  3.3,	  right	  panel)	  as	  assessed	  in	  each	  experiment. 
3.3 Mouse	   ES	   cells	   have	   conserved	   replication	   timing	   profiles	  
between	  cell	  lines	  from	  different	  genetic	  backgrounds	  
Replication	   timing	   profile	   was	   classified	   for	   each	   candidate	   locus	   according	   to	   its	   peak	  
abundance	  in	  the	  different	  cell	  cycle	  fractions	  from	  G1/S1	  (early),	  S2	  (middle-­‐early),	  S2	  and	  S3	  
(middle),	  S3	  (middle-­‐late)	  and	  S4/G2	  (late).	  For	  ease	  of	  comparison	  the	  replication	  timing	  data	  
is	   represented	  as	  a	  gradation	  of	  colours	   from	  early	   (green)	  to	   late	   (red)	  as	  shown	   in	   figure	  
3.4a.	  Three	  mES	  cell	   lines	  were	  used	   for	  analysis	  of	   their	   replication	   timing	  profiles.	  These	  
lines	   were	   all	   independently	   derived	   from	   inbred	   mouse	   lines	   from	   distinct	   genetic	  
backgrounds.	  The	  E14tg2A	  line	  was	  derived	  from	  a	  129	  strain	  in	  1987	  (Hooper	  et	  al.	  1987).	  
Line	  B6	  was	  derived	  in	  1993	  from	  a	  C57BL/6	  strain	  (Kontgen	  et	  al.	  1993).	  More	  recently	  the	  
Dc7	   line	  was	   derived	   from	   a	  mixed	   background	   of	   129/castaneus	   hybrid	  mouse	   (2007,	   T.	  
Nesterova,	   unpublished).	  All	   three	  mES	   cell	   lines	  were	  maintained	   in	  media	   containing	   LIF	  
and	   serum.	   E14tg2A	   was	   cultured	   on	   gelatin-­‐coated	   wells,	   whereas	   B6	   and	   Dc7	   lines	  
	  
Figure	  3.3	  DNA	  replication	  timing	  analysis	  controls.	  
Histograms	  showing	  the	  relative	  abundance	  of	  PCR	  products	  for	  early	  and	  late	  replicating	  controls	  (α-­‐globin	  and	  
Amylase,	  respectively)	  in	  each	  cell	  cycle	  fraction	  for	  mES	  (E14tg2A,	  B6	  and	  Dc7),	  hES	  (H1,	  H7	  and	  H9)	  and	  mEpiS	  
(129,	  B6/CBA	  and	  NOD)	  cells.	  The	  Drosophila	  melanogaster	  EMC	  gene	  provides	  an	  additional	  internal	  control	  to	  
ensure	   uniform	   recovery	   of	   BrdU-­‐labelled	   DNA.	   Mean	   and	   standard	   deviation	   of	   at	   least	   two	   independent	  




required	  co-­‐culture	  with	  MEFs	  as	  feeder	  cells.	  In	  addition	  to	  this	  the	  Dc7	  line	  was	  cultured	  in	  
media	  with	  a	  slightly	  different	  composition	  to	  the	  others	  (see	  section	  2.2.1	  for	  details).	  
Although	  all	  three	  mES	  cell	  lines	  have	  distinct	  genetic	  backgrounds,	  were	  derived	  at	  different	  
times	   and	   further	   maintained	   in	   different	   culture	   conditions,	   their	   the	   replication	   timing	  
profiles	  were	  highly	  conserved	  across	  many	  loci	  with	  only	  a	  few	  exceptions	  Bmp4	  and	  Gata6,	  
which	  replicated	  earlier	  during	  the	  S-­‐phase	  in	  E14tg2A	  and	  DC7	  cells	  respectively	  (Fig.	  3.4b).	  
Results	   from	   this	   analysis	   confirmed	   previous	   reports	   (Azuara	   et	   al.	   2006;	   Hiratani	   et	   al.	  
2008)	   showing	   that	   in	  mES	   cells	  majority	   of	   genes	   replicate	   early	   (green)	   or	  middle-­‐early	  
(light	   green)	  during	   the	   S-­‐phase	   (73-­‐76%,	   see	   Fig.	   3.4c	  &	  d)	   and	   is	   in	   accordance	  with	   the	  
most	   recent	   genome-­‐wide	   analysis	   (Hiratani	   et	   al.	   2008),	   which	   demonstrated	   that	  
replication	  timing	  occurs	  in	  megabase	  level	  domains	  and	  is	  conserved	  across	  mES	  cells	  from	  
distinct	  backgrounds.	  Loci	  replicating	  early	  included	  genes	  associated	  with	  pluripotency	  and	  
thus	  actively	  transcribed	  in	  mES	  cells	  (e.g.	  Oct4,	  Nanog,	  Sox2	  and	  Rex1),	  but	  also	  several	  loci	  
only	  expressed	  in	  specific	  somatic	  lineages	  (e.g.	  Hoxb1,	  Nestin	  and	  Pdx1),	  which	  are	  silent	  in	  
ES	   cells.	  Hence,	   these	   results	   reiterate	   that	  many	   lineage-­‐specifiers	   in	  mES	  cells	  harbour	  a	  
broadly	   accessible	   chromatin	   structure	   being	   primed	   for	   future	   gene	   activation	   upon	  
differentiation	   (Azuara	  et	  al.	  2006;	  Bernstein	  et	  al.	  2006;	  Hiratani	  et	  al.	  2008).	   In	   contrast,	  
other	  lineage-­‐specific	  genes,	  such	  as	  Foxa2,	  Myf5,	  NeuroD,	  Sox3	  and	  Zic1	  were	  consistently	  
replicating	   middle-­‐late	   (orange)	   or	   late	   (red)	   during	   the	   S-­‐phase	   in	   all	   three	   cell	   lines	  
analysed	  in	  agreement	  with	  lineage	  induction	  in	  mES	  cells	  being	  likely	  regulated	  by	  selective	  
locus	  derepression	  (Perry	  et	  al.	  2004;	  Williams	  et	  al.	  2006).	  
3.4 Replication	   timing	   profiles	   are	   distinct	   between	   pluripotent	  
mouse	  and	  human	  ES	  cells	  
Next,	   replication	   timing	  analysis	  was	  extended	  to	  several	  hES	  cell	   lines.	  The	  same	  panel	  of	  
selected	  loci	  (most	  of	  which	  are	  localised	  in	  syntenic	  regions	  of	  the	  genome	  between	  mouse	  
and	  human)	  was	  analysed	  in	  H1,	  H7	  and	  H9	  hES	  cells.	  These	  cell	  lines	  were	  all	  derived	  at	  the	  
same	   time	   in	   1998	   (Thomson	   et	   al.	   1998)	   and	   for	   this	   analysis	   were	   maintained	   and	  
expanded	   in	   widely	   used	   feeder-­‐free	   cell	   culture	   conditions	   (Xu	   et	   al.	   2001)	   on	   matrigel	  
coated	   plates	   in	   MEF-­‐conditioned	   media	   (CM),	   supplemented	   with	   Fgf2	   (as	   described	   in	  
section	  2.2.1).	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Figure	   3.4	   Independently	   derived	   mES	   cell	   lines	   from	   distinct	   genetic	   backgrounds	   have	   similar	   DNA	  
replication	  timing	  profiles.	  
(a)	  The	  replication	  timing	  of	  each	  candidate	  locus	  was	  defined	  according	  to	  its	  peak	  abundance	  in	  G1/S1	  (early),	  
S2	   (middle-­‐early),	   S2	   and	   S3	   (middle),	   S3	   (middle-­‐late)	   and	   S4/G2	   (late)	   phases	   and	   shown	  as	   a	   gradation	  of	  
colours	  from	  green	  (earliest)	  to	  red	  (latest).	  (b)	  E14tg2A,	  B6	  and	  Dc7	  mES	  cell	  lines	  (derived	  from	  129,	  C57BL/6	  
and	  129/castaneus	  backgrounds,	  respectively)	  show	  highly	  uniform	  replication	  timing	  profiles	  across	  a	  panel	  of	  
45	   candidate	   genes.	   Same	   assignment	   of	   colours	   for	   replication	   timing	   of	   candidate	   loci	   is	   followed	   in	   all	  
subsequent	  figures.	  (c)	  The	  proportion	  of	  genes	  that	  replicate	  early	  (E),	  middle-­‐early	  (ME),	  middle	  (M),	  middle-­‐
late	   (ML)	  or	   late	   (L)	   in	  S-­‐phase	  are	   represented	  as	  a	  pie-­‐chart.	  The	   late	   replicating	  set	   (from	  yellow	  to	   red)	   is	  
separated	   from	   the	  early	   set	   (dark	  and	   light	  green).	   (d)	  Proportion	  of	   candidate	   loci	   that	   replicate	   in	  each	  S-­‐




A	   profound	   difference	   between	   mES	   and	   hES	   cells	   was	   the	   increased	   proportion	   of	   loci	  
replicating	  in	  the	  later	  half	  of	  the	  S-­‐phase	  in	  hES	  cells.	  To	  allow	  easy	  comparison	  of	  mES	  and	  
hES	   replication	   timing	   profiles	   the	   relative	   proportion	   of	   loci	   replicating	   in	   early,	   middle-­‐
early,	   middle,	   middle-­‐late	   or	   late	   S-­‐phase	   was	   summarised	   as	   pie-­‐charts	   shown	   in	   figure	  
3.5a.	  Although	  the	  majority	  of	  examined	  loci	  replicated	  early	  or	  middle-­‐early	  (53-­‐58%)	  in	  hES	  
cells,	  a	  significant	  difference	  when	  compared	  to	  mES	  cell	  replication	  timing	  profiles	  was	  the	  
increased	  proportion	  of	   loci	   replicating	   in	  middle,	  middle-­‐late	  or	   late	  S-­‐phase	   (24-­‐27%	  and	  
42-­‐47%	  in	  mES	  and	  hES	  cells	  respectively)	  (Fig.	  3.5b).	  
This	   data	   was	   surprising	   as	   increased	   proportion	   of	   late	   replicating	   loci	   was	   previously	  
reported	  as	  a	  feature	  of	  differentiated	  cells	  (Azuara	  et	  al.	  2006).	  To	  exclude	  the	  possibility	  of	  
spontaneous	   differentiation	   as	   a	   possible	   cause	   for	   the	   observed	   late	   replication	   timing	  
profiles,	  H1,	  H7	  and	  H9	  cultures	  were	  carefully	  analysed	  for	  the	  expression	  of	  key	  markers	  of	  
pluripotency.	   TFs	   OCT4,	   NANOG	   and	   SOX2	   were	   analysed	   alongside	   the	   specific	   surface	  
markers	   SSEA4,	   TRA-­‐1-­‐81	   and	   TRA-­‐1-­‐60	   by	   immunofluorescence	   combined	   with	   FACScan	  
	  
Figure	  3.5	  Pluripotent	  mouse	  and	  human	  ES	  cells	  have	  distinct	  DNA	  replication	  timing	  profiles.	  
(a)	  The	  proportion	  of	  genes	  that	  replicate	  early	  (E),	  middle-­‐early	  (ME),	  middle	  (M),	  middle-­‐late	  (ML)	  or	  late	  (L)	  in	  
S-­‐phase	   in	  mES	   cells	   (E14tg2A)	  and	   in	   three	  hES	   cell	   lines	   (H1,	  H7	  and	  H9)	  are	   represented	  as	  pie	   charts.	   (b)	  
Proportion	   of	   candidate	   loci	   that	   replicate	   in	   each	   S-­‐phase	   fraction,	   expressed	   as	   a	   percentage	   of	   total	   as	  
assessed	   in	  mES	   (E14tg2A,	   B6	   and	  Dc7)	   and	   hES	   (H1,	   H7	   and	  H9)	   cells.	   For	   full	   comparison	   of	  mES	   and	   hES	  
profiles	  see	  Appendix	  II,	  Fig.	  A2.	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analysis.	  Figure	  3.6a	  and	  b	  demonstrate	  that	  hES	  cell	  cultures	  in	  this	  study	  displayed	  similar	  
expression	   levels	   of	  OCT4,	  NANOG	  and	   SOX2	  as	   seen	   across	   the	   three	   cell	   lines.	   TRA1-­‐60,	  
TRA1-­‐81	  and	  SSEA4	  were	  also	  highly	  expressed	  in	  H1,	  H7	  and	  H9	  cells,	  while	  SSEA1	  (a	  marker	  
of	  differentiation	  in	  hES	  cells)	  was	  virtually	  undetectable.	  The	  hES	  cell	  cultures	  furthermore	  
stained	   positive	   for	   AP	   activity	   (Fig.	   3.6c),	   confirming	   their	   undifferentiated	   status.	  
Moreover,	   the	   replication	   timing	   profiles	   of	   undifferentiated	  H7	   hES	   cells	   could	   be	   clearly	  
distinguished	   from	   differentiated	   neuronal	   progenitor	   cells	   and	   established	   neuronal	   cells	  
(Appendix	  II,	  Fig.	  A1).	  
Interestingly	  and	  in	  contrast	  to	  the	  highly	  conserved	  mES	  cell’s	  replication	  timing	  profile,	  hES	  
cells	  exhibited	  a	  significant	  degree	  of	  variability	  between	  their	  profiles,	  as	  seen	  among	  the	  
three	   cell	   lines	   analysed	   and/or	   independent	   cultures	   for	   each	   cell	   line	   (Fig.	   3.5	   and	   3.7,	  
Appendix	   II	  Fig.	  A2	  and	  A3).	  Eleven	  out	  of	  the	  45	   loci	  analysed	  (DPPA4,	  TERT,	  TLE1,	  SYCP1,	  
BMP4,	   EBF,	   FOXA2,	   GATA6,	   SOX17,	   SOX3	   and	   ZIC1)	   were	   observed	   to	   have	   different	  
replication	  timing	  profiles	  between	  H1,	  H7	  and	  H9	  hES	  cell	  lines	  (Fig.	  3.7a).	  Furthermore	  the	  
profile	   of	   the	   TERT	   locus	   varied	   even	   between	   cultures	   within	   the	   same	   cell	   line.	   The	  
observed	   variations	   ranged	   from	  drastic	   differences,	   from	  early	   to	   late	   as	   seen	   for	  DPPA4	  
and	  EBF,	  with	  DPPA4	  being	  selectively	  replicated	  in	   late	  S-­‐phase	  in	  H9	  cells	  only,	  while	  EBF	  
replicated	   in	   late,	   middle	   and	   middle	   early	   in	   H1,	   H7	   and	   H9	   cells,	   respectively.	   Subtler,	  
variations	  from	  middle	  to	  middle-­‐late,	  were	  also	  seen,	  for	  example	  at	  the	  GATA6	  and	  TLE1	  
loci	   (Fig.	   3.7b).	   In	   contrast,	   NANOG	   and	   NEUROD	   are	   shown	   as	   examples	   of	   genes	   that	  
consistently	   replicated	   in	   early	   and	   late	   S-­‐phase,	   respectively	   (Fig.	   3.7c).	   The	   loci	   with	  
variable	   replication	   timing	   profiles,	   did	   not	   show	   any	   bias	   towards	   a	   specific	   lineage.	  
Furthermore,	  no	  correlation	  was	   found	  with	  the	  variable	  replication	  timing	  and	  expression	  
levels	  of	  the	  specific	  genes,	  or	  with	  histone	  acetylation	  or	  DNA	  methylation	  (Appendix	  II	  Fig.	  
A4	  and	  A5).	  However,	  the	  loci	  found	  variable	  in	  hES	  cells	  were	  all	  among	  gene	  poor	  regions	  
of	   the	   genome,	   apart	   from	   TERT	   (Appendix	   II,	   Table	   A4).	   Although	   this	   is	   not	   a	   unique	  
feature	  of	  variable	  loci	  in	  hES	  cells,	  it	  implies	  that	  changes	  in	  replication	  timing	  as	  observed	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Figure	  3.6	  Human	  ES	  cell	  cultures	  analysed	  by	  replication	  timing	  display	  similar	  expression	  of	  pluripotency-­‐
associated	  markers.	  
H1,	   H7	   and	   H9	   hES	   cells	   were	   analysed	   by	   (a)	   immunofluorescence	   and	   (b)	   flow	   cytometry	   for	   the	   hES	   cell	  
differentiation	   surface	  marker	   SSEA1	   (red)	   and	   the	   characteristic	   pluripotency	   and	   undifferentiation	  markers	  
OCT4	   (green),	  NANOG	  (red),	  SOX2	   (red,	   immunofluorescence),	  SSEA4	   (green),	  TRA-­‐1-­‐60	   (green)	  and	  TRA-­‐1-­‐81	  
(FACS).	  Nuclei	   are	   shown	  by	  DAPI	   staining	   (blue).	   FACS	   analysis	   showed	   that	   84.2-­‐99.9%	  hES	   cells	   expressed	  
markers	  of	  undifferentiation,	  while	  only	  4.8-­‐7.4%	  cells	  were	  positive	  for	  SSEA1,	  as	  indicated	  in	  the	  histograms.	  
The	  profile	  of	  stained	  cells	  (black)	  was	  compared	  to	  cells	  stained	  with	  the	  secondary	  antibody	  only	  (dotted	  line).	  
(c)	   Positive	   staining	   for	   alkaline	   phosphatase	   (AP)	   activity	   (pink)	   was	   also	   strongly	   detected	   in	   all	   hES	   cell	  
colonies.	  Scale	  bars	  50	  µm.	  
	  
Figure	  3.7	  DNA	  replication	  timing	  variability	  between	  established	  hES	  cell	  lines.	  
(a)	  The	  replication	  timing	  of	   individual	  candidate	   loci	  was	  compared	  between	  three	  hES	  cell	   lines	  (H1,	  H7	  and	  
H9).	   Loci	   showing	   differential	   replication	   kinetics	   are	   marked	   by	   asterisks.	   (b	   &	   c)	   Histograms	   showing	   the	  
relative	  abundance	  of	  locus-­‐specific	  DNA	  within	  each	  cell	  cycle	  fraction	  (G1,	  S1-­‐S4	  and	  G2	  phases).	  Examples	  of	  
loci	  that	  switch	  their	  replication	  timing,	  (DPPA4,	  EBF,	  GATA6	  and	  TLE1)	  (b)	  or	  consistently	  replicate	  in	  early	  and	  
late	  S-­‐phase	  (NANOG	  and	  NEUROD),	  respectively	  (c).	  Are	  shown	  in	  H1	  (black),	  H7	  (grey)	  and	  H9	  (white)	  hES	  cell	  




3.5 Temporal	  comparison	  of	  hES	  and	  mEpiS	  cell’s	   replication	  profiles	  
suggests	  a	  common	  unstable	  or	  transitional	  state	  on	  the	  verge	  of	  
differentiation	  
Human	  ES	   cells	  have	  been	  proposed	   to	  more	   closely	   resemble	  mEpiS	   cells	   than	  mES	  cells,	  
which	  are	  derived	  from	  gastrulating	  mouse	  embryos	  and	  blastocysts	  respectively	  (Brons	  et	  
al.	   2007;	   Tesar	   et	   al.	   2007).	   This	   view	   was	   then	   further	   investigated	   by	   comparing	   the	  
replication	   timing	   profiles	   of	   three	   independent	   mEpiS	   cell	   lines	   from	   different	   genetic	  
backgrounds	  (NOD	  and	  B6/CBA	  (Brons	  et	  al.	  2007)	  and	  129	  (Vallier	  et	  al.	  2009a))	  to	  those	  of	  
mES	  and	  hES	  cells	  (Fig.	  3.8a	  and	  Appendix	  II	  Fig.	  A3,	  for	  full	  analysis).	  
To	   first	   ascertain	   that	   mES	   and	   mEpiS	   could	   be	   reliably	   discriminated	   at	   the	   replication	  
timing	  level,	  initial	  analysis	  was	  conducted,	  specifically	  looking	  at	  key	  ICM	  (Dppa4,	  Gbx2,	  and	  
Rex1)	  (Rogers	  et	  al.	  1991;	  Chapman	  et	  al.	  1997;	  Bortvin	  et	  al.	  2003;	  Maldonado-­‐Saldivia	  et	  al.	  
2007)	   and	   epiblast-­‐specific	  markers	   (Fgf5,	  Prce	   and	  Psc1)	   (Haub	   et	   al.	   1991;	   Hebert	   et	   al.	  
1991;	   Pelton	   et	   al.	   2002;	   Brons	   et	   al.	   2007;	   Tesar	   et	   al.	   2007)	   alongside	  Nanog,	  Oct4	   and	  
Sox2,	  which	  are	  expressed	  in	  both	  ICM	  and	  epiblast.	  Consistently	  with	  transcriptional	  status	  
Rex1	   and	   Dppa4	   were	   found	   to	   replicate	   early	   in	   mES	   cells	   and	   late	   in	   mEpiS	   cells,	  
respectively.	   Conversely	   Fgf5	   was	   found	   replicating	   late	   in	   mES	   but	   early	   in	   mEpiS	   cells,	  
where	   this	   gene	   is	   normally	   induced	   in	   a	   developmental-­‐regulated	   manner	   (Brons	   et	   al.	  
2007;	  Tesar	  et	  al.	  2007)	   (Fig.	  3.8a).	  The	  replication	   timing	  profile	  of	  Nanog,	  Oct4	  and	  Sox2	  
remained	  early	  in	  both	  mEpiS	  cells	  and	  mES	  cells,	  and	  furthermore	  profiles	  of	  Gbx2,	  Prce	  and	  
Psc1	  were	  also	  early	  across	  these	  cell	  types,	  regardless	  of	  their	  gene	  expression	  patterns.	  
Whether	   hES	   are	   more	   closely	   relate	   more	   closely	   to	   a	   mES	   or	   a	   mEpiS-­‐like	   pluripotent	  
identity,	  could	  not	  be,	  however,	  determined	  on	  this	   set	  of	  markers	  alone.	  While	  Rex1	  was	  
indeed	  found	  late	  replicating	  in	  both	  hES	  and	  mEpiS	  cell	  populations,	  Fgf5	  remained	  late	  in	  
hES	  cells	  as	  seen	  in	  mES.	  Dppa4	  was	  variably	  replicated	  from	  early	  to	  middle	   late	  between	  
the	  hES	  cell	  lines,	  as	  previously	  described.	  Nevertheless,	  it	  has	  to	  be	  noted	  that	  the	  selection	  
of	   these	   markers	   relied	   on	   gene	   expression	   datasets	   in	   mouse	   embryos,	   as	   equivalent	  
information	   was	   not	   available	   in	   human	   embryos.	   Interestingly,	   however,	   mEpiS	   and	   hES	  
cells	   were	   observed	   to	   have	   remarkably	   similar	   cell	   cycle	   profiles	   with	   a	   relatively	   lower	  
number	   of	   cells	   in	   S-­‐phase	   (25%	   and	   26%,	   respectively)	   as	   compared	   to	  mES	   cells	   (41%),	  
suggesting	  common	  growth	  properties	   (Fig.	  3.8b).	  The	   relatively	  high	  number	  of	  cells	   in	  S-­‐
phase	   in	  mES	   cells,	   compared	   to	  mEpiS	   and	   hES	   cells,	   is	   likely	   due	   to	   the	   faster	   cell	   cycle	  
kinetics	   of	   mES	   cells.	   Furthermore	   a	   high	   level	   of	   variable	   loci	   was	   observed	   among	   the	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replication	   timing	   profiles	   of	   the	   different	   mEpiS	   cell	   lines	   (22.2%	   variable	   loci),	   a	   level	  
similar	   to	   what	   was	   previously	   seen	   with	   hES	   cells	   (24.4%)	   and	   in	   contrast	   to	   the	  
homogeneous	   and	   steady	   replicating	   mES	   cell	   profiles	   (4.4%	   variable	   loci)	   (Fig.	   3.8c).	  
Together	  with	  previous	   analysis	   (Fig.	   3.7	   and	  Appendix	   II	   Fig.	  A3),	   these	  data	   suggest	   that	  
variability	  might	  link	  to	  the	  pluripotent	  state	  related	  to	  post-­‐implantation	  epiblast,	  and	  that	  
hES	  cells	  preferentially	  adopt	  a	  mEpiS-­‐like	  state	  in	  culture.	  
Figure	   3.8	  Mouse	   EpiS	   and	   hES	   cells	   have	   variable	  DNA	   replication	   timing	   profiles	   across	  many	   genes	   and	  
similar	  cell	  cycle	  kinetics	  
(a)	  Comparative	  replication	  timing	  analysis	  of	  mES	  (E14tg2A,	  B6	  and	  Dc7),	  mEpiS	  (129,	  B6/CBA	  and	  NOD)	  and	  
hES	  (H1,	  H7,	  and	  H9)	  cell	  lines.	  Selected	  loci	  shown	  for	  comparison	  are	  either	  associated	  with	  pluripotency	  and	  
self-­‐renewal	  (Nanog,	  Oct4	  and	  Sox2),	  selectively	  expressed	  in	  the	  inner	  cell	  mass	  (ICM)	  (Dppa4,	  Gbx2	  and	  Rex1),	  
and	   the	   epiblast	   (Fgf5,	   Prce	   and	   Psc1)	   or	   showing	   variable	   replication	   timing	   across	   lines	   and	   cultures	   with	  
specific	   roles	   during	   development	   (Bmp4,	   Cxcr4,	  Dazl,	   Ebf,	   Foxa2,	  Gata6,	   Ikaros,	  Mash1,	   Sox17,	   Sox3,	   Sycp1,	  
Tert,	  Tle1	  and	  Zic1).	  Genes	  that	  are	  variable	  in	  both	  mEpiS	  cell	  lines	  and	  hES	  cell	  lines	  are	  marked	  by	  asterisks.	  
For	  the	  full	  list	  of	  loci	  analysed	  see	  Appendix	  II,	  Fig.	  A3.	  (b)	  Representative	  cell	  cycle	  profiles	  of	  mES	  (E14tg2A),	  
mEpiS	  (129)	  and	  hES	  (H1)	  cells.	  Cells	  were	  stained	  with	  propidium	  iodide	  (PI)	  and	  DNA	  content	  analysed	  on	  a	  
FACScalibur	  flow	  cytometer.	  The	  percentages	  of	  cells	   into	  each	  phase	  of	  the	  cell	  cycle	  were	  determined	  using	  
the	   WinMDI	   2.9	   software.	   The	   cell	   cycle	   profiles	   of	   mEpiS	   cells	   and	   hES	   cells	   (middle	   and	   right	   panels,	  
respectively)	  show	  a	  similar	  pattern,	  with	  a	  lower	  number	  of	  cells	  seen	  in	  the	  S-­‐phase,	  which	  is	  notably	  different	  
from	  the	  pattern	  observed	  with	  mES	  cells.	  (c)	  Percentage	  of	  replication	  timing	  variable	  loci	  between	  cell	  lines	  of	  
the	   same	  population	   relative	   to	   the	   total	  45	  analysed	   loci	   in	  mES	   (4.4%),	  mEpiS	   (22.2%)	  and	  hES	   (24.4%)	  cell	  
lines.	  Mouse	  EpiS	  and	  hES	  cells	  have	  in	  common	  high	  percentages	  of	  variable	  replication	  timing	  loci	  in	  contrast	  





Results	   from	  this	  chapter	  highlight	   that	  mES	  cells	  have	  stable	  and	  broadly	  early	   replicating	  
profiles,	   regardless	   of	   their	   genetic	   background	   and	   in	   accordance	   with	   data	   previously	  
published	   (Azuara	   et	   al.	   2006;	   Hiratani	   et	   al.	   2008).	   Rather	   surprisingly	   replication	   timing	  
analysis	  of	  three	  independent	  hES	  cell	  lines	  revealed	  considerable	  differences	  between	  mES	  
and	  hES	  cells.	  Human	  ES	  cells	  had	  a	  notably	  higher	  proportion	  of	  candidate	  loci	  replicating	  in	  
either	  middle	  or	  later	  S-­‐phase	  as	  compared	  to	  mES	  cells.	  A	  shift	  toward	  late	  S-­‐phase	  across	  
many	  loci	  has	  previously	  been	  linked	  with	  cell	  differentiation	  (Azuara	  et	  al.	  2006),	  however	  
the	  undifferentiated	  status	  of	  hES	  cells	  was	  carefully	  assessed	  and	  confirmed	  and	  thus	  could	  
not	   solely	   explain	   the	   observed	   differences.	   Moreover,	   hES	   cells	   also	   exhibited	  
unprecedented	  variability	   in	  their	   replication	  timing	  profiles	  as	  seen	  between	  different	  cell	  
lines	  and	  cultures.	  No	  correlation	  was	   found	  with	   the	  variable	   loci	  and	  gene	  expression	  or	  
epigenetic	  modifications,	  however	  nearly	  all	  variable	   loci	  were	  within	  gene	  poor	  regions	  of	  
the	  genome	  (See	  Appendix	  II	  Fig.	  A4	  and	  Table	  A4).	  Analysis	  of	  the	  replication	  timing	  profiles	  
of	   mEpiS	   cells	   alongside	   mES	   cells	   could	   discriminate	   between	   these	   closely	   related	   cell	  
populations.	   Even	   though	  both	   cell	   types	  had	  mostly	   early	   replicating	  profiles,	   key	  marker	  
loci	   were	   found	   to	   be	   consistently	   distinct	   between	   mES	   and	   mEpiS	   cells,	   such	   as	   Rex1,	  
Dppa4	  and	  Fgf5	  (Appendix	  II	  Fig.	  A3).	  However,	  comparing	  hES	  replication	  timing	  profiles	  to	  
those	  of	  mES	  and	  mEpiS	  cells,	  was	  unable	  to	  clarify	  the	  lineage	  affiliation	  of	  hES	  cells,	  with	  
different	   markers	   aligning	   between	   mES	   and	   mEpiS	   cells.	   However,	   interestingly	   similar	  
replication	   timing	  variability	  as	   in	  hES	  cells	  was	  also	  observed	   in	  mEpiS	  cell	   lines	  analysed.	  
This	   similarity	   suggests	   that	   the	   variability	   might	   be	   linked	   to	   a	   shared	   pluripotent	   state	  
between	  mEpiS	  and	  hES	  cells.	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Chapter	  4 Distinct	  epigenetic	  states	  within	  pluripotent	  human	  
ES	  cells	  and	  characterisation	  of	  their	  regulation	  
4.1 Introduction	  
Phenotypic	  and	  functional	  heterogeneity	  within	  mES	  cultures	  has	  been	  previously	  reported	  
(Chambers	   et	   al.	   2007;	  Hayashi	   et	   al.	   2008;	   Toyooka	  et	   al.	   2008)	  within	   the	  mES	   cultures,	  
delineating	  distinct	  pluripotent	  states	  from	  a	  more	  naïve	  to	  a	  more	  primed	  state	  (Enver	  et	  al.	  
2009;	  Nichols	  et	  al.	  2009b).	  These	  different	  states	  are	  capable	  of	  interconvertion	  in	  response	  
to	  different	  culture	  conditions	  (Chou	  et	  al.	  2008;	  Bao	  et	  al.	  2009;	  Guo	  et	  al.	  2009;	  Hanna	  et	  
al.	   2009).	   For	   example,	   Nanog	   was	   seen	   to	   be	   expressed	   at	   varying	   levels	   within	   mES	  
populations	   cultured	   in	   serum	  containing	  medium	  with	   LIF	   supplementation.	   Interestingly,	  
Nanoglow	  cells	  were	  more	  prone	  for	  differentiation	  and	  Nanoghigh	  cells	  more	  prone	  for	  self-­‐
renewal,	  however	  both	  populations	  were	  able	  to	  also	  give	  rise	  to	  each	  other	  (Chambers	  et	  
al.	  2007).	  Rex1	  was	  also	  observed	  to	  exhibit	  similar	  varied	  expression	  patterns	  in	  mES	  cells,	  
as	   well	   as	   similar	   bias	   for	   differentiation	   and	   self-­‐renewal	   in	   Rex1low	   and	   Rex1high	   cells,	  
respectively,	   as	   seen	   with	  Nanog	   (Marks	   et	   al.	   2012).	   Importantly,	   when	   mES	   cells	   were	  
grown	  in	  2i	  conditions,	  thought	  to	  promote	  a	  naïve	  pluripotent	  state,	  both	  Nanog	  and	  Rex1	  
are	  expressed	  at	  a	  higher	  and	  more	  uniform	  level	  (Wray	  et	  al.	  2010).	  
Heterogeneity	   has	   also	   been	   reported	   previously	   in	   hES	   cell	   cultures.	  NANOG	   expression	  
levels	  have	  been	  show	  to	  be	  variable	  in	  hES	  cells	  (Fischer	  et	  al.	  2010),	  as	  well	  as	  patterns	  of	  
cell	  surface	  markers	  (Enver	  et	  al.	  2005;	  Stewart	  et	  al.	  2006b).	  These	  previous	  observations,	  
and	  the	  observed	  epigenetic	  variability	   in	  replication	  timing	  profiles	  of	  H1,	  H7	  and	  H9	  cells	  
could	  suggest	  the	  existence	  of	  sub	  states	  in	  hES	  pluripotent	  identity.	  Such	  states	  would	  likely	  
be	  regulated	  by	  culture	  conditions,	  as	  seen	  in	  mES	  cells.	  With	  hES	  cells,	  supplementation	  by	  
Activin	  A	  and/or	  Fgf2	  has	  been	  shown	  to	  be	  essential	  for	  the	  maintenance	  of	  pluripotent	  ES	  
cultures	   (Vallier	  et	  al.	  2005a;	   Levenstein	  et	  al.	  2006;	  Xiao	  et	  al.	  2006),	  despite	   this	  a	  great	  
variety	  of	  techniques	  to	  stably	  maintain	  pluripotent	  hES	  cultures	  have	  been	  developed	  and	  
are	   used	   in	   different	   laboratories	   (Adewumi	   et	   al.	   2007).	   To	   investigate	   the	   effects	   of	   the	  
culture	  conditions	  on	  hES	  epigenetic	  states,	  here,	  replication	  timing	  analysis	  was	  conducted	  




4.2 Replication	  timing	  profiles	  of	  undifferentiated	  pluripotent	  human	  
cell	  populations	  undergo	  extensive	  alterations	  upon	  different	  cell	  
culture	  conditions	  
4.2.1 Distinct	   replication	   timing	   profiles	   of	   H9	   hES	   cells	   grown	   in	   two	  
different	  laboratories	  
To	  directly	  assess	  the	  impact	  of	  culture	  environment	  on	  hES	  epigenetic	  states,	  H9	  hES	  cells	  
grown	  in	  our	  laboratory	  under	  CM	  conditions	  [matrigel-­‐coated	  plates	  and	  MEF-­‐CM	  with	  KSR	  
and	  Fgf2	   (Xu	  et	  al.	  2001)]	  were	  compared	   to	  cells	  of	   the	  same	  cell	   line	  grown	   in	  CDMactivin	  
conditions	   [FBS-­‐coated	  plates	   and	  KSR-­‐free	  defined	  medium	  supplemented	  with	   FGF2	  and	  
Activin	   A	   (Vallier	   et	   al.	   2005a)]	   grown	   in	   Dr	   Ludovic	   Vallier’s	   laboratory	   (Fig.	   4.1a).	  
Surprisingly	  the	  replication	  timing	  profiles	  of	  H9	  cells	  grown	   in	  CDMactivin	  were	  dramatically	  
different	  to	  those	  grown	  in	  CM	  conditions,	  with	  an	  increase	  in	  the	  proportion	  of	  candidate	  
loci	   replicating	   in	   the	   early	   and	  middle-­‐early	   S-­‐phase.	   In	   H9	   hES	   cells	   cultures	  maintained	  
under	  CDMactivin	  conditions	  for	  more	  than	  20	  passages	  [H9p50(CDM20)],	  75%	  of	  loci	  analysed	  
replicated	   in	   early	   or	   middle	   early	   S-­‐phase,	   as	   compared	   to	   H9-­‐CM	   cultures	   (H9p35CM),	  
where	  only	   55%	  of	   loci	  were	   found	   to	   replicate	   in	   the	   first	   half	   of	   the	   S-­‐phase	   (Fig.	   4.1b).	  
	  
Figure	   4.1	   Human	   ES	   cells	   grown	   in	   different	   cell	   culture	   conditions	   and	   different	   laboratories	   exhibit	  
different	  replication	  timing	  profiles	  
(a)	  The	  proportion	  of	  candidate	   loci	  replicating	  early	   (E),	  middle-­‐early	   (ME),	  middle	  (M),	  middle-­‐late	  (ML)	  and	  
late	   (L)	   in	   S-­‐phase	   are	   represented	   as	   pie	   charts.	   The	   replication	   timing	   profile	   of	  H9	   hES	   cells	   grown	   in	   our	  
laboratory,	   in	  feeder	  free	  cultures	  on	  matrigel-­‐coated	  plates	  and	   in	  conditioned	  medium	  (CM),	  prepared	  with	  
irradiated	  mouse	  embryonic	   fibroblasts,	  Knockout™	  Serum	  Replacement	   (KSR)	  and	   fibroblast	  growth	   factor	  2	  
(Fgf2)	  (Xu	  et	  al.	  2001)	  (H9p35CM),	  was	  compared	  to	  that	  of	  cells	  from	  the	  same	  line	  grown	  on	  gelatin	  coated	  
plates	  in	  KSR-­‐free	  chemically	  defined	  medium	  (CDM)	  supplemented	  with	  Fgf2	  and	  Activin	  A	  (CDMactivin)	  (Vallier	  
et	   al.	   2005a)	   kindly	   provided	   by	   Dr.	   Ludovic	   Vallier	   [H9p50(CDM20)].	   (b)	   Proportion	   of	   candidate	   loci	   that	  
replicate	  in	  each	  S-­‐phase	  fraction,	  expressed	  as	  a	  percentage	  of	  the	  total	  for	  H9	  hES	  cells	  grown	  under	  CM	  and	  
CDMactivin	  conditions.	  Note	   that	  nomenclature	   for	  culture	  conditions	   is	  according	   to	   the	   following	  convention:	  
cell	   line,	   number	   of	   passages	   in	   CM	   culture,	   plus	   additional	   passages	   in	   CDMactivin	   conditions.	   This	   format	   is	  
followed	  for	  all	  subsequent	  figures.	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These	   results	   indicate	   that	   cells	   maintained	   in	   different	   culture	   conditions	   in	   different	  
laboratories	  can	  adopt	  distinct	  epigenetic	  states.	  
4.2.2 Dynamic	  modulations	  of	  replication	  timing	  profiles	   in	  H1	  hES	  cells	   in	  
response	  to	  cell	  culture	  conditions	  
To	   address	  whether	   these	   alterations	  were	   reproducible	   and	   reversible,	   replication	   timing	  
analysis	   was	   conducted	   comparing	   with	   H1	   hES	   cell	   line	   when	   transferred	   from	   CM	  
conditions	  to	  CDMactivin	  conditions	  and	  subsequently	  reversed	  back	  to	  CM	  conditions.	  After	  
three	   passages	   H1	   cells	   were	   growing	   stably	   in	   CDMactivin	   conditions,	   with	   little	   or	   no	  
evidence	  of	  spontaneous	  differentiation	  (see	  section	  4.3.1)	  and	  already	  exhibited	  extensive	  
replication	  timing	  alterations	  (Fig.	  4.2a).	  The	  proportion	  of	  early	  and	  middle-­‐early	  replicating	  
loci	   increased	   from	   55%	   in	   H1p49CM	   to	   64%	   in	   H1p47(CDM3)	   and	   up	   to	   77%	   in	  
H1p47(CDM6)	  cells	  (Fig.	  4.2b).	  At	  the	  individual	  locus	  level,	  REX1	  was	  amongst	  the	  first	  loci	  
that	  promptly	  shifted	  their	  replication	  timing	  from	  late	  to	  early	  upon	  growth	  culture	  change	  
	  
Figure	  4.2	  H1	  hES	  cells	  undergo	  dramatic	   late	  to	  early	  shifts	  of	   replication	  timing	  profiles	  when	  transferred	  
from	  CM	  to	  CDMactivin	  conditions.	  
Replication	   timing	   profiles	   of	   H1	   cells	   grown	   in	   CM	   conditions	   (H1p49CM)	   were	   compared	   to	   H1	   cells	  
transferred	  to	  CDM	  conditions	  and	  grown	  for	  three	  [H1p47(CDM3)]	  or	  six	  passages	  [H1p47(CDM6)]	  or	  fourteen	  
passages	  in	  CDM	  and	  the	  re-­‐swapped	  back	  to	  CM	  growth	  conditions	  for	  six	  passages	  [H1p47(CDM14;RS6)].	  (b)	  
Proportion	  of	  candidate	  loci	  that	  replicate	  in	  each	  S-­‐phase	  fraction,	  expressed	  as	  a	  percentage	  of	  the	  total	  for	  




(Fig.	   4.3a).	   Others	   such	   as	   BMP4	   progressively	   advanced	   their	   replication	   timing	   over	   six	  
passages	  (Fig.	  4.3a).	  To	  further	  explore	  changes	  in	  replication	  timing	  of	  the	  REX1	  locus	  in	  its	  
genomic	   context,	   several	   additional	   sites	   spanning	   an	   approximately	   2	  Mb	   region	   around	  
REX1	  in	  H1	  CM	  and	  CDMactivin	  cell	  populations,	  were	  analysed.	  Late	  replication	  was	  observed	  
across	  the	  whole	  region	  studied	   in	  H1	  CM	  cells.	  Strikingly,	  however,	   in	  H1	  CDMactivin	  cells	  a	  
domain	  of	  early	  replication	  centred	  on	  the	  REX1	   locus	  was	  observed	  embedded	  within	  the	  
late	   replicating	   region	   (Fig.	   4.3b).	   This	   data	   could	   suggest	   that	   localised	   changes	   in	   the	  
chromatin	  structure	  and/or	  histone	  modifications	  promote	  the	  observed	  shift	  of	  replication,	  
by	   likely	  allowing	   firing	  of	  an	  origin	  of	   replication	   in	  H1	  CDMactivin	   cells.	   Similar	  evidence	  of	  
local	   regions	   of	   early	   replication	   at	   the	  Rex1	   locus	   have	   previously	   been	   reported	   in	  mES	  
cells	  (Perry	  et	  al.	  2004).	  
Remarkably,	   a	   significant	   overlap	   (11	   loci)	   could	   be	   observed	   between	   the	   loci	   that	  
consistently	  advanced	  their	   replication	  timing	  towards	  early	  S-­‐phase	   in	  H1	  and	  H9	  hES	  cell	  
lines	   in	   CDMactivin	   conditions	   (REX1,	   TERT,	   CGA,	   SYCP1,	   BMP4,	   FOXA2,	   GATA6,	   NEUROG1,	  
SOX1,	   SOX17	   and	   SOX3)	   as	   highlighted	   by	   asterisks	   in	   figure	   4.4a	   and	   summarised	   by	   the	  
	  
Figure	  4.3	  Individual	  loci	  undergo	  shifts	  of	  replication	  timing	  upon	  growth	  culture	  condition	  change.	  
(a)	   Replication	   timing	   shifts	   expressed	   as	   histograms	   of	   individual	   shifting	   loci	   demonstrating	   the	   relative	  
abundance	   of	   DNA	   within	   each	   cell	   cycle	   fraction	   (G1,	   S1-­‐S4	   and	   G2	   phases).	   Examples	   of	   loci	   shifting	  
immediately	  (REX1)	  and	  gradually	  (BMP4)	  towards	  early	  replication	  timing	  profile	  (CM	  to	  CDMactivin)	  and	  revert	  
back	  towards	  late	  profile	  upon	  re-­‐swap	  (CDMactivin	  to	  CM).	  The	  replication	  timing	  profile	  of	  DPPA4	  is	  consistently	  
early	   across	   cells	   grown	   in	   CM	   and	   CDMactivin	   but	   becomes	   unstable	   and	   heterogeneous	   within	   the	   same	  
population	   in	   the	  re-­‐swapped	  conditions,	  displaying	  bi-­‐phasic	  peaks.	  Mean	  and	  standard	  deviation	  of	  at	   least	  
two	  experiments	  are	  shown	  for	  each	  cell	   type	  analysed.	   (b)	  The	  observed	  shifts	  of	  replication	  timing	  occur	  at	  
specific	   region	   in	   the	   loci	   studied.	   The	   REX1	   locus	   was	   analysed	   more	   carefully	   for	   replication	   timing	   with	  
primers	  spanning	  2	  Mb	  around	  the	  locus.	  A	  line	  plot	  of	  the	  average	  peak	  replication	  timing	  abundance	  of	  two	  
H1	  CM	  and	  CDMactivin	  samples	  at	  the	  different	  primer	  pair	  positions.	  A	  shift	  towards	  an	  early	  replication	  (S1-­‐S2)	  
is	  observed	  at	  the	  REX1	  locus,	  in	  CDMactivin	  embedded	  within	  a	  region	  of	  late	  repletion.	  No	  similar	  ‘peak’	  of	  early	  
replication	  in	  CM	  samples	  where	  the	  whole	  region	  studied	  replicates	  in	  late	  S-­‐phase.	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Venn	   diagram	   in	   figure	   4.4b.	   Furthermore,	   these	   loci	   were	   all	   previously	   shown	   to	   have	  
variable	   replication	   kinetics	   across	   H1,	   H7	   and	   H9	   hES	   cell	   lines	   grown	   in	   CM	   yet	   are	  
consistently	  replicating	  earlier	  during	  S-­‐phase	  under	  CDMactivin	  conditions	  in	  both	  H1	  and	  H9	  
cells.	  Notably,	  the	  loci	  that	  underwent	  replication	  timing	  shift	  upon	  culture	  condition	  change	  
are	  all	  situated	  in	  gene	  poor	  regions.	  
	  
Figure	  4.4	  Loci	  shifting	  their	  replication	  timing	  in	  CDMactivin	  are	  shared	  between	  different	  human	  ES	  cell	  lines.	  
(a)	  Replication	  timing	  of	  individual	  candidate	  loci	  was	  assessed	  in	  H1	  and	  H9	  hES	  cells	  grown	  in	  CM	  conditions	  
and	  compared	  to	  that	  of	  cells	  cultured	  for	  different	  number	  of	  passages	  in	  CDMactivin.	  Late	  towards	  early	  shifts	  
of	   replication	  timing	   in	  H1	  cells	  were	  observed	   immediately	  after	   three	  passages	   in	  CDMactivin	   [H1p47(CDM3)]	  
and	  became	  more	  pronounced	  after	  six	  passages	  [H1p47(CDM6)].	  Re-­‐swapping	  the	  H1	  cells	  from	  CDMactivin	  back	  
to	   CM	   conditions	   lead	   to	   some	   degree	   or	   reversal	   of	   the	   replication	   timing	   shift	   in	   all	   observed	   shifting	   loci	  
[H1p47(CDM14;RS6)].	   Loci	   that	   consistently	   advance	   their	   replication	   timing	   towards	   early	   across	  H1	   and	  H9	  
hES	  cell	   lines	  when	   in	  CDMactivin	  conditions	   (REX1,	  TERT,	  CGA,	  SYCP1,	  BMP4,	  FOXA2,	  GATA6,	  NEUROG1,	  SOX1,	  
SOX17	   and	   SOX3)	   are	   marked	   by	   asterisks.	   (b)	   Venn	   diagram	   illustrating	   the	   11	   common	   targets	   (overlap)	  
between	  loci	  changing	  their	  replication	  timing	  towards	  early	  in	  CM	  to	  CDMactivin	  conditions	  across	  H1	  (13	  earlier	  




Significantly,	   however,	  modulations	   of	   hES	   cell	   epigenetic	   state	  were	   demonstrated	   to	   be	  
reversible	   as	   returning	   the	   cells	   from	   CDMactivin	   back	   to	   CM	   conditions	   was	   sufficient	   to	  
revert	   their	   replication	  timing	  to	  a	  more	  unstable,	   late-­‐replicating	  profile,	  as	  seen	   in	   figure	  
4.2a.	  The	  proportion	  of	  early	  and	  middle-­‐early	  genes	  decreased	  from	  77%	  to	  46%	  in	  H1	  re-­‐
swapped	   [H1p47(CDM14;RS6)]	   cells),	   uncovering	   the	   epigenetic	   plasticity	   of	   hES	   cells.	  
Consistently	  both	  REX1	  and	  BMP4	   loci	  shifted	  back	  from	  middle-­‐early	  to	  middle	  (Fig.	  4.3a),	  
as	  also	  seen	  for	  loci	  such	  as	  CGA	  and	  NEUROG1	  (Fig.	  4.4a).	  Others,	  such	  as	  FOXA2	  and	  SOX1	  
resumed	  a	   late	   replication	  profile,	   as	   seen	   in	   CM	  culture	   conditions	   (Fig.	   4.4a).	  Note	   that,	  
DPPA4,	  a	  locus	  that	  was	  consistently	  early-­‐replicating	  in	  H1	  hES	  cells	  grown	  in	  either	  CM	  or	  
CDMactivin	  conditions	  displayed	  a	  biphasic	  replication	  timing	  profile	  with	  two	  main	  peaks	  in	  S1	  
and	   S3	   fractions	   (Fig.	   4.3a,	   lower	   panel),	   underlying	   the	   level	   of	   instability	   in	   re-­‐swapped	  
cultures.	  Altogether,	  these	  data	  demonstrate	  that	  interchangeable	  subpopulations	  may	  exist	  
within	   hES	   cell	   cultures,	   as	   delineated	   by	   a	   stable,	   early-­‐replicating	   versus	   unstable,	   late-­‐
replicating	  profiles.	  
4.2.3 Fully	   reprogrammed	   human	   iPS	   cells	   share	   the	   same	   level	   of	  
epigenetic	  plasticity	  as	  hES	  cell	  
Reprogramming	   somatic	   cells	   to	   an	   induced	   pluripotent	   state	   holds	   a	   promise	   for	  
applications	   in	   regenerative	   medicine	   and	   disease	   modelling	   through	   the	   generation	   of	  
patient	  and	  disease	  specific	  pluripotent	  cells	  (Dimos	  et	  al.	  2008;	  Park	  et	  al.	  2008a;	  Yusa	  et	  al.	  
2011).	  Human	  iPS	  cells	  can	  be	  generated	  by	  the	  forced	  overexpression	  of	  key	  TFs	  (Takahashi	  
et	  al.	  2007;	  Yu	  et	  al.	  2007).	  These	  cells	  share	  the	  hall	  marks	  of	  pluripotent	  cells,	  being	  able	  to	  
self-­‐renew	   and	   give	   rise	   to	   differentiated	   progenitor	   cells	   as	   well	   as	   expressing	   the	   key	  
pluripotency	   factors	   OCT4,	   SOX2	   and	   NANOG	   (Takahashi	   et	   al.	   2007;	   Yu	   et	   al.	   2007).	  
However,	   iPS	   cells	   have	   been	   shown	   to	   have	   differences	   between	   themselves	   as	   well	   as	  
when	  compared	  to	  hES	  cells	  in	  epigenetic	  features	  such	  as	  DNA	  methylation	  (Newman	  et	  al.	  
2010;	  Polo	  et	  al.	  2010;	  Lister	  et	  al.	  2011;	  Nazor	  et	  al.	  2012;	  Ruiz	  et	  al.	  2012).	  It	  is	  essential	  to	  
completely	   understand	   the	   equivalence	   between	   hiPS	   and	   hES	   cells	   and	   clearly	   define	  
appropriate	  cell	  culture	  conditions	  for	  the	  derivation	  and	  maintenance	  of	  hiPS	  cells	  with	  full	  
developmental	   potential	   (Colman	   et	   al.	   2009).	   To	   investigate	   whether	   similar	   epigenetic	  
alterations,	  as	  observed	  in	  hES	  cells,	  also	  occur	  in	  hiPS	  cell	  cultures	  in	  response	  to	  changing	  
growth	  conditions,	   the	   replication	   timing	  profile	  of	  a	   fully	   reprogrammed	  hiPS	  40	  cell	   line,	  
which	  was	  derived	   from	  neonatal	   foreskin	   fibroblasts	  by	  overexpression	  of	  OCT4,	  SOX2,	  C-­‐
MYC	   and	   KLF4	   (Vallier	   et	   al.	   2009b),	   was	   similarly	   analysed	   when	   grown	   under	   CM	   and	  
CDMactivin	  conditions.	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Figure	  4.5	  Fully	  reprogrammed	  human	  iPS	  cells	  display	  similar	  shifts	  of	  replication	  timing	  at	  candidate	  loci	  as	  
observed	  in	  hES	  cells	  upon	  change	  of	  culture	  conditions.	  
The	   replication	   timing	   of	   fully	   reprogrammed	   hiPS	   40	   cells	   derived	   from	   neonatal	   foreskin	   fibroblasts	   by	  
overexpression	  of	  four	  reprogramming	  factors	  (OCT4,	  SOX2,	  C-­‐MYC	  and	  KLF4)	  (Vallier	  et	  al.	  2009b)	  grown	  under	  
CM	  conditions	  was	  compared	   to	   that	  of	   cells	  grown	   in	  CDMactivin	   conditions.	  The	  proportion	  of	   candidate	   loci	  
replicating	  early	  (E),	  middle-­‐early	  (ME),	  middle	  (M),	  middle-­‐late	  (ML)	  and	  late	  (L)	  in	  S-­‐phase	  are	  represented	  (a)	  
as	  pie	  charts	  or	  (b)	  as	  percentage	  of	  total	  candidate	  loci	  analysed.	  (c)	  The	  replication	  timing	  profiles	  of	  individual	  
candidate	   loci	   assessed	   in	   hiPS	   40	   cells	   comparing	   CM	   (hiPS	   40	   p18CM)	   and	   CDMactivin	   [hiPS	   p12(CDM12)]	  
cultured	   cells.	   Loci	   shifting	   their	   replication	   timing	   profile	   towards	   early	   in	   CDMactivin	   conditions	   (REX1,	   TERT,	  
TLE1,	  CGA,	  BMP4,	  EBF,	  FOXA2,	  SOX17,	  SOX3	  and	  ZIC1)	  are	  marked	  by	  asterisks.	  DPPA4	  was	  heterogeneous	   in	  
terms	  of	  replication	  timing	  within	  the	  same	  population	  of	  cells	  in	  CM	  conditions,	  displaying	  biphasic	  (S1	  and	  S4)	  
peaks.	  (d)	  Venn	  diagram	  illustrating	  the	  7	  common	  targets	  (REX1,	  TERT,	  CGA,	  BMP4,	  FOXA2,	  SOX17	  and	  SOX3)	  
between	  loci	  changing	  their	  replication	  timing	  towards	  early	  in	  CM	  to	  CDMactivin	  conditions	  across	  H1	  (13	  earlier	  




As	  previously	  shown	  for	  H1	  and	  H9	  hES	  cells,	   the	  hiPS	  cells	  showed	  contrasting	  replication	  
timing	  profiles	  when	  grown	  under	  different	  growth	  conditions	  (Fig.	  4.5a	  and	  b).	  Human	  iPS	  
cell	  replication	  timing	  profiles	  shifted	  dramatically	  from	  late	  under	  CM	  conditions	  to	  a	  more	  
early	  profile	  when	  cultured	  in	  CDMactivin	  conditions	  for	  more	  than	  12	  passages,	  with	  57%	  and	  
77%	  of	  genes	  replicating	  in	  early	  or	  middle-­‐early	  in	  CM	  and	  CDMactivin	  conditions,	  respectively	  
(Fig.	  4.5b).	  The	  loci	  shifting	  their	  replication	  timing	  included	  REX1,	  TERT,	  CGA,	  BMP4,	  FOXA2,	  
SOX17	   and	  SOX3	   loci	  previously	   seen	   to	  also	   shift	   their	   replication	   timing	   towards	  early	   in	  
CDMactivin	  in	  H1	  and	  H9	  hES	  cells	  (Fig.	  4.5c	  &	  d),	  these	  shared	  loci	  are	  of	  different	  types	  and	  
do	   not	   show	   any	   clear	   bias	   towards	   a	   specific	   lineage.	   These	   results	   provide	   additional	  
evidence	  that	  induced	  (iPS)	  and	  natural	  (ES)	  pluripotent	  cell	  lines	  share	  common	  properties	  
and	   reiterate	   the	   impact	   of	   culture	   conditions	   in	   modulating	   or	   supporting	   different	  
epigenetic	  states	  within	  pluripotent	  hES	  cell	  cultures.	  
4.3 Phenotypic	  and	  functional	  characterisation	  of	  H1	  hES	  cells	  grown	  
under	  CM	  and	  CDMactivin	  conditions	  
4.3.1 H1	   hES	   cells	   cultured	   in	   CDMactivin	   conditions	   retain	   their	  
undifferentiated	  state	  
Following	   transfer	   from	  CM	   to	   CDMactivin	   culture	   conditions,	   H1	   hES	   cells	   readily	   stabilised	  
and	   once	   acclimatised	   grew	   in	   tightly	   packed	   flat	   colonies,	   with	   little	   or	   no	   evidence	   of	  
spontaneous	  differentiation	  (as	  sometimes	  observed	  at	  the	  edges	  of	  H1	  colonies	  cultured	  in	  
CM	   conditions)	   (Fig.	   4.6a).	   Further	   phenotypic	   analysis	   of	   H1	   CDMactivin	   cells	   by	   AP,	   IF	   and	  
FACS	  analysis	  confirmed	  the	  undifferentiated	  state	  of	  these	  cultures.	  When	  assayed	  for	  AP	  
activity	  H1	  CDMactivin	  cells	  exhibited	  strong	  positive	  staining	  (pink)	  across	  colonies	  (Fig.	  4.6b).	  
Expression	   of	   cell	   surface	   markers	   TRA-­‐1-­‐60,	   SSEA4	   and	   TRA-­‐1-­‐81,	   associated	   with	  
undifferentiated	  ES	  cells,	  was	  highly	  and	  homogeneously	  detected	  in	  H1	  CDMactivin	  cells	  by	  IF	  
and/or	   FACS	   staining,	  whereas	   SSEA1,	   a	   surface	  marker	   upregulated	   upon	   differentiation,	  
was	  not	  observed	  by	  IF	  staining	  (Fig.	  4.6c	  &	  d).	  Furthermore	  H1	  hES	  cells	  stained	  positive	  for	  
key	  pluripotency	  associated	  factors	  OCT4,	  NANOG	  and	  SOX2	  by	  both	  IF	  (all)	  and	  FACS	  (OCT4	  
&	  NANOG)	   analysis	   (Fig.	   4.6c	  &d).	  Quantification	   by	   FACS	   analysis	   confirmed	   that	   98.5%	   -­‐	  
99.7%	   hES	   cells	   harboured	   an	   undifferentiation	   phenotype,	   while	   only	   5.7%	   cells	   were	  
positive	   for	   SSEA1.	   These	   results	   confirm	   that	  H1	  hES	   cells	   can	   assume	  distinct	   epigenetic	  
states	  while	  maintaining	   an	   undifferentiated	   state	   and	   are	   similar	   to	   the	   results	   obtained	  
when	  analysing	  H1	  cells	  grown	  in	  CM	  conditions	  (see	  Fig.	  3.6).	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Figure	  4.6	  Human	  ES	  cells	  transferred	  from	  CM	  to	  CDMactivin	  conditions	  retain	  
hallmarks	  of	  undifferentiation.	  
(a)	   Bright	   field	   (BF)	   picture	   of	   representative	   undifferentiated	   H1	   hES	   cell	  
colonies	  and	  (b)	  positive	  staining	  for	  alkaline	  phosphatase	  (AP)	  activity	  (pink)	  
in	   cells	   grown	   under	   CDMactivin	   conditions.	   Scale	   bars,	   70	   µm.	   (c)	  
Immunofluorescence	   and/or	   (d)	   flow	   cytometry	   analysis	   of	   H1	   cells	   grown	  
under	  CDMactivin	  conditions	  for	  the	  differentiation	  surface	  SSEA1	  (red)	  marker	  
and	  the	  pluripotency-­‐associated	  markers	  Oct4	  (green),	  Nanog	  (red),	  Sox2	  (red,	  
immunofluorescence),	   SSEA4	   (green),	   Tra-­‐1-­‐60	   (green)	   and	   Tra-­‐1-­‐81	   (FACS).	  
Nuclei	   are	   shown	   by	   DAPI	   staining	   (blue).	   FACS	   analysis	   showed	   that	   98.5-­‐
99.7%	  hES	  cells	  expressed	  markers	  of	  undifferentiation,	  while	  only	  5.7%	  of	  the	  
cells	   were	   positive	   for	   SSEA1,	   as	   indicated	   in	   the	   histograms.	   The	   profile	   of	  
stained	   cells	   (black)	   was	   compared	   to	   cells	   stained	   with	   the	   secondary	  
antibody	  only	  (dotted	  line).	  Cells	  were	  exposed	  to	  CDMactivin	  conditions	  for	  ≥	  4	  




4.3.2 H1	  CM	  and	  CDMactivin	  form	  embryoid	  bodies	  containing	  tri-­‐germ	  layer	  
differentiation	  
To	   determine	   whether	   H1	   CM	   and	   CDMactivin	  cells	   are	   pluripotent,	   the	   cells	   were	   assayed	  
using	   embryoid	   body	   (EB)	   differentiation	   assay.	   In	   this	   assay	   ES	   cells	   are	   induced	   to	  
spontaneously	   form	   cell	   aggregates	   in	   suspension	   then	   allowed	   to	   differentiate	   into	  
ectoderm,	   endoderm	   and	   mesoderm	   –like,	   a	   process	   that	   mimics	   early	   embryonic	  
development	   (Doetschman	   et	   al.	   1985;	   Leahy	   et	   al.	   1999).	   Here,	   EBs	   were	   formed	   by	  
growing	   H1	   CM	   or	   CDMactivin	   cells	   in	   non-­‐adherent	   conditions	   in	   differentiation	   media	  
(Knockout™	  DMEM	  supplemented	  with	  20%	  FBS,	  0.1	  mM	  NEAA,	  2	  mM	  L-­‐glutamine	  and	  0.55	  
mM	  β-­‐mercaptoethanol)	  for	  10	  days	  (Fig.	  4.7a)	  and	  then	  plating	  the	  cells	  back	  onto	  gelatin-­‐
coated	  plates	  for	  further	  differentiation	  up	  to	  20	  days	  (Fig.	  4.7b).	  After	  differentiation	  for	  up	  
to	   30	   days,	   a	   wide	   variety	   of	   morphologically	   different	   cell	   types	   were	   observed	   in	   the	  
culture	  plates,	   likely	   indicating	   the	  presence	  of	  neuronal-­‐like	  cells	  with	  extended	   filaments	  
(Fig.	  4.7b	  1	  &	  2),	  liver-­‐like	  cells	  with	  well-­‐defined	  cytoplasms	  and	  cell	  bodies	  (Fig.	  4.7b	  3	  &	  4)	  
and	   endothelial-­‐like	   cells	   with	   extended	   and	   flattened	   morphology	   (Fig.	   4.7b	   5	   &	   6).	   To	  
further	  corroborate	  the	  morphological	  evidence,	  qRT-­‐PCR	  analysis	  of	  differentiation	  markers	  
was	   used.	   Relative	   gene	   expression	   levels	   of	   markers	   for	   ectoderm	   (SOX1,	   P63	   and	   β-­‐
TUBULIN)	   endoderm	   (AFP,	   PDX1	   and	  GATA6)	   and	   mesoderm	   (BMP4,	   CD45	   and	   PECAM1)	  
were	  all	  upregulated	   in	  both	  H1	  CM	  and	  CDMactivin	   samples	  after	  30	  days	  of	  differentiation	  
(Fig.	   4.7c).	   Furthermore	   expression	   levels	   of	   pluripotency	   markers	   (OCT4,	   NANOG	   and	  
CRIPTO)	  were	  all	  reduced	  to	  minimal	  levels	  in	  both	  H1	  CM	  and	  CDMactivin	  cells	  as	  compared	  
to	   the	   undifferentiated	   samples,	   indicating	   a	   loss	   of	   pluripotent	   identity	   (Fig.	   4.7c).	  
Altogether,	   these	   results	   indicate	   that	   H1	   CM	   and	   CDMactivin	   hES	   cells	   can	   undergo	  
differentiation	  into	  derivatives	  of	  all	  the	  three	  germ	  layers.	  
	   	  
	  




Figure	  4.7	  Human	  ES	   cells	   from	  both	  CM	  and	  CDMactivin	   conditions	  are	  able	   to	   form	  derivatives	  of	  all	   three	  
germ	  lineages	  in	  an	  in	  vitro	  assay	  of	  differentiation.	  
(a)	  Morphology	  of	  embryoid	  bodies	  (EBs)	  formed	  in	  non-­‐adherent	  conditions	  for	  7	  days	  as	  well	  as	  (b)	  cell	  types	  
derived	  from	  EBs	  re-­‐plated	  onto	  gelatine-­‐coated	  surfaces	  for	  23	  days.	  After	  this	  period	  of	  time	  a	  wide	  variety	  of	  
morphological	  cell	  types	  could	  be	  observed	  in	  the	  plates	  of	  both	  H1	  CM	  and	  CDMactivin:	  neuronal	  (A2)-­‐(A6),	  liver	  
(A3)-­‐(A7)	   and	   endothelial-­‐like	   cells	   (A4)-­‐(A8).	  Magnification,	   100X.	   (c)	   Generation	   of	   derivatives	   of	   the	   three	  
germ	   layers	   was	   further	   confirmed	   by	   qRT-­‐PCR	   analysis	   looking	   at	   SOX1,	   P63,	   Β-­‐TUBULIN	   (ectoderm),	   AFP,	  
PDX1,	  GATA6	  (endoderm),	  BMP4,	  PECAM1	  and	  CD45	  (mesoderm)	  in	  both	  CM	  (white	  bars)	  and	  CDMactivin	  (black	  
bars)	  cells.	  Expression	  of	  the	  pluripotency-­‐associated	  markers	  OCT4,	  NANOG	  and	  CRIPTO	  is	  downregulated	  and	  
almost	   absent	   after	   30	   days	   of	   differentiation.	   Graphs	   are	   a	   representative	   qRT-­‐PCR	   analysis	   of	   three	  
independent	   experiments.	   Data	   was	   normalised	   to	   the	   expression	   of	   two	   housekeeping	   genes	   (GAPDH	   and	  




4.3.3 H1	  CDMactivin	  conditions	  favour	  an	  ICM-­‐like	  phenotype	  within	  hES	  cell	  
cultures	  
To	  further	  highlight	  possible	  phenotypic	  similarities	  and/or	  differences	  among	  H1	  hES	  cells	  
grown	  in	  CM	  and	  CDMactivin	  conditions,	  the	  expression	  patterns	  of	  several	  pluripotency	  and	  
early	   differentiation	   markers	   were	   analysed	   by	   qRT-­‐PCR	   in	   H1	   hES	   cells	   in	   CM	   and	   upon	  
transfer	  into	  CDMactivin	  growth	  conditions	  at	  the	  indicated	  passage	  numbers	  (3,	  6,	  14	  and	  25)	  
(Fig.	  4.8).	  As	  shown	  in	  figure	  4.8,	  OCT4	  and	  SOX2	  remained	  expressed	  largely	  at	  similar	  levels	  
upon	   growth	   condition	   changes.	   In	   contrast	   NANOG	   expression	   was	   transiently,	   yet	  
significantly	   upregulated	   upon	   transfer	   from	   CM	   to	   CDMactivin	   conditions	   (Fig.	   4.8a),	  
	  
Figure	  4.8	  H1	  hES	  cells	  cultured	  in	  CM	  and	  CDMactivin	  have	  distinct	  expression	  patterns	  of	  key	  marker	  genes.	  
Real-­‐time	  PCR	  analysis	  of	  selected	  genes	  in	  H1	  CM	  (H1p49CM,	  white	  bars)	  and	  cells	  transferred	  into	  CDMactivin	  
conditions	   and	   cultured	   for	   different	   passage	   numbers	   [H1p47(CDM3,	   6,	   14	   and	   25),	   black	   bars].	   (a)	  
Pluripotency-­‐associated	   genes	   (OCT4	   and	   SOX2)	   stably	   expressed	   in	   CM	   and	   CDMactivin	   cells	   or	   showing	   a	  
transient	  increase	  (NANOG)	  in	  CDMactivin	  cells.	  (b)	  Continued	  culture	  in	  CDMactivin	  strongly	  induced	  in	  H1	  hES	  cells	  
the	  expression	  of	  preimplantation-­‐epiblast/ICM	  markers	  (REX1,	  GATA2	  and	   IGF2R)	  and	  downregulation	  of	  the	  
postimplantation	  marker	  FGF5,	  as	  well	  as	  the	  (c)	  downregulation	  of	  germ	  layer	  markers	  (EOMES,	  GATA6,	  SOX17	  
and	   FOXA2).	  Mean	   and	   standard	   error	   of	   at	   least	   two	   experiments	   are	   shown.	   Data	   was	   normalised	   to	   the	  
expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  Un-­‐paired	  two	  tailed	  t-­‐test	  (*	  =	  P	  <	  0.05	  and	  **	  =	  P	  <	  
0.01).	  Primers	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  Table	  A1.	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furthermore	  this	  transient	   increase	  was	  also	  observed	  at	  the	  protein	   level	   (Appendix	   II	  Fig.	  
A6).	  
Remarkably,	   a	   robust	   and	   rapid	   induction	   of	   REX1	   messenger	   RNA	   (mRNA)	   levels	   was	  
observed.	  REX1	  is	  selectively	  expressed	  in	  both	  mouse	  and	  human	  blastocysts	  (Rogers	  et	  al.	  
1991;	  Pelton	  et	  al.	   2002;	  Reijo	  Pera	  et	  al.	   2009)	   in	  early	  development	   (Fig.	  4.8b).	   Similarly	  
two	   other	   genes	   associated	  with	   human	   ICMs,	  GATA2	  and	   IGF2R	   (Reijo	   Pera	   et	   al.	   2009),	  
were	  also	   induced	  to	  some	  extent	  by	  culture	   in	  CDMactivin	  conditions	  highlighting	  a	  possible	  
shift	  towards	  a	  more	  ICM-­‐like	  phenotype	  (Fig.	  4.8b).	  In	  addition	  the	  epiblast	  specific	  marker	  
gene	  FGF5	   (Pelton	  et	  al.	   2002;	  Tesar	  et	  al.	   2007)	  was	  downregulated	   following	   transfer	   to	  
CDMactivin	   conditions	   (Fig.	   4.8b).	   Furthermore,	   markers	   of	   early	   differentiation	   (EOMES,	  
GATA6,	   SOX17	   and	   FOXA2)	   were	   downregulated	   upon	   increasing	   passages	   in	   CDMactivin	  
conditions	  as	  compared	  to	  expression	  levels	  observed	  in	  cells	  cultured	  in	  CM	  conditions	  (Fig.	  
4.8c).	  Taken	  together,	  these	  data	  support	  the	  view	  that	  hES	  cells	  can	  adopt	  distinct	  yet	  still	  
pluripotent	   states	   in	   response	   to	   changing	   culture	   conditions,	   with	   CDMactivin	   conditions	  
favouring	  a	  stable	  epigenetic	  state	  with	  a	  possibly	  ICM-­‐like	  phenotype.	  
4.4 Investigating	   the	   molecular	   mechanisms	   underlying	   distinct	  
epigenetic	  states	  in	  hES	  cells	  
4.4.1 Increased	  TGF-­‐β/Activin	  signalling	  in	  CDMactivin	  conditions	  
Recent	   reports	  have	   indicated	   that	   the	  TGF-­‐β	   superfamily	   ligands	  are	   important	   to	   sustain	  
an	  undifferentiated	  state	  in	  hES	  cells.	  In	  particular	  TFG-­‐β/Activin	  signalling	  through	  the	  signal	  
inducer	   SMAD2/3	  was	   shown	   to	   be	   strictly	   required	   for	  maintaining	   hES	   cell	   pluripotency	  
(James	  et	  al.	  2005;	  Vallier	  et	  al.	  2005a;	  Xiao	  et	  al.	  2006;	  Xu	  et	  al.	  2008;	  Vallier	  et	  al.	  2009a).	  
NANOG	   has	   been	   identified	   as	   a	   direct	   target	   of	   TGF-­‐β/Activin	   signalling	   (Xu	   et	   al.	   2008;	  
Vallier	   et	   al.	   2009a)	   and	   interestingly	  was	   found	   transiently	   upregulated	   upon	   transfer	   to	  
CDMactivin	   at	   the	   transcriptional	   level	   in	   H1	   hES	   cells	   (Fig.	   4.8a).	   The	   expression	   pattern	   of	  
NANOG	   was	   mirrored	   by	   that	   of	   three	   TGF-­‐β	   members	   (CRIPTO,	   GDF3	   and	   NODAL)	  
(Appendix	  II	  Fig.	  A7).	  This	  directly	  points	  to	  a	  change	  in	  the	  cell	  signalling	  environment	  of	  hES	  
cells	   when	   grown	   under	   CM	   conditions	   and	   transferred	   into	   CDMactivin	   conditions,	   and	  




To	   further	   explore	   whether	   differential	  
levels	   of	   TGF-­‐β/Activin	   signalling	   indeed	  
operate	   on	   H1	   hES	   cultures,	   levels	   of	  
phosphorylated	   SMAD2/3	   (P-­‐SMAD2/3)	  
were	   compared	   between	   CM	   and	  
increasing	  passages	   (3,	  5,	  14	  and	  over	  25)	  
of	   CDMactivin	   H1	   hES	   cultures	   by	   western	  
blot	  analysis	  (Fig.	  4.9).	  Clear	  differences	  in	  
the	   levels	   of	   P-­‐SMAD2/3	   detected	   in	   CM	  
and	  CDMactivin	  cell	  cultures	  were	  observed.	  
Active	   P-­‐SMAD2/3	   levels	   became	  
consistently	   increased	   in	   hES	   cells	   when	  
transferred	   from	   CM	   to	   CDMactivin	  
conditions.	   This	   increase	   was	   also	  
accompanied	  by	  a	  transient	  increase	  in	  the	  
levels	   of	   NANOG	   protein	   in	   CDMactivin	   cell	  
cultures.	   While	   the	   increase	   in	   NANOG	  
levels	   was	   transient,	   levels	   of	   active	   P-­‐
SMAD2/3	  remained	  high	  in	  CDMactivin	  conditions,	  regardless	  of	  passage	  number.	  Note	  that	  no	  
change	   was	   observed	   in	   levels	   of	   Oct4	   protein	   between	   CM	   and	   CDMactivin	   cultures.	   Of	  
interest,	  NANOG	  was	   recently	   shown	   to	   interact	  directly	  with	   the	  SMAD2/3	  proteins,	   thus	  
modulating	   the	   activity	   of	   TGF-­‐β/Activin	   signalling	   pathway	   (Vallier	   et	   al.	   2009a).	   This	  
negative	   feedback	   loop,	   could	   in	   turn,	  modulate	   the	   levels	  of	  NANOG	   expression	  and	   thus	  
autoregulate	  its	  own	  expression	  levels	  in	  hES	  cell	  cultures.	  It	  would	  be	  interesting	  to	  quantify	  
the	  levels	  of	  SMAD2/3	  occupancy	  at	  the	  Nanog	  promoter	  in	  CM	  and	  early	  and	  late	  CDMactivin	  
cultures	  by	  ChIP	  assay	  to	  further	  investigate	  this	  hypothesis.	  
4.4.2 Changes	  in	  TGF-­‐β/Activin	  signalling	  impact	  on	  the	  expression	  levels	  of	  
P300	  histone	  acetyltransferase	  in	  hES	  cells	  
TGF-­‐β/Activin	   signalling	   through	   its	   inducer	   SMAD2/3	   was	   previously	   shown	   to	   recruit	  
various	   histone	   acetyltransferases	   including	   P300/CBP	   (Pouponnot	   et	   al.	   1998;	   Ross	   et	   al.	  
2006),	  PCAF	  (Itoh	  et	  al.	  2000;	  Kahata	  et	  al.	  2004)	  and	  GCN5	  (Kahata	  et	  al.	  2004)	  as	  well	  as	  
the	  chromatin	  remodeler	  SWI/SNF	  ATPase,	  BRG1	  (Ross	  et	  al.	  2008)	  leading	  to	  local	  chances	  
in	  chromatin	  accessibility.	  To	  further	  investigate	  a	  possible	  link	  between	  Smad2/3-­‐associated	  
	  
Figure	  4.9	  H1	  cells	  cultured	  in	  CDMactivin	  conditions	  have	  
increased	  levels	  of	  phosphorylated	  SMAD2/3	  complexes	  
when	  compared	  to	  cells	  cultured	  in	  CM.	  
Western	   blot	   analysis	   of	   H1	   hES	   cells	   cultured	   in	   CM	  
(H1p49CM)	   and	   CDMactivin	   conditions	   for	   increasing	  
passages	  [H1p47(CDM3,	  5,	  14	  and	  25).	  Membranes	  were	  
probed	  with	  antibodies	   specific	   for	  phosphorylated	   (P)	   -­‐
SMAD2/3,	   SMAD2/3,	   NANOG,	   OCT4	   and	   β-­‐ACTIN	   (as	   a	  
control	  for	  protein	  loading).	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chromatin	   remodelling	   activity	   and	   the	  
acquisition	  of	   an	  early-­‐replicating	  profile	  
in	  hES	  cells	  mRNA	  levels	  for	  each	  of	  these	  
epigenetic	  modulators	  were	   assessed	  by	  
qRT-­‐PCR	   (Fig.	   4.10).	   Interestingly,	   P300	  
levels	   were	   significantly	   increased	   upon	  
culture	  condition	  change	  and	  the	  level	  of	  
induction	   was	   maintained	   in	   CDMactivin	  
cultures	   as	   assessed	   over	   25	   passages	  
(Fig.	   4.10).	   In	   contrast,	   a	   transient	  
induction	   of	   both	   CBP	   and	   BRG1,	   was	  
observed,	   while	   PCAF	   and	   GCN5	   mRNA	  
levels	   were	   very	   low	   in	   all	   cell	  
populations	   and/or	   not	   significantly	  
altered	  respectively.	  	  
Whether	   P300	   gene	   expression	   levels	  
directly	   respond	   to	   TGF-­‐β/Activin	   cell	  
signalling	   activity	   was	   further	   tested	   in	  
H1	   hES	   cells	   cultured	   in	   CDMactivin	  
conditions.	   Here,	   untreated	   cells	   were	  
compared	   to	   cells	   starved	   of	   TGF-­‐
β/Activin	   signalling	   by	   treatment	   with	  
SB431542,	   a	   commonly	   used	   TGF-­‐β/Activin-­‐receptor	   inhibitor,	   followed	   by	   restimulation	  
with	   Activin	   A.	   Interestingly,	   inhibition	   of	   TGF-­‐β/Activin	   signalling	   led	   to	   a	   significant	  
reduction	  of	  approximately	  30%	  in	  the	  expression	  levels	  of	  P300	  after	  12	  hours	  of	  SB431542	  
treatment.	  Upon	  restimulation,	  the	  expression	  of	  P300	  returned	  to	  levels	  seen	  in	  untreated	  
cell	  samples	  (Fig.	  4.11a).	  Levels	  of	  NANOG,	  a	  known	  target	  of	  TGF-­‐β/Activin	  signalling	  (Xu	  et	  
al.	   2008),	   were	   also	   observed	   to	   effectively	   respond	   to	   TGF-­‐β	   signalling	   inhibition	   (by	  
approximately	   50%)	   and	   restimulation	   as	   expected,	   however	   expression	   levels	   of	  CBP	   did	  
not	  significantly	  vary	  in	  the	  same	  experiments	  (Fig.	  4.11a).	  
	  
Figure	   4.10	   Histone	   acetyltransferase	   P300	   expression	   is	  
significantly	  increased	  in	  H1	  hES	  cells	  cultured	  in	  CDMactivin	  
conditions	  as	  compared	  to	  CM	  conditions.	  
(a)	   Real-­‐time	   PCR	   analysis	   of	   histone	   acetyl	   transferases	  
(P300,	  CBP,	  PCAF,	  and	  GCN5)	  and	  chromatin	  modifier	  BRG1,	  
all	   known	   to	   be	   associated	  with	   phosphorylated	   SMAD2/3	  
complexes.	   H1	   CM	   (H1p49CM,	   white	   bars)	   and	   CDMactivin	  
hES	  cells	  [H1p47(CDM3,	  6,	  14	  and	  25),	  black	  bars]	  analysed.	  
Mean	   and	   standard	   error	   of	   at	   least	   experiments	   are	  
shown.	   Data	   was	   normalised	   to	   the	   expression	   of	   two	  
housekeeping	   genes	   (GAPDH	   and	  HPRT).	   Primers	   used	   for	  
this	   analysis	   are	   listed	   in	   Appendix	   I,	   Table	   A1.	   Un-­‐paired	  




	   	  	  	  	   	  
Figure	  4.11	  Levels	  of	  P300	  in	  hES	  cells	  respond	  to	  SMAD2	  activity.	  
Real-­‐time	  PCR	  analysis	  of	  selected	  genes	  in	  H1	  and	  H9	  ES	  cells	  cultured	  in	  CDMactivin	  conditions.	  (a)	  H1	  hES	  cells	  
grown	   in	  CDMactivin	   conditions	   (Untreated)	  were	   compared	   to	   cells	   starved	  of	  Activin	  A	   supplementation	  and	  
treated	  with	  TGF-β/Activin	  signalling	   inhibitor	  SB431542	  for	   three	   (3	  h	  SB)	  or	   twelve	   (12	  h	  SB)	  hours	  or	   first	  
starved	   for	   twelve	  hours	   and	   then	  washed	  with	  PBS	   and	   re-­‐supplied	  with	  normal	   CDMactivin	  medium	   for	   two	  
hours	   (12	   h	   SB	   +	   2	   h	   Act	   A).	   Relative	   expression	   levels	   of	   CBP,	   P300	   and	   NANOG	   were	   assessed	   and	   are	  
presented	  normalised	  to	  untreated	  samples.	  (b)	  Relative	  expression	  levels	  of	  NANOG,	  P300	  and	  SMAD2	  were	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Recent	   studies	   using	   ChIP-­‐sequencing	   revealed	   the	   presence	   of	   binding	   sites	   for	   both	  
NANOG	  (Kunarso	  et	  al.	  2010)	  and	  SMAD2/3	  (Brown	  et	  al.	  2011)	  upstream	  and	  downstream	  
of	   the	   human	   P300	   coding	   sequence	   respectively.	   The	   observed	   modulations	   in	   P300	  
expression	  levels	  in	  response	  to	  changes	  in	  TGF-­‐β/Activin	  signalling	  could	  be	  directly	  due	  to	  
SMAD2/3	   modulating	   P300	   levels	   or	  
indirectly	  via	  increased	  NANOG	   levels.	  To	  
investigate	   this	   question,	   previously	  
established	   H9	   hES	   cell	   lines	   with	  
knockdown	   of	   SMAD2	   as	   well	   as	  
overexpression	   and	   knockdown	   of	  
NANOG	   were	   utilised.	   These	   were	  
compared	   to	   cells	   expressing	   non-­‐
targeting	   scramble	   shRNA	   or	  
overexpression	   vector	   with	   GFP	  
sequence.	   All	   kind	   gifts	   from	   Dr	   Ludovic	  
Vallier	   (Vallier	   et	   al.	   2009a;	   Brown	   et	   al.	  
2011).	   H9	   cells	   with	   a	   knockdown	   of	  
SMAD2	   also	   exhibited	   a	   significant	  
reduction	   in	   the	   levels	   of	   both	   NANOG	  
and	  P300	   (Fig.	  4.11b).	   In	  contrast	  neither	  
knockdown	   nor	   overexpression	   of	  
NANOG	   in	  H9	  CDMactivin	  cells	  affected	  the	  
levels	   of	   P300	   expression	   (Fig.	   4.11c).	  
Altogether,	   these	   results	   indicate	   that	  
levels	  of	  P300	   can	  be	  directly	  modulated	  
in	   response	   to	   TGF-­‐β/Activin	   signalling	  
activity	   most	   likely	   via	   SMAD2/3	   in	   hES	  
cells.	  
	  
Figure	   4.12	   12	   P300	   protein	   levels	   are	   maintained	   and	  
global	   acetylation	   levels	   are	   increased	   at	   P300/CBP	  
preferred	   target	   residues	   with	   increasing	   passages	   in	  
CDMactivin	  conditions.	  
(a)	  Western	   blot	   analysis	   of	   H1	   hES	   cells	   cultured	   in	   CM	  
(H1p49CM)	   and	   CDMactivin	   for	   increasing	   number	   of	  
passages	   [H1p47(CDM3,	   5,	   14	   and	   25).	  Membranes	   were	  
probed	   with	   antibodies	   specific	   for	   P300	   and	   (b)	   for	  
p300/CBP	   preferentially	   acetylated	   histone	   H3	   targets	  
(H3K9ac,	   H3K18ac	   and	   H3K56ac).	   Antibodies	   against	   two	  
histone	   modifications	   independent	   of	   p300	   activity	   -­‐	  
H3K4me2	   and	   H3K27me3	   were	   also	   used	   as	   controls.	  
Equivalent	  protein	  loading	  is	  shown	  by	  the	  total	  H3	  and	  β-­‐
ACTIN	  loading	  controls.	  
assessed	   in	   H9	   hES	   cells	   with	   stable	   knockdown	   of	   SMAD2	   and	   compared	   to	   cells	   expressing	   non-­‐targeting	  
scramble	   shRNA,	   a	   kind	   gift	   from	   Dr.	   Ludovic	   Vallier	   (Brown	   et	   al.	   2011).	   (c)	   Relative	   expression	   levels	   of	  
NANOG	  and	  P300	  were	  assessed	  in	  H9	  hES	  cells	  with	  stable	  knockdown	  of	  NANOG	  or	  overexpressing	  NANOG	  
and	   compared	   to	   cells	   expressing	   non-­‐targeting	   scramble	   shRNA	  or	  GFP,	   a	   kind	   gift	   from	  Dr.	   Ludovic	  Vallier	  
(Vallier	   et	   al.	   2009a).	   Data	   normalised	   to	   either	   clones	   expressing	   non-­‐targeting	   scramble	   shRNA	   or	  
overexpressing	   GFP.	   Mean	   and	   standard	   error	   of	   three	   independent	   experiments	   are	   presented.	   Data	   was	  
normalised	  to	  the	  expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  Un-­‐paired	  two	  tailed	  t-­‐test	  (*	  =	  P	  




4.4.3 Global	   increase	   of	   P300-­‐mediated	   histone	   H3	   acetylation	   in	   H1	  
CDMactivin	  cell	  cultures	  
P300	  induction	  upon	  growth	  culture	  changes	  was	  confirmed	  in	  hES	  cells	  at	  the	  protein	  level	  
by	  Western	  blot	  analysis	   (Fig.	  4.12a)	  and	  was	   furthermore	  shown	  to	  be	  accompanied	  by	  a	  
global	   increase	   of	   its	   HAT	   activity	   (Fig.	   4.12b).	   For	   this	   analysis,	   P300	   preferentially	  
acetylated	   nucleosomal	   histone	   H3	   residues	   (H3K9ac,	   H3K18ac	   and	   H3K56ac)	   (Ross	   et	   al.	  
2006;	   Das	   et	   al.	   2009)	   were	   analysed,	   showing	   a	   steady	   and	   gradual	   increase	   in	   histone	  
acetylation	   levels	   in	  continued	  CDMactivin	   cultures	  as	  compared	   to	  H1	  CM	  cells.	   In	  contrast,	  
H3K4me2	   and	   H3K27me3	   levels,	   two	   histone	  modifications	   independent	   of	   P300	   activity,	  
remained	  unchanged	  between	  CM	  and	  CDMactivin	   cells.	  These	  results	  demonstrate	   that	  hES	  
cells	   grown	   under	   CDMactivin	   conditions	   are	   characterised	   by	   an	   enhanced	   expression	   of	  
SMAD2/3-­‐associated	  HAT	  P300	  and	  a	  global	  histone	  H3	  hyperacetylated	  state	  as	  compared	  
to	  cells	  in	  CM	  conditions.	  
4.4.4 Recruitment	   of	   active	   P300	   complexes	   at	   target	   loci	   is	   enhanced	   in	  
response	  to	  CDMactivin	  growth	  conditions	  
Histone	  acetylation	  positively	   correlates	  with	  early	  DNA	   replication	   timing	   (Méndez	  2009).	  
To	   investigate	  whether	  P300	   is	  directly	   recruited	   to	   loci	   subject	   to	   late-­‐to-­‐early	   replication	  
timing	   changes	   in	  hES	   cells,	   ChIP	   assay	   and	  qRT-­‐PCR	  analysis	  were	  used.	   In	   particular,	   the	  
levels	   of	   P300	   occupancy	   were	   compared	   in	   H1	   CM	   and	   CDMactivin	   hES	   cell	   cultures	   at	  
selected	  promoters	  as	  well	  as	  the	  levels	  of	  enrichment	  for	  associated	  acetylated	  histone	  H3	  
(H3K9ac,	  H3K18ac	  and	  H3K56ac).	  Note	  that,	  CGA,	  FOXA2,	  GATA6,	  REX1,	  SOX17	  and	  TERT	  are	  
all	   candidate	   targets	   for	   replication	   timing	   alterations	   in	   response	   to	   growth	   culture	  
condition	   change	   (Fig.	   4.13a).	  NANOG	   is	   here	   used	   as	   a	   control,	   being	   consistently	   early	  
replicating	  in	  both	  CM	  and	  CDMactivin	  populations.	  Interestingly,	  and	  as	  shown	  in	  figure	  4.13b,	  
P300	  was	  detected	  in	  the	  promoter	  regions	  of	  these	  genes	  at	  higher	  levels	  in	  CDMactivin	  hES	  
cells,	  where	  these	  loci	  replicate	  in	  early	  S-­‐phase	  as	  compared	  to	  in	  CM	  cells.	  In	  contrast,	  no	  
significant	  change	   in	   the	   levels	  of	  enrichment	   for	  P300	  at	  NANOG	  promoter	  was	  observed	  
between	   the	   two	   studied	   cell	   populations.	  As	   anticipated	   from	   the	  detection	  of	   P300,	   the	  
relative	  enrichment	  for	  acetylated	  H3K9,	  K18	  and	  56	  at	  the	  promoter	  regions	  of	  CGA,	  FOXA2,	  
GATA6,	  REX1	  and	   SOX17	  was	  also	   found	  generally	   higher	   in	  H1	  CDMactivin	   cells	   than	   in	  CM	  
cells	   (Fig.	   4.13c).	   The	   TERT	   locus	   did	   not	   however,	   show	   the	   same	   trend,	   yet	   replication	  
timing	  was	  found	  to	  be	  highly	  variable	  (from	  middle	  and	  middle-­‐early)	  across	  CM	  cultures	  of	  
the	   same	   line,	   highlighting	   TERT	   as	   a	   complex	   exception.	   These	   studies	   clearly	   suggest	   a	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direct	   correlation	   between	   the	   establishment	   of	   early-­‐replication	   profiles	   and	   P300	   loci;	  
REX1	   and	  TERT	   are	   two	   	   examples	   	   of	   genes	   	   that	   	   are	   	   expressed	   	   in	   	   hES	   cells	  while	   all	  	  
	  
	  
Figure	   4.13	   Loci	   changing	   replication	   timing	   from	   late	   in	   CM	   to	   early	   in	   CDMactivin	   hES	   cells	   harbour	   higher	  
levels	  of	  P300	  and	  histones	  acetylation	  at	  their	  promoter	  regions	  in	  CDMactivin	  hES	  cells.	  
(a)	  Replication	  timing	  status	  of	  CGA,	  FOXA2,	  GATA6,	  REX1,	  SOX17,	  TERT	  and	  NANOG	  was	  assessed	  in	  hES	  cells	  in	  
CM	   and	   CDMactivin	   conditions.	   The	   replication	   timing	   of	   each	   locus	   is	   indicated	   in	   a	   colour	   coded	   way	   as	  
previously	  designated.	  Relative	  enrichments	  for	  (b)	  P300	  and	  (c)	  acetylated	  histone	  H3	  (H3K9ac,	  H3K18ac	  and	  
H3K56ac)	  was	  assessed	  in	  H1p67CM	  and	  H1p47(CDM23)	  hES	  cells	  using	  ChIP	  assay	  and	  qRT-­‐PCR	  analysis	  (black	  
bars).	  Grey	  bars	  indicate	  background	  levels	  (control	  IgG).	  P300	  enrichments	  are	  expressed	  relative	  to	  input	  and	  





other	   candidate	   loci	   analysed	   are	   silent.	   These	   results	   are	   in	   accordance	   with	   recent	  
observations	   from	   Cedar	   and	   colleagues	   showing	   that	   HATs	   recruitment	   to	   the	   human	  β-­‐
GLOBIN	   locus	   in	  a	  non-­‐erythroid	  cell	   line	  (where	  this	  gene	   is	  not	  expressed)	   is	  sufficient	  to	  
trigger	   a	   change	   of	   replication	   timing,	   from	   late	   to	   early.	   Conversely,	   tethering	   a	   histone	  
deacetylase	  (HDAC)	  to	  this	  locus	  in	  an	  erythroid	  cell	  line	  (where	  it	  is	  normally	  expressed)	  was	  
sufficient	  to	  change	  its	  replication	  timing	  from	  early	  to	  late	  (Goren	  et	  al.	  2008).	  
4.4.5 Stable	  knockdown	  of	  P300	  in	  H1	  hES	  cells	  leads	  to	  differentiation	  and	  
gradual	  loss	  of	  cultures	  
To	  further	  investigate	  the	  role	  of	  P300	  in	  the	  maintenance	  of	  distinct	  epigenetic	  states	  in	  hES	  
cells,	   P300	   expression	   was	   stably	   knocked	   down	   in	   hES	   cells	   using	   two	   independent	  
puromycin-­‐selectable	   shRNA	   (shP300	   3	   and	   shP300	   4)	   vectors	   and	   further	   analysed	  
alongside	   cell	   lines	   expressing	   a	  non-­‐targeting	   shRNA	   control	   (shSCR)	   (see	   sections	  2.2.2.2	  
and	   2.2.2.4	   for	   details).	   Briefly,	   here	   H9	   hES	   cell	   cultures	   were	   transfected	   by	   specified	  
shRNA	   vectors	   using	   Lipofectamine	   2000.	   Approximately	   one	   week	   after	   transfection	  
puromycin	  selection	  was	  applied	  to	  the	  cells.	  Cells	  were	  then	  cultured	  for	  approximately	  2-­‐3	  
weeks	  to	  allow	  for	  establishment	  of	  clones,	  at	  this	  point	  12	  individual	  clones	  were	  picked	  for	  
each	   transfected	   vector	   for	   expansion	   (see	   Fig.	   4.14a	   for	   scheme	   of	   transfection).	   Four	  
clones	   transfected	   with	   shP300	   3	   and	   five	   of	   shP300	   4	   exhibited	   knockdown	   of	   P300	  
expression	   levels	  and	  were	  used	   for	  analysis.	  Both	  P300	   shRNAs	  were	   found	   to	  effectively	  
reduce	  P300	  gene	  expression	  by	  approximately	  60%	  as	  compared	  to	  shSCR	  controls	  with	  no	  
downregulation	  of	  the	  closely	  related	  HAT	  CBP	  (Fig	  4.14b).	  Note	  that	  CBP	  expression	  seemed	  
instead	   to	   increase	   in	   P300-­‐depleted	   hES	   cells,	   possibly	   pointing	   to	   compensatory	   effects	  
(Fig.	   4.14b).	   A	   dramatic	   loss	   of	   P300	   was	   observed	   at	   the	   protein	   level	   by	   western	   blot	  
analysis	   (Fig.	   4.14c).	   In	   all	   cases	   the	   P300	   knockdown	   clones	   could	   not,	   however,	   be	  
maintained	  and	  propagated	  beyond	  four	  or	  five	  passages	  after	  establishment	  of	  clones.	  The	  
P300	   knockdown	   clones	   became	   either	   overcome	   by	   differentiated	   cells	   or	   seemingly	  
stopped	  dividing	  leading	  to	  a	  loss	  of	  undifferentiated	  cultures,	  whereas	  clones	  with	  the	  non-­‐
targeting	   shSCR	   remained	   positive	   for	   the	   undifferentiation	   associated	   AP	   activity	   and	  
continued	  to	  grow	  in	  normal	  hES	  colonies	  (Fig.	  4.14d).	  Further	  qRT-­‐PCR	  analysis	  revealed	  a	  
reduction	   in	   the	   levels	   of	   OCT4	   and	   NANOG	   in	   the	   P300	   knockdown	   clones	   from	   the	  
beginning	  suggesting	  a	  bias	  towards	  differentiation	  in	  the	  shP300	  clones	  (Fig.	  4.14e).	  Taken	  
together,	  these	  data	  demonstrate	  that	  stable	  P300-­‐depletion	  is	  detrimental	  to	  hES	  cells,	  as	  
previously	  shown	  for	  e.g.	  human	  fibroblasts	  (Prieur	  et	  al.	  2011).	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Figure	  4.14	  Stable	  knockdown	  of	  P300	  leads	  to	  differentiation	  or	  loss	  of	  cultures	  in	  H9	  hES	  cells.	  
Clones	   expressing	   either	   non-­‐targeting	   shRNA	   (shSCR)	   or	   one	   of	   two	   independent	   shRNAs	   targeting	   P300	  
(shP300	   3	   and	   shP300	   4)	   were	   established	   in	   H9	   hES	   cells.	   (a)	   Schematic	   representation	   of	   hES	   stable	  
transfection	  time-­‐course.	  (b)	  Real-­‐time	  PCR	  analysis	  confirms	  knockdown	  of	  P300.	  Levels	  of	  P300	  and	  CBP	  were	  
assessed	  in	  shP300	  3	  and	  shP300	  4	  clones	  and	  compared	  to	  the	  shSCR	  clones.	  (c)	  Western	  blot	  analysis	  of	  H9	  
hES	   cells	   expressing	   shSCR,	   shP300	  3	  or	   shP300	  4	   cultured	   in	  CDMactivin	   conditions.	  Membranes	  were	  probed	  
with	  antibodies	  specific	   for	  P300	  and	  β-­‐ACTIN	  (as	  a	  control	   for	  protein	   loading).	   (d)	  Representative	   images	  of	  
shP300	  3,	  shP300	  4	  and	  two	  different	  shSCR	  colonies	  stained	  for	  alkaline	  phosphatase	  (AP)	  activity	  cultured	  for	  
4,	  5	  or	  7	  passages	  after	  establishment	  respectively.	  Positive	  staining	  (pink)	  for	  AP	  activity	  is	  evident	  in	  colonies	  
with	  normal	  hES	  morphology	  for	  shSCR	  clones,	  but	  is	  however	  completely	  absent	  in	  both	  shP300	  3	  and	  shP300	  
4	  clones.	  Scale	  bar	  25	  µm.	  (e)	  Real-­‐time	  PCR	  analysis	  of	  OCT4	  and	  NANOG	  in	  shP300	  3	  and	  shP300	  4	  clones	  and	  
compared	   to	   the	   shSCR	   clones.	   For	  qRT-­‐PCR	  analyses	  mean	  and	   standard	  error	   of	   three	   independent	   shSCR,	  
four	   independent	   shP300	   3	   and	   five	   independent	   shP300	   4	   clones	   averaged	   are	   presented.	   Data	   was	  
normalised	  to	  shSCR	  and	  to	  the	  expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  Un-­‐paired	  two	  tailed	  
t-­‐test	  (*	  =	  P	  <	  0.05,	  **	  =	  P	  <	  0.01	  and	  ***	  =	  P	  <	  0.001).	  Primers	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  
Table	  A1.	  All	  the	  P300	  knockdown	  and	  scramble	  control	  samples	  analysed	  here	  were	  collected	  between	  two	  to	  




4.4.6 Transient	   knockdown	   of	   P300	   by	   RNA	   interference	   does	   not	   impact	  
on	  the	  replication	  timing	  profile	  of	  H1	  CDMactivin	  hES	  cells	  
P300	  proved	  to	  be	  strictly	  necessary	  for	  the	  maintenance	  of	  self-­‐renewing	  hES	  cell	  cultures.	  
To	   further	   explore	   the	   role	   of	   P300	   in	   defining	   distinct	   epigenetic	   states	   within	   hES	   cell	  
cultures,	   hES	   cells	   were	   transiently	   targeted	   with	   either	   a	   pool	   of	   siRNAs	   targeting	   P300	  
(siP300)	  or	  non-­‐targeting	   siRNA	   control	   (siSCR).	  A	  double	   transfection	  protocol	   (day	  0	   and	  
day	  2)	  was	  applied	  to	  H1	  CDMactivin	  cells	  (Fig.	  4.15a).	  The	  extent	  of	  the	  knockdown	  was	  then	  
validated	   at	   day	   4	   by	   qRT-­‐PCR	   (Fig.	   4.15b),	   showing	   that	   P300	   expression	   was	   effectively	  
reduced	  by	  approximately	  60%,	  with	  no	  significant	  effect	  on	  CBP,	  SIRT1	  [an	  HDAC	  known	  to	  
target	   same	   residues	   as	   P300	   (Das	   et	   al.	   2009)],	  OCT4	   or	  NANOG	  mRNA	   levels	   compared	  
control	   cells.	   Note	   that	   the	   time	   of	   sample	   collection	   no	   obvious	   differences	   in	   colony	  
morphology	   or	   cell	   death	   were	   observed	   between	   siSCR	   and	   siP300	   cultures	   (Fig.	   4.15c).	  
Western	  blot	  analysis	  confirmed	  a	  partial	  loss	  of	  P300	  at	  the	  protein	  level,	  while	  in	  contrast	  
SIRT1	  or	  OCT4	  expression	  remained	  unchanged,	  confirming	  undifferentiated	  status	  of	  P300-­‐
depleted	  hES	  cultures.	  However	  despite	  the	  clear	  reduction	  of	  P300	  in	  the	  siP300	  samples,	  
only	  a	  slight	  decrease	   in	  the	  bulk	   levels	  of	  P300	  associated	  acetylated	  histone	  H3	  (H3K9ac,	  
H3K18ac	  and	  H3K56ac)	  was	  observed	  (Fig.	  4.15d).	  When	  siSCR	  and	  siP300	  H1	  CDMactivin	  cells	  
were	  next	  assayed	  by	  DNA	  replication	  timing	  analysis	  at	  day	  4,	  post	  initial	  transfection,	  both	  
cell	   populations	   were	   found	   to	   retain	   a	   mostly	   early	   replicating	   profile	   (Fig.	   4.15e).	   No	  
alterations	   could	   be	   observed	   at	   loci	   previously	   identified	   as	   targets	   for	   early-­‐to-­‐late	  
replication	  timing	  changes,	  upon	  growth	  culture	  condition	  change	  (Fig.	  4.15e;	  top	  panel)	  as	  
well	  as	  at	   loci	  that	  consistently	  replicated	  within	  the	  same	  time	  windows	  during	  S-­‐phase	  in	  
both	   CM	   and	   CDMactivin	   cells	   (Fig.	   4.15e;	   bottom	   panel).	   Taken	   together,	   these	   results	  
indicate	   that	   transient	   knockdown	   of	   P300	   is	   not	   sufficient	   to	   induce	   replication	   timing	  
changes	  in	  H1	  CDMactivin	  cells.	  This	  could	  possibly	  be	  due	  to	  unknown	  compensatory	  effects	  
or	  due	  to	  insufficient	  time	  for	  epigenetic	  alterations	  to	  occur.	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Figure	  4.15	  Transient	  siRNA	  induced	  knockdown	  of	  P300	  does	  not	  affect	  the	  replication	  timing	  profiles	  of	  H1	  
CDMactivin	  cultured	  cells.	  
H1	   hES	   cells	   cultured	   in	   CDMactivin	   conditions	   were	   double	   transfected	   with	   either	   non-­‐targeting	   siRNA	   pool	  





day	   2	   by	   normal	   transfection.	   (a)	   Schematic	   representation	   of	   hES	   siRNA	   double-­‐transfection.	   (b)	   Double	  
knockdown	   by	   siP300	   induces	   approximately	   60%	   reduction	   of	  P300	   expression	   levels	   as	   compared	   to	   siSCR-­‐
transfected	  controls.	  Quantitative	  RT-­‐PCR	  analysis	  of	  P300	  and	  the	  closely	  related	  histone	  acetyltransferase	  CBP	  
and	  histone	  deacetylase	  SIRT1,	  known	  to	  act	  on	  the	  same	  histone	  targets	  as	  P300,	  and	  of	  pluripotency	  markers	  
OCT4	   and	   NANOG.	   Mean	   and	   standard	   error	   of	   three	   independent	   experiments	   are	   presented.	   Data	   was	  
normalised	  to	  the	  levels	  of	  siSCR	  samples	  and	  to	  the	  expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  
Un-­‐paired	  two	  tailed	  t-­‐test	   (**	  =	  P	  <	  0.01).	  Primers	  used	  for	   this	  analysis	  are	   listed	   in	  Appendix	   I,	  Table	  A1.	   (c)	  
Representative	  bright	   field	   images	  of	  H1	  hES	   colonies	   transfected	  with	   siSCR	  and	   siP300.	   Scale	  bar	  10	  µm.	   (d)	  
Western	  blot	  analysis	  of	  siSCR	  and	  siP300	  transfected	  H1	  CDMactivin	  cell	  populations	  and	  analysed	  after	  four	  days	  
of	  culture.	  Membranes	  were	  probed	  with	  antibodies	  specific	  for	  P300/CBP,	  SIRT1,	  OCT4	  and	  β-­‐actin	  (as	  a	  control	  
for	   protein	   loading)	   or	   with	   antibodies	   specific	   for	   p300/CBP	   preferentially	   acetylated	   histone	   H3	   targets	  
(H3K9ac,	  H3K18ac	  and	  H3K56ac)	  and	  total	  H3.	  Equivalent	  protein	   loading	   is	  shown	  by	  the	  total	  H3	  and	  β-­‐actin	  
detection.	   (e)	   The	   replication	   timing	   of	   individual	   loci	   compared	   between	   siSCR	   and	   siP300	   transfected	   H1	  
CDMactivin	  cell	  populations	  and	  analysed	  after	  four	  days	  of	  culture.	  No	  effect	  on	  replication	  timing	  was	  observed	  in	  
loci	   that	   changed	   replication	   timing	   from	   late	   to	   early	   in	   response	   to	   CDMactivin	   conditions	   (BMP4,	   CGA,	   EBF,	  
FOXA2,	   GATA6,	   NEUROG1,	   REX1,	   SOX1,	   SOX17,	   SOX3,	   SYCP1,	   TERT	   and	   TLE1)	   or	   other	   loci	   that	   consistently	  
replicated	  early	  (DPPA4,	  GATA4,	  GBX2,	  HOXB1,	  NANOG,	  OCT4,	  WNT3	  and	  ZIC1),	  middle	  (SOX7)	  and	  late	  (IKAROS,	  
MASH1	   and	   NEURO	   D)	   in	   untreated	   CM	   and	   CDMactivin.	   Data	   representative	   of	   a	   single	   experiment	   with	   a	  
technical	  duplicate.	  
4.4.7 Inhibition	   of	   P300/CBP	   histone	   acetyltransferase	   activity	   leads	   to	  
early	  to	  late	  replication	  timing	  changes	  in	  H1	  CDMactivin	  hES	  cells	  
To	   assess	  whether	   inhibiting	   P300	  HAT	   activity	  might	   be	   a	   valuable,	   alternative	   approach,	  
the	   specific	   P300/CBP	   inhibitor	   curcumin	   (also	   known	   as	   diferuloylmethane),	   a	   major	  
curcumanoid	   in	   the	   spice	   turmeric,	   (Balasubramanyam	   et	   al.	   2004)	   was	   used.	   A	   range	   of	  
curcumin	  concentrations	  (10,	  25	  and	  50	  µM)	  were	  first	  tested	  in	  H1	  CDMactivin	  cells	  to	  assess	  
the	   impact	  of	   the	  drug	  on	  global	  histone	  H3	  acetylation	   levels	  upon	  24	  hour	   treatment	  by	  
Western	  blot	  analysis.	  Acetylation	  levels	  for	  all	  histone	  H3	  residues	  analysed	  were	  abrogated	  
(H3K9ac	  and	  H3K56ac)	  or	  significantly	  reduced	  (H3K18ac)	  in	  curcumin-­‐treated	  CDMactivin	  hES	  
cells	   with	   10	   and	   25	   µM	   curcumin,	   thereby	   confirming	   P300-­‐dependent	   histone	   H3	  
acetylation	   in	   hES	   cells.	   50	   µM	   concentration	   of	   curcumin	   resulted,	   however,	   in	   a	   high	  
incidence	  of	  cell	  death,	  as	  previously	  reported	   (Balasubramanyam	  et	  al.	  2004).	   In	  contrast,	  
treatment	   with	   curcumin	   did	   not	   induce	   any	   change	   in	   H3K27me3	   levels,	   an	   unrelated	  
histone	  modification,	   further	   highlighting	   the	   specificity	   of	   this	   treatment	   (Fig.	   4.16a).	   To	  
exclude	   any	   incidence	   of	   differentiation	   in	   curcumin-­‐treated	   H1	   CDMactivin	   cells,	   the	  
expression	  of	  undifferentiated	  ES-­‐associated	  genes	  (OCT4,	  NANOG	  and	  REX1)	  was	  verified	  by	  
qRT-­‐PCR	  analysis	  following	  four	  days	  of	  10	  µM	  treatment,	  showing	  similar	  levels	  in	  both	  H1	  
CDMactivin	   untreated	   and	   treated	   cells	   (DMSO	   and	   curcumin).	   Differentiation-­‐associated	  
markers	   (FOXA2,	   GATA6,	   EOMES	   and	   CDX2)	   were	   also	   analysed	   and	   found	   not	   to	   be	  
significantly	  different	  between	  the	  three	  conditions	  (Fig.	  4.16b).	  Cells	  treated	  for	  four	  days	  
with	  10	  µM	  curcumin	  were	  also	  assayed	  by	  IF,	  revealing	  homogeneous	  staining	  for	  OCT4	  and	  
NANOG,	   while	   the	   differentiation	   associated	   surface	  marker	   SSEA1,	   was	   absent	   in	   all	   cell	  
populations	  tested	  (Fig.	  4.16c).	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Figure	   4.16	   Inhibition	   of	   P300/CBP	   histone	   acetyltransferase	   activity	   by	   Curcumin	   leads	   to	   a	   reduction	   of	  
histone	  acetylation	  levels	  and	  induces	  early	  to	  late	  replication	  timing	  changes	  in	  H1	  CDMactivin	  cells.	  
(a)	  Western	  blot	  analysis	  of	  H1	  CDMactivin	  hES	  cells	  treated	  for	  24	  hours	  with	  DMSO	  (solvent	  control),	  10	  and	  25	  
µM	   of	   P300/CBP	   inhibitor	   curcumin.	   Membranes	   were	   probed	   with	   antibodies	   specific	   for	   P300-­‐mediated	  
acetylated	  histone	  H3	  (H3K9ac,	  H3K56ac	  and	  H3K18ac).	  Antibody	  against	  H3K27me3	  was	  also	  used	  as	  a	  control	  
for	  the	  specificity	  of	  curcumin	  P300/CBP	  inhibition.	  Equivalent	  protein	  loading	  is	  shown	  by	  the	  total	  H3	  and	  β-­‐
actin	  detection.	   (b)	  Quantitative	  RT-­‐PCR	  analysis	  of	   the	  expression	  of	  pluripotency-­‐associated	   (OCT4,	  NANOG	  
and	  REX1)	   and	  differentiated-­‐associated	   (FOXA2,	  GATA6,	   EOMES	   and	  CDX2)	   genes	   in	   untreated	  H1	  CDMactivin	  





Mean	  and	  standard	  error	  of	  at	   least	   two	   independent	  experiments	  are	  presented.	  Data	  was	  normalised	  to	  the	  
expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  Primers	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  
Table	  A1.	  (c)	  Immunofluorescence	  analysis	  of	  H1	  CDMactivin	  hES	  cells	  treated	  during	  4	  days	  with	  DMSO	  and	  10	  µM	  
of	  curcumin	  for	  OCT4	  (green),	  NANOG	  (green)	  and	  SSEA1	  (red).	  Nuclei	  are	  shown	  by	  DAPI	  staining	  (blue).	  Scale	  
bars,	  70	  µm.	  (d)	  The	  replication	  timing	  of	  individual	  loci	  was	  compared	  between	  untreated	  H1	  CM,	  CDMactivin	  and	  
CDMactivin	  hES	  cells	  treated	  during	  4	  days	  with	  10	  µM	  curcumin.	  Loci	  that	  changed	  replication	  timing	  from	  late	  to	  
early	  in	  response	  to	  CDMactivin	  conditions	  (BMP4,	  CGA,	  EBF,	  FOXA2,	  GATA6,	  NEUROG1,	  REX1,	  SOX1,	  SOX17,	  SOX3,	  
SYCP1,	  TERT	  and	  TLE1)	  delayed	  their	  replication	  timing	  towards	  late	  in	  curcumin-­‐treated	  CDMactivin	  cultures,	  with	  
the	   exception	   of	   TERT.	   Other	   loci	   consistently	   replicated	   early	   (DPPA4,	   GATA4,	   GBX2,	   HOXB1,	   NANOG,	   OCT4,	  
WNT3	  and	  ZIC1),	  middle	  (SOX7)	  and	  late	  (IKAROS,	  MASH1	  and	  NEURO	  D)	  in	  untreated	  CM	  and	  CDMactivin	  cells	  as	  
well	  as	  in	  CDMactivin	  cells	  treated	  during	  4	  days	  with	  10	  µM	  curcumin.	  
Interestingly,	  inhibiting	  P300/CBP	  activity	  with	  10	  µM	  curcumin	  treatment	  for	  four	  days	  was	  
sufficient	   to	   significantly	   alter	   the	   replication	   timing	   profile	   of	   H1	   CDMactivin	   cells.	   In	  
particular,	  11	  out	  of	  13	  loci	  previously	  identified	  as	  shifting	  their	  replication	  timing	  patterns,	  
from	   late	   to	   early,	   when	   transferred	   from	   CM	   to	   CDMactivin	   conditions	   (BMP4,	   CGA,	   EBF,	  
FOXA2,	  GATA6,	  NEUROG1,	  REX1,	  SOX1,	  SOX17,	  SYCP1	  and	  TLE1),	  were	  consistently	  found	  to	  
replicate	  in	  the	  second	  half	  of	  S-­‐phase	  upon	  P300/CBP	  HAT	  activity	  inhibition	  in	  H1	  CDMactivin	  
cell	  cultures	  (Fig.	  4.16d).	  Most	  of	  these	  loci	  started	  to	  display	  a	  replication	  timing	  similar	  to	  
that	   previously	   observed	   in	   H1	   CM	   cells.	   Importantly,	   loci	   that	   were	   consistently	   early	  
(DPPA4,	   GATA4,	   GBX2,	   HOXB1,	   NANOG,	   OCT4,	   WNT3	   and	   ZIC1),	   middle	   (SOX7)	   or	   late	  
(IKAROS	  and	  MASH1)	   replicating	   in	   both	   CM	   and	   CDMactivin	   cells	  were	   not	   affected	   by	   the	  
global	   inhibition	   of	   P300/CBP	   activity	   (Fig.	   4.16d),	   highlighting	   the	   target	   specificity	   of	  
P300/CBP	   action.	   Altogether,	   these	   results	   suggest	   a	   key	   role	   for	   P300/CBP-­‐mediated	  
histone	  acetylation	  in	  defining	  the	  distinct	  epigenetic	  states	  in	  hES	  cell	  cultures	  as	  reflected	  
at	  the	  DNA	  replication	  timing	  level.	  
4.5 Conclusions	  
Phenotypic	  and	  functional	  heterogeneity	  has	  been	  previously	  reported	   in	  mES	  cell	  cultures	  
(Chambers	  et	  al.	  2007;	  Hayashi	  et	  al.	  2008;	  Toyooka	  et	  al.	  2008)	  and	   it	  has	  been	   indicated	  
that	   mES	   cell	   populations	   harbour	   ES	   cells	   in	   naïve	   primed	   states	   (Nichols	   et	   al.	   2009b).	  
Heterogeneity	   has	   also	   been	   observed	   in	   hES	   cell	   cultures	   with	   regards	   to	   variable	  
expression	  patterns	  (Fischer	  et	  al.	  2010)	  and	  very	  recently	  for	  DNA	  methylation	  (Tompkins	  et	  
al.	   2012).	   Here	   replication	   timing	   analysis	   was	   used	   to	   demonstrate	   that	   pluripotent	   hES	  
cells	   reversibly	   adopt	   distinct	   epigenetic	   states	  when	   cultured	   under	   different	   cell	   culture	  
conditions	   and/or	   in	   different	   laboratories.	   In	   particular,	   dynamic	   replication	   timing	  
alterations,	   from	   late	   –	   to	   –	   early	   were	   observed	   when	   transferring	   the	   cells	   from	   CM-­‐
medium,	  conditioned	  on	   irradiated	  MEFs	  and	  supplemented	  with	  Fgf2,	   to	  CDM-­‐medium,	  a	  
chemically	  defined	  medium	  supplemented	  with	  Activin	  A	  and	  Fgf2.	  These	  alterations	  were	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accompanied	   by	   changes	   in	   gene	   expression	   patterns,	   with	   genes	   linked	   specifically	   with	  
human	  ICM	  and	  pre-­‐implantation	  epiblast	  being	  upregulated.	  
Importantly,	   a	   role	   for	   the	   HAT	   P300	   in	   stably	  maintaining	   an	   early	   replicating	   chromatin	  
conformation	  in	  hES	  cells	  cultured	  in	  CDMactivin	  conditions	  was	  uncovered.	  The	  late	  to	  early	  
replication	   timing	   alterations	   in	   hES	   cells	   in	   response	   to	   changing	   culture	   conditions	  were	  
accompanied	   by	   enrichment	   of	   P300	   occupancy	   at	   shifting	   loci	   as	   assessed	   by	   ChIP.	  
Inhibition	  of	  P300/CBP	  HAT	  activity	  by	  the	  chemical	  inhibitor	  curcumin	  in	  CDMactivin	  hES	  cells	  
was	   sufficient	   to	   revert	   their	   replication	   timing	   profiles	   back	   to	   a	   CM-­‐like	   profile,	   strongly	  
suggesting	   that	   P300	   might	   play	   a	   key	   role	   in	   determining	   the	   epigenetic	   status	   of	   hES.	  
Furthermore,	   P300	   expression	   was	   found	   to	   be	   directly	   modulated	   by	   TGF-­‐β/Activin	  
signalling	  in	  H1	  CDMactivin	  cells.	  Taken	  together,	  these	  findings	  support	  the	  view	  that	  distinct	  
epigenetic	  states	  exist	  within	  hES	  cell	  cultures,	  in	  response	  to	  different	  environmental	  cues.	  




Chapter	  5 Characterisation	   of	   REX1/ZFP42	   overexpressing	  
human	  ES	  cells	  
5.1 Introduction	  
Upon	  changing	  growth	  culture	  conditions	  from	  CM	  to	  CDMactivin	  media	  extensive	  epigenetic	  
alterations	  were	  observed	  in	  H1	  hES	  cell’s	  replication	  timing	  profile.	  This	  was	  accompanied	  
by	  dynamic	  fluctuations	   in	  gene	  expression	  patterns.	  Though	  only	  a	   limited	  panel	  of	  genes	  
were	  analysed	  in	  these	  experiments	  (see	  Fig.	  4.8	  and	  4.10),	  among	  these	  NANOG	  was	  found	  
to	  be	  transiently	  upregulated	  when	  transferring	  cells	  into	  CDMactivin	  conditions.	  Interestingly,	  
a	   significant	   and	   steady	   increase	   in	   the	   level	   of	   REX1	   expression	   was	   also	   observed	   in	  
CDMactivin	  hES	  cell	  cultures.	  
Rex1	   gene	   was	   first	   discovered	   in	   F9	   embryonal	   carcinoma	   cells	   due	   to	   its	   rapid	  
downregulation	  upon	  differentiation	  (Hosler	  et	  al.	  1989).	  The	  Rex1	  gene	  has	  arisen	  through	  
a	   retrotransposition	   of	   Yy1	   and	   is	   only	   present	   in	   placental	   mammals,	   furthermore	   DNA-­‐
binding	  zinc-­‐finger	  domains	  share	  homology	  with	  those	  of	  Yy1,	  but	  have	  been	  shown	  to	  bind	  
slightly	  different	  target	  sequences	  suggesting	  somewhat	  divergent	  roles	  for	  the	  two	  proteins	  
(Kim	   et	   al.	   2007).	   Recent	   evidence	   has	   demonstrated	   roles	   for	   Rex1	   in	   imprinting	   and	   X-­‐
inactivation	   in	  mouse	  development	   (Kim	  et	  al.	   2011;	  Gontan	  et	   al.	   2012).	  Rex1	   expression	  
has	  been	  confirmed	  in	  many	  pluripotent	  stem	  cell	  types	  including	  undifferentiated	  mES	  and	  
hES	  cells	  (Rogers	  et	  al.	  1991;	  Henderson	  et	  al.	  2002),	  mouse	  mesenchymal	  stem	  cells	  derived	  
from	   adult	   bone	  marrow	   (Jiang	   et	   al.	   2002)	   as	   well	   as	   in	   vivo	   in	   the	   ICM	   of	   early	  mouse	  
(Rogers	   et	   al.	   1991)	   and	   human	   (Vassena	   et	   al.	   2011)	   embryos.	  Rex1	   is	   widely	   used	   as	   a	  
marker	  of	  pluripotency	  both	  in	  mouse	  and	  human	  cells	  (Guallar	  et	  al.	  2012)	  and	  high	  levels	  
of	  Rex1	   expression	   have	   been	   linked	   to	   increased	   self-­‐renewal	   ability	   and	   pluripotency	   in	  
mES	  cells	  (Toyooka	  et	  al.	  2008;	  Wray	  et	  al.	  2010;	  Wray	  et	  al.	  2011;	  Marks	  et	  al.	  2012)	  as	  well	  
as	  complete	  reprogramming	  of	  human	  iPS	  cells	  (Chan	  et	  al.	  2009).	  Further	  insights	  into	  the	  
function	  of	  Rex1	  in	  mES	  cells	  by	  means	  of	  knockdown	  and	  overexpression	  experiments	  have,	  
however,	   produced	   conflicting	   results.	   Rex1	   knockdown	   has	   been	   reported	   to	   induce	  
differentiation	   in	  mES	  cells	   (Zhang	  et	  al.	  2006;	  Scotland	  et	  al.	  2009)	  and	  overexpression	  to	  
destabilise	  the	  ES	  cell	  self-­‐renewing	  state	  (Zhang	  et	  al.	  2006).	  Conversely	  other	  studies	  have	  
indicated	  that	  Rex1	  is	  dispensable	  for	  the	  pluripotent	  state	  Rex1-­‐null	  mES	  cells	  only	  showing	  
mild	  defects	  in	  the	  induction	  of	  some	  endoderm	  markers	  upon	  differentiation	  (Masui	  et	  al.	  
2008).	   Recently	   Rex1	   has	   also	   been	   reported	   to	   regulate	   the	   expression	   of	   endogenous	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retroviruses	   in	  both	  mES	  cells	  and	   in	  vivo	  mouse	  embryos	  (Guallar	  et	  al.	  2012).	  Hence,	  the	  
exact	  role	  played	  by	  Rex1	   in	  both	  mES	  and	  especially	  hES	  cells	  remains	  largely	  unclear.	  The	  
observed	   upregulation	   of	   REX1	   upon	   growth	   culture	   change	   in	   H1	   hES	   cells	   therefore	  
prompted	  further	   investigations	  to	  examine	  the	  possible	  role	  of	  REX1	   in	  regulating	  hES	  cell	  
self-­‐renewal	  and	  differentiation	  in	  response	  to	  cell	  signalling	  cues.	  
	  
Figure	  5.1	  Establishment	  of	  REX1	  overexpressing	  (Rex1OE)	  hES	  cell	  clones.	  
(a)	  Schematic	   representation	  of	   linearised	   transgene	  with	  CAG-­‐promoter,	   insert,	   internal	   ribosomal	  entry	  site	  
(IRES),	  Puromycin	  resistance	  gene,	  enhanced	  GFP	  (EGFP)	  and	  loxP-­‐sites	  specified.	  (b)	  Schematic	  representation	  
of	  hES	  cell	  stable	  transfection	  time-­‐course.	  (c-­‐d)	  Real-­‐time	  PCR	  analysis	  of	  Rex1OE	  and	  control	  hES	  cells	  for	  (b)	  
REX1	   and	   (c)	  OCT4,	  NANOG	   and	  SOX2.	   The	   two	  H1	   and	   two	  H9	  Rex1OE	   clones	   examined	   showed	   significant	  
upregulation	  of	  total	  REX1	  mRNA	  levels	  with	  no	  significant	  change	  in	  the	  levels	  of	  OCT4,	  NANOG	  and	  SOX2	  as	  
compared	   to	   control	   cells.	   Rex1OE	   clones	   were	   established	   in	   H1p47ic8+78	   and	   H9p94	   grown	   in	   CDMactivin	  
conditions.	  Mean	  and	  standard	  error	  of	  three	  independent	  experiments	  are	  shown.	  Data	  was	  normalised	  to	  two	  
housekeeping	  genes	  (GAPDH	  and	  HPRT)	  and	  then	  to	  the	  expression	  level	  of	  the	  control	  sample	  in	  each	  cell	  type.	  
Un-­‐paired	  two	  tailed	  t-­‐test	  (*	  =	  P	  <	  0.05,	  **	  =	  P	  <	  0.01	  and	  ***	  =	  P	  <	  0.001).	  Primers	  used	  for	  this	  analysis	  are	  




5.2 Establishment	  of	  REX1	  overexpressing	  human	  ES	  cell	  clones	  
To	  gain	  further	  insight	  into	  the	  role	  of	  REX1	  in	  hES	  cells,	  REX1	  was	  constitutively	  expressed	  in	  
H1	  and	  H9	  hES	  cell	  lines.	  For	  this	  analysis,	  cells	  were	  transfected	  with	  pPyfloxed	  expression	  
vector	  containing	  either	  REX1	  or	  Flag-­‐REX1	   cDNA,	  or	  with	  empty	  vector	  as	  control.	  Briefly,	  
H1	   and	   H9	   hES	   cell	   cultures	   were	   transfected	   with	   the	   overexpression	   constructs	   using	  
Lipofectamine	   2000	   (see	   section	   2.2.2.4).	   Approximately	   one	   week	   after	   transfection	  
puromycin	  selection	  was	  applied	  to	  the	  cells.	  Cells	  were	  then	  cultured	  for	  approximately	  2-­‐3	  
weeks	   to	   allow	   for	   establishment	   of	   clones.	   Two	   and	   six	   individual	   H1	   hES	   cell	   clones	  
overexpressing	   REX1	   (Rex1OE)	   and	   FLAG-­‐REX1	   (F-­‐Rex1OE)	   were	   established	   respectively.	  
Five	   clones	   expressing	   the	   empty	   vector,	   were	   also	   picked	   for	   further	   expansion.	   Eight	  
individual	  H9	  hES	  cell	  clones	  overexpressing	  REX1	  and	  seven	  clones	  carrying	  an	  empty	  vector	  
(Ctrl),	  were	  similarly	  expanded	  (see	  Fig.	  5.1a	  for	  scheme	  of	  transfection).	  One	  clone	  of	  each	  
H1	   Rex1OE	   II	   and	   F-­‐Rex1OE	   VI	   as	   well	   as	   two	   H9	   Rex1OE	   IX	   and	   X	   were	   selected	   for	  
subsequent	   characterisation	   and	   analysis.	   All	   cells	   transfected	   and	   cultured	   for	   these	  
experiments	  were	  grown	  in	  CDM	  medium	  with	  Activin	  A	  and	  FGF2	  supplementation,	  unless	  
otherwise	   specified.	   Furthermore,	   cells	   were	   propagated	   under	   puromycin	   selection	   to	  
ensure	  maintained	  expression	  of	  the	  transgene.	  
To	   assess	   the	   overexpression	   level	   of	   REX1	   in	   different	   clones,	   qRT-­‐PCR	   analysis	   was	  
performed	   confirming	   that	   the	   total	   level	   of	   REX1	   mRNA	   in	   all	   established	   clones	   was	  
significantly	   higher	   than	   in	   control	   cells.	   In	   particular,	   REX1	   was	   found	   expressed	   at	  
approximately	  2-­‐fold	  and	  20-­‐fold	  higher	  levels	  in	  H1	  and	  H9	  Rex1OE	  clones,	  respectively	  (Fig.	  
5.1b).	   In	  contrast,	  the	  core	  pluripotency	  genes	  OCT4,	  SOX2	  and	  NANOG	  (Boyer	  et	  al.	  2005;	  
Loh	  et	  al.	  2006)	  retained	  similar	  expression	  levels	  as	  control	  cells	  (Fig.	  5.1c).	  Protein	  levels	  of	  
REX1	   were	   not	   analysed	   in	   absence	   of	   specific	   anti-­‐REX1	   antibodies,	   despite	   extensive	  
efforts	   to	   identify	   one.	   Uniform	   protein	   expression	   patterns	   for	   OCT4,	   SOX2	   and	   NANOG	  
were	   also	   observed	   by	   immunofluorescence	   in	   both	   Rex1OE	   and	   control	   cells	   (Fig.	   5.2a).	  
Phenotypic	   analysis	   of	   the	   clones	   was	   extended	   to	   TRA-­‐1-­‐60	   and	   TRA-­‐1-­‐81,	   two	   known	  
markers	  of	  pluripotent	  cells	   (Henderson	  et	  al.	  2002),	  as	  well	  as	  OCT4	  using	  flow	  cytometry	  
(Fig.	   5.2b).	  H1	   control	   and	  F-­‐Rex1OE	   cells	   expressed	   these	  pluripotency	  markers	   at	   similar	  
levels	  with	  90-­‐95%	  of	   cells	   staining	  positive	   for	  TRA-­‐1-­‐60	  and	  TRA-­‐1-­‐81	  and	  approximately	  
62%	  staining	  positive	  for	  OCT4.	  Consistently,	  H9	  control	  and	  Rex1OE	  cells	  expressed	  OCT4	  at	  
similar	  levels	  with	  approximately	  73%	  staining	  positive.	  Slightly	  lower	  numbers	  of	  H9	  Rex1OE	  
cells	  stained	  positive	  for	  TRA-­‐1-­‐60	  and	  TRA-­‐1-­‐81	  than	  control	  cells	  with	  only	  approximately	  
79%	  and	  76%	  staining	  positive	  	  for	  	  TRA-­‐1-­‐60	  and	  TRA-­‐1-­‐81	  	  compared	  to	  approximately	  85%	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Figure	  5.2	  REX1	  overexpressing	  cells	  retain	  expression	  of	  pluripotency	  markers	  in	  culture.	  
(a)	   Control	   and	   Rex1OE	   cells	   established	   from	   H1	   and	   H9	   cell	   lines	   were	   analysed	   for	   the	   expression	   of	  
pluripotency	  markers	  SOX2,	  OCT4	  and	  NANOG	  by	  immunofluorescence.	  Nuclei	  were	  stained	  with	  DAPI.	  Positive	  
staining	  was	  observed	  for	  all	  markers.	  These	  images	  are	  representative	  of	  a	  single	  experiment.	  Scale	  bar,	  50	  µm.	  
(b)	   Flow	   cytometry	   analysis	   for	   H1	   and	  H9	   control	   and	   Rex1OE	   cells	  with	   TRA-­‐1-­‐60,	   TRA-­‐1-­‐81	   and	  OCT4.	   H1	  
control	   (Ctrl	   IV)	  and	  Rex1OE	   (F-­‐Rex1OE	  VI)	   cells	  express	   these	  pluripotency	  markers	  at	   similar	   levels	  with	  90-­‐
95%	  of	  cells	  being	  stained	  positive	  for	  TRA-­‐1-­‐60	  and	  TRA-­‐1-­‐81	  and	  approximately	  62%	  for	  OCT4,	  as	  indicated	  in	  
histograms.	   H9	   control	   (Ctrl	   IV)	   and	   Rex1OE	   (Rex1OE	   IX)	   cells	   stained	   for	   OCT4	   at	   similar	   levels	   with	  
approximately	  73%	  staining	  positive.	  Slightly	   lower	  numbers	  of	  H9	  Rex1OE	  cells	   stained	  positive	   for	  TRA-­‐1-­‐60	  
and	  TRA-­‐1-­‐81	  than	  control	  cells	  (79%	  &	  76%	  versus	  85%	  &	  88%).	  The	  profile	  of	  positively	  stained	  cells	  (red)	  was	  
compared	  to	  (black)	  cells	  stained	  with	  an	  isotype-­‐matched	  control.	  Histograms	  representative	  of	  at	  least	  three	  
independent	   experiments	   for	   H9	   and	   of	   a	   single	   experiment	   for	   H1.	   Antibodies	   and	   dilutions	   used	   for	   this	  




and	  88%	  for	  control	  cells	  respectively.	  Both	  Rex1OE	  and	  control	  cells	  similarly	  formed	  typical	  
hES	   cell	   colonies	  with	  a	   flattened	  compact	  morphology	   (Thomson	  et	  al.	   1998)	  and	   stained	  
positive	   when	   assayed	   for	   alkaline	   phosphatase	   activity,	   a	   commonly	   used	   indicator	   for	  
undifferentiated	   cells	   (Thomson	   et	   al.	   1998)	   (Fig.	   5.3).	   Taken	   together,	   these	   results	  
demonstrate	  that	  REX1	  overexpressing	  hES	  cells	  can	  be	  established	  and	  stably	  maintained,	  
and	  that	  these	  cells	  retain	  an	  undifferentiated	  character	  upon	  propagation.	  
5.3 Examination	  of	  the	  growth	  characteristics	  of	  REX1	  overexpressing	  
hES	  cell	  clones	  
Interestingly,	  a	  trend	  showing	  that	  Rex1OE	  clones	  might	  grow	  faster	  than	  control	  clones	  was	  
observed	   during	   routine	   cell	   culture.	   For	   example,	   Rex1OE	   wells	   would	   typically	   reach	  
confluency	   a	   day	   or	   two	   days	   earlier	   than	   control	   wells.	   This	   suggested	   that	   REX1	   might	  
enhance	  cell	  proliferation.	  To	  assess	  whether	  this	  is	  the	  case,	  a	  colony	  formation	  assay	  was	  
used	  to	  test	  the	  self-­‐renewal	  ability	  of	  the	  Rex1OE	  and	  control	  cells.	  Rex1OE	  and	  control	  hES	  
clones	  were	  trypsinised	  to	  a	  single	  cell	  level	  and	  seeded	  into	  12-­‐well	  plates	  at	  5000	  cells	  per	  
cm2	  in	  normal	  CDMactivin	  growth	  conditions	  and	  allowed	  to	  grow	  for	  eight	  days.	  At	  this	  point	  
cells	   were	   stained	   with	   alkaline	   phosphatase	   and	   then	   the	   number	   of	   undifferentiated,	  
mixed	  and	  differentiated	  colonies	  counted	  (see	  Fig.	  5.4	  for	  examples	  of	  colony	  morphology).	  
In	   proliferating	   conditions	   both	   control	   and	   Rex1OE	   clones	   formed	   a	   high	   proportion	   of	  
undifferentiated	   and	   mixed	   colonies	   (75-­‐90%)	   as	   expected.	   However,	   the	   percentage	   of	  
undifferentiated	  colonies	  was	  increased	  at	  the	  expense	  of	  differentiated	  and	  mixed	  colonies	  
in	  Rex1OE	  wells,	  most	   strikingly	   in	  H1	  cells	  with	  approximately	  40%	  versus	  55%	   in	  H1	  and	  
	  
Figure	  5.3	  Rex1OE	  hES	  cells	  retain	  normal	  morphology	  and	  stain	  positive	  for	  alkaline	  phosphatase	  
activity.	  
Representative	   bright	   field	   (BF)	   images	   depicting	   normal	   hES	   cell	   morphology	   with	   flat	   and	   well	  
defined	   colonies	   and	   positive	   staining	   (pink)	   following	   fixation	   and	   alkaline	   phosphatase	   (AP)	  
treatment	   for	   both	   control	   and	   Rex1OE	   cells	   established	   from	   H1	   and	   H9	   cells.	   AP	   images	   are	  
representative	  of	  at	   least	  three	  independent	  experiments.	  Magnification	  20x	  for	  H9	  BF	  images	  and	  
10x	  for	  all	  others.	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50%	   versus	   60%	   in	  H9	   clones	   of	   undifferentiated	   colonies	   counted	   in	   control	   and	   Rex1OE	  
wells,	  respectively.	  
Other	   key	   pluripotency	   factors,	   such	   as	  NANOG,	   have	   previously	   been	   shown	   to	   directly	  
impact	  on	  the	  cell	  cycle	  regulation	  of	  hES	  cells	  (Zhang	  et	  al.	  2009).	  To	  assess	  whether	  REX1	  
overexpression	  may	   similarly	   impact	  on	  hES	   cell	   cycle	   regulation,	   cells	  were	  pulse-­‐labelled	  
with	  BrdU	  and	  co-­‐stained	  for	  PI.	  This	  allowed	  the	  quantification,	  by	  flow	  cytometry,	  of	   the	  
relative	   number	  
of	   cells	   in	   G1,	   S	  
and	  G2	  phases	  of	  
the	  cell	  cycle	  and	  
thus	   the	  
comparison	   of	  
the	   cycling	   state	  
of	   Rex1OE	   and	  
control	   hES	   cells.	  
As	   illustrated	   by	  
figure	   5.5,	   both	  
control	   and	  
	  
Figure	  5.5	  H9	  control	  and	  Rex1OE	  cells	  have	  similar	  cell	  cycle	  profiles.	  
Bivariate	  distributions	  of	  H9	  control	  and	  Rex1OE	  cells	  grown	  under	  CDMactivin	  conditions,	  
showing	   incorporation	   of	   5-­‐bromo-­‐2-­‐deoxyuridine	   (BrdU)	   and	   propidium	   iodide	   (PI)	  
staining	  reflecting	  the	  DNA	  content.	  Percentage	  of	  cells	  in	  G1,	  S	  and	  G2/M	  phases	  in	  each	  
sample	  is	  indicated.	  Data	  representative	  of	  four	  independent	  experiments.	  
	  
Figure	  5.4	  REX1	  overexpression	  does	  not	  inhibit	  hES	  cell	  self-­‐renewal	  ability	  
Self-­‐renewal	   capability	   of	   both	   control	   and	   Rex1OE	   cells	   was	   tested	   by	   colony	   formation	   assay.	  
Cells	  were	  trypsinised	  and	  seeded	  in	  single	  cell	  suspension	  at	  5000	  cells	  per	  cm2	  onto	  12-­‐well	  plates	  
under	  normal	  CDMactivin	  conditions.	  After	  eight	  days	  cells	  were	  stained	  with	  alkaline	  phosphatase,	  
colonies	   counted	   and	   assessed	   as	   being	   differentiated	   (red),	   mixed	   (green)	   or	   undifferentiated	  
(blue).	   H1	   Rex1OE	   (F-­‐Rex1OE	   VI)	   wells	   had	   a	   higher	   proportion	   of	   undifferentiated	   colonies	   as	  
compared	  to	  control	  (Ctrl	  I)	  wells	  (55%	  versus	  37%).	  Similar	  trend	  was	  also	  observed	  for	  H9	  when	  
comparing	  Rex1OE	   (Rex1OE	   IX)	   and	   control	   (Ctrl	   IV)	  wells	   (60%	   versus	   50%).	   All	   cell	   populations	  
assessed	  gave	   rise	   to	  differentiated,	  mixed	  and	  undifferentiated	   colonies.	  Data	   representative	  of	  




Rex1OE	  clones	  were	  actively	   cycling	  and	  displayed	   similar	  percentages	  of	   cells	   in	  each	  cell	  
cycle	   phase	   (G1:	   49-­‐50%,	   S:	   22.9-­‐24.5%	   and	   G2/m:	   19.1-­‐20.5%).	   Taken	   together	   these	   data	  
suggest	   that	   REX1	   overexpression	   might	   confer	   a	   self-­‐renewal	   advantage	   in	   hES	   cells,	  
however	  no	  direct	  effect	  can	  be	  seen	  on	  hES	  cell	  cycle	  properties.	  Note	  that	  these	  data	  are	  
preliminary	  will	  need	  to	  be	  repeated	  with	  additional	  Rex1OE	  clones	  as	  well	  as	  with	  revertant	  
clones	  to	  validate	  a	  direct	  role	  for	  REX1	  as	  a	  self-­‐renewal	  enhancer	  in	  hES	  cells.	  
5.4 H9	   Rex1OE	   cells	   form	   embryoid	   bodies	   containing	   cells	   derived	  
from	  all	  three	  germ-­‐layers	  
To	  next	  test	  the	  ability	  of	  Rex1OE	  cells	  to	  give	  rise	  to	  derivatives	  of	  all	  three	  germ	  layers,	  an	  
in	  vitro	  EB-­‐based	  assay	  was	  used,	  as	  described	  in	  section	  4.2.2.	  Here,	  in	  vitro	  differentiation	  
was	  induced	  by	  growing	  H9	  Rex1OE	  and	  control	  cells	  as	  EBs	  in	  non-­‐adherent	  conditions	  and	  
using	  differentiation	  media	  (Knockout™	  DMEM	  supplemented	  with	  20%	  FBS,	  0.1	  mM	  NEAA,	  
2	  mM	  L-­‐glutamine	  and	  0.55	  mM	  β-­‐mercaptoethanol)	  for	  10	  days	  (Fig.	  5.6a).	  EBs	  were	  then	  
plated	  onto	  gelatin-­‐coated	  plates	  and	  allowed	  to	  further	  differentiate	  for	  up	  to	  an	  additional	  
20	  days	  (Fig.	  5.6b).	  At	  this	  stage,	  a	  wide	  variety	  of	  morphologically	  different	  cell	  types	  were	  
observed.	   The	   most	   obvious	   differentiated	   cell	   types	   were	   beating	   cardiac	   muscle-­‐like	  
clusters	  observed	   in	  both	  control	  and	  Rex1OE	  clones	   (Fig.	  5.6b	  5	  &	  6).	   Liver-­‐like	   cells	  with	  
well-­‐defined	  cytoplasms	  and	  cell	  bodies	  were	  also	  observed	  in	  all	  populations	  (Fig.	  5.6b	  3	  &	  
4).	   Neuronal-­‐like	   cells	   with	   extended	   filaments	   were	   not	   observed,	   however	   evidence	   of	  
neuronal	  differentiation	  was	  consistently	  seen	  in	  control	  wells	  with	  a	  number	  of	  cells	  having	  
short	  dendritic-­‐like	  extensions	  (Fig.	  5.6b	  1),	  note	  however	  that	  only	  a	  few	  of	  these	  cells	  were	  
observed	   in	  Rex1OE	  plates	   (Fig.	   5.6b	  2).	   These	  observations	  will	   require	   further	   validation	  
using	  lineage	  specific	  markers	  and	  immunofluorescence.	  
To	   gain	   more	   insight	   into	   the	   differentiation	   ability	   of	   Rex1OE	   cells,	   qRT-­‐PCR	   analysis	   of	  
differentiation	  markers	  was	  conducted	  on	  EB	  samples.	  Gene	  expression	  levels	  of	  markers	  for	  
ectoderm	  (PAX6,	  P63	  and	  OLIG3),	  endoderm	  (AFP,	  PDX1	  and	  GATA6)	  and	  mesoderm	  (BMP4,	  
CD45	  and	  PECAM1)	  were	  all	  upregulated	  in	  both	  Rex1OE	  and	  control	  samples	  after	  30	  days	  
of	  differentiation	  (Fig.	  5.6c).	  Furthermore,	  expression	  levels	  of	  pluripotency	  markers	  (OCT4,	  
NANOG	  and	  CRIPTO)	  were	  all	  reduced	  to	  minimal	  levels	  in	  both	  Rex1OE	  and	  control	  cells	  as	  
compared	   to	   the	  undifferentiated	   samples,	   confirming	   a	   loss	   of	   their	   pluripotent	   status	   in	  
culture	  conditions	  favouring	  differentiation	  (Fig.	  5.6c).	  Altogether,	  these	  results	  indicate	  that	  
H9	   Rex1OE	   hES	   cells	   are	   able	   to	   differentiate	   into	   derivatives	   of	   the	   three	   germ	   layers.	   It	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would	   be	   interesting	   to	   further	   assess	  whether	   Rex1OE	  hES	   cells	  might	   be	   biased	   in	   their	  
differentiation	  ability	  using	  directed	  differentiation	  protocols	  towards	  specific	  cell	  lineages.	  





5.5 H9	   Rex1OE	   cells	   are	   able	   to	   maintain	   hall-­‐marks	   of	   pluripotent	  
cells	  in	  culture	  without	  Activin	  A	  supplementation	  
It	   has	   been	   reported	   previously	   that	   overexpression	   of	   NANOG	   in	   hES	   cells	   confers	  
independence	  from	  feeder	  cells	  or	  conditioned	  media	  (Darr	  et	  al.	  2006).	  This	  is	  reminiscent	  
of	  the	  impact	  of	  overexpression	  of	  Nanog	  or	  another	  important	  pluripotency	  factor	  Esrrb	  on	  
mES	   cells	   self-­‐renewal,	   negating	   LIF-­‐dependence	   (Chambers	   et	   al.	   2003;	   Festuccia	   et	   al.	  
2012;	   Martello	   et	   al.	   2012).	   To	   test	   whether	   Rex1OE	   may	   confer	   increased	   resistance	   to	  
differentiation	  in	  hES	  cells,	  colony	  forming	  assays	  were	  repeated	  in	  the	  absence	  of	  Activin	  A	  
supplementation.	   Interestingly,	   the	   proportion	   of	   undifferentiated	   colonies	   was	   increased	  
with	  H1	  F-­‐Rex1OE,	  from	  35%	  to	  60%	  in	  control	  versus	  Rex1OE	  cells;	  a	  trend	  also	  observed	  to	  
a	  lesser	  extent	  in	  H9	  Rex1OE	  cells	  (Fig.	  5.7a).	  To	  investigate	  whether	  Rex1OE	  hES	  cells	  may	  	  
	  
Figure	  5.6	  	  H9	  Rex1OE	  hES	  cells	  are	  able	  to	  differentiate	  in	  vitro	  into	  derivatives	  of	  the	  three	  germ	  layers.	  
(a)	   Morphology	   EBs	   formed	   in	   non-­‐adherent	   conditions	   and	   cultured	   for	   10	   days.	   Scale	   bar	   10	   µm.	   (b)	  
Morphology	  of	  EBs	  plated	  onto	  adherent	  culture	  dishes	  and	  allowed	  to	  differentiate	  for	  up	  to	  30	  days.	  Neuronal	  
like	  (1-­‐2)	  liver	  like	  (3-­‐4)	  and	  cardiomyocyte	  like	  (5-­‐6)	  cells	  were	  observed	  among	  control	  and	  Rex1OE	  cultures.	  
Scale	  bar	  10	  µm.	   (c)	  Both	  control	  and	  Rex1OE	  cells	  efficiently	  downregulated	   the	   three	  pluripotency	  markers	  
OCT4,	   NANOG	   and	   CRIPTO,	   and	   upregulated	   markers	   of	   all	   three	   germ	   lineages	   PAX6;	   P63	   and	   OLIG3	  
(ectoderm),	  AFP;	  PDX1	  and	  GATA6	  (endoderm)	  and	  BMP4;	  CD45	  and	  PECAM1	  (mesoderm),	  as	  assessed	  by	  qRT-­‐
PCR	   at	   day	   0	   and	   day	   30	   after	   of	   EB	   assay.	   Results	   shown	   are	   representative	   of	   at	   least	   two	   independent	  
experiments.	  Data	  was	  normalised	  to	  the	  expression	  of	   two	  housekeeping	  genes	   (GAPDH	  and	  HPRT).	  Primers	  
used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  Table	  1.	  
	  




Figure	  5.7	  H9	  Rex1OE	  hES	  cells	  can	  be	  serially	  passaged	  in	  absence	  of	  Activin	  A	  supplementation.	  
(a)	  H9	  and	  H1	  Rex1OE	  and	  control	  cells	  were	  assayed	  for	  colony	  formation	  as	  described	  in	  figure	  5.5	  in	  absence	  
of	  Activin	  A.	  In	  H1	  cells	  a	  significant	  increase	  of	  undifferentiated	  cells	  was	  observed	  as	  compared	  to	  control	  cells	  
(approximately	  60%	  compared	  to	  35%	  respectively),	  however	  for	  H9	  cells	  a	  very	  slightly	  increased	  proportion	  of	  
colonies	   remained	  undifferentiated	   in	  Rex1OE	  wells	  as	  compared	   to	  control	   cells.	  Data	   representative	  of	   two	  
independent	   experiments.	   (b)	   H9	   control	   and	   Rex1OE	   cells	   were	   cultured	   in	   CDM	   conditions	   in	   absence	   of	  
Activin	  A	  for	  up	  to	  eight	  passages	  and	  tested	  for	  AP	  activity.	  At	  both	  passage	  three	  and	  eight,	  the	  majority	  of	  
control	   cells	  were	   negative	   for	   AP	   activity	   and	   only	   a	   few	  undifferentiated,	   AP-­‐positive	   (pink),	   colonies	  were	  
observed	  (1	  &	  3).	  In	  contrast,	  Rex1OE	  cells	  stained	  positive	  for	  AP	  with	  little	  or	  no	  evidence	  of	  differentiation	  at	  
both	  passage	   three	  and	  eight	   (2	  &	  4).	   Images	   representative	   for	   three	   independent	  experiments	   for	  passage	  




indeed	   be	   capable	   of	  maintaining	   self-­‐renewal	   without	   Activin	   A,	   H9	   Rex1OE	   and	   control	  
cells	  were	  grown	  for	  multiple	  passages	  without	  Activin	  A.	  High	  proportion	  of	  H9	  control	  cells	  
cultured	  without	  Activin	  A	  readily	  differentiated	  after	  three	  passages	  in	  these	  conditions	  as	  
judged	  by	  morphological	  changes	  and	  lack	  of	  positive	  staining	  for	  AP	  activity	  (Fig.	  5.7b	  1	  &	  
3).	  By	  comparison,	  H9	  Rex1OE	  cells	  cultured	  without	  Activin	  A,	  interestingly,	  retained	  typical	  
hES	  colony	  morphology	  and	  continued	  to	  stain	  positive	  for	  AP	  activity	  with	  little	  evidence	  of	  
differentiation	  for	  more	  than	  eight	  passages	  (Fig.	  5.7b	  2	  &	  4).	  	  
Further	  evidence	  that	  REX1	  overexpression	  may	  at	  least	  partly,	  inhibit	  differentiation	  of	  hES	  
cells	   in	  absence	  of	  Activin	  A	  came	  from	  FACS	  analysis	  with	  TRA-­‐1-­‐60	  and	  OCT4	  antibodies.	  
While	  TRA-­‐1-­‐60	  expression	  was	  almost	  completely	  lost	  in	  control	  cells	  without	  Activin	  A	  (6%	  
positive	  cells),	  approximately	  71%	  of	  H9	  Rex1OE	  X	  cells	  retained	  positive	  staining	  for	  TRA-­‐1-­‐
60,	  as	  assessed	  here	  after	  18	  passages	  in	  absence	  of	  Activin	  A	  (Fig.	  5.8a).	  For	  reference,	  H9	  
Rex1OE	  cells	  maintained	   in	   routine	  CDMactivin	   conditions	   stained	  79%	  positive	   for	  TRA-­‐1-­‐60	  
using	   identical	   flow	   cytometry	   settings	   (see	   Fig.	   5.2b).	   Similar	   trend	   was	   observed	   with	  
regards	  to	  OCT4	  staining.	  While	  only	  13%	  of	  control	  cells	  stained	  positive	  for	  OCT4	  after	  18	  
passages	  in	  the	  absence	  of	  Activin	  A	  signalling,	  48%	  of	  Rex1OE	  cells	  retained	  OCT4	  staining	  in	  
similar	  conditions	   (Fig.	  5.8a).	  Note	  however	  that,	   the	  percentage	  of	  OCT4	  positive	   in	  these	  
cultures	   without	   Activin	   A	   was	   significantly	   lower	   than	   the	   73%	   of	   OCT4-­‐positive	   Rex1OE	  
cells	   detected	   in	   routine	   CDMactivin	   cultures	   (see	   Fig.	   5.2b),	   suggesting	   that	   Rex1OE	   cells	  
ultimately	   differentiate	   and/or	   adopt	   a	   transitional	   phenotype.	   Interestingly,	   intermediate	  
OCT4	  mRNA	  expression	   levels	  were	   also	  observed	  by	  qRT-­‐PCR	  analysis	   in	  H9	  Rex1OE	   cells	  
cultured	   without	   Activin	   A	   for	   up	   to	   11	   passages	   (Fig.	   5.8b).	   In	   contrast,	   expression	   of	  
NANOG	  mRNA	  levels	  gradually	  decreased	   in	  Rex1OE	  cells	  when	  cultured	  without	  Activin	  A,	  
as	  seen	  in	  control	  cells.	  Altogether,	  these	  results	  suggest	  that	  REX1	  overexpression	  enhances	  
hES	  cell’s	  resistance	  to	  differentiation	  upon	  Activin	  A	  withdrawal.	  Following	  serial	  passages	  
in	   absence	   of	   Activin	   A,	   Rex1OE	   cells	  would,	   however,	   adopt	   an	   intermediate/transitional	  
phenotype	  with	  lower	  yet	  detectable	  OCT4	  expression	  levels,	  but	  no	  expression	  of	  NANOG.	  
	  







REX1	  is	  a	  widely	  used	  as	  a	  marker	  of	  pluripotency	  in	  both	  mouse	  and	  human	  cells,	  however	  
its	   exact	   role	   in	   pluripotent	   ES	   cells	   remains	   largely	   unclear.	   Conflicting	   results	   have	   been	  
reported	  with	  Rex1	  being	   found	  both	  necessary	  and	  dispensable	   for	  mES	  cell	  pluripotency	  
(Zhang	  et	  al.	  2006;	  Masui	  et	  al.	  2008;	  Scotland	  et	  al.	  2009).	  Overexpression	  of	  Rex1	   in	  mES	  
cells	  was	  similarly	  suggested	  to	  interfere	  with	  self-­‐renewal	  (Zhang	  et	  al.	  2006).	  However	  high	  
endogenous	   expression	   of	   Rex1	   have	   been	   linked	   to	   high	   self-­‐renewal	   ability	   and	   to	   the	  
‘ground-­‐state’	  of	  pluripotency	  in	  mES	  cells	  in	  other	  studies	  (Toyooka	  et	  al.	  2008;	  Wray	  et	  al.	  
2010;	  Wray	  et	  al.	  2011;	  Marks	  et	  al.	  2012).	   In	  addition	  to	  this,	  high	  REX1	   levels	  have	  been	  
associated	  with	  complete	  reprogramming	  of	  human	  iPS	  cells	  (Chan	  et	  al.	  2009).	  
Here	  the	  role	  of	  REX1	  was	  investigated	  in	  hES	  cells	  upon	  generation	  and	  characterisation	  of	  
REX1	  overexpressing	  clones.	  These	  preliminary	  results	   indicate	  that	  REX1	  overexpression	   is	  
not	   detrimental	   to	   the	   self-­‐renewal	   ability	   of	   hES	   cells,	   but	   might	   instead	   confer	   a	   self-­‐
renewal	   advantage,	   as	   indicated	   by	   increased	   proportion	   of	   undifferentiated	   colonies	   in	   a	  
colony	  forming	  assay.	  REX1	  overexpressing	  hES	  cells	  were	  found	  to	  express	  similar	  levels	  of	  
the	   pluripotency	   factors	  OCT4,	   SOX2	   and	  NANOG	   and	  were	   able	   to	   give	   rise	   to	   cells	   from	  
three	   different	   germ	   lineages,	   indicating	   that	   the	   cells	   remain	   pluripotent.	   However,	   a	  
possible	  bias	  of	  differentiation	  was	  observed	  in	  REX1	  overexpressing	  cells	  with	  only	  a	  few	  or	  
no	  cells	  of	  neuronal	  morphology	  being	  detected	  following	  EB	  differentiation	  as	  compared	  to	  
control	   EBs	   (see	   Fig.	   5.6b	   2).	   Further	   insight	   into	   the	   possible	   differentiation	   bias	   of	  REX1	  
overexpressing	   cells	   could	   be	   obtained	   from	   experiments	   using	   lineage-­‐specific	  
differentiation	  protocols.	  
Figure	  5.8	  Rex1OE	  hES	  cells	  retain	  intermediate	  OCT4	  expression	  levels	  in	  prolonged	  culture	  without	  Activin	  
A.	  
(a)	  Expression	  of	  pluripotency	  markers	   in	  H9	  control	  and	  Rex1OE	  cells	  cultured	  without	  Activin	  A	  for	  up	  to	  18	  
passages	  was	   analysed	   by	   flow	   cytometry.	   Histograms	   representative	   of	   staining	   for	   TRA-­‐1-­‐60	   and	  OCT4	   for	  
both	  H9	  control	  and	  Rex1OE	  cells.	  Up	  to	  70.5%	  of	  Rex1OE	  cells	  stained	  positive	  for	  TRA-­‐1-­‐60,	  whereas	  only	  5.8%	  
of	   control	   cells	   were	   positive.	   For	   OCT4	   47.6%	   of	   Rex1OE	   cells	   stained	   positive,	   compared	   to	   only	   12.5%	   of	  
control	  cells.	  The	  profile	  of	  positively	  stained	  cells	  (red)	  was	  compared	  to	  (black)	  cells	  stained	  with	  an	  isotype-­‐
matched	   control.	   Percentage	   of	   positively	   gated	   cells	   from	   each	   individual	   example	   shown	   in	   graphs.	  
Histograms	  representative	  of	  two	  independent	  experiments.	  (b)	  Relative	  expression	  levels	  of	  OCT4	  and	  NANOG	  
were	   assayed	   by	   qRT-­‐PCR	   from	   control	   and	   Rex1OE	   cells	   cultured	   in	   absence	   of	   Activin	   A	   for	   up	   to	   eleven	  
passages	  and	  compared	  to	  samples	  from	  cells	  cultured	  in	  normal	  CDM	  conditions.	  Both	  Rex1OE	  and	  control	  H9	  
cells	   down	   regulate	   NANOG	   in	   absence	   of	   Activin	   A.	   Interestingly,	   while	   both	   control	   and	   Rex1OE	   cells	  
downregulate	  OCT4	  following	  withdrawal	  of	  Activin	  A,	  Rex1OE	  cells	  retain	  an	  intermediate	  level	  of	  expression,	  
even	  after	  eleven	  passages.	  Mean	  and	  standard	  error	  of	  three	  independent	  experiments	  are	  shown.	  Data	  was	  
normalised	   to	   two	   housekeeping	   genes	   (GAPDH	   and	   HPRT)	   and	   then	   to	   the	   expression	   level	   of	   the	   sample	  
cultured	  with	  Activin	  A	  supplementation	  in	  each	  cell	  type.	  Primers	  used	  for	  this	  analysis	  are	  listed	  in	  Appendix	  I,	  
Table	  1.	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Interestingly	   REX1	   overexpressing	   cells	   could	   be	   maintained	   in	   culture	   in	   the	   absence	   of	  
Activin	   A	   supplementation	   for	   numerous	   passages,	   where	   control	   cells	   underwent	   rapid	  
differentiation.	  Gene	  expression	  analysis	   indicated	   that	  REX1	  overexpressing	   cells	   retained	  
an	  intermediate	  level	  of	  OCT4	  expression	  as	  compared	  to	  control	  cells.	  Studies	  in	  mES	  cells	  
have	  indicated	  that	  Rex1	  binds	  the	  Oct4	  locus	  and	  therefore	  could	  modulate	  Oct4	  levels	  (Kim	  
et	  al.	  2008).	   It	   is	  possible	  that	  this	  regulatory	   link	   is	  conserved	   in	  humans	  and	  hence	  could	  
explain	   the	   observed	   intermediate	   OCT4	   levels	   in	   REX1	   overexpressing	   as	   compared	   to	  
control	   hES	   cells,	   despite	   the	   loss	   of	   NANOG	   expression	   in	   both	   populations.	   Further	  
experiments	  would	  be	  required	  to	  better	  understand	  the	  role	  of	  REX1	  in	  hES	  cells.	  It	  would	  
be	  interesting	  to	  see	  the	  effect	  of	  knock	  down	  of	  REX1	  in	  hES	  cells	  as	  well	  as	  mapping	  of	  the	  
genome-­‐wide	  REX1	  binding	  site	  distribution,	  for	  which	  Flag-­‐REX1	  overexpressing	  cells	  would	  
be	  instrumental	  in	  the	  absence	  of	  commercially	  available	  human	  REX1	  specific	  antibodies.	  




Chapter	  6 Discussion	  
Pluripotent	   stem	   cells	   offer	   a	   tremendous	   possibility	   for	   research	   into	   mammalian	  
development	  in	  vitro.	  Through	  the	  development	  of	  reprogramming	  technologies	  (Takahashi	  
et	  al.	  2006;	  Takahashi	  et	  al.	  2007;	  Yu	  et	  al.	  2007),	  they	  hold	  the	  promise	  of	  revolutionising	  
regenerative	  medicine	  and	  novel	  insights	  into	  previously	  incurable	  diseases.	  A	  growing	  panel	  
of	  both	  mouse	  and	  human	  pluripotent	  cell	  lines	  have	  been	  derived	  from	  a	  various	  embryonic	  
stages	  (Evans	  et	  al.	  1981;	  Martin	  1981;	  Brook	  et	  al.	  1997;	  Thomson	  et	  al.	  1998;	  Brons	  et	  al.	  
2007;	   Tesar	   et	   al.	   2007)	   as	  well	   as	   postnatal	  mouse	   testis	   (Kanatsu-­‐Shinohara	   et	   al.	   2004)	  
and	  by	  reprogramming	  somatic	  cells	  to	  pluripotency	  (Takahashi	  et	  al.	  2006;	  Takahashi	  et	  al.	  
2007;	  Yu	  et	  al.	  2007).	  These	  cells	  share	  the	  expression	  of	  key	  pluripotency	  factors	  (such	  as	  
Oct4,	   Sox2	   and	   Nanog),	   are	   able	   to	   self-­‐renew	   indefinitely	   in	   culture	   and	   give	   rise	   to	  
differentiated	  progeny	  when	  induced	  (Jaenisch	  et	  al.	  2008;	  Pera	  et	  al.	  2010).	  However,	  their	  
relationship	  to	  each	  other	  and	  whether	  they	  correspond	  to	  distinct	  pluripotent	  states	  in	  vivo	  
remains	  unclear.	  Especially	  the	  true	  lineage	  affiliation	  of	  hES	  cells	  in	  relation	  to	  that	  of	  mES	  
and	  mEpiS	  cells	  remains	  a	  point	  of	  debate.	  Mouse	  and	  human	  ES	  cells	  are	  derived	  from	  the	  
ICM	  of	  pre-­‐implantation	  embryos,	  however	  hES	  cells	  are	  able	  to	  give	  rise	  to	  extra-­‐embryonic	  
tissues	  (Itskovitz-­‐Eldor	  et	  al.	  2000;	  Reubinoff	  et	  al.	  2000;	  Xu	  et	  al.	  2002)	  whereas	  mES	  cells	  
cannot.	  One	   possible	   explanation	   could	   be	   that	   hES	   cells	   originate	   from	   a	   less	   committed	  
(possibly	   pre-­‐epiblast)	   stage	   while	   mES	   cells	   represent	   the	   lineage-­‐restricted	   epiblast	  
progenitors	   in	   the	   ICM.	   However	   such	   an	   explanation	   contradicts	   with	   recent	   reports	  
suggesting	   that	  hES	   cells	   closely	   resemble	  mEpiS	   cells	   -­‐	   a	   pluripotent	   stem	  cell	   population	  
derived	   from	   post-­‐implantation	   mouse	   embryos	   (Brons	   et	   al.	   2007;	   Tesar	   et	   al.	   2007).	  
Furthermore	   recent	   evidence	   indicates	   that	   the	   extra-­‐embryonic	   tissues	   which	   hES	   cells	  
were	  thought	  to	  give	  rise	  to	  are	  actually	  of	  mesodermal	  lineage	  (Bernardo	  et	  al.	  2011).	  This	  
study	  sought	  to	   investigate	  whether	  distinct	  pluripotent	  states	  could	  be	  reliably	  delineated	  
at	  the	  chromatin	  level	  by	  assaying	  and	  comparing	  the	  DNA	  replication	  timing	  profiles	  of	  mES,	  
hES	  and	  mEpiS	  cells.	  This	  notably	  uncovered	  that	  hES	  cells	  can	  adopt	  distinct	  yet	  reversible	  
epigenetic	   states	   that	   could	   be	   modulated	   in	   response	   to	   different	   cell	   signalling	  
environments.	  Moreover,	  these	  findings	  identified	  a	  role	  for	  TGF-­‐β/Activin	  signalling	  through	  
SMAD2/3	  and	  the	  histone	  acetyltransferase	  P300	  in	  defining	  these	  epigenetic	  states.	  Finally,	  
preliminary	  evidence	  from	  this	  study	  also	  hints	  at	  a	  possible	  role	  for	  REX1	  in	  sustaining	  hES	  
cell	  self-­‐renewal,	  possibly	  via	  modulating	  levels	  of	  OCT4.	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6.1 Human	  and	  mouse	  ES	  cells	  have	  distinct	  replication	  timing	  profiles	  
The	   present	   study	   was	   designed	   to	   investigate	   whether	   the	   distinct	   yet	   closely	   related	  
pluripotent	  developmental	  states	  represented	  by	  mES,	  hES	  and	  mEpiS	  cells	  could	  be	  reliably	  
discriminated	   using	   candidate	   locus	   based	   replication	   timing	   analysis.	   The	   candidate	   loci	  
selected	  for	  this	  analysis	  mainly	  encode	  human	  and	  mouse	  homologs	  selectively	  expressed	  
in	  embryonic	  and	  extra-­‐embryonic	  tissues	  of	  the	  early	  embryo	  or	   involved	   in	  early	  somatic	  
and	  germ-­‐line	  lineage	  specification.	  
The	  current	  study	  found	  that	  replication	  timing	  profiles	  of	   independently	  derived	  mES	  cells	  
lines	  from	  distinct	  genetic	  backgrounds	  were	  highly	  conserved	  across	  cell	  lines.	  Interestingly,	  
this	   contrasts	  with	   the	   reports	   describing	   high	   transcriptional	   variability	   in	  mES	   cells,	  with	  
regards	   to	  pluripotency	  associated	  genes	   such	  as	  Nanog,	  Rex1	   and	  Stella	   (Chambers	  et	   al.	  
2007;	  Hayashi	   et	   al.	   2008;	   Toyooka	  et	   al.	   2008).	   This	   could	   suggest	   that	   replication	   timing	  
profiles	  may	  be	  a	  more	  robust	  identifier	  of	  mES	  cell	  identity	  than	  transcriptional	  profiles.	  The	  
replication	   timing	  profiles	  of	  mES	   cells	  were	   found	   to	  be	   replicating	  early	   in	   S-­‐phase	   for	   a	  
majority	  of	  the	  candidate	  loci	  studied;	  a	  result	  corroborating	  previous	  findings	  (Azuara	  et	  al.	  
2006;	  Hiratani	  et	  al.	   2008)	  and	   reflecting	  a	  broadly	  accessible	   chromatin	   conformation.	  By	  
the	  means	  of	  replication	  timing	  analysis,	  mES	  cells	  could	  also	  be	  reliably	  distinguished	  from	  
closely	   related	   pluripotent	   mEC	   cells	   and	   mES	   cell	   derived	   progenitors,	   such	   as	   neural	  
progenitor	  cells	   (Perry	  et	  al.	  2004;	  Azuara	  et	  al.	  2006;	  Hiratani	  et	  al.	  2008).	  This	  prompted	  
the	  use	  of	  replication	  timing	  analysis	  to	  characterise	  hES	  cells,	  where	  lineage	  affiliation	  and	  
functional	  verification	  of	  embryonic	  potential	   in	  vivo	   is	  not	  possible,	  due	  to	  obvious	  ethical	  
reasons.	  	  
Unexpectedly,	   the	   replication	   timing	   profiles	   of	   hES	   cell	   lines	   were	   significantly	   different	  
from	  those	  of	  mES	  cells.	  All	  of	  the	  three	  hES	  cell	   lines	  analysed	  H1,	  H7	  and	  H9	  displayed	  a	  
much	  increased	  proportion	  of	  candidate	  loci	  replicating	  in	  middle,	  middle-­‐late	  or	  late	  parts	  
of	  S-­‐phase	  as	  compared	  to	  mES	  cells.	  Previously	  such	  an	  increase	  in	  the	  proportion	  of	  later	  
replicating	   loci	   has	   been	   associated	   with	   differentiation	   and	   loss	   of	   pluripotent	   identity	  
(Hiratani	   et	   al.	   2004;	   Perry	   et	   al.	   2004;	   Azuara	   et	   al.	   2006).	   Despite	   this,	   hES	   cultures	  
analysed	   in	   this	   study	   were	   confirmed	   to	   express	   high	   and	   homogeneous	   levels	   of	   key	  
pluripotency	  markers	  such	  as	  OCT4	  and	  NANOG	  and	  other	  markers	  of	  the	  undifferentiated	  
hES	  cell	  state,	  thus	  excluding	  that	  increased	  incidence	  of	  spontaneous	  differentiation	  could	  
account	  for	  the	  observed	  differences.	  Furthermore,	  H7	  hES	  cells	  could	  still	  be	  distinguished	  




Fig.	  A1),	  as	  previously	  reported	  for	  mES	  cells	  (Perry	  et	  al.	  2004;	  Azuara	  et	  al.	  2006;	  Hiratani	  
et	   al.	   2008).	   The	   observed	   divergence	   between	   mES	   and	   hES	   replication	   timing	   profiles	  
correlates	  with	  data	  from	  genome-­‐wide	  experiments	  (Ryba	  et	  al.	  2010),	  where	  mES	  and	  hES	  
replication	   timing	   profiles	   were	   reported	   highly	   conserved	   within	   regions	   of	   conserved	  
synteny,	   but	   were	   found	   to	   have	   significant	   differences	   at	   the	   genome-­‐wide	   scale.	  
Interestingly,	   the	   coordinated	   DNA	   replication	   in	   megabase-­‐sized	   replication	   domains	   is	  
conserved	  between	  mouse	  and	  human	  cells,	  however	  in	  mES	  cells	  early	  and	  late	  replicating	  
domains	   are	   of	   similar	   sizes	   and	   contrastingly	   in	   hES	   cells	   late	   replication	   domains	   are	  
significantly	  larger	  and	  less	  numerous	  than	  early	  domains	  (Ryba	  et	  al.	  2010).	  
6.2 Human	   ES	   and	   mouse	   EpiS	   cells	   share	   a	   common	   variable	  
epigenetic	  state	  as	  defined	  at	  the	  replication	  timing	  level	  
Another	   unanticipated	   feature	   of	   hES	   cell’s	   replication	   timing	   profiles	   was	   the	   significant	  
degree	   of	   variability	   observed	   between	   different	   hES	   cell	   lines	   and	   cultures.	   In	   particular,	  
many	   differentiation-­‐associated	   loci	   were	   found	   to	   replicate	   at	   different	   times	   during	   S-­‐
phase,	  regardless	  of	  their	  lineage	  affiliation	  and	  cell	  lines	  analysed.	  This	  contrasts	  with	  mES	  
cells,	  which	  instead	  display	  stable	  and	  largely	  early	  replicating	  profiles	  across	  cell	  lines.	  Such	  
variability	  could	  not	  be	  simply	  explained	  by	  differences	  in	  derivation	  and	  culture	  histories	  of	  
the	  analysed	  cell	  lines	  (H1,	  H7	  and	  H9)	  as	  they	  were	  all	  derived	  at	  the	  same	  time	  in	  the	  same	  
laboratory	  (Thomson	  et	  al.	  1998)	  and	  have	  been	  maintained	  in	  the	  same	  culture	  conditions	  
(Xu	  et	  al.	  2001).	   Furthermore,	   it	   is	  worth	  noting	   that	   this	   replication	   timing	  variability	  was	  
specific	  only	   to	  certain	   loci	   (DPPA4,	  TERT,	  TLE1,	  SYCP1,	  BMP4,	  EBF,	  FOXA2,	  GATA6,	  SOX17,	  
SOX3	   and	   ZIC1);	   a	   number	   of	   variable	   loci	   that	   is	   likely	   to	   increase	   with	   the	   analysis	   of	  
additional	   candidate	   genes	   or	   hES	   cell	   lines.	   An	   alternative	   explanation	   for	   the	   observed	  
variability	  might	  be	  that	  it	  reflects	  the	  substantial	  level	  of	  genetic	  variation	  found	  in	  human	  
populations,	  in	  contrast	  to	  inbred	  laboratory	  mouse	  populations.	  Recent	  studies	  have	  clearly	  
reported	  variability	  between	  hES	  cell	  populations	  at	  the	  transcriptional	  level	  (Skottman	  et	  al.	  
2005;	   Wei	   et	   al.	   2005;	   Adewumi	   et	   al.	   2007;	   Guenther	   et	   al.	   2010;	   Narva	   et	   al.	   2010;	  
Newman	  et	   al.	   2010;	  Amps	  et	   al.	   2011)	   and	  at	   the	  epigenetic	   level	   (Guenther	  et	   al.	   2010;	  
Bruck	  et	   al.	   2011;	  Nazor	  et	   al.	   2012).	  However,	   analysis	  of	   the	   replication	   timing	   status	  of	  
variable	  replicating	  loci	  (as	  defined	  in	  hES	  cells)	  in	  human	  CD34+	  haematopoietic	  stem	  cells	  
isolated	  from	  blood	  samples	  of	  three	  unrelated	  volunteers	  ruled	  out	  genetic	  variation	  as	  the	  
primary	  explanation.	  The	  replication	   timing	  profiles	  of	  human	  CD34+	  haematopoietic	  stem	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cells	   were	   shown	   to	   be	   remarkably	   similar	   across	   samples,	   with	   no	   or	   little	   evidence	   of	  
epigenetic	  variability	  (Appendix	  II,	  Fig.	  A8).	  
The	  loci,	  which	  exhibited	  variable	  replication	  timing	  profiles	  in	  hES	  cells,	  were	  also	  analysed	  
for	   histone	   acetylation.	   Acetylated	   histones	   are	   thought	   to	   reflect	   variations	   in	   chromatin	  
accessibility	  and	  transcriptional	  permissiveness	  (Bickmore	  et	  al.	  1995;	  Vogelauer	  et	  al.	  2002;	  
Donaldson	   2005).	   Analysis	   with	   histone	   acetylation	   marks	   (H3K9ac,	   H3K14ac,	   H3ac	   and	  
H4ac),	  failed	  to	  find	  any	  correlation	  with	  the	  variable	  replication	  timing	  profiles	  observed	  in	  
hES	  cells	  (Appendix	   II,	  Fig.	  A4).	  No	  correlation	  was	  also	  found	  with	  the	  expression	   levels	  of	  
the	  variable	  genes	  (Appendix	  II,	  Fig.	  A4).	  In	  addition	  to	  this,	  DNA	  methylation	  did	  not	  show	  
any	  correlation	  with	  the	  variable	  loci	  (Appendix	  II,	  Fig.	  A5).	  Analysis	  of	  the	  genomic	  features	  
(GC	   content	   and	   LINE	   density)	   at	   variable	   loci,	   also	   failed	   to	   identify	   any	   clear	   correlation	  
(Appendix	  II,	  Table	  A4),	  however	  all	  variable	  loci,	  apart	  from	  TERT,	  were	  found	  in	  gene	  poor	  
regions.	  
In	  an	  attempt	  to	  determine	  the	  lineage	  affiliation	  of	  hES	  cells,	  replication	  timing	  analysis	  was	  
also	  extended	   to	   several	  mEpiS	   cell	   lines	   and	   their	   profiles	   compared	   to	   those	  of	  hES	  and	  
mES	  cells.	  Restricting	  this	  analysis	  to	  a	  set	  of	  known	  ICM/epiblast-­‐specific	  markers	  was	  not	  
sufficient	  to	  clarify	  the	  developmental	  status	  of	  hES	  cells.	  Rex1	  –	  an	  ICM-­‐specific	  marker	  that	  
is	  shutdown	   in	   the	  epiblast	  –	  replicates	  early	  during	  S-­‐phase	   in	  mES	  cells	  as	  expected,	  and	  
consistently	  late	  in	  all	  mEpiS	  and	  hES	  cell	  lines	  analysed.	  In	  contrast,	  the	  replication	  timing	  of	  
Fgf5,	   an	   epiblast-­‐specific	  marker,	   shifts	   from	   late	   in	  mES	   cells	   to	   early	   in	  mEpiS	   cells,	   yet	  
remains	   late	   replicating	   in	   hES	   cells,	   suggesting	   that	   hES	   cells	   may	   not	   strictly	   resemble	  
mEpiS	  cells,	  as	  previously	  reported	  (Brons	  et	  al.	  2007;	  Tesar	  et	  al.	  2007).	  It	  should,	  however,	  
be	   noted	   that	   the	   selection	   of	   these	   markers	   was	   based	   on	   gene	   expression	   analysis	   in	  
mouse	  embryos,	   in	   the	  absence	  of	  equivalent	   information	   in	  human	  embryos	  at	   the	   time.	  
Use	   of	   loci	   determined	   from	   human	   embryonic	   development	   could	   provide	   a	   better	  
correlation	  between	  hES	  and	  mEpiS	  cells.	  Replication	  timing	  analysis	  was	   further	  extended	  
to	  other	  target	  loci	  previously	  analysed	  in	  mES	  and	  hES	  cells	  that	  are	  subjected	  to	  replication	  
timing	   variability	   in	   hES	   cells,	   i.e.	   differentiation-­‐associated	   markers	   such	   as	   Ebf,	   Ikaros,	  
Foxa2,	  Sox17,	  Sox3	  and	  Zic1.	  Remarkably,	  similar	  variability	  as	  in	  hES	  cells	  was	  also	  observed	  
across	   many	   of	   these	   loci.	   What	   could	   be	   the	   functional	   significance	   of	   the	   observed	  
replication	  timing	  variability	   in	  hES	  and	  mEpiS	  cells?	  Such	  a	  level	  of	  plasticity	  could	  suggest	  
an	  unstable	  or	  transitional	  state:	  primed	  on	  the	  verge	  of	  differentiation.	  Mouse	  EpiS	  cells	  are	  
thought	  to	  represent	  such	  a	  transitional	  state	  and	  it	  has	  been	  suggested	  that	  hES	  cells	  share	  




furthermore	   harbour	   similar	   cell	   cycle	   properties,	   most	   likely	   reflecting	   their	   common	  
growth	   requirements	   (Brons	   et	   al.	   2007;	   Tesar	   et	   al.	   2007).	   Interestingly	   the	   replication	  
timing	  profiles	  of	  hES	  and	  mEpiS	  cells	  were	  shown	  to	  be	  more	  significantly	  aligned	  to	  each	  
other	   than	   to	   mES	   profiles,	   at	   the	   genome-­‐wide	   scale	   (Ryba	   et	   al.	   2010).	   Hence,	   the	  
observation	  of	   shared	  variability	   in	  hES	  and	  mEpiS,	   cell’s	  profiles	   further	   support	   the	  view	  
that	   hES	   cells	  might	   preferentially	   harbour	   an	   epiblast-­‐like	   phenotype	   in	   culture,	   possibly	  
suggesting	  a	  pre-­‐gastrulating	  developmental	  stage	  affiliation	  in	  vivo.	  
6.3 Distinct	  and	  reversible	  epigenetic	  states	  within	  hES	  cell	  cultures	  
A	   key	   finding	   from	   the	   current	   study	   is	   the	   demonstration	   that	   hES	   cells	   can	   undergo	  
extensive	   yet	   reversible	   epigenetic	   alterations	   in	   response	   to	   changing	   cell	   culture	  
conditions.	   Both	   H9	   and	   H1	   cells	   replication	   timing	   profiles	  were	   shifted	   towards	   early	   S-­‐
phase	   as	   seen	   at	  many	   specific	   loci	  when	   transferring	   cells	   from	  CM	  medium	   to	  CDMactivin	  
medium.	  Furthermore,	  experiments	  on	   fully	   reprogrammed	  hiPS	  cells	   confirmed	   that	   both	  
pluripotent	   hES	   and	   hiPS	   cells	   share	   the	   same	   level	   of	   epigenetic	   plasticity	   in	   response	   to	  
environmental	   cues.	   Importantly,	   there	   was	   a	   high	   degree	   of	   overlap	   between	   loci	   that	  
advance	  their	  replication	  kinetics	  toward	  early	  S-­‐phase	   in	  H9,	  H1	  and	  hiPS	  cells,	  suggesting	  
that	  specific	  chromosomal	  regions	  may	  be	  targeted	  across	  the	  genome	  and	  that	  a	  conserved	  
underlying	  mechanism	  would	   operate	   in	   both	   natural	   (hES)	   and	   induced	   (iPS)	   pluripotent	  
cells.	   Interestingly,	   when	   the	   REX1	   locus	   was	   studied	   in	   detail,	   it	   was	   observed	   that	   in	  
CDMactivin	   cultured	   hES	   cells	   a	   small	  window	  of	   early	   replication	   centred	   around	  REX1	  was	  
embedded	   within	   a	   domain	   of	   late	   replication,	   where	   as	   in	   CM	   cultured	   cells	   the	   whole	  
studied	   region	   replicated	   in	   late	   S-­‐phase	  This	  would	   suggest	   the	  existence	  of	   a	   replication	  
origin	  within	  the	  studied	  region	  and	  that	  change	  of	  the	  cell	  culture	  environment	  allowed	  its	  
early	  firing.	   It	  would	  be	   interesting	   in	  future	  studies	  to	  try	  to	   localise	  the	  possible	  origin	  of	  
replication	  perhaps	  by	   in	   situ	  hybridisation	  and	   immunofluorescence	   targeted	  at	  members	  
of	  the	  DNA	  replication	  complex,	  such	  as	  PCNA.	  
Importantly,	   no	   such	   replication	   timing	   alterations	   were	   observed	   when	   comparing	   the	  
profiles	  of	  ‘normal’	  versus	  late-­‐passage,	  ‘culture	  adapted’	  hES	  cell	  cultures	  often	  associated	  
with	  karyotypic	  changes	  that	  provide	  some	  advantages	  in	  terms	  of	  clonogenic	  capacity	  and	  
self-­‐renewal	   properties	   of	   these	   cells	   (Draper	   et	   al.	   2004;	   Enver	   et	   al.	   2005;	   Baker	   et	   al.	  
2007b;	  Amps	  et	  al.	  2011)	  (Appendix	  II,	  Fig.	  A9).	  Moreover,	  the	  dynamic	  and	  reversible	  nature	  
of	   the	   observed	   replication	   timing	   shifts	   argues	   against	   cell	   adaptation.	   Nevertheless,	   the	  
demonstration	   that	   different	   hES	   cell	   populations	   with	   distinct	   epigenetic	   properties	   can	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predominate	  under	  varying	  cell	  culture	  conditions	  is	  of	  critical	  importance	  and	  might	  at	  least	  
partly	  explain	  variation	  in	  experimental	  results	  observed	  at	  different	  laboratories.	  Different	  
starting	   populations	   of	   pluripotent	   cells,	   according	   to	   their	   epigenetic	   identity,	   might	  
respond	   differently	   to	   protocols	   of	   differentiation	   and	   have	   unforeseen	   biases	   for	  
generation	  of	  certain	  tissues.	  
Here,	   it	   was	   verified	   that	   H1	   hES	   cells	   cultured	   under	   both	   CM	   and	   CDMactivin	   conditions	  
retain	   the	  expression	  of	  markers	  of	  undifferentiated	  state,	  and	  the	  ability	   to	  give	  rise	  cells	  
from	   all	   three	   germ	   lineages.	   However,	   phenotypic	   and	   functional	   differences	   were	  
observed	  between	  these	  cell	  populations.	   Interestingly,	  transcriptional	  analysis	  of	  a	   limited	  
panel	  of	  genes	  demonstrated	  that	  markers	  associated	  with	  the	  ICM-­‐stage	  in	  human	  embryos	  
became	  upregulated	   in	   the	  CDMactivin	   cultured	  cells.	   Furthermore,	  when	   the	  differentiation	  
kinetics	  of	  CM	  and	  CDMactivin	  grown	  H1	  hES	  cells	  were	  analysed,	  CM	  cultured	  population	  was	  
observed	  to	  more	  rapidly	  upregulate	  markers	  of	  differentiation	  (Appendix	  II,	  Fig.	  A10).	  Taken	  
together	   these	   results	   demonstrate	   that	   human	   ES	   cells	   can	   reversibly	   adopt	   different	  
epigenetic	   identities	  and	   supports	   the	  view	   that	  pluripotency	   is	  not	  a	   fixed	   state,	  but	   that	  
heterogeneous	   pluripotent	   sub	   states	   can	   exist	   with	   distinct	   phenotypical	   and	   functional	  
properties.	  Furthermore,	  this	  emphasises	  the	  importance	  of	  determining	  the	  true	  identity	  of	  
any	   pluripotent	   cell	   population	   for	   future	   applications	   in	   regenerative	   medicine,	   as	  
responses	  to	  differentiation	  protocols	  are	   likely	  to	  vary	  depending	  on	  the	  status	  of	  the	  cell	  
population.	  It	  would	  be	  of	  interest	  to	  extend	  this	  study	  to	  other	  growth	  culture	  conditions	  of	  
hES	   and	   iPS	   cells	   such	   as	   mTeSR	   (Ludwig	   et	   al.	   2006)	   and	   Essential	   8	   (Chen	   et	   al.	   2011)	  
media,	  which	  do	  not	  contain	  Activin	  A,	  but	  are	  dependent	  on	  FGF2	  and	  TGFβ1	  or	  FGF2	  and	  
Nodal/TGFβ1,	  respectively.	  
6.4 Investigating	   the	   molecular	   pathways	   underlying	   distinct	  
pluripotent	  states	  in	  hES	  cells	  
Previous	   reports	   have	   demonstrated	   the	   critical	   role	   of	   TGF-­‐β/Activin	   signalling	   in	  
maintaining	   pluripotent	   hES	   cell	   cultures.	  Here,	   upon	   transfer	   of	  H1	  hES	   cells	   from	  CM	   to	  
CDMactivin	   conditions,	   levels	   of	   activated	   SMAD2/3,	   the	   intracellular	   signalling	   molecule	  
associated	  with	  the	  TGF-­‐β/Activin	  pathway,	  were	  increased.	  This	  increase	  is	  likely	  due	  to	  the	  
Activin	   A	   supplementation	   in	   chemically	   defined	   media	   as	   well	   as	   the	   lack	   of	   inhibitory	  
and/or	  modulatory	  signalling	   factors	  known	  to	  be	  present	   in	  conditioned	  media	   (Lim	  et	  al.	  
2002;	  Chin	  et	  al.	  2007;	  Prowse	  et	  al.	  2007;	  Villa-­‐Diaz	  et	  al.	  2009).	  The	  increased	  P-­‐SMAD2/3	  




only	   transiently	   upregulated.	   This	   transient	   increase	   could	   be	   due	   to	   a	   negative	   feedback	  
thought	  to	  exist	  between	  NANOG	  expression	  levels	  and	  SMAD2/3	  signalling	  possibly	  leading	  
to	  the	  observed	  ‘self-­‐regulation’	  (Vallier	  et	  al.	  2009a).	  Similar	  transient	   increases	  were	  also	  
observed	   in	   the	  expression	   levels	  of	   several	  members	  of	   the	  TGF-­‐β	   family,	   such	  as	  NODAL	  
(Appendix	   II,	   Fig.	   A7),	   whose	   expression	   is	   already	   known	   to	   be	   controlled	   by	   negative	  
feedback	  regulation	  (Besser	  2004).	  
Significantly,	   profiling	   of	   the	   expression	   of	   various	   histone	   and	   chromatin	  modifiers	   in	   H1	  
hES	   cells	   upon	   changing	   growth	   culture	   conditions	   demonstrated	   that	   P300,	   a	   known	  
SMAD2/3	   co-­‐activator	   (Pouponnot	   et	   al.	   1998;	   Ross	   et	   al.	   2006),	   levels	   were	   specifically	  
upregulated	   in	   H1	   CDMactivin	   cells.	   Subsequently,	   it	   was	   observed	   that	   modulating	   TFG-­‐
β/Activin	   signalling	   induced	   changes	   in	   the	   levels	   of	   P300	   expression	   in	   H1	   hES	   cells;	   a	  
previously	   unreported	   regulation	   link.	   Analysis	   of	   established	   hES	   cell	   lines	   with	   stable	  
SMAD2	   knockdown	   and	   either	   NANOG	   knockdown	   or	   overexpression	   furthermore	  
suggested	   that	   the	   observed	   effect	   on	   P300	   expression	   might	   be	   mediated	   through	  
SMAD2/3	  only	  and	  not	  via	  NANOG.	  Interestingly,	  recent	  studies	  mapping	  SMAD2/3	  binding	  
sites	   in	  hES	  cells	  have	   indicated	  a	  SMAD2/3	  binding	   site	   located	  10	  kb	  downstream	  of	   the	  
P300	   gene.	   Further	   analysis,	   by	   means	   of	   for	   example	   luciferase	   activity	   assays	   and	   site	  
directed	  mutation,	   is	   required	   to	  determine	  whether	   this	   binding	   site	   is	   indeed	   regulating	  
P300	  levels	  in	  hES	  cells	  in	  response	  to	  TGF-­‐β/Activin	  signalling.	  
The	   functional	   significance	  of	  P300	  upregulation	   in	  H1	  CDMactivin	   cultures	  was	   then	   further	  
investigated	  and	  linked	  to	  the	  acquisition	  of	  an	  early	  replicating	  profile	  across	  many	  silenced	  
loci.	  Notably,	  a	  gradual	   increase	  in	  the	  bulk	  levels	  of	  P300	  preferentially	  acetylated	  histone	  
targets	   was	   observed	   over	   serial	   passages	   of	   H1	   hES	   cells	   under	   CDMactivin	   conditions.	  
Importantly,	   it	   was	   shown	   that	   P300	   is	   selectively	   recruited	   to	   target	   loci	   shifting	   their	  
replication	  timing	  from	  late	  to	  early	  upon	  change	  of	  growth	  culture	  conditions,	  with	  higher	  
enrichment	   levels	   observed	   in	   H1	   CDMactivin	   cultured	   cells	   when	   compared	   to	   H1	   CM	   cell	  
populations.	   In	   accordance	   to	   this,	   increased	   enrichment	   levels	   of	   associated	   histone	   H3	  
acetylation	  were	   also	  observed	  at	   these	   target	   loci.	  Histone	  acetylation	   is	   generally	   linked	  
with	  increased	  locus	  accessibility	  (Kouzarides	  2007),	  as	  seen	  here,	  in	  CDMactivin	  cells,	  at	  both	  
active	  (i.e.	  REX1)	  and	  inactive	  genes	  (i.e.	  CGA	  and	  FOXA2)	  and	  consistently	  reflected	  at	  the	  
level	  of	  DNA	  replication	  timing;	  hyperacetylation	  at	   these	   loci	  positively	  correlates	  with	  an	  
early	  replication	  profile.,	  as	  previously	  reported	  (Méndez	  2009).	  
Functionally,	   inhibiting	   P300	   HAT	   activity	   in	   CDMactivin	   hES	   cell	   cultures	   using	   the	   specific	  
P300/CBP	   inhibitor	   curcumin,	   was	   sufficient	   to	   induce	   early-­‐to-­‐late	   replication	   timing	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alterations	  at	   loci	   that	  were	  previously	   found	   to	   shift	   their	   replication	   timing	   from	   late-­‐to-­‐
early	  upon	   transfer	   from	  CM	   to	  CDMactivin	   conditions.	   This	   suggests	   a	   role	   for	  P300	  and/or	  
CBP	  in	  stably	  maintaining	  a	  hyperacetylated	  and	  early	  replicating	  profile	  in	  hES	  cell	  cultures.	  
Attempts	  to	  establish	  stable	  P300	  knockdown	  hES	  cell	  lines	  and	  thus	  validate	  a	  direct	  role	  for	  
P300	   proved	   unsuccessful,	   as	   P300-­‐depleted	   cultures	   could	   only	   be	   propagated	   for	   a	   few	  
(three	  to	  five)	  passages	  before	  they	  became	  either	  overcome	  by	  differentiation	  or	   lost	  due	  
to	  senescence	  and	  cell	  death.	  This	  phenotype	  might	  be	  potentially	  caused	  by	  multitude	  of	  
factors	   that	   relate	   to	   the	   pleiotropic	   role	   of	   P300.	  Over	   400	   different	   proteins	   have	   been	  
described	   to	   interact	   with	   P300/CBP	   (Bedford	   et	   al.	   2012),	   including,	   for	   example,	   the	  
tumour	   suppressor	   P53	   (Gu	   et	   al.	   1997),	   transcriptional	   activator	  β-­‐CATENIN	   (Hecht	   et	   al.	  
2000),	  cell	  cycle	  regulator	  CDK2	  (He	  et	  al.	  2011)	  and	  TF	  YY1	  (Lee	  et	  al.	  1995).	  Homozygous	  
P300	  or	  CBP	  –null	  mouse	  embryos	  die	  by	  E10.5,	  due	  to	  heart	  and	  neural	  tube	  defects	  (Yao	  et	  
al.	   1998).	   Interestingly,	   the	   compound	   heterozygous	  mutant	   embryos	   are	   also	   embryonic	  
lethal,	   indicating	   that	   gene	   dosage	   of	   P300	   and	   CBP	   needs	   to	   be	   tightly	   regulated	   during	  
normal	  development	   (Yao	  et	  al.	  1998).	  Perhaps	  most	   importantly	  P300/CBP	  activity	   is	  also	  
required	   for	   the	   G1/S-­‐phase	   transition	   of	   the	   cell	   cycle	   (Ait-­‐Si-­‐Ali	   et	   al.	   2000).	   This	   could	  
explain	  the	  observed	  arrest	  of	  cell	  cultures	  upon	  stable	  P300	  knockdown.	  Furthermore	  P300	  
has	  also	  been	  reported	  to	  regulate	  the	  expression	  of	  Nanog	  in	  mES	  cells	  (Zhong	  et	  al.	  2009).	  
Whether	   such	   a	   link	   is	   conserved	   in	   hES	   cells	   remains	   to	   be	   confirmed,	   however	   reduced	  
levels	  of	  NANOG	  expression	  as	  seen	  in	  P300-­‐depleted	  hES	  cells	  might	  be	  a	  plausible	  reason	  
for	  the	  increased	  incidence	  of	  differentiation	  in	  these	  clones.	  
Transiently	  transfecting	  hES	  cells	  with	  siRNA	  oligos	  that	  specifically	  target	  P300,	  in	  contrast,	  
did	  not	  lead	  to	  cell	  proliferation	  arrest	  and/or	  differentiation.	  However,	  even	  though	  levels	  
of	   P300	   were	   effectively	   reduced	   at	   both	   mRNA	   and	   protein	   level	   four	   days	   post	  
transfection,	  only	   a	   very	  mild	   reduction	   in	   global	   acetylation	   levels	  of	  H3	  histone	   residues	  
was	   observed.	   Subsequently,	   analysis	   of	   the	   replication	   timing	   demonstrated	   no	   change	  
between	  control	  and	  siP300-­‐treated	  hES	  cell	  samples.	  A	  possible	  explanation	  for	  the	  lack	  of	  
reduction	  in	  histone	  acetylation	  is	  that	  P300	  knockdown	  could	  be	  masked	  by	  compensation	  
through	  activity	  by	  the	  closely	  related	  CBP.	  It	  would	  be	  interesting	  to	  address	  this	  question	  
with	  a	  double	  targeting	  of	  CBP	  and	  P300	  simultaneously.	  It	  is	  equally	  possible	  that	  the	  effect	  
of	   P300	   depletion	   on	   histone	   acetylation	   would	   need	   several	   rounds	   of	   cell	   division	   to	  
manifest.	  Note	  that	  a	  gradual	  increase	  in	  histone	  acetylation	  was	  evident	  upon	  transferring	  




Inhibition	  of	  P300/CBP	  activity,	  by	  curcumin,	  in	  H1	  CDMactivin	  cells	  induced	  early	  to	  late	  shifts	  
of	  replication	  timing	  at	  ten	  out	  of	  the	  twelve	  loci	  shown	  to	  shift	  upon	  transfer	  from	  CM	  to	  
CDMactivin	   conditions	   and	   had	   no	   effect	   on	   loci	   not	   subject	   for	   epigenetic	   alterations.	   This	  
suggests	  a	  role	  for	  P300/CBP	  activity	  in	  specifically	  determining	  the	  epigenetic	  status	  of	  hES	  
cells.	   Attempts	   to	   duplicate	   the	   effects	   of	   P300/CBP	   inhibition	   with	   a	   small	   molecule	  
inhibitor	  of	  P300/CBP,	  C646	  (Bowers	  et	  al.	  2010),	  failed	  to	  induce	  similar	  reversion	  of	  early	  
replication	   as	   seen	   with	   curcumin	   (Appendix	   II,	   Fig.	   A11).	   An	   explanation	   for	   C646	   and	  
curcumin	   having	   different	   efficiencies	   of	   inhibiting	   P300/CBP	   HAT	   activity	   in	   H1	   CDMactivin	  
cells	  could	  lie	  with	  their	  mechanism	  of	  action.	  C646	  has	  been	  described	  to	  interact	  with	  the	  
HAT	  domain	  of	  P300/CBP	  in	  a	  similar	  manner	  as	  another	  inhibitor	  Lys-­‐CoA,	  and	  thus	  reduce	  
the	   binding	   and	  HAT	   activity	   (Liu	   et	   al.	   2008;	   Bowers	   et	   al.	   2010).	   Curcumin	   on	   the	   other	  
hand,	  has	  been	  shown	  to	  covalently	  bind	  P300/CBP	  and	  inhibit	  their	  activity	  as	  well	  as	  target	  
them	   for	   proteasome-­‐mediated	   degradation	   (Marcu	   et	   al.	   2006),	   which	   could	   explain	   the	  
higher	  effects	  observed	  with	  curcumin	  treatment.	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Taken	  together,	  these	  data	  suggest	  that	  P300/CBP	  HAT	  activity	  might	  play	  an	  important	  role	  
in	   regulating	   the	   epigenetic	   state	   of	   hES	   pluripotent	   cells	   in	   response	   to	   TGF-­‐β/Activin	  
signalling	  (Fig.	  6.1),	   favouring	  a	  stable,	  hyperacetylated	  profile	  and	  inducing	  the	  expression	  
of	  ICM-­‐related	  markers.	  It	  does	  however	  remain	  to	  be	  determined,	  whether	  both	  P300	  and	  
CBP	   are	   involved	   in	   this	   process,	   as	   transiently	   knocking-­‐down	   P300	   alone	   did	   not	  
significantly	  impact	  on	  hES	  cell	  epigenetic	  state.	  It	  should	  also	  be	  noted	  that	  both	  chemical	  
inhibitors	  used	   in	   these	  experiments	  do	  not	  selectively	  act	  on	  P300	  but	  on	  both	  HATs	  and	  
thus	  cannot	  shine	  light	  on	  this	  question.	  Future	  experiments	  refining	  the	  dose	  of	  C646	  used	  
or	   the	   use	   of	   a	   different	   inhibitor	   such	   as	   Lys-­‐CoA	   (Liu	   et	   al.	   2008),	   could	   provide	   further	  
	  
Figure	   6.1	   Summary	   for	   observed	   interplay	   between	   TGF-­‐β 	   signalling	   and	   P300	  HAT	  
activity	  in	  the	  regulation	  of	  distinct	  epigenetic	  states	  in	  hES	  cells.	  
Epigenetically	   distinct	   states	   are	   determined	   in	   hES	   cell	   cultures	   grown	   under	   varying	  
culture	  conditions,	  as	  exemplified	  here	  by	  two	  different	  cell	  culture	  conditions,	  CM	  and	  
CDMactivin,	   respectively	   relying	  on	   TGF-­‐β/Activin	   signalling	  pathway	   for	  maintenance	  of	  
hES	  pluripotency.	  Human	  ES	  cells	  are	  able	  to	  transit	   from	  one	  state	  to	  the	  other	  when	  
transferred	  from	  CM	  to	  CDMactivin	  conditions.	  This	  was	  accompanied	  by	  increase	  in	  TGF-­‐
β/Activin	  signalling	  activity	  as	  indicated	  by	  higher	  levels	  of	  active	  P-­‐SMAD2/3.	  This	  leads	  
to	   the	   induction	   of	   P300	   expression	   and	   activity	   upon	   changing	   cell	   signalling	  
environment,	   favouring	   and	   stably	   maintaining	   a	   hyperacetylated	   state	   and	   early	  
replicating	  profile	  at	  many	  key	  developmental	  loci.	  Interestingly	  levels	  of	  REX1	  were	  also	  
low	   in	   H1	   hES	   CM	   cells	   and	   high	   in	   CDMactivin	   cells,	   suggesting	   that	   these	   reversible	  




confirmation	  on	  the	  key	  role	  of	  P300/CBP	  in	  regulating	  the	  hES	  epigenetic	  state.	  
6.5 Effects	  of	  REX1	  overexpression	  in	  hES	  cells	  
Interestingly,	  upon	  change	  of	  culture	  conditions	  from	  CM	  to	  CDMactivin	  REX1	  was	  significantly	  
upregulated	   in	  H1	   hES	   cells.	   To	   gain	   further	   insight	   to	   the	   role	   of	  REX1	   in	   hES	   cells,	  REX1	  
overexpressing	   cell	   lines	   were	   established	   in	   H1	   and	   H9	   hES	   cells.	   Preliminary	  
characterisation	  of	   these	  cells	   indicates	   that	   they	   retain	  key	  hall-­‐marks	  of	  undifferentiated	  
hES	   cells.	   They	   were	   also	   able	   to	   give	   rise	   to	   a	   multitude	   of	   different	   cell	   types	   via	   EB	  
differentiation,	   however	   REX1	   overexpressing	   cells	   may	   in	   fact	   possibly	   exhibit	   a	  
differentiation	  bias	  as	  no	  clear	  morphological	  evidence	  of	  neuronal-­‐like	  cells	  was	  seen	  during	  
the	  EB	  analysis.	  Gene	  expression	  analysis	  of	  markers	  of	  differentiation	  did,	  however,	  indicate	  
an	  upregulation	  of	  ectodermal	  markers,	  alongside	  endo-­‐	  and	  mesodermal	  markers.	  To	  test	  
whether	   the	   Rex1OE	   cells	   in	   fact	   do	   have	   a	   bias	   for	   differentiation	   they	   should	   be	   tested	  
with	  lineage-­‐specific	  protocols	  of	  differentiation.	  
Interestingly,	  preliminary	  evidence	  also	  indicates	  that	  REX1	  overexpression	  in	  hES	  cells	  might	  
actually	   confer	   a	   slight	   advantage	   for	   self-­‐renewal,	   as	   indicated	   by	   colony	   forming	   assays.	  
Unexpectedly,	   Rex1OE	   cells	   were	   also	   found	   to	   be	   able	   to	   partially	   resist	   differentiation	  
when	  cultured	   in	  the	  absence	  of	  Activin	  A	  supplementation.	  Rex1OE	  cells	  cultured	  without	  
Activin	   A	   retained	   an	   intermediate	   level	   of	  OCT4	   expression	  whereas	   expression	   levels	   of	  
NANOG	   were	   substantially	   downregulated.	   A	   regulatory	   link	   between	   Rex	   and	   Oct4	  
expression	  has	  been	  reported	  in	  mES	  cells	  (Kim	  et	  al.	  2008),	  whether	  this	   link	  also	  exists	   in	  
hES	   cells	   yet	   remains	   unclear,	   however	   it	   could	   provide	   an	   explanation	   to	   the	   observed	  
phenotype	   in	   Rex1OE	   cells	   by	   direct	   regulation	   of	   OCT4	   levels	   by	   REX1.	   Interestingly	   a	  
binding	  site	  for	  SMAD2/3	  has	  also	  been	  mapped	  near	  the	  REX1	  locus,	  if	  this	  binding	  site	  acts	  
to	   regulate	   the	  expression	  of	  REX1,	   it	   could	  explain	   the	   increase	  of	  REX1	   expression	  upon	  
growth	   culture	   change	   in	   hES.	   Moreover,	   Rex1OE	   cells	   could	   be	   thus	   less	   dependent	   on	  
Activin	   A	   signalling.	   Interestingly	   evidence	   from	   the	   literature	   also	   suggests	   a	   possible	  
connection	  between	  REX1	  and	  P300.	  P300	  has	  been	  shown	  to	  interact	  with	  YY1	  to	  modulate	  
transcription	   (Lee	   et	   al.	   1995).	   Binding	   of	   YY1	   to	   P300	   and	   CBP	   has	   been	  mapped	   to	   zinc	  
finger	  domains	  (Austen	  et	  al.	  1997),	  which	  are	  highly	  conserved	  between	  YY1	  and	  REX1	  (Kim	  
et	  al.	  2007).	  Taken	  together,	  these	  preliminary	  data	  suggest	  a	  putative	  role	  for	  REX1	   in	  the	  
regulation	   of	   hES	   pluripotent	   identity.	   However,	   the	   nature	   of	   the	   potential	   regulation	  
remains	  undetermined.	  Further	  characterisation	  of	  the	  Rex1OE	  and	  F-­‐Rex1OE	  hES	  cell	   lines	  
possibly	   utilising	   the	   FLAG-­‐epitope	   in	   chromatin	   binding	   site	   mapping	   and	   the	   ability	   of	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establishing	   revertant	   cell	   lines	   by	   Cre-­‐Lox	   excision	   of	   the	   transgene	   should	   provide	  more	  
insight	   to	   the	   role	   of	  REX1	   in	   the	   regulation	   of	   hES	   cells.	   Furthermore,	   it	  would	   be	   highly	  
interesting	  to	  elucidate	  the	  possible	  roles	  REX1	  might	  play	  during	  X-­‐inactivation	  in	  hES	  cells	  
as	  was	  recently	  shown	  in	  mES	  cells	  (Gontan	  et	  al.	  2012),	  utilising	  the	  established	  RexOE	  and	  
Flag-­‐RexOE	  hES	  cell	  lines.	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Appendix	  I	   Primer	  sequences	  used	  
Table	   A1.	   Primers	   for	   the	   amplification	   of	   human	   or	   mouse	   transcripts	   by	   real	   time	  
quantitative	  PCR	  
Human	  primers	  	  
Species/Gene	   	   Sequence	  5’-­‐3’	  
β-­‐TUBULIN	   s	   CAGATGTTCGATGCCAAGAA	  as	   TGCTGTTCTTGCTCTGGATG	  
hAFP	   s	   AAATGCGTTTCTCGTTGCTT	  as	   GCCACAGGCCAATAGTTTGT	  
hBMP4	   s	   TGGTCTTGAGTATCCTGAGCG	  as	   GCTGAGGTTAAAGAGGAAACGA	  
hBRG1	   s	   TGGACTACAGCGACTCACTGA	  as	   TCGATGGCCTTTGACGCAC	  
hCBP	   s	   GACAAGCGAAACCAACAAACC	  as	   TGGGGTCTATGGGATTTGGGT	  
hCD19	   s	   GCTCAAGACGCTGGAAAGTATTATT	  as	   GATAAGCCAAAGTCACAGCTGAGA	  
hCD45	   s	   CCCCATGAACGTTACCATTTG	  as	   GATAGTCTCCATTGTGAAAATAGGCC	  
hCDX2	   s	   CAGGACGAAAGACAAATATCGAGTG	  as	   CCAGATTTTAACCTGCCTCTCAGA	  
hC-­‐MYC	   s	   TTGTACCTGCAGGATCTGAG	  as	   CTTGTTCCTCCTCAGAGTCG	  
hCRIPTO	   s	   AGAAGTGTTCCCTGTGTAAATGCTG	  as	   CACGAGGTGCTCATCCATCA	  
hDNMT3B	   s	   GTCAAGCTACACACAGGACTTGACAG	  as	   AGTTCGGACAGCTGGGCTTT	  
hEBF	   s	   GGAGATCGAGAGGACAGCGT	  as	   GTCAATGAGGCGCACGTAGA	  
hEOMES	   s	   CAAAGGCGCAAATAACAACAAC	  as	   CCACGCCATCCTCTGTAACTTC	  
hESRRB	   s	   TGAGGCCAGAGGTGATCCAG	  as	   TCTTGATGAAGGAGCCGCAG	  
hFGF5	   s	   CAGCACCAAAGGCTCAGCTT	  as	   CCTTGCTTCTAACCCATCATATCC	  
hFOXA2	   s	   GGGAGCGGTGAAGATGGA	  as	   TCATGTTGCTCACGGAGGAGTA	  
hGAPDH	   s	   TCTGCTCCTCCTGTTCGACA	  as	   AAAAGCAGCCCTGGTGACC	  
hGATA6	   s	   ACCACCTTATGGCGCAGAAAC	  as	   TTTTTCATAGCAAGTGGTCTGGG	  
hGCN5	   s	   GCTACATCAAGGACTACGAG	  as	   GCTTCTTGATGATCTCTTTCTG	  
hGDF3	   s	   GTACTTCGCTTTCTCCCAGAC	  
	  
	   	   	  
179	  
as	   GCCAATGTCAACTGTTCCCTT	  
hHPRT	   s	   TCCTTGGTCAGGCAGTATAATCC	  
as	   GTCAAGGGCATATCCTACAACAAA	  
hKLF4	   s	   CACATTAATGAGGCAGCCACC	  
as	   AAGTCGCTTCATGTGGGAGAG	  
hLIN28	   s	   TGCGGGCATCTGTAAGTGG	  
as	   GGAACCCTTCCATGTGCAG	  
hNANOG	   s	   CCAACATCCTGAACCTCAGCTAC	  
as	   GCCTTCTGCGTCACACCATT	  
hNODAL	   s	   AGAAGCAGATGTCCAGGGTAGCT	  
as	   GAGAGGTTGGAGTAGAGCATAAGGA	  
hOCT4	   s	   TCGAGAACCGAGTGAGAGGC	  
as	   CACACTCGGACCACATCCTTC	  
hP300	   s	   TCAGCCAAGCGGCCTAAAC	  
as	   TCACCACCATTGGTTAGTCCC	  
hP63	   s	   TTTCAGAGGCAATCCACACA	  
as	   ATGCATGCAAATGAGCTCTG	  
hOLIG3	   s	   TTTCTTCTCACGTCTTGCCGCG	  	  	  
as	   TGGGGAGGCTTTAGGCGGGAAATT	  	  	  
hPAX6	   s	   TCCGTTGGAACTGATGGAGT	  
as	   GTTGGTATCCGGGGACTTC	  
hPCAF	   s	   CGAATCGCCGTGAAGAAAGC	  
as	   GAGGGGTTAGGGTTTTTCCAG	  
hPDX1	   s	   CCTTTCCCATGGATGAAGTC	  
as	   GGAACTCCTTCTCCAGCTCTA	  
hPECAM1	   s	   AACAGTGTTGACATGAAGAGCC	  
as	   TGTAAAACAGCACGTCATCCTT	  
hPPAR-­‐γ	   s	   GCTGGCCTCCTTGATGAATA	  
as	   TTGGGCTCCATAAAGTCACC	  
hREX1/ZFP42	   s	   GCGTACGCAAATTAAAGTCCAGA	  
as	   CAGCATCCTAAACAGCTCGCAGAAT	  
hSMAD2	   s	   GCCATCACCACTCAAAACTGT	  
as	   GCCTGTTGTATCCCACTGATCTA	  
hSIRT1	   s	   TAGGCGGCTTGATGGTAATC 
as	   TCTGGCATGTCCCACTATCA 
hSOX1	   s	   AACACTTGAAGCCCAGATGGA	  
as	   GCAGGCTGAATTCGGTTCTC	  
hSOX17	   s	   GGCGCAGCAGAATCCAGA	  
as	   CCACGACTTGCCCAGCAT	  
hSOX2	   s	   CACACTGCCCCTCTCACACAT	  
as	   CATTTCCCTCGTTTTTCTTTGAA	  
hSOX3	   s	   TTTGATAAGCCTACCCTTCC	  
as	   GTTCTTGAGTTCAGTCTCCA	  
hTERT	   s	   GCCAGCATCATCAAACCCC	  
as	   CTGTCAAGGTAGAGACGTGGCTC	  




as	   AAGTACTGGCTTCCCCTCCC	  
hZIC1	  
s	   CTGGCTGTGGCAAGGTCTTC	  
as	   CAGCCCTCAAACTCGCACTT	  
	  
Table	   A2.	   Primers	   used	   for	   the	   amplification	   of	   human	   transcripts	   by	   semi-­‐quantitative	  
RT-­‐PCR	  
Human	  primers	  	  
Species/Gene	   Tm	   n	   	   Sequence	  5’-­‐3’	  
hβ-­‐ACTIN	   60ºC	   25	   s	   TCACCACCACGGCCGAGCG	  as	   TCTCCTTCTGCATCCTGTCG	  
hGATA6	   60ºC	   25	   s	   CCATGACTCCAACTTCCACC	  as	   ACGGAGGACGTGACTTCGGC	  
hNANOG	   60ºC	   25	   s	   AGCCTCTACTCTTCCTACCACC	  as	   TCCAAAGCAGCCTCCAAGTC	  
hNESTIN	   65ºC	   25	   s	   CAGCTGGCGCACCTCAAGATG	  as	   AGGGAAGTTGGGCTCAGGACTG	  
hOCT4	   60ºC	   25	   s	   CTTGCTGCAGAAGTGGGTGGAGGAA	  as	   CTGCAGTGTGGGTTTCGGGCA	  
hPAX6	   60ºC	   25	   s	   AACAGACACAGCCCTCACAAACA	  as	   CGGGAACTTGAACTGGAACTGAC	  
hSOX1	   60ºC	   25	   s	   CAATGCGGGGAGGAGAAGTC	  as	   CTCTGGACCAAACTGTGGCG	  
hSOX2	   60	  ºC	   25	   s	   CCCCCGGCGGCAATAGCA	  as	   TCGGCGCCGGGGAGATACAT	  
hT	   63ºC	   30	  
s	   GTGACCAAGAACGGCAGGAGG	  
as	   TGTTCCGATGAGCATAGGGGC	  
	  
Table	  A3.	  Primers	  for	  the	  selective	  amplification	  of	  human	  or	  mouse	  genomic	  regions	  by	  
real	  time	  quantitative	  PCR	  
Human	  specific	  primers	  for	  replication	  timing,	  ChIP	  and	  MeDIP	  analysis	  
Species/Gene	   	   Sequence	  5’-­‐3’	  
ha-­‐GLOBIN	  promoter	  	   s	   TTTGTCCCCGGACCTGCTGCC	  as	   CCCCACGGTCGGCTGACAC	  
hAMYLASE	  promoter	   s	   GGTGAGTCTGTGTGGTCAGCAGTCTCT	  as	   CCACGGTGCTCTGGTAGATAACGTAAG	  
hBMP4	  promoter	   s	   CAGCTCCTTTCTCCATAACCTGA	  as	   GGTACTAGAAAGCATGCACCGAC	  
hCDX2	  promoter	   s	   AACAACCACTGCTCCTGTCTCC	  as	   CGACCTGACACAGCTAAATATTCAA	  
hCGA	  promoter	   s	   ATGGCTCCAAACAAAAATGACC	  as	   TCCTCACCTGCTTTTATACCAGC	  
hCRIPTO	  promoter	   s	   ACTTCAAGTCTGGAGCCCCC	  as	   GCCTGAGGAGCTAGGTGTGTGT	  
hCXC4R4	  promoter	   s	   GAAGTCACTATGGGAAAAGATGGG	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as	   GCTTGCTTTCTTCAGGAAATTCTG	  
hDAZL	  promoter	   s	   TCCTGAATGTCAAACTGGCATT	  
as	   CGCCATCACTTTTAGCTTCACA	  
hDNMT3B	  promoter	   s	   TGTGTGTCTCCGTTCGGGTT	  
as	   ATCAGAAGCCCTAAGCGGGA	  
hDPPA4	  promoter	   s	   AAATAGCTTTCTTCAAGCCGCC	  
as	   CGGAGACATTGGGAGATTGAG	  
hEBF	  promoter	   s	   ACTTGAAGTAGCAAAGCCGGCA	  
as	   TGTAATGATCACAGGCCGGTGG	  
hEOMES	  promoter	   s	   AGGAAAAGAAAGTCACAGGCGA	  
as	   CATCGGTCAAGTTGACCACTTG	  
hESXL1	  promoter	   s	   AGCATGTTCACTACCTGCACCA	  
as	   TATAGCGGTACGGTGCCTTCC	  
hFGF5	  promoter	   s	   AAAAACAGCCTTCTCCCCGAAC	  
as	   CACTGCTTCTACGTCTTTCGGC	  
hFOXA2	  promoter	   s	   CCCTTACTCAAGCTTCAATGCG	  
as	   TTCTTGGTTCTGAAAACCTGGC	  
hGATA4	  promoter	   s	   CGGTAGCACTTGGGCATTTT	  
as	   AGCAGGCAAAGTCCAGGCT	  
hGATA6	  promoter	   s	   ACGACCTGAGCCGTAGCAT	  
as	   CCTAGCCCCTTCACAGCAAA	  
hGBX2	  promoter	   s	   GGCAGGCAAAATGTGAATGAG	  
as	   GAAGCCGGCGTACTTATCTCC	  
hGDF3	  promoter	   s	   AAAGCCATCGTGAGCCTCAT	  
as	   GACAGAGTGAAAAGGAGACATGCA	  
hHOXB1	  promoter	   s	   CTAGCCCACCACCCTAAGACAA	  
as	   GGCTCCTGGGTTATTAGATTTGG	  
hIGF2/hH19	  ICR	   s	   ACATTCACACGAGCATCCAGG	  
as	   GCTCTTTAGGTTTGGCGCAAT	  
hIKAROS	  promoter	   s	   GAACAATGCGAGTGAGCAACTTCAGG	  
as	   GGCCGAGCGTCCCGCCCAGGCTG	  
hMASH1	  promoter	   s	   CAATTTCTAGGGTCACCGAGGA	  
as	   GAACGGTGTGGAGGTGAGGA	  
hMIXL1	  promoter	   s	   GTTTGACCAACCTGGTACAGGG	  
as	   GCAGGCGACAGAACTCTCTTCT	  
hMYF5	  promoter	   s	   TGTCTGTAGAGGAAAGGCGGA	  
as	   ATATTCTTTCGGGAGGGAGGC	  
hNANOG	  promoter	   s	   ACGGCCTCCCAATTTACTGG	  
as	   GGTTCAACAGGAATGGGATAAAAC	  
hNESTIN	  promoter	   s	   TTTCCAGGCAGCGTCTCTCTAG	  
as	   GGATGTGGCCAGGTTTTTGTT	  
hNEUROD	  promoter	   s	   CTTCACTGCGTGCCTCAGTCT	  
as	   GAGAGATTAACCCTTTCAGGCG	  
hNEUROG1	  promoter	   s	   TTGTTGCGCCGGGTACTTAAG	  
as	   GCCGGTCTCCTGAGTGATGT	  




as	   AGGCTGGTCTTGAATTCCTGTC	  
hPAX6	  promoter	   s	   AAAGGACAGCACAGAAACTTGC	  
as	   TCAAGTGAAGGTTTCTGGGTTG	  
hPDX1	  promoter	   s	   GAATGCCAGAGTTTCGTGTGTTT	  
as	   CCCAGCTCTCTAGGTCAGAAGC	  
hPSC1/RBM27	  promoter	   s	   GTGAACGTATTGCACGTTGTGTTGC	  
as	   TCAGCCTGGTTCCTTCCTCTCGTTT	  
hPRCE/ESPL1	  promoter	   s	   AGGAAGGAAGAGCGGAATCGT	  
as	   GGAAGGAGGCAAAGAATCACAT	  
hREX1/ZFP42	  promoter	  	   s	   CTCATGTGATCCCCCCGTCT	  
as	   TACGCGTGGGTGTAATCACATT	  
hREX1	  promoter	  -­‐1Mb	  
s	   GCACACGTTTTTCCAGTGTGCAA 
as	   AGGGGAAAAACTGCCTTGTGTGGA 
hREX1	  promoter	  -­‐0.5Mb	  
s	   AGGGAGTGTGGTTTTCAGGCGT 
as	   ACATGCAGGAGCCGTATGGGTA 
hREX1	  promoter	  +0.5Mb	  
s	   TCAAGTCGTGGGCTGCTACACA 
as	   TGTGCTGACAAGCACGCAGA 
hREX1	  promoter	  +1Mb	  
s	   AAAGCCTTCATGGCCCGACTGT 
as	   TTGCTTCCCTCCTTTGTCGCGT 
hSatellite	  repeats	   s	   ATCGAATGGAAATGAAAGGAGTCA	  
as	   GACCATTGGATGATTGCAGTCA	  
hSOX1	  promoter	   s	   TCTTTGGCAAGTGGTTTGTGC	  
as	   GGAGGCAACGACAACAAAAAAA	  
hSOX17	  promoter	   s	   TATCAACGGTGTCTTTCGCATT	  
as	   AAGCCGAGGGTGTTTCAGTG	  
hSOX2	  promoter	  	   s	   CGTGAGAGAGTGTTGGCACCT	  
as	   TTGTTCTCCCGCTCATCCAC	  
hSOX3	  promoter	   s	   AATGGCCACAGAGCAGAGACA	  
as	   TGTGGAAAGTATGTGTGGGACG	  
hSOX7	  promoter	   s	   TGGCAGTCGGAGTATTAAGAACG	  
as	   TCAGAAAATCAACCCAACCAGG	  
hSYCP1	  promoter	   s	   GAGCCTGACAGTTTCCCTAGCA	  
as	   CTGGCAGTTCAACGGCTAAATA	  
hTEKT1	  promoter	   s	   GAGTGACTTCTGGAGTGTTTGCC	  
as	   GAGGGTTAAAAATCAGGAAGCCA	  
hTERT	  promoter	   s	   TCACGTCCGGCATTCGTGGT	  
as	   TCGAATCGGCCTAGGCTGTG	  
hTLE1	  promoter	   s	   CTGTTTTCCCCACCATCTCGT	  
as	   TCCTTCACCTTCGTGTGCTTCT	  
hWNT3	  promoter	   s	   CGCGTGATTGACAGGCTG	  
as	   CAGCCGGGTTTGAGGATGT	  
hZIC1	  promoter	   s	   CTGTGTTTACTAGCCCCATCCC	  
as	   ATTCCTCTTCCTCCTTTGCCC	  
D.	  melanogaster	  EMC	  	  
s	   GGTTTCAAGTTGTGGTCCAAGTTCC	  
as	   GTTCGTTCGGCTGGAGAGAGAT	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Mouse	  specific	  primers	  for	  replication	  timing,	  ChIP	  and	  MeDIP	  analysis	  
Species/Gene	   	   Sequence	  5’-­‐3’	  
ma-­‐globin	  promoter	  	   s	   CCACAAGCTGCGTGTGGAT	  as	   ATGCCGCCTGCCAGGT	  
mAmylase	  promoter	   s	   CAAAGCAAAATGAAGTTCGTTCTGCTGC	  as	   GAAGTTATCTTACCTGCACCCCTCCAAATC	  
mBmp4	  promoter	   s	   TTGAAGAGGTATCTCCTTCGGG	  as	   GATTGGTTTAAAGGGTGGCCT	  
mCdx2	  promoter	   s	   ACCACCTTCTGCCTGAGAATGTAC	  as	   CCTCCAATCACAGGTTCAAAGACT	  
mCga	  promoter	   s	   GCCATCCAATCACTGGGTAGA	  as	   TCCCACTGTCTTTTATACCAGC	  
mCripto	  promoter	   s	   CTGTATAGGGTCAGCACTTCCAGCC	  as	   CCCCGGAGGCACCCTTTACT	  
mCxcr4	  promoter	   s	   CCTTCCTCCTTTGGCTAATCCT	  as	   TCACTCTCAAAACTGTGTGCGG	  
mDazl	  promoter	   s	   TGCCGCCCGTTATTAATTTC	  as	   CAAAAATGGCACCTCGAAGG	  
mDnmt3b	  promoter	   s	   CGAAAAGCCAATGCAGGGTTGCTGT	  as	   GCACACACGCACATACAAGCACATTCAC	  
mDppa4	  promoter	   s	   TCCCAGATCTACAGTTGCCAGG	  as	   GGCCAGAAATGCGCTTTGT	  
mEbf	  promoter	   s	   ATTGGCTGTGATAAGGCGGAAGGATGACG	  as	   CCCCAGAGCTAAACACAGGCACACTAA	  
mEomes	  promoter	   s	   CCTCCTCTCACCCCAACAGAGCGAA	  as	   AACCGATGTCTAGCTTGTTGGTCACAGG	  
mEsx1	  promoter	   s	   GCGAACTCGGAGCTGCTAAA	  as	   TCCACGTGCTGTTAACTGACTTTT	  
mFgf5	  promoter	   s	   CATGTGTCCCAGCCAACTCACT	  as	   TTCCCAGGCTCCAGATGGC	  
mFoxa2	  promoter	   s	   CAGCCTAGACTTCTCTGAGATCCTCC	  as	   TCAATAATGGGCCTTGTGGGA	  
mGata4	  promoter	   s	   GATCTGAGGCTAGCAAGGCAT	  as	   TTTGCTGCTCTGCCAAGGA	  
mGata6	  promoter	   s	   AGCTCTTATTGTCCGCTAGGGC	  as	   TGAAGAGAAGGAGGAGGGATCC	  
mGbx2	  promoter	   s	   CGAACAGCTGCTGGAGCTGGAGAAAG	  as	   GCACCTCGCTGAGTTTGAGGGCG	  
mGdf3	  promoter	   s	   GCTCCCAGAAGTTATCTTATTGCC	  as	   TCAGCAGTGTACAGCGTGAGTG	  
mHoxb1	  promoter	   s	   CTTCCTAGTCATCCTTTTGTCCCA	  as	   CTTATCCCAGAACCCCCATTC	  
mIkaros	  promoter	   s	   CCAGTTTCAGGGACTCGGCT	  as	   TCGGGGAACACGGGACAC	  




mMixl1	  promoter	   s	   CACAGATACTCTAGGCAGGAGCAGC	  as	   CCTGTCACCATCAAAGGCGC	  
hMyf5	  promoter	   s	   GGAGATCCGTGCGTTAAGAATCC	  as	   CGGTAGCAAGACATTAAAGTTCCGTA	  
mNanog	  promoter	   s	   CCCTCTGAGTTTGACCGGTGA	  as	   CAAGCTAGGATGTTAGGTCTCCCTG	  
mNestin	  promoter	   s	   GGAGCACTGGCAGACTTCCCT	  as	   GGTGTTGGAAACCTCGTGAACTG	  
mNeuroD	  promoter	   s	   TTCAGGCTAGGACATAGACTCAGTGA	  as	   CCCTTTGTGGCAGCAGAAGA	  
mNeurog1	  promoter	   s	   TTGTTGCGCGCCGTACTTAAGG	  as	   TGGTCTCCTGAGTGATGTCGCC	  
mOct4/Pou5f1	  promoter	  	   s	   GGCTCTCCAGAGGATGGCTGAG	  as	   TCGGATGCCCCATCGCA	  
mPax6	  promoter	   s	   GGTCAGAGGTAATTATGTCACCGCG	  as	   TTATTCCAGAGTTGAGCCGTGAGCA	  
mPdx1	  promoter	   s	   GGACTACATCTTGAGTTGCAGGC	  as	   CCCCCTCGCTATGTTTTTTGT	  
mPsc1/Rbm27	  promoter	   s	   ACATAAACGCACCGCACGTTGT	  as	   CCTGGTTACTTCCGCTGGTTTTT	  
mPrce/Espl1	  promoter	   s	   GACAGCGCGGCAGATAAACTAC	  as	   GCACCTCCTTTCAAATATCCCTAG	  
mRex1/Zfp42	  promoter	  	   s	   TTTGCGGGAATCCAGCAGT	  as	   CGTCCCATCGCCACTCTAGAC	  
mSox1	  promoter	   s	   ACAAGAGGAGGCAGCGAACC	  as	   TCGCAGGTGGAAAGTTTCTCC	  
Sox17	  promoter	   s	   TGAGGCTCGCTGTAGAAGAGTG	  as	   AGCTGTGCCCGTAACCATTT	  
mSox2	  promoter	  	   s	   CCATCCACCCTTATGTATCCAAG	  as	   CGAAGGAAGTGGGTAAACAGCAC	  
mSox3	  promoter	   s	   AGGAGGAAGCGGGAATCCAG	  as	   AAACCTCCGCTGCCCG	  
mSox7	  promoter	   s	   TCCACAGTGCCAGTTTAGGGAA	  as	   CAGTAAACGTGGGCAGCCAC	  
mSycp1	  promoter	   s	   AAGCCATCTTTAGCACCCAGC	  as	   TGGTTGTTAGTTGCCTGGTGG	  
mTekt1	  promoter	   s	   GATAAGCAGATACACCCAGCTCATC	  as	   CCTTCTGGTGTGCATGAAAACA	  
mTert	  promoter	   s	   GTCGCACCACAATAAAGCCTTAAC	  as	   GCTGTGGTTGACACAGACAGTGA	  
mTle1	  promoter	   s	   ATCCCTCCCCCAACAAGAAA	  as	   TTGAAGTTTGCAGAAGCCTGTG	  
mWnt3	  promoter	   s	   CATTTTCCTAGCCCCTGATCC	  as	   TTTCTGTGATCCCTTGGCACTT	  
mZic1	  promoter	  
s	   AGGGAAAAGAAATCGTGGCATT	  
as	   CGCTTGACATCCCCTTTTGA	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Figure	  A1	  H7	  undifferentiated	  hES	  cells	  can	  be	  clearly	  distinguished	  by	  replication	  timing	  analysis	  from	  neural	  
progenitors	  (NP)	  H7-­‐derived.	  
(a)	   Phase-­‐contrast	   images	   of	   undifferentiated	   H7	   hES	   cells	   (top	   panel)	   grown	   on	   matrigel-­‐coated	   plates	   in	  
conditioned	   media	   and	   NP7	   cells	   with	   typical	   bipolar	   morphology	   (bottom	   panel)	   after	   >60	   days	   of	  
differentiation,	   induced	  as	  previously	  described	  (Gerrard	  et	  al.	  2005b).	  Scale	  bar,	  75	  µm.	   (b)	  Undifferentiated	  
H7	  hES	  and	  NP7-­‐derived	  cells	  were	  analysed	  for	  the	  expression	  of	  OCT4,	  SOX2,	  NESTIN,	  MUSASHI	  and	  PAX6	  by	  
immunofluorescence	   staining.	   Nuclei	   were	   stained	  with	   DAPI.	  Magnification,	   200X	   (c)	   Semi	   quantitative	   PCR	  
analysis	  of	  the	  expression	  of	  ES-­‐associated	  genes	  (OCT4,	  NANOG	  and	  SOX2),	  neural	  determinants	  (NESTIN,	  SOX1	  
and	  PAX6),	  endodermal	  and	  mesodermal	  markers	  (GATA6	  and	  T,	  respectively)	  in	  H7	  hES	  and	  NP7	  cells.	  β-­‐ACTIN	  
was	  used	  to	  standardise	  input.	  (d)	  Replication	  timing	  comparison	  between	  H7	  and	  NP7-­‐derived	  cells	  alongside	  
the	  well-­‐characterized	  ReNcell	  VM	  human	  NP	  cell	   line	  derived	  from	  a	  10-­‐week	  human	  foetal	  brain,	  used	  as	  a	  
reference	   for	   neural	   differentiation.	   The	   loci	   selected	   for	   this	   analysis	   included	   key	   pluripotency	   markers	  
(CRIPTO,	  DPPA4,	  NANOG,	  OCT4,	  REX1,	  SOX2,	  TERT	  and	  TLE1),	  trophoblast	  (EOMES),	  endoderm	  (FOXA2,	  GATA6	  
and	  SOX17),	  mesoderm	  (BMP4,	  EBF,	  IKAROS	  and	  MYF5)	  and	  neuroectoderm	  (MASH1,	  NESTIN,	  NEUROD,	  PAX6,	  




Table	  A4	  -­‐	  Genomic	  features	  of	  replication	  timing	  analysed	  genes	  	  
 Loci 
GC content     
(%)a 
LINE density   
(%)b  Gene   density 
c 
          
hES cell 
variable loci 
    BMP4 39,7 23,2 2,0 
DPPA4 41,6 17,9 5,0 
EBF 39,2 14,2 5,0 
FOXA2 42,9 15,3 4,0 
GATA6 43,9 9,4 2,0 
SOX17 40,8 24,7 4,0 
SOX3 40,3 25,2 3,0 
SYCP1 36,6 31,9 10,0 
TERT 55,1 10,2 15,0 
TLE1 43,3 8,9 3,0 
ZIC1 38,8 10,0 1,0 
               
hES cell 
steady loci 
AMYLASE 35,4 19,5 4,0 
CDX2 44,1 15,1 9,0 
CGA 38,7 17,8 9,0 
CRIPTO 44,6 17,9 19,0 
CXCR4 42,6 13,9 5,0 
DAZL 39,8 22,2 5,0 
DNMT3B 47,5 6,0 17,0 
EOMES 40,5 19,1 2,0 
ESXL1 41,1 15,1 7,0 
FGF5 38,5 22,9 3,0 
GATA4 47,2 15,1 22,0 
GBX2 47,8 12,8 7,0 
GDF3 43,6 14,3 18,0 
HOXB1 48,5 4,1 23,0 
IKAROS 40,9 17,9 6,0 
MASH1  39,9 26,5 3,0 
MIXL1 42,5 15,5 14,0 
MYF5 35,5 15,9 6,0 
NANOG 44,9 7,0 19,0 
NESTIN 51,1 7,6 32,0 
NEUROD 38,3 24,2 6,0 
NEUROG1 47,0 15,3 9,0 
OCT4/POU5F1 47,1 13,2 40,0 
PAX6 41,6 14,8 6,0 
PDX1 44,3 18,8 11,0 
PRCE/ESPL1 50,8 10,5 31,0 
PSC1/RBM27 39,0 4,6 9,0 
REX1/ZFP42 41,4 20,8 2,0 
SOX1 47,4 13,1 1,0 
SOX2 39,5 9,5 0,0 
SOX7 46,6 15,7 7,0 
TEKT1 42,1 39,5 34,0 
WNT3 49,0 7,3 12,0 
α-GLOBIN 52,1 6,5 53,0 
               
a & b - Genes displaying a GC content <43% and a LINE density >6% are highlighted in black.                                                                                                                                                     
c - Light grey boxes indicate gene poor regions which contain ≤10 genes in the surronding 500 kb. 
	   	  
	  





Figure	  A2	  Comparison	  of	  replication	  timing	  profiles	  between	  mES	  (E14tg2A,	  B6	  and	  Dc7),	  mEpiS	  (129,	  B6/CBA	  
and	  NOD)	  and	  hES	  (H1,	  H7	  and	  H9)	  cell	  lines.	  
(a)	  The	  proportion	  of	  genes	  that	  replicate	  early	  (E),	  middle-­‐early	  (ME),	  middle	  (M),	  middle-­‐late	  (ML)	  or	  late	  (L)	  in	  
S-­‐phase	  are	  represented	  as	  a	  pie-­‐chart.	  The	  late	  replicating	  set	  (from	  yellow	  to	  red)	  is	  separated	  from	  the	  early	  
set	  (dark	  and	  light	  green)	   in	  mouse	  and	  human	  cells.	   (b)	  Proportion	  of	  candidate	   loci	  that	  replicate	   in	  each	  S-­‐
phase	  fraction,	  expressed	  as	  a	  percentage	  of	  the	  total	  for	  mES	  (E14tg2A,	  B6	  and	  Dc7),	  mEpiS	  (129,	  B6/CBA	  and	  







	   	  
	  
Figure	  A3	   Comparative	   replication	   timing	   analysis	   of	  mES	   (E14tg2A,	   B6	   and	  Dc7),	  mEpiS	   (129,	   B6/CBA	   and	  
NOD)	  and	  hES	  (H1,	  H7	  and	  H9)	  cell	  lines.	  
The	  replication	  timing	  of	  each	  gene	  was	  defined	  as	  early	  (E),	  middle-­‐early	  (ME),	  middle	  (M),	  middle-­‐late	  (ML)	  or	  
late	  (L)	  and	  shown	  as	  a	  gradation	  of	  colours	  from	  green	  (earliest)	  to	  red	  (latest).	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Figure	  A4	  Human	   ES	   cells	   replication	   timing	   variability	   is	   not	   associated	  with	   gene	   expression	   or	  
histone	  acetylation	  specific	  patterns.	  
(a)	   Replication	   timing	   status	   and	   expression	   of	   variable	   loci	   (BMP4,	   DPPA4,	   EBF,	   FOXA2,	   GATA6,	  
SYCP1,	  SOX17,	  SOX3,	  TERT,	  TLE1	  and	  ZIC1)	  and	  early	  (OCT4,	  NANOG,	  SOX2	  and	  EOMES)	  or	  late	  (REX1	  
and	  MYF5)	  steady	  control	   loci	  between	  H1,	  H7	  and	  H9	  hES	  cell	   lines.	  The	  replication	  timing	  of	  each	  
locus	  is	  indicated	  in	  a	  colour	  coded	  way	  as	  previously	  designated.	  The	  relative	  expression	  of	  variable	  
and	  steady	  replicating	  loci	  was	  assessed	  by	  qRT-­‐PCR	  and	  compared	  between	  H1	  (black),	  H7	  (grey)	  and	  
H9	  (white)	  hES	  cell	  lines.	  Data	  was	  normalized	  to	  the	  expression	  of	  two	  housekeeping	  genes	  (GAPDH	  
and	  HPRT).	   Values	   shown	  are	   the	  mean	  of	   three	   independent	   experiments	   and	   error	   bars	   indicate	  





H4ac)	  were	  assessed	  in	  H1,	  H7	  and	  H9	  hES	  cells	  using	  chromatin	  immunoprecipitation	  and	  qRT-­‐PCR.	  The	  colour	  
code	  for	  different	  histone	  marks	  is	  indicated	  in	  each	  panel.	  Primers	  for	  satellite	  repeats	  (Sat.	  rept.)	  were	  used	  as	  
a	   negative	   control	   for	   active	   histone	  marks	   immunoprecipitation.	   To	   eliminate	   bias	   for	   different	   nucleosome	  
density,	  data	  was	  normalized	  to	  enrichments	  obtained	  with	  antibodies	  recognizing	  total	  histone	  H3	  or	  H4.	  Error	  
bars	  indicate	  standard	  deviations	  of	  at	  least	  two	  independent	  experiments.	  Background	  levels	  (from	  control	  IgG	  
antibodies)	  are	  shown	  as	  dashed	  grey	  lines.	  The	  red	  open	  box	  highlights	  the	  variable	  replicating	  cohort	  of	  genes	  
across	  H1,	  H7	  and	  H9.	  
	  
	  
	   	  
	  
Figure	   A5	   Human	   ES	   cells	   replication	   timing	   variability	   is	   not	   associated	  with	   DNA	  methylation	   specific	  
patters.	  
Abundance	   of	   CpG	   DNA	   methylation	   at	   each	   promoter	   region	   of	   replication	   timing	   variable	   loci	   (BMP4,	  
DPPA4,	   EBF,	   FOXA2,	   GATA6,	   SYCP1,	   SOX17,	   SOX3,	   TERT,	   TLE1	   and	   ZIC1)	   highlighted	   by	   the	   red	   open	   box,	  
between	  H1	   (black),	   H7	   (grey)	   and	  H9	   (white)	   hES	   cells.	   DNA	  methylation	  was	   assessed	   using	  methylated	  
DNA	   immunoprecipitation	   (MeDIP)	   (Weber	   et	   al.	   2005)	   and	   qRT-­‐PCR	   analysis.	   Error	   bars	   indicate	   the	  
standard	   deviation	   of	   three	   independent	   experiments.	   Early	   (OCT4	   and	   EOMES)	   and	   late	   (MYF5	   and	  
NEUROD)	  steady	  replicating	  loci	  across	  H1,	  H7	  and	  H9	  hES	  cells	  were	  also	  analysed.	  Controls	  for	  methylated	  
(H19-­‐IGF2	   imprinting	   control	   region)	   and	   unmethylated	   (OCT4)	   regions	   were	   included.	   The	   enrichment	  
indicates	   the	   ratio	   of	   methylated	   DNA	   over	   input	   DNA.	   The	   replication	   timing	   of	   each	   locus	   (steady	   and	  
variable)	  in	  H1,	  H7	  and	  H9	  cells	  is	  indicated	  by	  a	  colour	  code	  as	  previously	  designated.	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Figure	  A6	  Transient	  increase	  in	  the	  expression	  levels	  of	  Nanog	  in	  H1	  CDMactivin	  hES	  cells	  
Flow	  cytometry	  analysis	  of	  OCT4	  (left	  panel)	  and	  NANOG	  (right	  panel)	  levels	  in	  H1	  CM	  (H1p58CM)	  and	  
CDMactivin	  early	  [H1p53(CDM4)]	  and	  long	  term	  cultures	  of	  CDMactivin	  [H1p53(CDM21)].	  The	  red	  dotted	  
lines	  indicate	  the	  mean	  fluorescence	  intensity	  of	  OCT4	  and	  NANOG	  in	  H1p58CM	  cells.	  The	  profile	  of	  
stained	   cells	   (black)	  was	   compared	   to	   cells	   stained	  with	   the	   secondary	   antibody	   only	   (dotted	   line).	  






Figure	  A7	  Differential	   gene	   expression	  profiles	   of	   TGF-­‐β 	  members	   in	  H1	  CM	  
and	  CDMactivin	  hES	  cell	  populations.	  
Real-­‐time	  PCR	  analysis	  of	  selected	  genes	  in	  H1	  CM	  (H1p49CM,	  white	  bars)	  and	  
cells	   transferred	   and	   cultured	   for	   different	   passage	   numbers	   in	   CDMactivin	  
conditions	   [H1p47(CDM3,	   6,	   14	   and	   25),	   black	   bars].	   TGF-­‐β	   superfamily	  
members	   transiently	   increased	   (CRIPTO,	  GDF3	   and	  NODAL)	   in	   CDMactivin	   cells.	  
Mean	   and	   standard	   error	   of	   at	   least	   two	   experiments	   are	   shown.	   Data	   was	  
normalised	  to	  the	  expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  
	  
Figure	   A8	   Replication	   timing	   variability	   is	   not	   observed	   across	  
human	  CD34+	  haematopoietic	  stem	  cells.	  
The	   replication	   timing	   of	   variable	   loci	   across	   different	   hES	   cell	   lines	  
was	  analysed	   in	  CD34+	  cells	   isolated	   from	  peripheral	  blood	  of	   three	  
different	   healthy	   volunteers	   (here	   represented	   as	   a,	   b	   and	   c),	  
alongside	  loci	  that	  showed	  steady	  replication	  timing.	  All	  the	  loci	  that	  
were	  shown	  to	  be	  steady	  were	  maintained,	  while	  all	  other	  targets	  of	  
variability	   in	   hES	   cells	   replicated	   at	   similar	   times	   across	   the	   three	  
different	  sources	  of	  adult	  stem	  cells,	  with	  the	  exception	  of	  BMP4	  and	  
TLE1	  that	  were	  earlier	  in	  c.	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Figure	   A9	   Cell	   culture	   adaptation	   and	   karyotype	   abnormalities	   are	   not	   associated	   with	   earlier	   replication	  
timing	  profiles	  in	  hES	  cells.	  
The	   replication	   timing	   of	   individual	   loci	   was	   assessed	   in	   H1-­‐BH1	   hES	   cells	   from	   early	   (P19)	   and	   late	   (P154)	  
passage	  number	  cultures,	  as	  provided	  by	  Peter	  Andrews’s	  laboratory.	  H1-­‐BH1	  late	  passage	  cells	  were	  previously	  









Figure	  A10	  Human	   ES	   cells	   cultured	   in	   CDMactivin	   differentiate	  more	   slowly	   by	   EBs	   differentiation	   than	   hES	  
cells	  cultured	  in	  CM	  
Time	  course	  analysis	  of	  the	  expression	  of	  pluripotency-­‐associated	  (OCT4,	  NANOG	  and	  Cripto),	  ectoderm	  (SOX1,	  
SOX3	  and	  P63),	  endoderm	  (AFP,	  PDX1	  and	  CDX2)	  and	  mesoderm	  (EBF,	  PECAM1	  and	  PPAR-­‐γ)	  markers,	  during	  an	  
9	  day	  course	  of	  EB	  differentiation	   in	  H1	  CM	  (H1p63CM;	  blue	  curves)	  and	  CDMactivin	  cells	   [H1p47(CDM19);	   red	  
curves].	   Graphs	   show	   a	   representative	   qRT-­‐PCR	   analysis	   of	   three	   independent	   experiments.	   Data	   was	  
normalized	  to	  the	  expression	  of	  two	  housekeeping	  genes	  (GAPDH	  and	  HPRT).	  Primers	  used	  for	  this	  analysis	  are	  
listed	  in	  Appendix	  I,	  Table	  A1.	  
	  




Figure	  A11	  Inhibition	  of	  P300/CBP	  histone	  acetyltransferase	  activity	  by	  small	  molecule	  inhibitor	  C646	  does	  
not	  affect	  the	  replication	  timing	  profiles	  of	  H1	  CDMactivin	  cultured	  cells.	  
(a)	   Western	   blot	   analysis	   of	   H1	   CDMactivin	   hES	   cell	   populations	   treated	   for	   24	   hours	   with	   DMSO	   (solvent	  
control),	  10	  µM	  or	  25	  µM	  C646,	  P300/CBP	  histone	  acetyltransferase	  activity	  inhibitor,	  and	  analysed	  after	  four	  
days	   of	   culture.	   Membranes	   were	   probed	   with	   antibodies	   specific	   for	   p300/CBP	   preferentially	   acetylated	  
histone	  H3	   targets	   (H3K9ac,	  H3K18ac	   and	  H3K56ac)	   and	   total	   H3	   and	  OCT4	   and	   β-­‐ACTIN	   (as	   a	   control	   for	  
differentiation	   and	   protein	   loading).	   Equivalent	   protein	   loading	   is	   shown	   by	   the	   β-­‐ACTIN	   detection.	   (b)	  
Representative	  bright	  field	  images	  of	  H1	  CDMactivin	  hES	  cell	  colonies	  treated	  with	  either	  DMSO	  or	  10	  µM	  C636	  
for	  four	  days.	  Scale	  bar	  10	  µm.	  (c)	  The	  replication	  timing	  of	   individual	   loci	  compared	  between	  H1	  CDMactivin	  
cell	   populations	   treated	  with	  DMSO	  or	   10	  µM	  C646	   and	   analysed	   after	   four	   days	   of	   culture.	  No	   effect	   on	  
replication	   timing	   was	   observed	   in	   loci	   that	   changed	   replication	   timing	   from	   late	   to	   early	   in	   response	   to	  
CDMactivin	  conditions	  (BMP4,	  CGA,	  EBF,	  FOXA2,	  GATA6,	  NEUROG1,	  REX1,	  SOX1,	  SOX17,	  SOX3,	  SYCP1,	  TERT	  and	  
TLE1)	  or	  other	  loci	  that	  consistently	  replicated	  early	  (DPPA4,	  GATA4,	  GBX2,	  HOXB1,	  NANOG,	  OCT4,	  WNT3	  and	  
ZIC1),	   middle	   (SOX7)	   and	   late	   (IKAROS,	   MASH1	   and	   NEURO	   D)	   in	   untreated	   CM	   and	   CDMactivin.	   Data	  
representative	  of	  two	  independent	  experiments.	  
